export const IPP_IMFINZI_PERU_FOOTER_HTML = `
<html>
	<head>
		<meta charset="utf-8" />
		<title>
		</title>
		
	<STYLE> 
 .pdf24_ sup {
	vertical-align: baseline;
	position: relative;
	top: -0.4em;
}
.pdf24_ sub {
	vertical-align: baseline;
	position: relative;
	top: 0.4em;
}
.pdf24_ a:link {text-decoration:none;}
.pdf24_ a:visited {text-decoration:none;}
@media screen and (min-device-pixel-ratio:0), (-webkit-min-device-pixel-ratio:0), (min--moz-device-pixel-ratio: 0) {.pdf24_view{ font-size:10em; transform:scale(0.1); -moz-transform:scale(0.1); -webkit-transform:scale(0.1); -moz-transform-origin:top left; -webkit-transform-origin:top left; } }
.pdf24_layer { }.pdf24_ie { font-size: 1pt; }
.pdf24_ie body { font-size: 12em; }
@media print{.pdf24_view {font-size:1em; transform:scale(1);}}
.pdf24_grlink { position:relative;width:100%;height:100%;z-index:1000000; }
.pdf24_01 {
	position: absolute;
	white-space: nowrap;
}
.pdf24_02 {
	font-size: 1em;
	line-height: 0.0em;
	width: 51em;
	height: 66em;
	border-style: none;
	display: block;
	margin: 0em;
}

@supports(-ms-ime-align:auto) { .pdf24_02 {overflow: hidden;}}
.pdf24_03 {
	position: relative;
	width: 51em;
}
.pdf24_04 {
	height: 6.6em;
}
.pdf24_ie .pdf24_04 {
	height: 66em;
}
@font-face {
	font-family:"MMPTWE+Times New Roman Bold";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_05 {
	font-size: 0.92em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_06 {
	line-height: 1.107422em;
}
.pdf24_07 {
	letter-spacing: -0.0026em;
}

.pdf24_ie .pdf24_07 {
	letter-spacing: -0.0377px;
}
.pdf24_08 {
	letter-spacing: -0.0008em;
}

.pdf24_ie .pdf24_08 {
	letter-spacing: -0.0125px;
}
.pdf24_09 {
	letter-spacing: -0.0106em;
}

.pdf24_ie .pdf24_09 {
	letter-spacing: -0.1557px;
}
.pdf24_10 {
	letter-spacing: -0.004em;
}

.pdf24_ie .pdf24_10 {
	letter-spacing: -0.0592px;
}
.pdf24_11 {
	-o-transform: scale(1,1.026315);
	-webkit-transform: scale(1,1.026315);
	-moz-transform: scale(1,1.026315);
	transform: scale(1,1.026315);
	-o-transform-origin: top left;
	-webkit-transform-origin: top left;
	-moz-webkit-transform-origin: top left;
	-transform-origin: top left;
	-ms-transform: matrix(1,0,0,1.026315,0,-0);
	-ms-transform-origin: top left;
}
.pdf24_12 {
	font-size: 0.896411em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_13 {
	letter-spacing: 0.002em;
}

.pdf24_ie .pdf24_13 {
	letter-spacing: 0.0287px;
}
@font-face {
	font-family:"EAJTTK+Times New Roman";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_14 {
	font-size: 0.92em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_15 {
	letter-spacing: 0em;
}

.pdf24_ie .pdf24_15 {
	letter-spacing: 0px;
}
.pdf24_16 {
	letter-spacing: -0.0049em;
}

.pdf24_ie .pdf24_16 {
	letter-spacing: -0.0729px;
}
.pdf24_17 {
	letter-spacing: -0.0082em;
}

.pdf24_ie .pdf24_17 {
	letter-spacing: -0.1211px;
}
.pdf24_18 {
	letter-spacing: -0.0017em;
}

.pdf24_ie .pdf24_18 {
	letter-spacing: -0.0257px;
}
.pdf24_19 {
	letter-spacing: -0.0015em;
}

.pdf24_ie .pdf24_19 {
	letter-spacing: -0.0224px;
}
@font-face {
	font-family:"BTSFMJ+Times New Roman";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_20 {
	font-size: 0.92em;
	font-family: "BTSFMJ+Times New Roman";
	color: #000000;
}
.pdf24_21 {
	letter-spacing: -0.0009em;
}

.pdf24_ie .pdf24_21 {
	letter-spacing: -0.0129px;
}
.pdf24_22 {
	letter-spacing: -0.0014em;
}

.pdf24_ie .pdf24_22 {
	letter-spacing: -0.0212px;
}
.pdf24_23 {
	letter-spacing: -0.0094em;
}

.pdf24_ie .pdf24_23 {
	letter-spacing: -0.1379px;
}
.pdf24_24 {
	letter-spacing: -0.0035em;
}

.pdf24_ie .pdf24_24 {
	letter-spacing: -0.0516px;
}
.pdf24_25 {
	letter-spacing: -0.0118em;
}

.pdf24_ie .pdf24_25 {
	letter-spacing: -0.173px;
}
.pdf24_26 {
	letter-spacing: 0.0033em;
}

.pdf24_ie .pdf24_26 {
	letter-spacing: 0.0478px;
}
.pdf24_27 {
	letter-spacing: -0.0047em;
}

.pdf24_ie .pdf24_27 {
	letter-spacing: -0.0691px;
}
.pdf24_28 {
	-o-transform: scale(1,1.018517);
	-webkit-transform: scale(1,1.018517);
	-moz-transform: scale(1,1.018517);
	transform: scale(1,1.018517);
	-o-transform-origin: top left;
	-webkit-transform-origin: top left;
	-moz-webkit-transform-origin: top left;
	-transform-origin: top left;
	-ms-transform: matrix(1,0,0,1.018517,0,-0);
	-ms-transform-origin: top left;
}
@font-face {
	font-family:"VVBRWD+Symbol";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_29 {
	font-size: 0.903274em;
	font-family: "VVBRWD+Symbol";
	color: #000000;
}
.pdf24_30 {
	line-height: 1.225098em;
}
.pdf24_31 {
	letter-spacing: -0.0016em;
}

.pdf24_ie .pdf24_31 {
	letter-spacing: -0.0243px;
}
.pdf24_32 {
	letter-spacing: -0.0019em;
}

.pdf24_ie .pdf24_32 {
	letter-spacing: -0.0279px;
}
.pdf24_33 {
	letter-spacing: -0.0024em;
}

.pdf24_ie .pdf24_33 {
	letter-spacing: -0.035px;
}
.pdf24_34 {
	letter-spacing: -0.002em;
}

.pdf24_ie .pdf24_34 {
	letter-spacing: -0.0289px;
}
.pdf24_35 {
	letter-spacing: -0.001em;
}

.pdf24_ie .pdf24_35 {
	letter-spacing: -0.0147px;
}
.pdf24_36 {
	letter-spacing: -0.0011em;
}

.pdf24_ie .pdf24_36 {
	letter-spacing: -0.0162px;
}
.pdf24_37 {
	letter-spacing: -0.0025em;
}

.pdf24_ie .pdf24_37 {
	letter-spacing: -0.0371px;
}
.pdf24_38 {
	letter-spacing: -0.0013em;
}

.pdf24_ie .pdf24_38 {
	letter-spacing: -0.0187px;
}
.pdf24_39 {
	letter-spacing: -0.0012em;
}

.pdf24_ie .pdf24_39 {
	letter-spacing: -0.017px;
}
.pdf24_40 {
	letter-spacing: -0.0113em;
}

.pdf24_ie .pdf24_40 {
	letter-spacing: -0.1664px;
}
.pdf24_41 {
	font-size: 0.83em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_42 {
	letter-spacing: 0.0018em;
}

.pdf24_ie .pdf24_42 {
	letter-spacing: 0.0243px;
}
.pdf24_43 {
	font-size: 0.83em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_44 {
	letter-spacing: 0.005em;
}

.pdf24_ie .pdf24_44 {
	letter-spacing: 0.0664px;
}
.pdf24_45 {
	letter-spacing: -0.0181em;
}

.pdf24_ie .pdf24_45 {
	letter-spacing: -0.24px;
}
.pdf24_46 {
	position: relative;
}
.pdf24_47 {
	position: absolute;
	pointer-events: none;
	clip: rect(28.4525em,45.06em,58.59967em,5.960333em);
	width: 100%;
}
.pdf24_48 {
	letter-spacing: -0.0044em;
}

.pdf24_ie .pdf24_48 {
	letter-spacing: -0.0644px;
}
.pdf24_49 {
	letter-spacing: -0.0069em;
}

.pdf24_ie .pdf24_49 {
	letter-spacing: -0.1012px;
}
.pdf24_50 {
	letter-spacing: -0.0018em;
}

.pdf24_ie .pdf24_50 {
	letter-spacing: -0.0263px;
}
.pdf24_51 {
	letter-spacing: -0.0068em;
}

.pdf24_ie .pdf24_51 {
	letter-spacing: -0.0996px;
}
.pdf24_52 {
	letter-spacing: -0.009em;
}

.pdf24_ie .pdf24_52 {
	letter-spacing: -0.1322px;
}
.pdf24_53 {
	letter-spacing: -0.0038em;
}

.pdf24_ie .pdf24_53 {
	letter-spacing: -0.0562px;
}
.pdf24_54 {
	letter-spacing: -0.0086em;
}

.pdf24_ie .pdf24_54 {
	letter-spacing: -0.1265px;
}
@font-face {
	font-family:"TMOTAN+Times New Roman Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_55 {
	font-size: 0.92em;
	font-family: "TMOTAN+Times New Roman Italic";
	color: #000000;
}
.pdf24_56 {
	letter-spacing: -0.0027em;
}

.pdf24_ie .pdf24_56 {
	letter-spacing: -0.0393px;
}
.pdf24_57 {
	letter-spacing: -0.0101em;
}

.pdf24_ie .pdf24_57 {
	letter-spacing: -0.1479px;
}
.pdf24_58 {
	letter-spacing: -0.0033em;
}

.pdf24_ie .pdf24_58 {
	letter-spacing: -0.0488px;
}
.pdf24_59 {
	letter-spacing: -0.0063em;
}

.pdf24_ie .pdf24_59 {
	letter-spacing: -0.092px;
}
.pdf24_60 {
	letter-spacing: -0.0096em;
}

.pdf24_ie .pdf24_60 {
	letter-spacing: -0.142px;
}
.pdf24_61 {
	letter-spacing: -0.0092em;
}

.pdf24_ie .pdf24_61 {
	letter-spacing: -0.135px;
}
.pdf24_62 {
	letter-spacing: -0.0004em;
}

.pdf24_ie .pdf24_62 {
	letter-spacing: -0.0064px;
}
.pdf24_63 {
	letter-spacing: -0.0134em;
}

.pdf24_ie .pdf24_63 {
	letter-spacing: -0.1967px;
}
.pdf24_64 {
	letter-spacing: -0.0217em;
}

.pdf24_ie .pdf24_64 {
	letter-spacing: -0.32px;
}
.pdf24_65 {
	letter-spacing: -0.0054em;
}

.pdf24_ie .pdf24_65 {
	letter-spacing: -0.0797px;
}
.pdf24_66 {
	letter-spacing: -0.0007em;
}

.pdf24_ie .pdf24_66 {
	letter-spacing: -0.0099px;
}
.pdf24_67 {
	letter-spacing: -0.0006em;
}

.pdf24_ie .pdf24_67 {
	letter-spacing: -0.0084px;
}
.pdf24_68 {
	letter-spacing: -0.0083em;
}

.pdf24_ie .pdf24_68 {
	letter-spacing: -0.1227px;
}
.pdf24_69 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,58.32967em,5.960333em);
	width: 100%;
}
.pdf24_70 {
	font-size: 0.696em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_71 {
	letter-spacing: -0.0023em;
}

.pdf24_ie .pdf24_71 {
	letter-spacing: -0.0332px;
}
.pdf24_72 {
	letter-spacing: -0.01em;
}

.pdf24_ie .pdf24_72 {
	letter-spacing: -0.1475px;
}
.pdf24_73 {
	letter-spacing: -0.0052em;
}

.pdf24_ie .pdf24_73 {
	letter-spacing: -0.0764px;
}
.pdf24_74 {
	letter-spacing: -0.0053em;
}

.pdf24_ie .pdf24_74 {
	letter-spacing: -0.0777px;
}
.pdf24_75 {
	letter-spacing: -0.0098em;
}

.pdf24_ie .pdf24_75 {
	letter-spacing: -0.144px;
}
.pdf24_76 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,58.40967em,5.960333em);
	width: 100%;
}
.pdf24_77 {
	letter-spacing: -0.0258em;
}

.pdf24_ie .pdf24_77 {
	letter-spacing: -0.3798px;
}
.pdf24_78 {
	letter-spacing: -0.006em;
}

.pdf24_ie .pdf24_78 {
	letter-spacing: -0.0886px;
}
.pdf24_79 {
	letter-spacing: -0.0084em;
}

.pdf24_ie .pdf24_79 {
	letter-spacing: -0.123px;
}
.pdf24_80 {
	letter-spacing: -0.0109em;
}

.pdf24_ie .pdf24_80 {
	letter-spacing: -0.16px;
}
.pdf24_81 {
	letter-spacing: -0.0005em;
}

.pdf24_ie .pdf24_81 {
	letter-spacing: -0.0079px;
}
.pdf24_82 {
	letter-spacing: 0.0014em;
}

.pdf24_ie .pdf24_82 {
	letter-spacing: 0.0205px;
}
.pdf24_83 {
	letter-spacing: -0.0022em;
}

.pdf24_ie .pdf24_83 {
	letter-spacing: -0.0322px;
}
.pdf24_84 {
	letter-spacing: -0.0003em;
}

.pdf24_ie .pdf24_84 {
	letter-spacing: -0.0038px;
}
.pdf24_85 {
	letter-spacing: 0.0001em;
}

.pdf24_ie .pdf24_85 {
	letter-spacing: 0.0012px;
}
.pdf24_86 {
	letter-spacing: 0.0004em;
}

.pdf24_ie .pdf24_86 {
	letter-spacing: 0.0065px;
}
.pdf24_87 {
	letter-spacing: -0.0111em;
}

.pdf24_ie .pdf24_87 {
	letter-spacing: -0.1631px;
}
.pdf24_88 {
	font-size: 0.54em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_89 {
	letter-spacing: 0.0024em;
}

.pdf24_ie .pdf24_89 {
	letter-spacing: 0.0322px;
}
.pdf24_90 {
	letter-spacing: 0.0013em;
}

.pdf24_ie .pdf24_90 {
	letter-spacing: 0.0175px;
}
.pdf24_91 {
	letter-spacing: 0.0021em;
}

.pdf24_ie .pdf24_91 {
	letter-spacing: 0.0282px;
}
.pdf24_92 {
	letter-spacing: 0.0015em;
}

.pdf24_ie .pdf24_92 {
	letter-spacing: 0.0195px;
}
.pdf24_93 {
	letter-spacing: 0.0022em;
}

.pdf24_ie .pdf24_93 {
	letter-spacing: 0.0297px;
}
.pdf24_94 {
	letter-spacing: -0.0021em;
}

.pdf24_ie .pdf24_94 {
	letter-spacing: -0.0315px;
}
.pdf24_95 {
	position: absolute;
	pointer-events: none;
	clip: rect(13.34em,44.47em,40.7375em,5.940333em);
	width: 100%;
}
.pdf24_96 {
	letter-spacing: -0.0037em;
}

.pdf24_ie .pdf24_96 {
	letter-spacing: -0.0551px;
}
.pdf24_97 {
	letter-spacing: -0.0081em;
}

.pdf24_ie .pdf24_97 {
	letter-spacing: -0.1197px;
}
.pdf24_98 {
	letter-spacing: -0.0032em;
}

.pdf24_ie .pdf24_98 {
	letter-spacing: -0.0476px;
}
.pdf24_99 {
	font-size: 0.75em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_100 {
	letter-spacing: -0.0089em;
}

.pdf24_ie .pdf24_100 {
	letter-spacing: -0.1072px;
}
.pdf24_101 {
	font-size: 0.75em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_102 {
	letter-spacing: -0.02em;
}

.pdf24_ie .pdf24_102 {
	letter-spacing: -0.24px;
}
.pdf24_103 {
	font-size: 0.6em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_104 {
	font-size: 0.6em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_105 {
	letter-spacing: -0.0121em;
}

.pdf24_ie .pdf24_105 {
	letter-spacing: -0.1456px;
}
.pdf24_106 {
	letter-spacing: -0.0131em;
}

.pdf24_ie .pdf24_106 {
	letter-spacing: -0.1567px;
}
.pdf24_107 {
	letter-spacing: -0.0115em;
}

.pdf24_ie .pdf24_107 {
	letter-spacing: -0.1383px;
}
.pdf24_108 {
	letter-spacing: -0.0142em;
}

.pdf24_ie .pdf24_108 {
	letter-spacing: -0.1701px;
}
.pdf24_109 {
	letter-spacing: -0.0116em;
}

.pdf24_ie .pdf24_109 {
	letter-spacing: -0.0925px;
}
.pdf24_110 {
	letter-spacing: -0.012em;
}

.pdf24_ie .pdf24_110 {
	letter-spacing: -0.144px;
}
.pdf24_111 {
	letter-spacing: -0.0288em;
}

.pdf24_ie .pdf24_111 {
	letter-spacing: -0.346px;
}
.pdf24_112 {
	letter-spacing: -0.0432em;
}

.pdf24_ie .pdf24_112 {
	letter-spacing: -0.346px;
}
.pdf24_113 {
	letter-spacing: -0.0433em;
}

.pdf24_ie .pdf24_113 {
	letter-spacing: -0.346px;
}
.pdf24_114 {
	letter-spacing: -0.0255em;
}

.pdf24_ie .pdf24_114 {
	letter-spacing: -0.306px;
}
.pdf24_115 {
	letter-spacing: -0.0382em;
}

.pdf24_ie .pdf24_115 {
	letter-spacing: -0.306px;
}
.pdf24_116 {
	letter-spacing: 0.0012em;
}

.pdf24_ie .pdf24_116 {
	letter-spacing: 0.0159px;
}
.pdf24_117 {
	font-size: 0.83em;
	font-family: "TMOTAN+Times New Roman Italic";
	color: #000000;
}
.pdf24_118 {
	letter-spacing: -0.0048em;
}

.pdf24_ie .pdf24_118 {
	letter-spacing: -0.0636px;
}
.pdf24_119 {
	letter-spacing: -0.0077em;
}

.pdf24_ie .pdf24_119 {
	letter-spacing: -0.1024px;
}
.pdf24_120 {
	letter-spacing: 0.0007em;
}

.pdf24_ie .pdf24_120 {
	letter-spacing: 0.0094px;
}
.pdf24_121 {
	letter-spacing: 0.001em;
}

.pdf24_ie .pdf24_121 {
	letter-spacing: 0.0136px;
}
.pdf24_122 {
	letter-spacing: -0.0093em;
}

.pdf24_ie .pdf24_122 {
	letter-spacing: -0.1366px;
}
.pdf24_123 {
	letter-spacing: -0.0097em;
}

.pdf24_ie .pdf24_123 {
	letter-spacing: -0.1423px;
}
.pdf24_124 {
	letter-spacing: -0.0372em;
}

.pdf24_ie .pdf24_124 {
	letter-spacing: -0.5471px;
}
.pdf24_125 {
	letter-spacing: -0.0117em;
}

.pdf24_ie .pdf24_125 {
	letter-spacing: -0.1721px;
}
.pdf24_126 {
	letter-spacing: -0.0042em;
}

.pdf24_ie .pdf24_126 {
	letter-spacing: -0.0624px;
}
.pdf24_127 {
	letter-spacing: -0.0102em;
}

.pdf24_ie .pdf24_127 {
	letter-spacing: -0.1505px;
}
.pdf24_128 {
	letter-spacing: -0.0139em;
}

.pdf24_ie .pdf24_128 {
	letter-spacing: -0.2048px;
}
.pdf24_129 {
	letter-spacing: -0.0002em;
}

.pdf24_ie .pdf24_129 {
	letter-spacing: -0.003px;
}
.pdf24_130 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.05em,58.53967em,5.960333em);
	width: 100%;
}
.pdf24_131 {
	letter-spacing: -0.0057em;
}

.pdf24_ie .pdf24_131 {
	letter-spacing: -0.0835px;
}
.pdf24_132 {
	letter-spacing: -0.0103em;
}

.pdf24_ie .pdf24_132 {
	letter-spacing: -0.1522px;
}
.pdf24_133 {
	letter-spacing: -0.0164em;
}

.pdf24_ie .pdf24_133 {
	letter-spacing: -0.1522px;
}
.pdf24_134 {
	letter-spacing: -0.0041em;
}

.pdf24_ie .pdf24_134 {
	letter-spacing: -0.0609px;
}
.pdf24_135 {
	font-size: 0.696em;
	font-family: "BTSFMJ+Times New Roman";
	color: #000000;
}
.pdf24_136 {
	letter-spacing: -0.0158em;
}

.pdf24_ie .pdf24_136 {
	letter-spacing: -0.1471px;
}
.pdf24_137 {
	letter-spacing: -0.0066em;
}

.pdf24_ie .pdf24_137 {
	letter-spacing: -0.0975px;
}
.pdf24_138 {
	letter-spacing: -0.0099em;
}

.pdf24_ie .pdf24_138 {
	letter-spacing: -0.1454px;
}
.pdf24_139 {
	letter-spacing: -0.0157em;
}

.pdf24_ie .pdf24_139 {
	letter-spacing: -0.1454px;
}
.pdf24_140 {
	letter-spacing: -0.0036em;
}

.pdf24_ie .pdf24_140 {
	letter-spacing: -0.053px;
}
.pdf24_141 {
	letter-spacing: -0.003em;
}

.pdf24_ie .pdf24_141 {
	letter-spacing: -0.0444px;
}
.pdf24_142 {
	letter-spacing: -0.0039em;
}

.pdf24_ie .pdf24_142 {
	letter-spacing: -0.0578px;
}
.pdf24_143 {
	letter-spacing: -0.0034em;
}

.pdf24_ie .pdf24_143 {
	letter-spacing: -0.0313px;
}
.pdf24_144 {
	letter-spacing: -0.0095em;
}

.pdf24_ie .pdf24_144 {
	letter-spacing: -0.1399px;
}
.pdf24_145 {
	letter-spacing: -0.0112em;
}

.pdf24_ie .pdf24_145 {
	letter-spacing: -0.1651px;
}
.pdf24_146 {
	letter-spacing: 0.0008em;
}

.pdf24_ie .pdf24_146 {
	letter-spacing: 0.0116px;
}
.pdf24_147 {
	letter-spacing: -0.0061em;
}

.pdf24_ie .pdf24_147 {
	letter-spacing: -0.0901px;
}
.pdf24_148 {
	letter-spacing: -0.0176em;
}

.pdf24_ie .pdf24_148 {
	letter-spacing: -0.1635px;
}
.pdf24_149 {
	letter-spacing: -0.0055em;
}

.pdf24_ie .pdf24_149 {
	letter-spacing: -0.0813px;
}
.pdf24_150 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.05em,56.59em,5.960333em);
	width: 100%;
}
.pdf24_151 {
	letter-spacing: 0.0017em;
}

.pdf24_ie .pdf24_151 {
	letter-spacing: 0.0232px;
}
.pdf24_152 {
	font-size: 0.83em;
	font-family: "BTSFMJ+Times New Roman";
	color: #000000;
}
.pdf24_153 {
	letter-spacing: 0.0016em;
}

.pdf24_ie .pdf24_153 {
	letter-spacing: 0.0211px;
}
.pdf24_154 {
	font-size: 0.648em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_155 {
	letter-spacing: 0.0011em;
}

.pdf24_ie .pdf24_155 {
	letter-spacing: 0.0152px;
}
.pdf24_156 {
	letter-spacing: -0.0064em;
}

.pdf24_ie .pdf24_156 {
	letter-spacing: -0.0941px;
}
.pdf24_157 {
	letter-spacing: -0.0029em;
}

.pdf24_ie .pdf24_157 {
	letter-spacing: -0.043px;
}
.pdf24_158 {
	font-size: 0.903274em;
	font-family: "VVBRWD+Symbol";
	color: #212121;
}
.pdf24_159 {
	font-size: 0.92em;
	font-family: "EAJTTK+Times New Roman";
	color: #212121;
}
@font-face {
	font-family:"IOVIOE+Courier New";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_160 {
	font-size: 0.903274em;
	font-family: "IOVIOE+Courier New";
	color: #212121;
}
.pdf24_161 {
	line-height: 1.132813em;
}
.pdf24_162 {
	letter-spacing: -0.0076em;
}

.pdf24_ie .pdf24_162 {
	letter-spacing: -0.1112px;
}
.pdf24_163 {
	position: absolute;
	pointer-events: none;
	clip: rect(18.89em,24.69533em,51.02em,5.960333em);
	width: 100%;
}
.pdf24_164 {
	letter-spacing: -0.0028em;
}

.pdf24_ie .pdf24_164 {
	letter-spacing: -0.0411px;
}
.pdf24_165 {
	letter-spacing: -0.0031em;
}

.pdf24_ie .pdf24_165 {
	letter-spacing: -0.0451px;
}
.pdf24_166 {
	letter-spacing: -0.0071em;
}

.pdf24_ie .pdf24_166 {
	letter-spacing: -0.1044px;
}
.pdf24_167 {
	letter-spacing: -0.0105em;
}

.pdf24_ie .pdf24_167 {
	letter-spacing: -0.1553px;
}
.pdf24_168 {
	position: absolute;
	pointer-events: none;
	clip: rect(50.58667em,26.79783em,58.07967em,5.960333em);
	width: 100%;
}
.pdf24_169 {
	letter-spacing: -0.0073em;
}

.pdf24_ie .pdf24_169 {
	letter-spacing: -0.1071px;
}
.pdf24_170 {
	letter-spacing: -0.0062em;
}

.pdf24_ie .pdf24_170 {
	letter-spacing: -0.0915px;
}
.pdf24_171 {
	letter-spacing: -0.0065em;
}

.pdf24_ie .pdf24_171 {
	letter-spacing: -0.0963px;
}
.pdf24_172 {
	position: absolute;
	pointer-events: none;
	clip: rect(20.6125em,25.77534em,57.64em,5.960333em);
	width: 100%;
}
.pdf24_173 {
	letter-spacing: 0.006em;
}

.pdf24_ie .pdf24_173 {
	letter-spacing: 0.08px;
}
.pdf24_174 {
	position: absolute;
	pointer-events: none;
	clip: rect(39.58416em,15.59367em,39.7075em,5.960333em);
	width: 100%;
}
.pdf24_175 {
	position: absolute;
	pointer-events: none;
	clip: rect(13.23em,18.35533em,13.35333em,5.960333em);
	width: 100%;
}
.pdf24_176 {
	letter-spacing: -0.0108em;
}

.pdf24_ie .pdf24_176 {
	letter-spacing: -0.1586px;
}
.pdf24_177 {
	letter-spacing: 0.004em;
}

.pdf24_ie .pdf24_177 {
	letter-spacing: 0.0581px;
}
.pdf24_178 {
	letter-spacing: 0.0039em;
}

.pdf24_ie .pdf24_178 {
	letter-spacing: 0.0581px;
}
.pdf24_179 {
	position: absolute;
	pointer-events: none;
	clip: rect(11.13em,22.56533em,36.5475em,5.960333em);
	width: 100%;
}
.pdf24_180 {
	position: absolute;
	pointer-events: none;
	clip: rect(13.23em,43.6995em,51.31em,5.960333em);
	width: 100%;
}
.pdf24_181 {
	letter-spacing: -0.0059em;
}

.pdf24_ie .pdf24_181 {
	letter-spacing: -0.0863px;
}
.pdf24_182 {
	letter-spacing: -0.0123em;
}

.pdf24_ie .pdf24_182 {
	letter-spacing: -0.1803px;
}
@font-face {
	font-family:"SPGDHR+Times New Roman Bold Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_183 {
	font-size: 0.92em;
	font-family: "SPGDHR+Times New Roman Bold Italic";
	color: #000000;
}
.pdf24_184 {
	letter-spacing: -0.0091em;
}

.pdf24_ie .pdf24_184 {
	letter-spacing: -0.1332px;
}
.pdf24_185 {
	letter-spacing: -0.0087em;
}

.pdf24_ie .pdf24_185 {
	letter-spacing: -0.1276px;
}
.pdf24_186 {
	position: absolute;
	pointer-events: none;
	clip: rect(58.08633em,21.74533em,58.20967em,5.960333em);
	width: 100%;
}
.pdf24_187 {
	letter-spacing: -0.0347em;
}

.pdf24_ie .pdf24_187 {
	letter-spacing: -0.511px;
}
.pdf24_188 {
	position: absolute;
	pointer-events: none;
	clip: rect(32.3125em,43.87em,59.69967em,5.960333em);
	width: 100%;
}
@font-face {
	font-family:"JOSUAS+Times New Roman Bold";
	src:url("data:application/octet-stream;base64,d09GRgABAAAAAEnQAA0AAAAAapgAAQABAAAAAAAAAAAAAAAAAAAAAAAAAABPUy8yAAABMAAAAGIAAABkHDJVpWNtYXAAAAGUAAAA0AAABR5k3XPzY3Z0IAAAAmQAAAZ9AAAILHTi+Z1mcGdtAAAI5AAAA6EAAAZAN554EGdseWYAAAyIAAAuPgAAPel6YdVyaGVhZAAAOsgAAAAvAAAANj4a+dNoaGVhAAA6+AAAAB4AAAAkDpYGV2htdHgAADsYAAAAjQAAAKinMwsjbG9jYQAAO6gAAACXAAAArAAFNwhtYXhwAAA8QAAAACAAAAAgD9Mktm5hbWUAADxgAAABGwAAAohJvzjzcG9zdAAAPXwAAAAMAAAAIAADAABwcmVwAAA9iAAADEUAABNoAl9gKHjaY2BhzmLaw8DKwME6i9WYgYFRFUIzL2BIYxJiZGVi4mBmZ2VlYmZ5wKD3/wBDRTQDAwMnEDOE+DorMADhbxZ2xX+ujMbsioy7HRgY////D9S9nNUHqESBQRSkEgAZOxE6AAB42u3RN04EQRBA0Te7M3jvPcNilwABESEEBEhIrAQRGbAbIOHNfTgM1+EMSw1XYMLpVptSlUrd/yNFPdaGJHbJd0Rxq7fj7CNLpclXJFqOZcbkNu1o2rVn34FDR06cOnPuIqouXbl249adto57Dx49efbi1Zt3Hz795Hm+1uh0u9G5/I7ljlbJs9eyleC9pd+SVYvBecCseZPBYdt6kG+Gl8xC8B43qseIQUPmTBs2YcqMhlpwK5xVfio/lZ9/+Ik6EdWKxxb//2MQ0S9pkZMbeNpNVWtQldcVXXuf79yLNiWmlohvFFEitiSKinUcARERX6Sj0SgMRjANGp1EHd/ViJpGNA2phqiYViPaNGRKWxFfVYnamCYIEqpxhFFQYjFIZDoxaQnc0wV2Jr17vj/3+84+a++19tr21+hvp3Y+fcwu9AZcPZ8GPo2BFNdmFyM8sMjVme6ADHr4/O8XgS0YhEbk4yzS8akaTJSfYg48CUVPqIzBFOmGHrDSFZEIxxSkIgQp+EJ+iGI8hS8lCZskAjOwDwMxHY8jHm9iv0xyd7EJ1ZKNIp5+T+IwBFMl2d3E00h1x3gHMBZvY68Eoz/fdJVwd4MZluNXOImrcJiL3XY/s6Ti51jqjiENVTJX5rk+mIyl2IDdOIDTaJDXpMyzbj5GYgGWiV+6S6TJce8h1l7rctRdcJfRjd8fYNZ7GuUlua8Qh0ZP3Asw6I4RjKV4F6WolVAZaSYgGDG8Kx3rUWwiiTEZ21jbSVknxSbYFbKa0cjERtTJainTAfaabXFr8SPWF0OkuSjEhziPJmZLkplmSWC8mw5BEKIwkTdtwav4Izt3jnFBHpUBMpmZP5QbUm+WmjvM/Hs04xv8WyIlWzboeM2xw9s3uaMYzArjmGMyZuNFfCCDJU7m8ew+XaUbdKMpNbVepHffxbrz8CGa3+bgfdZVgWp8Tr6SZJpc1Q3miH3VrSPeaLzAKrbgEE7ggVjpIo/IjyVMRshoVrZOyqRe+2q4zjELTLHd4da41zGAWknHQp5chM3YimOoxC00oVl68WQ0T46XVHld3pALWmlmmzST78V5+V6Rd85rs4/Zc4GqQB273pHnSUxjpON5rGWvjzPO47oY6S39mGmcpDBThjwv6yVP3pKDclhK5aJclrtyX/6jobpDd+kp/ZtW6mXT1ww1ieZ3ptwb4F33vvM/1943cDZw3/3ARbkRLs/tczWuuZOFPlT8eEyguhbjFVafh7fwDntegku4Qt3d7IwGtJCD78RHNfUkooESLkNkGKubLXNkleTKTimUj6ReGqRNoY/oQMZQHaUpmqY5ek/bTFcTbuLNavO2+cy0emvscEaRPWpbfA3+iKDytoL2GwEEsgP5gQI3klr0UXndOXMxSKDmUshyFl5mLMNKrGKP1rLj+6icYvwFp/Axytn7StSgthNvR9wlE1+jHQFR8mkliPEQ+5NkZgLVMl8WktuHsU5yZJvsZhTIb+UA+1sln0m13JTb8oA1QX+i8TqJFaXqPE1nZGimbtLtWsKo0Ktao7e01XQzj5n+ZoiZaH5hXjO55k+mxPzDXPEGe/FesrfYu+hVsfJkO9lm2Ey73R6wB+05+4ltsM630/eu77iv0d/VP8qf6p/p3+b/g/+Uv9bvgoZQT9OI/gl8/9sp87xozROnx1n3GV1hPtVdUvR/X8DmEkEWMvS4Oa3vrM8zt8wHmgN4iZ2vx9HFyvFXlNtqL8Q24qL2wlf0w13mOT2jezRURpmx3lavnK6zhjgP6k31azG/aCIbGZglPfEv7xncZ/8rbS57mqQ3pEg/0hQq+RoK9RT2YD8Wymiiy8JRtOJNOWHCpJS624jLuIe679F60e0JOt4Xqit9PyNDJ+Rpd1GfcE2c+nrZihrTSu0/I9MlGodxm6xfkRjp7wW83qii8/VDAVX7TxzhDH7iDeIEPcAJE4O5Xh05j27/eyDRrjCb5RuNJ509Op17Rocb04N306s6fDQYxVQCXaRzoptwSQayi9W+69iLN3DShCDCHNJX1JmPvTD8BnVmKm/9Jf2pj8Qw0xJks44wdydQyAyLEItYWSBzkcg3yejnlhD5YXpRnEtze+yzNgoVMlVCcJbuFcou5tsugWZ+WcI5rEGybMeRQBbKuFdCJUKGU03NdqXNs+/bEnvGXvI9hdWc2gKyeAtfc2uESSZ78SW+pdYTOD3DOD/xRJHMHfaiPmtOY4L0wkv0wEj6dgJ7MJdMLmeWHOzgPB3iDqlAi3STNJzBNU5OD855Ju8PYp4pmEXWl+Mw3XGzHOE/WeiHoexTqwRLrK7gfR0+m0+fLSOmWtyhc7hOXMNkrCSSvUx82zHLvGEUUuXP3MmlGMNNmWjK8QUGcbsmcEYLeW4+tRGMvhhjb4tiWGC6i9Vsc1oe5zYMpqpmcrOPk5eJ4lHW0Y4QmYGRgUnMVkQvS7WHuH2juBlCNMSbbWcR93Vusgosc3Nkrz/RfG5avJf+CybcJAkAAAB42o1UTW/bRhDdpRRbluWYjmPLltJm2Y3k1JLqfgVVFdchRJFwIRSIbAUgjRxIfRRyTj4FSE+6BDHWLtB/0P6EodsDlVP+QP9DDz02QC85u7NLSZF6KCoQ5Jv33nBmd0c060/a5qODb/Yf1r6ufvXgyy8+/+zTvU8q5dLux/d3ioV7/COD3f3wgzv53PZWdnPj9vqtNX315kpmOb2UWly4kUxolJRt7vgMij4ki/zwsCJjHiARzBA+MKSceQ8wX9nYvNNE5/f/cpqx05w6qc72yX6lzGzO4PcGZxE9abmIf2xwj8Fbhb9T+CeFVxAbBiYwe2vQYEB9ZoPzfCBsv4GvC5fTFrf66UqZhOllhMuIIMvPQpo9oApoWbsWaiS1gk1Bjjds2OYN2QEkCnbQg8ct127kDcOrlIFaXd4BwuuwWlIWYqkysGDBoirDTuVqyAULy2/EZaSTjl/K9HgveOpCIvBkjbUS1m1A9oc/t96H+PJblvtqVs0nhL11ymQoxCsGv7TcWdWQd8/Dd2CuVnB84WDpS9zE5jHDatpLzwX6EksyuRK5qnh9fW5Lxn/GYInX+UA88/FocgLI0QvjKpczR9d/kJzNRNvlBjzKcy9o3AlvE3H04tdtk23PK5VyqK/FGxveXB2DzMos6E81hZRdoubRdGep7Ih/iwMBrMuwE5fjmqry1q8S0a2iDX8exSzo4YmcwpLlC70meZkPNwo6Z+IdwQngb/+aZ4Ixs1DQ3xEJ5ZxMRw31CYZSCXZ35YgsWnim2OOBih9Uys8j7Wd+pjN84PaRx7i3gVfbw+03DHnAF5FJOhjAsOXGMSOd/BUx90oeaL5U3kyUjSdSGU6UabrPcZJ/I5QQsgGp4vRa1TfX7UEN6OZ/yP1Ybx7zZuvEZbbwx3vbbM9FsV6damME65abyGtjpOUTSsWhfDo1y8DNQLKA14Ia6l60mMKpVAxlDuj+YXz30obxP5Oi679llnq8Txu3CbXSfPxwLp5rLyMS2HCyqDXbJ0Kk5zQHv0BCOJw5whdBdD3scKZzMUrsJHbEme1PTjS6fn2RB+fSw0UMaA2nVSP1kNPzVmjS8+MTd6QTws7b7pVGNcuve+E91NwRI8RUrCZZScqAyYA0KQ76lZZS/vzIJGSo1KQiVNyNKFFcasJR0o20mNPjQkVVyCQaKslYMSfuJHKpmBvG7vtjdwoVXSqvCX7UiRLjn/xqWG13dh7Un8yrkH8AVmG4KAAAAHjajXsJfBvVue85ZzSjkTTSjNbRvow2S2NZsiXZli1b4zhxnMWJUyAkAZGQQAhr7BQCScp1gJBAFxL2JRRSCgECbUKcBBFoccPech/u8hruvbTNa9311kAfbrqA5XfOSE7C5f7ee17Od2bmzJHmnO/8v//3fWcAAvgHrWABoIAWAFj/qZ0FYPo7aAkuDwOAW4C/A0ADoD1NLgLTzHzNchoCBujBY0qsn4YMTR+CwAZpDQQaXEeUDdEMojQUoBid/pDCal9GevxBAI4dQd+F36UrcEyxBim2EWobNRS+wIii2wBRZWZMMegsOSSKLm78Aae8RJh3+dzTcpGIqaKAfwcmhAmQdrmnJycnncLponu6CC1iYRfbJGtuFl7H0qlWmjOwbIV2mIeQCtlDvKbv0+PU8Ge7oab/0woNq7lvVHMH4Aa44dNvPAogWFfdSD1KLwYKePhokPUHc/7KzMejWLZXZv6uiFZ3bkHXii5UbJEYM4CSt8gwAJoqlPlIXmzQ5Sto9HDHiYZX0CiwUWaQpgLHAqCjQSfOqcDrDrfslHCDow0nRPNOkdS8h3t+dqdTFqYmJoTpqYnfkQcDpamJqekJ8pAT6WIhXYRmS6FgKeASP8uwLMswnBfisXhraxujZZiwFMvnWrMtDjEWj9WrdhuDL2lxC/xbOw5L+GrcIeLzZmRvDttbmpvZlChta2jpm5dueGy+Nu0XFrbkFgtFo45OtymNBocr3zev2e3idy7gy0W7p7pxFbz5o/u/Ll95Hs0a+uY2N885X7/ysjnt/tLSxXOkwo2pYKvGGnVpmLktmTksvZB5aOkLj71bvQuP60KsOhwe1yB4/iUgzYyNOt05iUxzp2DJBSVFGpTGJE0GVxD8hVb7GfJBZ9AnSJIu6OOlcOAXbvdnfl9A624AQSTwLBjCWlqBSUVieV1Ah3TdLsEJg85B5x4n5QwKARgMDAZGAnsCmsBxmARO9N3R0HUr8FifnioPFwX8P10uTpXxcBdLRaw7wuSfgTCNB7dWIUNdxkfmMB61WDhstjkc2aw9lM+2kDHNm8MSHuCwmeYiwSVzY6svF3s7UtMdqc6ImzesvbP7QjFGL67ePbIxZPn0Txty8WjUbpKc6zWOjmUPwI14+Vw88wn1S+o10AyK6GLFzghCQRMUCi1KcW7ua/l7tXvzVDcZn0sX5Y8V4L9o96eeL76YejP1fuhk6v3871K6vHaedqF1obggv0Jcz94P9uafgsfgMZbLauH27oc1j6QebdaA7sHudY413ZvEB+wH4VMdr8JT3XrWMdh9fSfVzyK7xY46yae0i4WPOmFLltWxWrmxQW6Myo2JYva57MtZSpPtyg5kb85+I/t49jvZ72X/R/YX2cmsYSgLs51sZeZd5UGdDl1gY0Ps5ewNrAaxnexidit7J/s4u599m/03VmdgPewQS9ksLOU0xgIy7juxPt3Zj1oeBOV0GjmVhJzjnQHnaudG5+POg85XndpfOf/s/AxPpVMxCTknCmiRgW8MNKYbS42axrmJXj4aiKLonwDQOcnHp3Ul3YjuVZ0miAUCOgGrRAW+rAhK9/ZupHSv6Ubdz9ih3UOetmGwoTTjgR4ZtAltqK2FVsLR3Eb6YxplaIUepNfQGtrV1X6BswKbb8fYgzVGHpgcnhqWf1DGmjNVLm/CUDRdPj1RBqWSpSCncQO8XqcmhUmyjoVJs1goD2+SLaQ0FwrqEhbeYYWiqVgEZRlueoFBveevOMI5fU4EyiubM71blJb2Dm9YL1AaPuqLhaKGWCFm8pv9gAvq/FAKd1BtfiB4jX6ol3DRrun0A0DgAH+0XPu5Bf/ATcNlgP8xVACCFtE6QkTzuViMaK3dJtYAgZxVgcNhV9W7pU1U4SRuZmqtsi1owXN3DF5VgXlRaehJur2xBZ2lCza9e93te0WT3mZ0e/wtV88dXKXf0hkPuVItX33wyqVXP3fXJVe1JXwWpz0gNzTPW5ztv61veE7ywer9SkiIOhf2LrofFuYva21rCnvwQpBnJjQejAwiiMNlCm/pY4EoiAg6XeZIQKzADxVPOLaD0vpjBoNpE88LBhEAQYKSonVbEng6Dy/KJ1Qd7uzKDSbGEyiTUBKDiaHEvsShxFhCmzCZAO8KuJArabYoAswIijAojAnjAi24GpYME0woD/devOIlIGBgcoVKQoUAVFCVh8VACY/iSgIXhbSAZ15WmyZqTRP1polzmp6eLKuoIkyUJkuTMmUSikVYrk2xO6ox0tFIzOP2uhGjiwWjUY0Uhz7O5QdGU0CP62EmFoduo98PQqw//rkpTpIp7l2hhG+mh3RDwZHIA+zT9H72RQ17K3u7Do1oRvQjgZHoA/SDEQaWwXB5JTSTGVYNAplZjFg5Ygfy0IznF09wa2senwhL8ODmr685sGbru7ct3lzYK2n1chbuYPSLO7MLmlvjc5bTi6entw6P3/HwP2/LtF6ueWqZ1etB0eknq2tGwp0LOp4/dXKwA8O8jJlBBE+mAMYUr2W7WSytscBDFsjTmCcIAVrAOMcYIgEGz+sRCUYCNKmEuUhAIDPtCOM7GVoPeBiACCY5g4K7MJCx7cgTMZrK5VQZDKtSCVvF3CED3G2AwCAYkGFbwLLPcshCpS0ly27LmOWUhbaQ9s25HJHHUk0585IxPOWyXB4+XS4Pq+uGTK46ZWSsy4QyDGPotzlEDPgq2ufIkI029Va13X5b0xx68aeb17VpIhEkieuot9e2aaKY1vTPTFAVeh3W5AhogUuVBorTWM2czTqP2xDbEtNGYZu4vOVGzW1oh+sR497IAeOBSIU9ZuNqYKCIOsrOJ5slDxd1Ai6XJUITaApUoP6whW7C4gXGCIhOmTHTgaTwKHkZlECOo87jBqPruC9ztwE6yhmNLc5IBHC8M9osAbuHU3gBXRB1ckDDWFpgJFKhdIrd2GLDDWGEklqMzbwxAls0zDkfdpgxErQcNRhzngoFFJ890/yBQg1S+yiKcud4KSAh6QM+k1R0xlyStDDt1kGdYrXndK7sX/9C1pW8aVKemiwLp4cnp6Zl9bvXvnqB8JnCLlOTvMt08+uAPItMTte4jhYvmV0m4fXXQRkScCQCOs6iVts5REc7q8IYshwUYUR2FczwWXR898a//eydD0bu+9ZFv3/nxI+HX4tG2pMLey+5MhUw2oKZlekFl6HqlUdvePI3b+6+9sm52x694o73Xty+5l625SsLb52Xv7R/wTerb3vF8M4Fl4y0X10+gTV81czv4dMwBwxAOgIWMAaqAq2KIajLYIPj4jbeSbjqZ+WBSfysWI9azn5nCPouXTtv3qWXwpwq5s1bi9FPwLzoEL0BhEAEZpR7JcFgKa0XNgs3hncJO8MHjC8K2geMo0YEI2EEpHA4pDcZfHox5PSJBjzYiPXpHGa7zwEjeiA5vhzmhWAYhIQQCoVRKGUWbGazEEbhEGow8TaTiUebTdCk32qGIbPAaxzhkNmENFAM81KkQaX/ExgdeQpjg16vY3kHdByHt4IwbFLCQb0rExuKbY/ti43HTsWYqBALxpTYID6zJ3Yopt19LX72YaE85XIPTGMIdJZUol4qurGpxBTLXDijtmVsGNXJZwlVN2Gqjivl12VsKvGfEwiTUBirleVzD7QYSbXFYl0hZBiq2Sl1mba2wSx01A4ISSNKEY9jVT2/Gip4mzxXVbsWXDIP/tYK/9iXkrqnhzxLgw4Gea/64Ti8dcccueAR2GjUsG6vpuPTZx5LBOho1CH4LVbdnE/gT6spPPV9AGjaMGWTkeYlwMz84aihoGNgSrU9i/KDKUjTNBNlqH9DP6f+p5uyM3m6D1E/h7/yIAtvwlMsB0xCSJAP8q/yLPR4bZEAX0H/oZilWCQQCkv6SMAUDnsjgWAF/btiD8cjARnPeDDI8ya9az1NabSeClw9Ok6o78xRZbkzD7dg+8DoA1gVkna7TQn1lGxKV563waDtPRuyKfPm52xKb96mFDpwJd+Ki0wzLuQULuINuJAiuPAHcCGYc4IN2ght4gOpQymUTg2lUErpzpNnHMU9qBJ3okrcjyobm2oS96ZK3Jc6JjwGgpSXBwGs5sl4PEbOmfAX/DgG07ExrEMUOTXa1pFTZbpZlYrOF8nFXI1LbiEraUomOC0XB4gKCXWWIxMKJstnj2SVjREExzcMT5aKxcma7qnXKcFE7K9qtYP4gyyGUlD9IBtX4hVcqEdWhxEfiSZcuHhceIQST+xOyFaa/SACRJswr4KYBGBqBe3nsKdzLAUhWV+wHa/171h80U02Id5djedFwSK7ly+M56vxTpc53k09vWXJ/MsXFZ6o3ndNXhuJaKOudXDfl4uhbVXDle34BBN0XIOEq3JsFI/lQmxmXsRqaAQheL7ifMsN4xy0XMiaYkYItGJMq2MNPkWjDneLq6RRYphca6DGHa6RJVXMr4mSKkYLXTkilUiDnBsLj2OoCSvhNWFSxdz4cQwgvCVgQRZl3ABV84v7VSXumshjnClncEm4j+1H4vl2TKlm525gsrxEIFSY/JzGM0WQUZ2f4qTKiOZCTApRNOAP+hFjs9qtiGFiHq/b6/JSDG+0xPFT+vzQobP4gVPri0MzZ4pDP2XyQ6te9AMvLcYJRcIcSSVIScKRMEVqboAFuAAuELZw9BAzwo0IQ67tzG5ut7Dd9TZ6M6Af0Q4Zh/gR527tduN2freTxYSpPLwSu31QJUxajNson7OIEqOCjKPm+ZHpjMHq1p9ce/nWkz+d+ON72QWiydDflPLHjbZY1E299i9/+OpbO5+ADa+9A+X5A7/54dXl+QtdUtdqGDow4rNjHFkEAHUdnsAEjCt6Q8xQMNg4oTaeeDFi+ftRTyAn12kLltsPB/Lqoc9fO80LqlTiNkdOkOEDhj0yMriM5hzvA36QCPgEv5BgoN0hikB6IuBX2Zb4ZsCnsq1wJJAgbMsX1rfwir+Itd3bVuKvIAADEozfp+fLQH8crgYauPrFPdpx7Sktpa3A44oBJHgxICIxGZZqyiSpSJBTfflRT7Dm09ssjtyYBIckCCQBk4R/Ty65QGXZNbqF2dbUVHlyUphQORdRBVnGfzIx+zWqDGRYp2ayjGe3vtRqtjSuejEY+e0imZYa+Odnee075a/3tPf2NOWXaPVGnzthD0Itl26vartkVh/LUE//7O7V80q9C+dqGIdUuvSGk+0FweOiIhG6sBXRgw6vm47iOVoMAHMDnqM+tEQJzEfQYgkoen8by1tBEfQFrBhd+hjY2uaKBGwVdPKIlIoEGnBFsUk9kUAxLPGRgDUcVuJQigTiFfT+i2GlE7ZFAp24riTDcyKBvnBYK6VaQ1qo8Rdb1mv86/V6PAF9TLGzIW6z6vsVvMr6yXhe4JdyoH9f/6H+sX5Nvyi6TTwf4BGfdLsw2LsImD/uetX1notSXLuxn/PHkJRsSuFLKfVS6tXUeylKSe3GYP5HwLcFsM+bnNNDenb7pNyanlM9aF/PoZ6xHiqNi/Eeqsc1v7+CzhsNERSWl0yRBVwcwBB7WgXb6VlZLi6Zd/nc3+E6WdT4h8zmAHaCZxlqgfBp8ncWh9VVH0k3e3wGI81kYt5YM93kh4zWZ3D7IWdMMy1+6OH8fkgmHmO4CuPEswULzt+iWAJBVhfEjhEd0IXiIBhitVCFelBzjSJr+k/1I4aLcDlO6f+5gV5KL2WX6JYaxvrpdrSUWcr9k9EQ+jC8aaVqEvqx4jp86kCPCvYSU5n5+yg2CqrEpoIj8b9ZaTbWzmOpHvOG2jFfvy7U78OSHL9gKICzdgoD1Er8wXWr0Vrzy75gOhituc5outGsNWG+aE/eGbhtyaqtocF7By/9cgobFV/BY7HJPnlFyiz2VL3xFG9LexpC6Ty+5q8bmW3n956/fNXgyjsfqN5yTY7FKh/3XArvuXluqFSq6i/Hril2aMLNX4L3jCgRe2BRVb+uxPwX45PEDl6YvgbTXy/4D8XhJy4ebwYW4A2YBYvgZcRIwKLCjTESMKtw44wEvC/DD0EYc6YxxZxrzR1kIKMAyHkZi1mvI3roxWdrQRuFSnAcbwwYkTHpFIn7J9bcP7Hu9qkSe31EKulUJndIhLtFqAYNxG2Kf9CPAv41/n3+Q35N2l/y78aVMf8pP+NT/T48759z+wTsnsg1HJpU1VT1/+Rzmbv1C6Mf61l1kaKsWvXuWY/wGvWEolxU7Zz2nPENkbSO+IYILJ2Z0MzDjrEfpOBWJfyQ8RnjS8YXHRqLpY0FfsGPxEBKxzoxVr8R5rUBLdKSsYNPMAFcuehFVt7BcawBe2erFZe4JRSzaXFXALACi9gkcApO5EzCWZPPw6UQHcIs0Z2uoTQRo51dubSKzthYD6bH02govS+N0oEYjCkk0qHYya2z8ZFxQSO4mtprLEyNfxFDTuz46drRZM1lnpwiXGtS+OvkZ/Cv5Vqw48wyb5CSRmskGo4ixhJriCfiiDFFJWssDpJGXETNoTiM87Ia5IA1860u4jQ2zdYhaSh5KD2WZoZMI5bN4kh4KLEttVP8auoh44OOvY37Hc81Hm80befvNCMwTPxEdTmna3GZdD0uk67HZUjvZPWZayaDzjNqRHw2AqZaj3Deqq424kCS4Fcb9ROGTbVXb5i/sW90w/kbjm7o3dCp4zJzdi28OuqMpnMpsWHFEnrxp+9eawsFNaGB+5Z377v1ew9+tDXXA91XO3ze5PTOu2yBR7/1woGY9as1LaDK2KrYQRDmlRWMZZGtbNto22C/3LnFpo3qn0ZvonfMP0Y/pt43vm//hPq7UT9ihxJxqZdT66mN0o3UiHQbtdP0J+Mf7LokO+OArE4nEzUIshRbpoMOAPscFdhwxBOzaukK9I9yBp1Dzafg2XUoLinnuBIQykYmGxs61cM35YhUnOY8cKelkrRa+kjSSMFELQzTItQpnyr9lpqMZXKq1nBYncYFKLhC7XfVlIWsImwsJrC+nJZloix4qam+/9Q0oeVT5QkovDOsaojf7PdFnaJLRIzXEvADt83hh36zxw9Fu6dmAoha3IJNCJnkYRhSp6a1FqokE2jB86fN1VmB3U6Vp2d0q+ZdWlzbLi2ubBm/evn0gbt+/GE4ag/nQp3wr8evOa/3QsfeW/bd8uqfoP2PT3zrpoAlu3JvGA/FspkJ9DM8Oy3ogHKxIWMXShrBmLAJvoSGsTlsb0bfjP2b8CfhH4I2IUST7UJrcpfh/vD9kWcN3w5XDEfCBpqjjWzCzs03LOIYxaBwyNISAHtRAELiZ0AFO/ePq3mLeYoV7LWk8Ylc+hPZGXDt9QTcbjItuMkeN3RX4NWK37XX8YnFQsdkrcUfsxgstelQLPYcvMgSqsycOqKzMReQiqLX2dAFNcdfnWwDn6sdSSZy3IFnL4A9fzefg+nc0tzq3MbcSO5gjslZ2CDphJToAp4NYDxR8M21muRONMzqSgNsUL0mPN0Nrizh+ITi49mdwLg5rEZFj7JB7DaxpJmIb2EVW6jEFu1hXDii+BA/W92TIj7B6U0ERmZvDQXxCKmPosN9hC7B95MnGcVdqBL3okrcEZGHz/Qlr5yQSfRWcUGlwYkH2WvGheDBhUnEhdFRa7gSayD5IL/fz5f8lZlfj3K2msQtiDyMm6sN1XYvARq72BbclvbjhrQft6Jts02EPxOzAQWMfkD4M3kAhU8renMpreh4XOBnIc1Io1or8snRFP5qmN6Pj9YkflTsakZT2OnERz9VdLgSTWE/NFqZ+csoBi0sJ17EIMZ5MaKdZRIrAV47KuSVMU+2hmO14Jfo0NTjvOpaCFPZehgMr414LV5WWzroPl7quq0n0WELwlh5yV3Le4f8hpAjJEipb/ZluoobHk7Nuf8bi+d7zBaHk/pB9Qd3bWiLeFyJt762fMkDg0lDCxzcsaMzmembf1X7l9ZdczDK82T5xACgjdjERcFupXUtvBFuCw/FNXvCeyL7I5Q+6EOS5A76LIslQ9BnlsKRsER5whEAokJ0KLo9ui9KRyvwJUUIhhqQxYwg1r/oT8A3YQUdVBxu3hPwIE+3Qe+KZeJKfF+c6lqBVbAsTKnEdGpqGpRK2BJNk6QeybiImHvK9UgRdTZvRxhVOB+y130Iswr1JA7eRhuzny4mCTyTwdFbSKGfdqrJPGfYtWb4mj1XpuEH1Ugti0d95WxG77N9Gwom3eIn95ERmPkEPaCZBi7wkGLabdjNIbUwcMBVgcewgmpsNsp+G4JM0JAxKAbKsEl3ucmAqAo0KT7acIxze6BGA3g6QCM6aXXYt9hsVgWrn5WsKQGT9bR1zDpupawuN3GpamiLGfeUGgDB4LpEOD0wiQ9BaXqiTBKbKuAWMd6SjCYYhuasPXwm26N6U3lzWI2eVX75Sz4m9HT4lx1buc2s3/ovL8zRTFcPrJt+dVnat84xtq5LegD+I7zy9S3Yki2pLtQsxFjpA03wSuzwWfpYXgTOgCg4NX7gs9RTN7Gw782A8w0pEuO0jTs0Bqdo4jcJglnL8+ZAAPgEH/IlzZYzxMWy1IIOWaDFnakRl0yduGTOEJfMeAYNZfZlUCaAEUlRwUZPbmXhOAvZWYhiXek6d5G/QF5UhcG+SRqoOZqimqX5fJomKNOmWFQfCwWlIGKSMSYaNTTEQdgY8EMTL9O4HtdF4jBoivhhQtv436dpkkP0kGEoOiQfyoxlmCFmRD8SG0pua7qz6SH4MP1o0zP0waYK/WrTO00mcIbAZGoEJlMnMJlzCUyU0X6OtrRlZ50Fksgxm2fNoFlN3rWil7ryfYsPrV+27eRNgzenvikJ7qXTE93t9nDaGV2cnFOId0cuWqu4I9+8+bt3z+xqbbv203kXi1EYjXqb5sPvwVu+tSFm7b2i+oeTF3a2YP0uYRLbTD0NJHjPSyCCR3r/ovxgZDyCdJyHS3ILOE2Be8T7rLfi1Xyk/ZBFkmIw5kKk4GlgDdCCVfMrLZzRQpL4CYdrLrI/EpDCYZqh9a7LdQa9AUgSVnoGMMl6EsjPkCgmg91ZRunF/4UOfJBpxkW8ARdSBBfYzWVIEJMhQcz3GMgzMMi8xyDACAxiSERTHyHB0YjSnY/Ug5mRehAzUg9iEnk4WbuMe47UY5lEKi7MwMYiMBA5FEHpyFAERWwBO7QneWJdR3HHpnoo01QPZZpqnanG1+qL5D42wbRpzDRuokyu8JIzrFr1Qog6nomRkZ+p8rlHxE2ZVIObajS9OFlStaw8XPNUVF6EdXs2X6Um+mI1RyVUX+mtbeoh9W5DV/W23p3nLd2WjHfDm60JT8TX0E58w+nI1Xlt5ObBBZfe+gT8MnH2pm+5rMNvdS+FU6rrB0ECAM0/Mb43wyXKpEPj0qFgNpMdyu7JPiOetJ0Ufyf+TdRt0V9v/0rTndQ9NvpO/UPUQ/p77c9Qz+iZoG2eXckOZrdQtJ7S61GWmMj7NI/qntR8V7ffRnMQaJdx3I9YnzYY9DklSV7W3Py/Gn0yswzCH9E+JhT0JaQwZACnNQK7YEd2h2yzOyhRKzpGLU3O5oYEbOI4ZwI5WUbLa5dqUQkXu7UHte9pf6VleO1G7FS1ZA/Kr8ooLZfkpfJqeaM8Iu+WH5dZ+TbBMeTY46AcbiULs6DmgHaHgq6WrqPqZKmzRBhteWCiPGxWM/vpopr+T5O0/+RkcTbmUa7lsWa3ksxuLalLSqDrGQx5uIx/VEzGVjlrDjeh+j4TcniuzYqre1DwdNZ2o6Amzy3XC7EYN7D+UmuuY9n3f9sS7fr0mprtovWe2JyUZmPMd+Wa9kc01en3n3hsuuP6+7LVW4dagoeOVJfNGrGL7WGrN1rdeO92vwVDehxDuhtDugTS8HrFZUmzPAO0wBxgBK1gZqxpbOS5CPFHP1QMJHfLvBGuO/mKJ5zaIWrNFuzQM9FYwMBoTUICJhSP29JcQ/LmOpITqWTwchpsHm9GmWalebB5qFnTXCe3SaNF4WCGU7hBbowb52jOlflcip6rwSNXh0fuv6To6zCvNm2uNW2uN20+N0U/UMvRT9Ycf1n+L45rMNbo9LuicswXi0cbnYk4jPlxkXSn4rDBGz3jsMp1pO+MKKX5uTApRpwj/pHYSKPmetuIa8j3FUyCRuTbbV8PP2B70Pmw/2Fpb2S/7VnpQOSY7ZWIZa4dqusXEHRXJ//cQEPIXtu/dYbXxR2zqS0M8/CgmOmb/k81/gDvaM4uWH7Fsysu+s5VA70tbcvXtoZzhZhyec/q6pP9OWc0ikLiGuo/SDhiW38wfetvd9z1n9sk95NbC+f/+X+v7LyntsDRh3iBB8BXlVRIafOWzrI2SfIEfVAK17gbpmeYn53lZKrz2BcundLDjF7RD+nH9JrVuEB6V1D1RzweX+5UCA6FxkIoE1JCq0PbQ4fwAdO1mZA4jHbC2SDjbCZeJvAWtf/fuJsjiz6c7jyHtL1R24El9hai0f+GrO3AdfykS7Afvhqrehj8Rbn2rwyM6OBK3X7/G+iN8PvwT/DXSKtnYSNK2i4MrNddEdis26zf5H/Q+rz1eVsFHbcd8x8Pv+F/L2oG0G4FlMk7Dk7hBTQOT0GkgTasxiGr3elyfmyG5v90xgzaUL/GwGP3S4Z1T1oN1Xh05hwP4T54CN/hPhj9KIqivDfgRd4Wbb0dkcca5Ny4FmpnqY3WFal72nJZrlMbNR47MLFJ9bInh4WimkktDxeG1Xyryv7IfhC4aTiqes4on2s7N6Red59rgY9WSgnMeWPjy6fWb3v/7ufmtXcO6BhRDGSk3PkL2hY1r/iL8ytboPvNV+8+eM+qwtwll5VcruzA4zv+0ik34cFtAYB6lN4AvOAPSuQO9F30PEXFufsppMfWHQLaY9nnOOJADi9CItQbWG8FrjlmSYuHRIQ5o3QYWtj6tgO2QkWOmGjIYYI8pXgALWBa/IHlp7wXvuqFXrcfj96r2J92+Y7DFXAPIIOCwZlgxcDUdHkCo/Ok6ptZWQW7VSxJ77EkvccqxkLNj5uu5QVF4lka1VDjKG6kSuyGqqFH7KzV3EyzummhhvBkQ2ZhdlzLoVAeWLCjhccwXg/s2rQMDBG3IksNfvZruPGbt17yyAXR1g/2XHFgzcLLq8/D6DU9SSnigEdh054rv/aIcayy5ukFt9/5UvWoRZ5XT/MdxcPowD7eQsWl8zABJqpLiFqnxx60R50JnZaFN7K+2oaNOBajjNEiVii9EgVKJJYDityEi2wrLjDwKmAQ7AMUcKcsta0bpKVptxEaSXjJ6GokOzaWkC0bWKUwpImSEonnJNKJRDqRSCcbJXUHKnHgT6uVgcne+vDhxuqw4faqxLcQeRTftUas36Wqpwqwa2EyGAqEEMObBBNiIuFoGDEGTs/pOJbTMHaHzYEYl9Pt9DgpBkEKaiDFJOWEjBi/WVoLYlpceK3iWthA4yJk8q2FYS6+FjgduCZDXDubFKz/3IJN7TC0aU2orvJkDdRSuLQwuwQYszCb66OOFqQv37N87WNdjSG5Ozt+/eZ/zfRW39XoY6522RV12/j2phZXkkH7f3Tomq8uu6w8d/jhb//ipYe//a07Xv4AXtb5teagM/zC9EfVU2vnZ4LtNwAa3DXzlnYTfTWeBh77yy1gARw8+hp4jUIySRu4fVjlazJNthubcMXEur25ZqfFRk79YRRL3PQPiglXEuSsiRRs/RJHLulwhSFnF6lZeFwBEB4km7ERhWCFMh9LxYtk92YF5RS+u9jYlDICSqMvjnigh5wThCLNa+hFougeT55KomQF/euLc0+Ot59qR+24fkQZy8BMBfYdC4KDYxSk8E1HsDVSkHqOpAuRltwTOjluP4WZGq4rujHjOKZUroWLXoEnQQhshU5Qyy0NTG86Pb3JPe12TuKV65x2T5fdTvWcmlwimaWB6dPlSYGkl4pqbaq4i26Sa7u75XNSLCR6D2EYL7yz0XuxFtEVayHd1vrGkBj8fzdhop917aROfKbc9drrd+/+3om7HCaXy6x38jaHUTSYBYOL0yTvfu3Nr3/tte/fbTM5sd1xG+1WzsWZBc7J0Vf/82L6yXce//aPXt/31L/mjeLwC98YaHQYOXt68Z3PLMo5DdNXvvWtb7/77r5v/TDHOa595Mn+rMgZxNyC+x7tz9kNGEq/VF2P7sHqYgGDSsMu04s8atM8hO7TPYOe0tHwBKC4E0arkeMAgBkbSRukSaIW3a/oFAEKy60bH1CZE9mAVaztLVfXnxoTsZMd4ljbLcSBjAGzANA9G5rnxjIXLsqV/1J9AS6hr26a27PqGwerb1bfr1Yu78u3LIOfwLlQgZP4u+3CML8O45MIbnsFmOB3YB6w8Klj0mpCtGGPUT2jhf/ARtYBnwI8/Buw4zMOhBQTzwKa1XL1bX5kM5pgMg3yG/mDPCXwkHc5Td9HALDoTeDERuJXgDzGBHGZyrWtIIQiWApqzoFkF7EanLNBu/XMNox4FO119A0EplsjFy7EVDSYXWCBn9AbPn3u5nmN0WhD33b06iXpUDAygR9ITW1h71YADyu2X/1/71n0hoHAnLtncY1hyIBqexJrWxWl2lZFg9WRq29SVAMe2NjmApY1Z3crUuZ6hko+XSb+3aYvbkv84qbEw2dSUNiJ+0LiCYIJTQDdTm/FiNOhcADhb0jVtuTgtXpkhLzqUYFzj1A3IZemAmdeWKcSC2w9Qbqs+qVF9WNh2Ipurx5dfj29tfoUvGhmRh2tQdzvEyAIgELeF8ElvBWEfnTmCNgVHbRxO/plCC0voUcwwcSAnMdf6qqZU5oQ1usCTCkFZ+bCxI0hijFBHa+VmYyTF+UULwsJc1oKypHG1mSrfEXizsSdyWdzleTxnLXgA6uQj4TRFyh2sIpvDbSi1mebfT7/qqAvEAzAQAXepPT5VwG34EbuZ+0JmWdjvIHnvQYvr9nMb07s5Z8yHDW8zjNygjdownS+mQrn7bqlcDXcCEfgbkjDC0FMiKFYBQoYbN2dJIrRWYuK41NHAs1Nro4KLLywojZgE4SGycStIHvCyRZNsgNc3ehYAMKfy1OT5dloMa6r1fquzyBloHgUTcTkqwxX8lsNW/ididvl+/nnDS8bfmj4IW8ku1LImsX+/rnB3tqv3aapb4kgbyOcifjG4k2oHvFVQ77UCUPC95sd62+0+5T0gQ/P+1L1b+8qm5ZnAu4OSzTa+OndQ7dnN+x46YkLPzw6pzu9y+P2G+mrq8UD7107PxVON4XOv2HDhp0H/uqO2BoSCLz/m63LMquW9Vy0/bHVT0wIXE+wC0+qC4PVShWsvqRIrZpd9B18hdc8gB7W7UfP6jQYrqwYriigFbTBOkyZlxKYsmH7xHHGjPVL6rswKlKpqHUOXFnz6rssZgFhZM47CFy5NjT3xmtoBZdWX6iub5rXs+rrh2AHbIDzVbSqGquvVH9QteIvd131Kupu7NtcDzsV08NdD3e/3fV29/td73cz3ZWZf1caTdYSLeCijbW6c2/Bn3ed7qLuZHZ07ejeOUczp0cpdXcxtAbbT265ys2NZpWbKylOKGnBhouLCj5TVPBRsXfxcu3uIixuLI4Udxep4gKwvXe8F/X2Lsgfp8zARLitpWSqoNEjBf2JhJtU0rYnwwvI1avxQd+mE+etOY5GwVLKrDgve3Il0LtPFBKJPnPjhmDjxbHG5S2NizdXqNDhDTsvJndvWnOi7zzy6tHinctfgf3gBvAzmK1h5lRxukheLJqo/+Khna69YqReSE8V1YqMyW16GHsNZVyqWivLtRJ7D/V3YWRMn+pmkmG03ejse0XEL60p4+z+XNW2nHkzySFihVTNau2tpc9fOeeVJdKpeLZX3K0D7So2eW0dXQ26/u0JZ0sXxqOBVr8txmgNvlhXS7Z7qSFq8bSen28udiec6T2KQS50OHxNpdZmtvtAU1OxJLtavqYYzp/TlOkxKbpE7muBxriv2OxxGJq68ym6Cf227aqLbp2TTrb3tuiKXEFuLERcOpqSRalrsLGl2JVufK6follXtJBMdpsUunNuU2NT92U3DeUTA62apV3Jhi5Tie46lGmZ15Nxt9zdpxF6Ih452c4gu1fQti3E+rcJXU7dhRfHIvBHxah36uZ0OjvnaIJWaK2grcdcrkBwPpz/PbQV9GAlKIIGynwU5IQcyhGYLqruH9yo2EwgsL9pPzgxUoS/wiqmxQ636nyTvV/6HtNHGqjBipjT9ACH0pF3TJvmqhywIz93Giim/WB/4ETxRJQ4lY1NuT1RGK3AOYquTcFHj7fBtlfhHAznTSgJFtdVyCWcdk9ukskfedHOLUzK5G9CHib/oLSpPOn662+FonNyE7bLE8IUcT6FSTVBBesYVJvb1s+9ioaNsx+JZ9zPWJw58y5bN2qLS+doj+iAk5S5pycul7rNdHsmXepoLC7stGWd3ugiObPZbe1IyPOMrDUQcrDGOY2JztSWpsarva5OR6G/M1W63uykTnUU/yXc1NeTS1zfVRSllt6OBnkOdiqao0XJFZc751/U2ZrLd7ReNLc93lDqlRrJQOKebjKasanMAaB5CoOHG0TAe2QT6d8Pc4UgYegXGwpLY/BB52nxdPAfkibJegHkgj6tJMGgj5HCRhI6CXuaLKDJ62WsFqRlWCEEQ79c49jueNxBOb6ajsGYp0YdMA3nBA4Ncms4xN0cjb0CESbKXVBbJ8qb1OjIgBqDrL9iUgs+qpur1KgiyagHwjZ3LaMetoXSMODGhWSPpGFQ9KfrgavkLbeAWtQJzgadztCmfCio7qtnKHPdmoRRwjPv4umll/R6PHPLaCmMVJ/cc+nvQ+atO3bchtZX77iuIEWj4fbrqCFSG390xyuSEz00fQzd/dCDX8cDODjzv+iPsfYbgR8+p2Q3CBusD+lPWk663ne/7z3p+71Fp3Vq/SJycqJb9MaFuDVua3Dr/dt1+pxICntlZvsolnxdGusSOz7blctwhSGtICksD0Jsc5iH2Qe4B4370X7uLfot3Zu+k/Ck0Yg0WpbRMXoRikjkRKPDp1vvWu+9ib6R2+za7HuQP+Y85jvp+Zg1LDeZ8oBy5LU6i8EVuK5u5bFb7AIewYM8Awr2e9zpYCmIgrW9sQN/VAMxw1h6FP5zDSwDk7VLk7Me8KLztrywjMWzVYR+IeqL2WK6KB1zuZ1uRDa9RvE4eaLQzuKayOCamTNFodGLcAmtekcUuDW4kOUi/q1vfFVjkWqQp/fiFUdYxlKgKzNTisFSQE5LgcP/CHuHh80F7CT+GQuaHBkLOnz0gvHsPrWV8IwrNVyGEWxotSgUjMewwaVJZkmo+UiWvIBilIi9gfsffLt6b/Wetx+De2H78UuXbr3g4SvmrVh72V56NVe9rvqTavX16md/fx0aYRO8d/H3H61+UH1q//UtCnT9Gp8zXIfBMQQA3YLXlw2KigEKFn8JxCzOkrptJWPx53AzGhh80GygD9LPMk8LUzrNGmYzs4u+nbmfvp95mn5WOEYfYl4RXjbPvkzDk1gTa2UcdoOgE3KwMvOxYsAVQwMmwQ16FtSyfvW3aLJa1mI1WDnIIux3QWT2lmBKb7DpcS/IwG10QAf2hhV2kF3DDrHbWZq9EFTQB4rbxh5iIasHXIPNBhDCHdtWW2/Tu+yO4/A8EIK5F65VF+/A1AT5xCLZGYmNLBSqU+Xa3klAbPIueqBJlnepb8KoQSbhHeGd+osvxPRC7NK2qcGkEMTQaULasFXz689+A9GLC258PhRv+zRG+d+5Idq3bZkYjdKLPwVi5AdPVB000hoHtq+F3/g/qkV8dwAAeNpjYGQAg+pp+7Xj+W2+ckhygPlPN11vgtG/O/8mCjBwFDEwMrABMVAHAGcvDRoAeNpjYGRgYFf858rAwMHAwPD/BXsRAzrQAgBdqQP/AAB42mOKYGBgSWHgY2FgSGYNY/AC0jEsxQzaTJZAzACUY2DwANJRrMcZBIDibkC+F3MvgzfbKgYfoBotoJg/kO/PLMsQCNSvxrSKQQ0o5gfE9kC+JpBWB8ppAtX4AfUagfRzMDD0AdUFAdntIDOA7Ccg+4Bqs4BsSaB4HhAXsTxmMGGzZAgAmqMIAJkxGPEAAAB42iXNQUoCcQCF8V8F4hgaEkyIkJIS4ww1johjogfQcNEdpFVtImgngpdo0SU6UbugvQfoTz34Vo/3Pf4y5ajB8SMnb1R2VNdEq39O88CWesrZJ80XzmPiWy7CpvVEu8blks493QlXGf0B1xFJ6JID6QPZOzfP5B8Mw28R+uKLURl4ZRwc42/K4L3rMdsw37P4+QV29xQxAAABAAAAKhAABAAA/wD/AAIAEAAvAP8AAAibE2gA/wAeeNqdkUFqwkAYhd9olFZKF12UQhfNrotUISIJdmc0IIJRTHTdiFlETAbMIpfoGXqEnqbLHqZv4qAbEeoMM/837/1vAhkA9/iGgBoCz9WuRg0GTweuk140K/VdcwN3WGpu4hGx5hZeUTIljFsqDr4013CDH8116r+aDTjiQXMDT2KsuYk38aG5hUB8TmbhchBaUZolhRkkpbmQWZybntxt1LpgX7BWyb5IZW66HduufNqVOw/byp9G3nAU+L513uy7Xacn11vHxQQzhPwjA+4WIqTIkKCAiYC1ZF1AUouRkz3yDptjvS59XWpFb8+ulGelu+jA5jzlD+lTds7728f8lJ0ehhixz+e0/pXs83tdvn+P2hpbkvsHRaxy0AB42mNgZsALAAB9AAR42sVXe3BU1Rk/j8s+srnZTQIhGsJdssu67BISb4BglM3dPPARNwRIbYIUAsrKayCYwFRrSbDjWMcqmdqpgq1EsZVqld1zHV2M6M50arUdh4zTDvgoSauO1Sqhtur4TH/n3Ag6w1/9pxt+3+875/ud73zn3HN3D8lC0qnNYAdIJTG0GfibrpWSy+CX2q5KI5jTCu3CIlOyKJ1p5jSfHQ0a/mRAKyGDACN+2EZgHcCVpcTSSsT366wc6EaHtju0xaHOOutZCK8idZN5rcSeWW7Kbrug0ByU7PHKdrFYXWclvVoxuUbpiskqh0VHnQqnZJZicrnTa7e0OqOanO7ElLihzkiG0Q4CFtALHAHOAC5UX0xqgCFgEtBUS+oGgH3AMDAutSqbp86frNACiATU2gPYqQDGBLD2Hs2LtWeU9Wse7IqHLAcOam6iaQWCbDOOIgm3W1Wl3I4vUCyi80wVEBfOMo9pnO0nFxEDHVSUVagIEU1NU87iJY5jx6rNsWSBRsgEwDSiURJ1RtnRBeaZ59Gm/Cvip1T28i/swHTMxr+0/aWmlQzwT0kHwEiGZ0keYGQH/4gMAAzyI6L6YjkRP2IXFJkB6CdIEBgEOBmGpaptAVI/YZeWyfTvCH+xGjcmahc6jh0oNzuS0/kbqOcl/goJEYP/HTwb/AcwDh5/gb9IdFXnw7Y/YA5ivkOQH+I3kXkI/4rfTEzwYb6HVCjZq6LImedVEY2ZyQL+CL9FSfr4TrIQvI1vFaYRHOEPy/PI37e9Plnf+yIwwzzG3+VbyXSo3oJqpuE/xreTGkCuJGd7dXMoWchzWGYO22KgRkoOKmvxVwQSYb7f8EFShthxvpfMAD/KbxUzjPwI/0TJPpZZMN9DODGSbL3IzCe9/CF5QviH2PEP1Wz/sSNLTJKM8J+QWoBhU9+E9ya8AD8N7zQe02k8mtN4NKdRxWkcWsI/QOQDaGr4KdLLXydDwEH4GlLeJLCDR5UTjppH+Q/5LdiJwAj2jqJ3j+0tkpXdIkpKlewW+YI3HuMnyHKAofiT8o3cMcLvVksZsssr5IA/C28htu4HzrPAwJvlMzjGB/mtaif2qh3IPIcmzj//kRo8aRcWmwN4+p1o7oDdB4wCE4AGWSfW0EnWARzyDrvIb/pH+Go1+EpRVGcc41dg6Veo3bpCzKhSNV8+5Wh+UTHbfE46pJoSYmpFmkvUGCtGeBvOz3LeLq43UPsKgbxyYLu9pMGsHeHtai/ahRFyukXpBcpZJrzOuWq2C4plJS1KGBeeItUdn3olecyePtM0cE4b1GrrYAmvx+Orx6Opx3tSpx6GaQdKcPqv56ZakUl6gGEgA2h4xibkJp6xScZVj58vxnIXk0mA49kuJmcAfNXwi0kjsA94HhgHpqneHoChvxYz9MAOAQwZa9AOwFpADzAIDAN54AzgJsd5NeaphroWdhDIAGOAhmc1H3XMR6yEB8mXHkIMMsD2Ww10gAzQATbAB7SBaQOBgWKPtWjufNPaIs0CaaIw9T3eXu+gl9d6LW+Hlwe8QS/LTeaFu6EOZJW4GupeS72X+izFS+qHXENudjxZSIvJGDABcHKcBtAKoBWwbufHE2OJiQQ/nhpLTaT48VNjpyZO8ePVY9UT1dxKVTSY9evoDjpA91HNoDW0kS6n2jq+gw/wfVwzeA1vxFnQeny9vkEfr/VZvg4fD/iCPjbkG/ZlfHnfqG9axpV3jbrGXWdc0zpcPa5e16BryDXschnuGnej23JpZ5LN7HVs6jBsBmBkEHZIeQEVycOOqvaQavfA9qq2BduhvBBsrfSAEHK9Bt0g7BAgdbIdgq2VbSCEb/dX0dcLOwQw9qo1q6o2bIVZIBwMMxKmZ8J0NDweZplwPszyyQZ2UlV5ElWeVFWexMiTau6TyAsPCKHaE0p3AroTSncCOumdr68Htld5FmyH8kKwtdJjJ0So3p+cye5HxnWwB4ExgJMa2EZgh2oZUsHuh7XYAfui+fjBZwdEBN+RoCqHZjs0S5F9wYXmuqQfF5SDwBjAiWwZQKNsTebZftEitfvFUoca6saSl+BXVJaynxwBGFkOe1B5NbCNyjuiNP6z7QzsuPJ6YYfPjlunPKkzgK/Ha+wA/vbD87Ob0Xuz5WOkrIwQUlLsKcmxZ8TmEiPHnhTRAMh2SEhKljKO/dfpaWWfUPagsj9T9rvK+i1fSP80pP8+pD8S0pMF7CoSRvcZZd9VdotVFNb/EdZfCOuHwvpDYX2EvkmqEJhjXVilv12l/7VKf7pKf7RKv6dKX1Olr6jSr66SqaIkSHRWKS1dq+wsa2ZQ/yKo/y2o/ymovxjUHwzq3UG9IQg5/RC/qTr9hbL3Krvo6YW6sVCvXKg/w7A39FrhJ94Rxui1ROcFIpYwctyriM0RqbmgWSKVBFWI1ErQhSJ1I6hUpO4xkl7mp1lcWAxWRLMeyYUithdhn0MeEVsLmiZilxg5+pWIhUCfi3Ql6DORng36WKQXgj6S9Cz9N0kzpKH/EukHkJ6+R6IyLX2HRNhj4JxINUL9tDM7fZIk6Fx0C9z8pOy3Iobi6GERi4IeEbEw6NcOHRIxA/SgSC8APSDS94B+KdJvgQ6I6DaZbz+Jqjz3kYjiPpGqQHinSMkMvSJVA9ohUotAW0XiZdBmkXhLDr2BZilON02TmKp0vUjHEF43tZDvkagKryGLVObLRUpuyTKZJKnT1qmFtNBmee+jTTSrslgiVgtZQsQioKXOzl0m0nHQEhHFHtN6EX0AO7d4aoJ58vk8S8MoQyYKidhjEBkiPQ80W6RbQRVyJIoqnZq1hCRUUcUiJlUBEQsaz1EfSauMBSRCDzxlfIm8nydy9BphfGblPFQYn0RBTxnvpzYY/0zlcOs13sNr/NhTxhikpxJwLZ/xRuwt4/V0lfHHGBRWhfFSbIHxu8hNRi46Ytip2UYWhWXSG4wjaZXhiQiGCeNwNMcoRg+nrzbui8WNeyM5WcNPIb5dzoFEt8VuMm6N7DV24Sj0p+4w+mKVRm90rbElKieaaWyOrTQ2YSE3YMzG9A3G+tg9Rs8iVfHa2MvGqkVqDW1ptaIrEypwRXqlsQwVINAoA6jgUpxLE0MXLBqRe4TbSrP9svGd+mcZfonpIHCjtcB9zL3HvcHd6W7Cb85F7rnuOe7Z7umeEk/AU+Qp9BR4PB6XR/MwD/EQNj03OW7FCb7BprsCklyatJryA0xaGHkvYdTD8J+tTClvY22rmjL18bace3JlZkm8LePpuLYrS+nd3bQtk7+OtG0IZj5eFcrRghWrM9NCTTRT0kbaOpvKIc6wH+co6ezK0Uk54raKTElz11FC6fzb7qqQvOy2u7q7SdnuxvLGkkTxJctazmN6pmxrS/zcpzwe/1arMvPztlVdmUcruzOmdCYru9sy81YF13QdZdvYltaWo2yrpO6uo3QT29a6UvbTTS3dkF2qZCTBtkJGUpIgY2tIQsrQv+YbMppFd0s2kXBEy2lWivDSLFei1Y6o+ZsifidtVqJmfqcSPeBMGEMdmNCSBNm0bSSmJoxN26Zk5VKWjUSQKR2RkqwZgSAbMVV4xblw1Ak/7oQfl+EcpefiiyJOtVESUTNEWBSa+P/xs7HpfxhE7aW7t3e1bgy19oRaNwI9mTt3byrPDG4IBrPbd8tAMMMjPRuu2yR5/cbM7tDGlsz2UEswu7TrPOEuGV4aasmSrtbOrmyXtbFFLLWWtobWt3Tb7XuX7PzWXHecnWvJ3vMk2yuTLZFzte88T3inDLfLuXbKuXbKudqtdjVX28om2tbRlfWQpu7mNQ7bzFeAt6WnYk53U1mgN6FenUvnlO+peEYj9DDxxbszhaGmjA7IUHWyOilDeKVlqAjd/qlQ+Z5L51Q8Qw9PhQLoLg41kf7y1s0t+NeHT3//Lnywx319U6+UE+iPt6o4BP3w+tUHSvgSfap3Kt5Pdp37xOOOlvTFm7uyqVRr+eaWClzkbXn3jnf3kXjcmTAeJ5gTq1aX/TJ12fe5yur+kno79VGK59UtfxQYV7f8PG74o8A4bvmzeT4xmhhP8HxqNDUO7anRU+OneL56tHq8mtdPVSCn6qao8NzfrnjfLtkdp2q1at2yEBQNR676623oU4F+tTH4OP1qaByJ4meHx885fU5wlxri9PadO8MIyPT9u85zvp1eJMfex+P/BVwtKV8AAAA=") format("woff");
}
.pdf24_189 {
	font-size: 0.92em;
	font-family: "JOSUAS+Times New Roman Bold";
	color: #000000;
}
.pdf24_190 {
	letter-spacing: -0.0132em;
}

.pdf24_ie .pdf24_190 {
	letter-spacing: -0.195px;
}
.pdf24_191 {
	letter-spacing: -0.0075em;
}

.pdf24_ie .pdf24_191 {
	letter-spacing: -0.1108px;
}
.pdf24_192 {
	letter-spacing: -0.0088em;
}

.pdf24_ie .pdf24_192 {
	letter-spacing: -0.1293px;
}
.pdf24_193 {
	letter-spacing: -0.0162em;
}

.pdf24_ie .pdf24_193 {
	letter-spacing: -0.1505px;
}
.pdf24_194 {
	letter-spacing: -0.0129em;
}

.pdf24_ie .pdf24_194 {
	letter-spacing: -0.1194px;
}
.pdf24_195 {
	letter-spacing: -0.0046em;
}

.pdf24_ie .pdf24_195 {
	letter-spacing: -0.0683px;
}
.pdf24_196 {
	letter-spacing: -0.0043em;
}

.pdf24_ie .pdf24_196 {
	letter-spacing: -0.0637px;
}
.pdf24_197 {
	letter-spacing: -0.0148em;
}

.pdf24_ie .pdf24_197 {
	letter-spacing: -0.1374px;
}
.pdf24_198 {
	letter-spacing: -0.013em;
}

.pdf24_ie .pdf24_198 {
	letter-spacing: -0.1206px;
}
.pdf24_199 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.05em,59.33966em,5.950333em);
	width: 100%;
}
.pdf24_200 {
	letter-spacing: -0.0149em;
}

.pdf24_ie .pdf24_200 {
	letter-spacing: -0.2198px;
}
.pdf24_201 {
	letter-spacing: -0.0237em;
}

.pdf24_ie .pdf24_201 {
	letter-spacing: -0.2198px;
}
.pdf24_202 {
	letter-spacing: 0.0002em;
}

.pdf24_ie .pdf24_202 {
	letter-spacing: 0.0025px;
}
.pdf24_203 {
	letter-spacing: -0.0172em;
}

.pdf24_ie .pdf24_203 {
	letter-spacing: -0.16px;
}
.pdf24_204 {
	letter-spacing: 0.0005em;
}

.pdf24_ie .pdf24_204 {
	letter-spacing: 0.0067px;
}
.pdf24_205 {
	font-size: 0.696em;
	font-family: "JOSUAS+Times New Roman Bold";
	color: #000000;
}
.pdf24_206 {
	letter-spacing: -0.0159em;
}

.pdf24_ie .pdf24_206 {
	letter-spacing: -0.1471px;
}
.pdf24_207 {
	font-size: 0.696em;
	font-family: "MMPTWE+Times New Roman Bold";
	color: #000000;
}
.pdf24_208 {
	letter-spacing: -0.0051em;
}

.pdf24_ie .pdf24_208 {
	letter-spacing: -0.0752px;
}
.pdf24_209 {
	letter-spacing: -0.005em;
}

.pdf24_ie .pdf24_209 {
	letter-spacing: -0.0743px;
}
.pdf24_210 {
	letter-spacing: -0.0056em;
}

.pdf24_ie .pdf24_210 {
	letter-spacing: -0.0828px;
}
.pdf24_211 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.05em,9.763331em,5.950333em);
	width: 100%;
}
.pdf24_212 {
	letter-spacing: 0.0019em;
}

.pdf24_ie .pdf24_212 {
	letter-spacing: 0.0246px;
}
.pdf24_213 {
	letter-spacing: -0.0045em;
}

.pdf24_ie .pdf24_213 {
	letter-spacing: -0.0668px;
}
.pdf24_214 {
	position: absolute;
	pointer-events: none;
	clip: rect(49.18666em,45.05em,58.99966em,5.960333em);
	width: 100%;
}
.pdf24_215 {
	letter-spacing: -0.007em;
}

.pdf24_ie .pdf24_215 {
	letter-spacing: -0.1024px;
}
.pdf24_216 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,59.59967em,5.960333em);
	width: 100%;
}
.pdf24_217 {
	letter-spacing: -0.0143em;
}

.pdf24_ie .pdf24_217 {
	letter-spacing: -0.133px;
}
.pdf24_218 {
	letter-spacing: -0.014em;
}

.pdf24_ie .pdf24_218 {
	letter-spacing: -0.1301px;
}
.pdf24_219 {
	letter-spacing: -0.0138em;
}

.pdf24_ie .pdf24_219 {
	letter-spacing: -0.1279px;
}
.pdf24_220 {
	letter-spacing: -0.0079em;
}

.pdf24_ie .pdf24_220 {
	letter-spacing: -0.1162px;
}
.pdf24_221 {
	letter-spacing: -0.0125em;
}

.pdf24_ie .pdf24_221 {
	letter-spacing: -0.1162px;
}
.pdf24_222 {
	letter-spacing: -0.0151em;
}

.pdf24_ie .pdf24_222 {
	letter-spacing: -0.1403px;
}
.pdf24_223 {
	letter-spacing: 0.0003em;
}

.pdf24_ie .pdf24_223 {
	letter-spacing: 0.0044px;
}
.pdf24_224 {
	font-size: 0.648em;
	font-family: "BTSFMJ+Times New Roman";
	color: #000000;
}
.pdf24_225 {
	letter-spacing: 0.0032em;
}

.pdf24_ie .pdf24_225 {
	letter-spacing: 0.0427px;
}
.pdf24_226 {
	letter-spacing: -0.0147em;
}

.pdf24_ie .pdf24_226 {
	letter-spacing: -0.1364px;
}
.pdf24_227 {
	letter-spacing: -0.0191em;
}

.pdf24_ie .pdf24_227 {
	letter-spacing: -0.2812px;
}
.pdf24_228 {
	letter-spacing: -0.0303em;
}

.pdf24_ie .pdf24_228 {
	letter-spacing: -0.2812px;
}
.pdf24_229 {
	letter-spacing: -0.0085em;
}

.pdf24_ie .pdf24_229 {
	letter-spacing: -0.1246px;
}
.pdf24_230 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,16.85333em,5.960333em);
	width: 100%;
}
.pdf24_231 {
	letter-spacing: -0.0107em;
}

.pdf24_ie .pdf24_231 {
	letter-spacing: -0.157px;
}
.pdf24_232 {
	position: absolute;
	pointer-events: none;
	clip: rect(19.66em,43.87em,56.41em,5.960333em);
	width: 100%;
}
.pdf24_233 {
	letter-spacing: -0.011em;
}

.pdf24_ie .pdf24_233 {
	letter-spacing: -0.1619px;
}
.pdf24_234 {
	letter-spacing: -0.0154em;
}

.pdf24_ie .pdf24_234 {
	letter-spacing: -0.1427px;
}
.pdf24_235 {
	letter-spacing: -0.0156em;
}

.pdf24_ie .pdf24_235 {
	letter-spacing: -0.1444px;
}
.pdf24_236 {
	letter-spacing: -0.0072em;
}

.pdf24_ie .pdf24_236 {
	letter-spacing: -0.1056px;
}
.pdf24_237 {
	letter-spacing: -0.0114em;
}

.pdf24_ie .pdf24_237 {
	letter-spacing: -0.1056px;
}
.pdf24_238 {
	position: absolute;
	pointer-events: none;
	clip: rect(22.7325em,44.88em,54.4em,5.960333em);
	width: 100%;
}
.pdf24_239 {
	letter-spacing: -0.015em;
}

.pdf24_ie .pdf24_239 {
	letter-spacing: -0.1392px;
}
.pdf24_240 {
	letter-spacing: 0.0023em;
}

.pdf24_ie .pdf24_240 {
	letter-spacing: 0.0303px;
}
.pdf24_241 {
	position: absolute;
	pointer-events: none;
	clip: rect(9.009999em,45.05em,59.07967em,5.960333em);
	width: 100%;
}
@font-face {
	font-family:"FWQGNP+Times New Roman Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_242 {
	font-size: 0.92em;
	font-family: "FWQGNP+Times New Roman Italic", "Times New Roman";
	color: #000000;
}
.pdf24_243 {
	letter-spacing: -0.0128em;
}

.pdf24_ie .pdf24_243 {
	letter-spacing: -0.1883px;
}
.pdf24_244 {
	letter-spacing: -0.0104em;
}

.pdf24_ie .pdf24_244 {
	letter-spacing: -0.1525px;
}
.pdf24_245 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.05em,59.76967em,5.960333em);
	width: 100%;
}
.pdf24_246 {
	letter-spacing: -0.0078em;
}

.pdf24_ie .pdf24_246 {
	letter-spacing: -0.1152px;
}
.pdf24_247 {
	letter-spacing: -0.0174em;
}

.pdf24_ie .pdf24_247 {
	letter-spacing: -0.1617px;
}
.pdf24_248 {
	letter-spacing: -0.0326em;
}

.pdf24_ie .pdf24_248 {
	letter-spacing: -0.48px;
}
.pdf24_249 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,44.46em,15.80333em,5.960333em);
	width: 100%;
}
.pdf24_250 {
	letter-spacing: 0.0006em;
}

.pdf24_ie .pdf24_250 {
	letter-spacing: 0.008px;
}
.pdf24_251 {
	letter-spacing: -0.0119em;
}

.pdf24_ie .pdf24_251 {
	letter-spacing: -0.1755px;
}
.pdf24_252 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,44.46em,58.99966em,5.960333em);
	width: 100%;
}
.pdf24_253 {
	letter-spacing: -0.0067em;
}

.pdf24_ie .pdf24_253 {
	letter-spacing: -0.0989px;
}
.pdf24_254 {
	letter-spacing: -0.0265em;
}

.pdf24_ie .pdf24_254 {
	letter-spacing: -0.3905px;
}
.pdf24_255 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,60.00966em,5.960333em);
	width: 100%;
}
.pdf24_256 {
	letter-spacing: 0.0009em;
}

.pdf24_ie .pdf24_256 {
	letter-spacing: 0.0115px;
}
.pdf24_257 {
	letter-spacing: -0.0145em;
}

.pdf24_ie .pdf24_257 {
	letter-spacing: -0.2132px;
}
.pdf24_258 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,46.24em,59.88967em,5.960333em);
	width: 100%;
}
.pdf24_259 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,46.24em,25.09583em,5.960333em);
	width: 100%;
}
.pdf24_260 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,44.64em,59.15967em,5.940333em);
	width: 100%;
}
.pdf24_261 {
	font-size: 0.58em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_262 {
	letter-spacing: -0.0278em;
}

.pdf24_ie .pdf24_262 {
	letter-spacing: -0.4095px;
}
.pdf24_263 {
	letter-spacing: -0.0058em;
}

.pdf24_ie .pdf24_263 {
	letter-spacing: -0.0852px;
}
.pdf24_264 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.03em,59.85966em,5.940333em);
	width: 100%;
}
.pdf24_265 {
	letter-spacing: 0.0044em;
}

.pdf24_ie .pdf24_265 {
	letter-spacing: 0.0411px;
}
.pdf24_266 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.03em,59.50966em,5.960333em);
	width: 100%;
}
.pdf24_267 {
	letter-spacing: -0.0074em;
}

.pdf24_ie .pdf24_267 {
	letter-spacing: -0.1082px;
}
.pdf24_268 {
	letter-spacing: -0.0227em;
}

.pdf24_ie .pdf24_268 {
	letter-spacing: -0.2103px;
}
.pdf24_269 {
	letter-spacing: -0.0153em;
}

.pdf24_ie .pdf24_269 {
	letter-spacing: -0.1422px;
}
.pdf24_270 {
	letter-spacing: -0.0166em;
}

.pdf24_ie .pdf24_270 {
	letter-spacing: -0.154px;
}
.pdf24_271 {
	letter-spacing: -0.0161em;
}

.pdf24_ie .pdf24_271 {
	letter-spacing: -0.1491px;
}
.pdf24_272 {
	letter-spacing: -0.0163em;
}

.pdf24_ie .pdf24_272 {
	letter-spacing: -0.151px;
}
.pdf24_273 {
	letter-spacing: -0.0192em;
}

.pdf24_ie .pdf24_273 {
	letter-spacing: -0.1783px;
}
.pdf24_274 {
	letter-spacing: -0.008em;
}

.pdf24_ie .pdf24_274 {
	letter-spacing: -0.1183px;
}
.pdf24_275 {
	letter-spacing: -0.0168em;
}

.pdf24_ie .pdf24_275 {
	letter-spacing: -0.1564px;
}
.pdf24_276 {
	letter-spacing: -0.0175em;
}

.pdf24_ie .pdf24_276 {
	letter-spacing: -0.1624px;
}
.pdf24_277 {
	letter-spacing: -0.0213em;
}

.pdf24_ie .pdf24_277 {
	letter-spacing: -0.3133px;
}
.pdf24_278 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.03em,29.72583em,5.960333em);
	width: 100%;
}
.pdf24_279 {
	letter-spacing: -0.0001em;
}

.pdf24_ie .pdf24_279 {
	letter-spacing: -0.0011px;
}
.pdf24_280 {
	position: absolute;
	pointer-events: none;
	clip: rect(21.5825em,19.25533em,58.59967em,5.960333em);
	width: 100%;
}
.pdf24_281 {
	position: absolute;
	pointer-events: none;
	clip: rect(26.8825em,45.06em,51.21em,5.960333em);
	width: 100%;
}
.pdf24_282 {
	font-size: 0.92em;
	font-family: "EAJTTK+Times New Roman";
	color: #0000FF;
}
.pdf24_283 {
	position: absolute;
	pointer-events: none;
	clip: rect(17.39em,13.71367em,44.8875em,5.960333em);
	width: 100%;
}
.pdf24_284 {
	position: absolute;
	pointer-events: none;
	clip: rect(12.18em,14.73367em,23.90583em,5.960333em);
	width: 100%;
}
.pdf24_285 {
	position: absolute;
	pointer-events: none;
	clip: rect(41.80416em,44.47em,59.87967em,5.960333em);
	width: 100%;
}
.pdf24_286 {
	letter-spacing: -0.0207em;
}

.pdf24_ie .pdf24_286 {
	letter-spacing: -0.3054px;
}
.pdf24_287 {
	letter-spacing: -0.0329em;
}

.pdf24_ie .pdf24_287 {
	letter-spacing: -0.3054px;
}
.pdf24_288 {
	letter-spacing: -0.0155em;
}

.pdf24_ie .pdf24_288 {
	letter-spacing: -0.2282px;
}
.pdf24_289 {
	letter-spacing: -0.0124em;
}

.pdf24_ie .pdf24_289 {
	letter-spacing: -0.1825px;
}
.pdf24_290 {
	letter-spacing: -0.03em;
}

.pdf24_ie .pdf24_290 {
	letter-spacing: -0.2784px;
}
.pdf24_291 {
	letter-spacing: -0.0178em;
}

.pdf24_ie .pdf24_291 {
	letter-spacing: -0.1653px;
}
.pdf24_292 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.1875em,46.41167em,5.960333em);
	width: 100%;
}
.pdf24_293 {
	position: absolute;
	pointer-events: none;
	clip: rect(34.42417em,44.56em,47.9775em,5.960333em);
	width: 100%;
}
.pdf24_294 {
	letter-spacing: -0.0221em;
}

.pdf24_ie .pdf24_294 {
	letter-spacing: -0.205px;
}
.pdf24_295 {
	font-size: 0.83em;
	font-family: "JOSUAS+Times New Roman Bold";
	color: #000000;
}
.pdf24_296 {
	position: absolute;
	pointer-events: none;
	clip: rect(12.025em,44.18333em,33.91583em,5.990334em);
	width: 100%;
}
.pdf24_297 {
	letter-spacing: -0.0215em;
}

.pdf24_ie .pdf24_297 {
	letter-spacing: -0.2854px;
}
.pdf24_298 {
	font-size: 0.903274em;
	font-family: "IOVIOE+Courier New";
	color: #000000;
}
.pdf24_299 {
	font-size: 0.92em;
	font-family: "IOVIOE+Courier New";
	color: #000000;
}
.pdf24_300 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.04em,58.50967em,5.960333em);
	width: 100%;
}
.pdf24_301 {
	letter-spacing: -0.0203em;
}

.pdf24_ie .pdf24_301 {
	letter-spacing: -0.2981px;
}
.pdf24_302 {
	letter-spacing: -0.0321em;
}

.pdf24_ie .pdf24_302 {
	letter-spacing: -0.2981px;
}
.pdf24_303 {
	letter-spacing: -0.0238em;
}

.pdf24_ie .pdf24_303 {
	letter-spacing: -0.3499px;
}
.pdf24_304 {
	letter-spacing: -0.0377em;
}

.pdf24_ie .pdf24_304 {
	letter-spacing: -0.3499px;
}
.pdf24_305 {
	position: absolute;
	pointer-events: none;
	clip: rect(15.95em,43.87em,30.60583em,5.960333em);
	width: 100%;
}
.pdf24_306 {
	letter-spacing: -0.017em;
}

.pdf24_ie .pdf24_306 {
	letter-spacing: -0.2495px;
}
.pdf24_307 {
	letter-spacing: -0.0201em;
}

.pdf24_ie .pdf24_307 {
	letter-spacing: -0.2966px;
}
.pdf24_308 {
	letter-spacing: -0.032em;
}

.pdf24_ie .pdf24_308 {
	letter-spacing: -0.2966px;
}
.pdf24_309 {
	position: absolute;
	pointer-events: none;
	clip: rect(6.162501em,44.2275em,27.1975em,6.160334em);
	width: 100%;
}
.pdf24_310 {
	position: absolute;
	pointer-events: none;
	clip: rect(25.9825em,43.29em,35.8475em,5.960333em);
	width: 100%;
}
.pdf24_311 {
	letter-spacing: -0.0133em;
}

.pdf24_ie .pdf24_311 {
	letter-spacing: -0.1238px;
}
.pdf24_312 {
	position: absolute;
	pointer-events: none;
	clip: rect(6.458333em,47.22083em,28.10583em,5.271544em);
	width: 100%;
}
.pdf24_313 {
	position: absolute;
	pointer-events: none;
	clip: rect(39.81417em,44.47em,57.24em,5.960333em);
	width: 100%;
}
.pdf24_314 {
	letter-spacing: -0.0126em;
}

.pdf24_ie .pdf24_314 {
	letter-spacing: -0.1854px;
}
.pdf24_315 {
	position: absolute;
	pointer-events: none;
	clip: rect(15.47417em,43.26075em,34.715em,7.770833em);
	width: 100%;
}
@font-face {
	font-family:"DALEHV+Arial";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_316 {
	font-size: 0.58em;
	font-family: "DALEHV+Arial";
	color: #000000;
}
.pdf24_317 {
	line-height: 1.117188em;
}
.pdf24_318 {
	font-size: 0.832em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_319 {
	position: absolute;
	pointer-events: none;
	clip: rect(37.58416em,45.06em,59.40967em,5.960333em);
	width: 100%;
}
.pdf24_320 {
	letter-spacing: -0.0241em;
}

.pdf24_ie .pdf24_320 {
	letter-spacing: -0.3545px;
}
.pdf24_321 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,45.06em,39.91167em,5.960333em);
	width: 100%;
}
.pdf24_322 {
	letter-spacing: 0.0028em;
}

.pdf24_ie .pdf24_322 {
	letter-spacing: 0.0365px;
}
.pdf24_323 {
	font-size: 0.67em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_324 {
	position: absolute;
	pointer-events: none;
	clip: rect(22.8325em,44.47em,41.9175em,5.960333em);
	width: 100%;
}
.pdf24_325 {
	letter-spacing: -0.025em;
}

.pdf24_ie .pdf24_325 {
	letter-spacing: -0.368px;
}
.pdf24_326 {
	letter-spacing: -0.0233em;
}

.pdf24_ie .pdf24_326 {
	letter-spacing: -0.3434px;
}
.pdf24_327 {
	letter-spacing: -0.037em;
}

.pdf24_ie .pdf24_327 {
	letter-spacing: -0.3434px;
}
.pdf24_328 {
	letter-spacing: -0.0338em;
}

.pdf24_ie .pdf24_328 {
	letter-spacing: -0.3135px;
}
.pdf24_329 {
	position: absolute;
	pointer-events: none;
	clip: rect(7.008331em,43.88em,59.46967em,5.960333em);
	width: 100%;
}
.pdf24_330 {
	letter-spacing: -0.0356em;
}

.pdf24_ie .pdf24_330 {
	letter-spacing: -0.3818px;
}
.pdf24_331 {
	letter-spacing: -0.0315em;
}

.pdf24_ie .pdf24_331 {
	letter-spacing: -0.3377px;
}
.pdf24_332 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.878336em,44.23em,52.9275em,5.960333em);
	width: 100%;
}
.pdf24_333 {
	letter-spacing: -0.0235em;
}

.pdf24_ie .pdf24_333 {
	letter-spacing: -0.346px;
}
.pdf24_334 {
	letter-spacing: -0.0135em;
}

.pdf24_ie .pdf24_334 {
	letter-spacing: -0.1444px;
}
.pdf24_335 {
	font-size: 0.672em;
	font-family: "EAJTTK+Times New Roman";
	color: #000000;
}
.pdf24_336 {
	font-size: 0.92em;
	font-family: "EAJTTK+Times New Roman";
	color: #333333;
}
.pdf24_337 {
	position: absolute;
	pointer-events: none;
	clip: rect(19.0625em,19.4em,22.45em,5.666667em);
	width: 100%;
}

 body > div {
	box-shadow: 0 0 5px rgba(0,0,0,0.3) !important;
	margin: 20px auto !important;
}

</STYLE> 
</head>
	<body>
		<div id="page_0" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:15.3017em;top:6.0418em;"><span class="pdf24_05 pdf24_06 pdf24_07" style="word-spacing:-0.0295em;">FICHA TCNICA: Informacin para el profesional &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7042em;top:7.9218em;"><span class="pdf24_05 pdf24_06 pdf24_08" style="word-spacing:-0.0033em;">IMFINZI 50 mg/ mL &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.4042em;top:9.8018em;"><span class="pdf24_05 pdf24_06 pdf24_09">(Durvalumab) &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.9242em;top:11.6918em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.0235em;">Concentrado para solucin para Perfusin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:13.7918em;"><span class="pdf24_12 pdf24_06 pdf24_13">1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.9119em;"><span class="pdf24_14 pdf24_06 pdf24_10">IMFINZI</span><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0297em;"> </span><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.025em;">50 mg/ mL, concentrado para solucin para Perfusin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:17.9908em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.9685em;">2. </span><span class="pdf24_05 pdf24_06 pdf24_16" style="word-spacing:-0.0432em;">COMPOSICIN CUALITATIVA Y CUANTITATIVA &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:13.7918em;"><span class="pdf24_05 pdf24_06 pdf24_17" style="word-spacing:-0.0248em;">NOMBRE DEL MEDICAMENTO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1243em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.06em;">IMFINZI (DURVALUMAB) se suministra en viales de un solo uso de 500 mg/10 ml y 120 mg/2.4 ml, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0242em;">Cada vial de 10 mL contiene 500 mg de durvalumab y excipientes c.s. Cada vial de 2.4 mL contiene 120 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.2343em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0012em;">mg de durvalumab y excipientes c.s &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.7843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2812em;">Cada mililitro de solucin de IMFINZI contiene 50 mg de durvalumab, L-Histindina, L-Histidina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.8443em;"><span class="pdf24_20 pdf24_06 pdf24_21" style="word-spacing:-0.0092em;">clorhidrato monohidrato, ,</span><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0007em;">-Trehalosa dihidrato, Polisorbato 80 y agua para inyeccin. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:26.9643em;"><span class="pdf24_12 pdf24_06 pdf24_13">3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:26.9643em;"><span class="pdf24_05 pdf24_06 pdf24_23" style="word-spacing:-0.0305em;">FORMA FARMACUTICA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.0643em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:-0.0254em;">Concentrado para solucin para Perfusin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:31.1643em;"><span class="pdf24_12 pdf24_06 pdf24_13">4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:31.1643em;"><span class="pdf24_05 pdf24_06 pdf24_25">INDICACIONES &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:7.782em;top:33.2033em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2298em;">4.1. </span><span class="pdf24_05 pdf24_06 pdf24_27" style="word-spacing:-0.0135em;">Cncer de Pulmn de Clulas No Pequeas &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:34.7409em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:34.846em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0386em;">IMFINZI en combinacin con quimioterapia con platino como tratamiento neoadyuvante, seguido de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:35.906em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0285em;">IMFINZI como agente nico como tratamiento adyuvante despus de la ciruga, est indicado para el &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.956em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1178em;">tratamiento de pacientes adultos con cncer de pulmn de clulas no pequeas (CPCNP) resecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.006em;"><span class="pdf24_20 pdf24_06 pdf24_33" style="word-spacing:0.2376em;">(tumores  4 cm y/o ganglios positivos) y sin mutaciones conocidas del receptor del factor de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:39.066em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0001em;">crecimiento epidrmico (EGFR) o reordenamientos de la quinasa del linfoma anaplsico (ALK). &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:40.186em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0679em;">IMFINZI, como agente nico, est indicado para el tratamiento de pacientes adultos con CPCNP no &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:41.236em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1321em;">resecable en estado III cuya enfermedad no ha progresado despus de la quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0042em;">platino asociada a la radioterapia concurrente (QRTc). &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:40.0809em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:43.3109em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:43.416em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.1072em;">IMFINZI, en combinacin con tremelimumab-actl y quimioterapia basada en platino, est indicado &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:44.466em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1059em;">para el tratamiento de pacientes adultos con CPCNP metastsico sin mutaciones sensibilizantes del &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.516em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.004em;">EGFR ni aberraciones tumorales genmicas de la ALK. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:7.782em;top:47.545em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2298em;">4.2. </span><span class="pdf24_05 pdf24_06 pdf24_27" style="word-spacing:-0.0161em;">Cncer de Pulmn de Clulas Pequeas &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:49.0834em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:52.3134em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:49.1885em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1093em;">IMFINZI, como agente nico, est indicado para el tratamiento de pacientes adultos con cncer de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:50.2385em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0597em;">pulmn de clulas pequeas en estado limitado (CPCP-EL) cuya enfermedad no ha progresado despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:51.2885em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0016em;">de la quimioterapia basada en platino asociada a la radioterapia concurrente (QRTc). &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0047em;">IMFINZI, en combinacin con etopsido y carboplatino o cisplatino, est indicado para el tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0862em;">de primera lnea de pacientes adultos con cncer de pulmn de clulas pequeas en estado extenso &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:54.5185em;"><span class="pdf24_14 pdf24_06 pdf24_40">(CPCP-EE). &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">1 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_1" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAWlklEQVR4nO3aMaqdZRhG0QMWTkIwDkYQR2AZnIZFWqegEVNYZRoZmSdYBMG8nd5H9lrw9X/xcO+74TweAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAkK+f75XneV7wffkAAP53fnq+N57necH31QMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAODf9+H53nneZ94vA9/ged7LvbfP9/vAd3ie9+m9f77XDwj746U/gGn2AW0fj6UvXvojgL/54fm+f+mPgJfkQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyPvt+d543meefXhe+/kb4Hl77+fn+/YBYR//Ob3yvM88+/C89vvl+b4Z+A7P8z69H5/vuweE+YkQF/uAtncPPyGDNX5CRp4DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFD3ofHX/+gPO+f3q8D3+B53su9t8/3+8B3eJ736b1/vtcPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOC/9Ccais3YrnoogAAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_47" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_11" style="left:7.782em;top:6.0108em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2298em;">4.3. </span><span class="pdf24_05 pdf24_06 pdf24_48" style="word-spacing:-0.017em;">Cncer de Vas Biliares &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.5818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1157em;">IMFINZI, en combinacin con gemcitabina y cisplatino, est indicado para el tratamiento de pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.6418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0019em;">adultos con cncer de vas biliares (CVB) localmente avanzado o metastsico. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:7.782em;top:10.6708em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2298em;">4.4. </span><span class="pdf24_05 pdf24_06 pdf24_49" style="word-spacing:-0.026em;">Carcinoma hepatocelular &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.2518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0672em;">IMFINZI, en combinacin con tremelimumab-actl est indicado para el tratamiento de pacientes adultos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.3018em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0024em;">con carcinoma hepatocelular (CHC) irresecable. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:7.782em;top:15.3308em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2298em;">4.5. </span><span class="pdf24_05 pdf24_06 pdf24_51" style="word-spacing:-0.0162em;">Cncer de endometrio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.9118em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0085em;">IMFINZI, en combinacin con carboplatino y paclitaxel est indicado para el tratamiento de primera lnea &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.9618em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0294em;">de adultas con cncer de endometrio primario avanzado o recurrente que son candidatas a terapia sistmica, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.0218em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0007em;">seguido de tratamiento de mantenimiento con: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:20.0392em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:20.1443em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.16em;">IMFINZI en monoterapia en cncer de endometrio con deficiencia en la reparacin de errores de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:21.1943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0002em;">emparejamiento (dMMR, por sus siglas en ingls) &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:22.2092em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:22.3143em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0046em;">IMFINZI en combinacin con olaparib en cncer de endometrio con reparacin competente de errores &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:23.3643em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0011em;">de emparejamiento (pMMR, por sus siglas en ingls). &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:25.4743em;"><span class="pdf24_12 pdf24_06 pdf24_13">5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:25.4743em;"><span class="pdf24_05 pdf24_06 pdf24_52" style="word-spacing:-0.0064em;">DOSIS Y ADMINISTRACIN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.5743em;"><span class="pdf24_14 pdf24_06 pdf24_53" style="word-spacing:-0.0171em;">Test de MMR para pacientes con cncer de endometrio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.6343em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0324em;">Las pacientes con cncer de endometrio deben ser evaluadas para el tratamiento, en base al estado de MMR &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.6843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0002em;">del tumor confirmado mediante un test validado &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.272em;top:31.7443em;"><span class="pdf24_12 pdf24_06 pdf24_26">5.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5717em;top:31.7443em;"><span class="pdf24_05 pdf24_06 pdf24_54" style="word-spacing:-0.012em;">Dosis Recomendada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0346em;">Las dosis recomendadas para IMFINZI como agente nico e IMFINZI en combinacin con otros agentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.346em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.044em;">teraputicos se presentan en la Tabla 1. La pauta de las dosis y los regmenes de administracin de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.406em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:0.0588em;">recomendados para el tratamiento del CPCNP metastsico se proporcionan en las Tablas 2 y 3 [</span><span class="pdf24_55 pdf24_06 pdf24_56">consulte &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.456em;"><span class="pdf24_55 pdf24_06 pdf24_57">Indicaciones</span><span class="pdf24_14 pdf24_06 pdf24_49">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.566em;"><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:0.212em;">Administrar IMFINZI como una infusin intravenosa despus de la dilucin segn lo recomendado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.616em;"><span class="pdf24_55 pdf24_06 pdf24_59" style="word-spacing:-0.0136em;">[consulte Dosis y Administracin]</span><span class="pdf24_14 pdf24_06 pdf24_59" style="word-spacing:-0.0136em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.736em;"><span class="pdf24_05 pdf24_06 pdf24_48" style="word-spacing:-0.0169em;">Tabla 1. Dosis Recomendadas de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.756em;"><span class="pdf24_05 pdf24_06 pdf24_60">Indicacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:43.916em;"><span class="pdf24_14 pdf24_06 pdf24_61">Tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0026em;">neoadyuvante y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:46.026em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.008em;">adyuvante del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.086em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0646em;">CPCNP resecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:42.756em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:-0.0205em;">Dosis recomendada de</span><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:0.2102em;">&nbsp;</span><span class="pdf24_05 pdf24_06 pdf24_63">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:43.926em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0311em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:45.146em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:42.756em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0067em;">Duracin de la Terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:43.916em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">Hasta la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0504em;">enfermedad que impide la ciruga &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:46.026em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0024em;">definitiva, recurrencia, toxicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:47.086em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0016em;">inaceptable o un mximo de 12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:48.1385em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0017em;">ciclos despus de la ciruga &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:47.186em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0004em;">Neoadyuvante: 1500 mg de IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:48.3985em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.06em;">combinacin con quimioterapia* cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:49.6185em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0134em;">semanas, durante un mximo de 4 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:50.8285em;"><span class="pdf24_14 pdf24_06 pdf24_67" style="word-spacing:-0.0045em;">antes de la ciruga &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:52.8685em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0065em;">Adyuvante: 1500 mg de IMFINZI como &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:54.0785em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0254em;">agente nico cada 4 semanas, durante un &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:55.2885em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0027em;">mximo de 12 ciclos despus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:56.5085em;"><span class="pdf24_14 pdf24_06 pdf24_68">ciruga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">2 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_2" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_69" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:15.0017em;top:6.0018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0264em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:7.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:9.2518em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0001em;">Neoadyuvante: 20 mg/kg de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:10.4718em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0031em;">cada 3 semanas en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:11.6818em;"><span class="pdf24_14 pdf24_06 pdf24_67">quimioterapia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.0948em;">* </span></sup><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0386em;">durante un mximo de 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:12.8918em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0051em;">ciclos antes de la ciruga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:14.8518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0368em;">Adyuvante: 20 mg/kg de IMFINZI cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:15.9018em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0005em;">4 semanas, como agente nico, durante &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:16.9618em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0049em;">un mximo de 12 ciclos despus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:18.0118em;"><span class="pdf24_14 pdf24_06 pdf24_68">ciruga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:19.1918em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0617em;">CPCNP Estado III &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:20.2443em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:0.0014em;">no resecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:19.1918em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0347em;">Despus de la quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:20.2443em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0054em;">platino asociada a la radioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:21.3043em;"><span class="pdf24_14 pdf24_06 pdf24_72">concurrente: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:19.1918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">Hasta la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:20.2443em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0627em;">enfermedad, toxicidad inaceptable o &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:21.3043em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0004em;">un mximo de 12 meses. &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:22.3544em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0251em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.038em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:23.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:24.4643em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0438em;">10 mg/kg cada 2 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:25.5143em;"><span class="pdf24_14 pdf24_06 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:26.5643em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0099em;">1500 mg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:28.6843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0233em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:29.7343em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:30.7143em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0069em;">10 mg/kg cada 2 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:31.8843em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0646em;">CPCP Estado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:32.9343em;"><span class="pdf24_14 pdf24_06 pdf24_60">Limitado &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:31.8843em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0369em;">Despus de la quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:32.9343em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0054em;">platino asociada a la radioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:33.986em;"><span class="pdf24_14 pdf24_06 pdf24_72">concurrente: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:31.8843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">Hasta la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:32.9343em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0627em;">enfermedad, toxicidad inaceptable o &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:33.986em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0004em;">un mximo de 24 meses. &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:35.046em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0311em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:36.096em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:37.156em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0072em;">1500 mg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:39.256em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0264em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:40.316em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:41.296em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0069em;">20 mg/kg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.456em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0646em;">CPCP Estado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:43.516em;"><span class="pdf24_14 pdf24_06 pdf24_75">Extenso &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:42.456em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0251em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.038em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:43.516em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:42.456em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">Hasta la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:43.516em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0602em;">enfermedad o toxicidad inaceptable. &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:44.566em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">1500 mg en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:45.626em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0337em;">quimioterapia* cada 3 semanas (21 das) &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0084em;">durante 4 ciclos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:47.7285em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0377em;">seguido de 1500 mg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:48.7885em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0033em;">como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:50.8885em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0233em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:51.9485em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:52.9985em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0026em;">20 mg/kg en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:54.0585em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0337em;">quimioterapia* cada 3 semanas (21 das) &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:55.1085em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0084em;">durante 4 ciclos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:56.1585em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0368em;">seguido de 10 mg/kg cada 2 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:57.2182em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0033em;">como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">3 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_3" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAl3ElEQVR4nO3ZsY215RWF0Su5FNpAgoTEogAggT4c0AA5goA/gAbsZkxGK74TjZA1J71betaS3vwLtkbnmft4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP/vu+f70vM+eJ8PfIPnea97b38Dvhj4Ds/z3t/Xz/fZA8L+/Xzfe94H79eBb/A873Xvl+f7YeA7PM97fz8937cPCPv91R/ANPuAtk/P949XfwTwN9883z9f/RHwSg5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMh7O1A/ed4Hzz48r/3+eL7fBr7D87z39/PzffWAMP9h52If0PZ2LPkFBrb4BYY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0Chry3A/WT533w7MPz2u+P5/tt4Ds8z3t/Pz/fVw8I8x92LvYBbW/Hkl9gYItfYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOQ5ULnYB7QJGNgjYMhzoHKxD2gTMLBHwJDnQOViH9AmYGCPgCHPgcrFPqBNwMAeAUOeA5WLfUCbgIE9AoY8ByoX+4A2AQN7BAx5DlQu9gFtAgb2CBjyHKhc7APaBAzsETDkOVC52Ae0CRjYI2DIc6BysQ9oEzCwR8CQ50DlYh/QJmBgj4Ahz4HKxT6gTcDAHgFDngOVi31Am4CBPQKGPAcqF/uANgEDewQMeQ5ULvYBbQIG9ggY8hyoXOwD2gQM7BEw5DlQudgHtAkY2CNgyHOgcrEPaBMwsEfAkOdA5WIf0CZgYI+AIc+BysU+oE3AwB4BQ54DlYt9QJuAgT0ChjwHKhf7gDYBA3sEDHkOVC72AW0CBvYIGPIcqFzsA9oEDOwRMOT95/m+97wP3q8D3+B53uveL8/3w8B3eJ73/n56vm8fEPbd833peR+8zwe+wfO81723vwFfDHyH53nv7+vn++wBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPB6/3q+Hz3P8zzP8z54b7cCwIw/n+8vz/M8z/O8D95/HwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAkPQ//beWFJFNxJ8AAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_76" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.492em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_77">CVB &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:5.9918em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0223em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:7.0418em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:5.9918em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.063em;">Hasta la progresin de la enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:7.0418em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0038em;">o hasta toxicidad inaceptable &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:8.1018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">1500 mg en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:9.1518em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0337em;">quimioterapia* cada 3 semanas (21 das) &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:10.1918em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0017em;">hasta 8 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:11.2618em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0327em;">seguidos de 1500 mg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:12.3118em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0033em;">como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:14.4318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0233em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:15.4818em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:16.5318em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0026em;">20 mg/kg en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:17.5918em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0337em;">quimioterapia* cada 3 semanas (21 das) &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:18.6418em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0017em;">hasta 8 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:19.7043em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0328em;">seguidos de 20 mg/kg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:20.7543em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0033em;">como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_79" style="word-spacing:-0.0209em;">CHC irresecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:21.8544em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0046em;">Pacientes con un peso corporal de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:0.0055em;"> </span><span class="pdf24_14 pdf24_06 pdf24_80">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:21.8544em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.5046em;">Despus del Ciclo 1 de terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.7812em;">combinada, administre IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_67" style="word-spacing:0.1315em;">como agente nico cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:25.0143em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:0.0018em;">hasta la progresin de la enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:26.0643em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0023em;">o toxicidad inaceptable. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:15.1317em;top:23.9192em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:16.3242em;top:24.0243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0173em;">IMFINZI 1500 mg luego de una dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:25.0743em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:0.0677em;">nica de tremelimumab-actl</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.2672em;">$ </span></sup><span class="pdf24_14 pdf24_06 pdf24_82" style="word-spacing:0.0612em;">300 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:26.1343em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0028em;">en el Da 1 del Ciclo 1; &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:15.1317em;top:27.1492em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:16.3242em;top:27.2543em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.4799em;">Contine con IMFINZI 1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:28.3043em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0009em;">como agente nico cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:30.4143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0051em;">Pacientes con un peso corporal de &lt; 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:31.4643em;"><span class="pdf24_14 pdf24_06 pdf24_64">kg: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:15.1317em;top:32.4792em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:16.3242em;top:32.5843em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1926em;">IMFINZI 20 mg/kg despus de una &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:33.636em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.1263em;">dosis nica de tremelimumab-actl</span><sup style="top: -0.3317em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.3362em;">$ </span></sup><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.212em;">4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0035em;">mg/kg en el Da 1 del Ciclo 1; &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:15.1317em;top:35.6409em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:16.3242em;top:35.746em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3301em;">Continuar con IMFINZI 20 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:36.796em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0009em;">como agente nico cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:37.966em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0045em;">Cncer de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:39.016em;"><span class="pdf24_14 pdf24_06 pdf24_72">Endometrio &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:37.966em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">1120 mg en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:39.016em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0257em;">carboplatino y paclitaxel cada 3 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:40.076em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0255em;">(21 das) durante un mnimo de 4 y hasta &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:41.126em;"><span class="pdf24_14 pdf24_06 pdf24_85" style="word-spacing:-0.0002em;">6 ciclos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:37.966em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.063em;">Hasta la progresin de la enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:39.016em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0036em;">o hasta toxicidad inaceptable. &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:43.226em;"><span class="pdf24_14 pdf24_06 pdf24_86" style="word-spacing:-0.0075em;">seguido de 1500 mg</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.1446em;">j </span></sup><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:0.0026em;">de IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:44.286em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0272em;">monoterapia cada 4 semanas (pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:45.336em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0388em;">dMMR) o en combinacin con olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:46.396em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0025em;">300 mg dos veces al da (pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.0017em;top:47.376em;"><span class="pdf24_14 pdf24_06 pdf24_87">pMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.6487em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.0593em;">* Administre IMFINZI antes de la quimioterapia el mismo da. Consulte la informacin de prescripcin del agente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.6087em;"><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0528em;">administrado en combinacin con IMFINZI para obtener informacin sobre la dosis recomendada, segn corresponda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5271em;"><span class="pdf24_88 pdf24_06 pdf24_15">$</span></div>
					<div class="pdf24_01" style="left:6.632em;top:50.5587em;"><span class="pdf24_41 pdf24_06 pdf24_89" style="word-spacing:0.18em;">Administrar tremelimumab-actl antes de IMFINZI el mismo da. Cuando se administre tremelimumab-actl en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.5187em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0496em;">combinacin con IMFINZI, consulte la Informacin de prescripcin para obtener informacin sobre la dosificacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4787em;"><span class="pdf24_41 pdf24_06 pdf24_91" style="word-spacing:-0.0001em;">de tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4071em;"><span class="pdf24_88 pdf24_06 pdf24_15">j</span></div>
					<div class="pdf24_01" style="left:6.432em;top:53.4387em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.0815em;">Las pacientes con cncer de endometrio con un peso corporal de 30 kg o menos deben recibir durante la fase de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.3987em;"><span class="pdf24_41 pdf24_06 pdf24_93" style="word-spacing:0.0024em;">mantenimiento una dosis basada en el peso, equivalente a 20 mg/kg de IMFINZI hasta que el peso aumente a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.3487em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0043em;">30 kg. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.3582em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.0341em;">IMFINZI en combinacin con tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">4 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_4" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_95" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0004em;">El esquema de dosificacin y los regmenes recomendados para IMFINZI para el tratamiento de CPCNP &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0038em;">metastsico se proporcionan en las Tablas 2 y 3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1318em;"><span class="pdf24_14 pdf24_06 pdf24_96" style="word-spacing:-0.0139em;">Pesar a los pacientes antes de cada perfusin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0356em;">Calcule la dosis adecuada utilizando la Tabla 3 a continuacin segn el peso del paciente y la histologa del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2418em;"><span class="pdf24_14 pdf24_06 pdf24_97">tumor. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_05 pdf24_06 pdf24_98" style="word-spacing:-0.0272em;">Tabla 2. Horario de dosificacin recomendado para CPCNP metastsico &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6342em;top:13.4233em;"><span class="pdf24_99 pdf24_06 pdf24_100">Semana</span><span class="pdf24_101 pdf24_06 pdf24_102">*</span><sup style="top: -0.25em;"><span class="pdf24_103 pdf24_06 pdf24_72">,</span><span class="pdf24_104 pdf24_06 pdf24_72">$ &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:11.9217em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:13.1017em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">1</span></div>
					<div class="pdf24_01" style="left:14.1817em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">2</span></div>
					<div class="pdf24_01" style="left:15.2717em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:16.4642em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01" style="left:17.5442em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:19.8342em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:20.9042em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:21.9942em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:23.2042em;top:14.3433em;"><span class="pdf24_99 pdf24_06 pdf24_102" style="word-spacing:0.698em;">10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_105">Ciclo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.9217em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">1</span></div>
					<div class="pdf24_01" style="left:11.9217em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:11.9217em;top:17.1733em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:15.2717em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">2</span></div>
					<div class="pdf24_01" style="left:15.2717em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:15.2717em;top:17.1733em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:17.1733em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:21.9942em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01" style="left:21.9942em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:21.9942em;top:17.1733em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:31.6858em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:31.6858em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:31.6858em;top:17.1733em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:37.3558em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:37.3558em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:43.0283em;top:15.2833em;"><span class="pdf24_99 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:43.0283em;top:16.2133em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:6.472em;top:16.2133em;"><span class="pdf24_101 pdf24_06 pdf24_106">IMFINZI*</span><sup style="top: -0.25em;"><span class="pdf24_104 pdf24_06 pdf24_72">, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:17.1833em;"><span class="pdf24_101 pdf24_06 pdf24_107">Tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:18.0533em;"><span class="pdf24_101 pdf24_06 pdf24_108">actl</span><sup style="top: -0.25em;"><span class="pdf24_104 pdf24_06 pdf24_109">,# &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:19.0033em;"><span class="pdf24_101 pdf24_06 pdf24_110">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.9217em;top:19.0033em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:15.2717em;top:19.0033em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:19.0033em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:21.9942em;top:19.0033em;"><span class="pdf24_99 pdf24_06 pdf24_15">X</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:19.2133em;"><span class="pdf24_99 pdf24_06 pdf24_111">X</span><sup style="top: -0.21em;"><span class="pdf24_104 pdf24_06 pdf24_112"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.6858em;top:19.2133em;"><span class="pdf24_99 pdf24_06 pdf24_111">X</span><sup style="top: -0.21em;"><span class="pdf24_104 pdf24_06 pdf24_113"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:37.3558em;top:19.2133em;"><span class="pdf24_99 pdf24_06 pdf24_114">X</span><sup style="top: -0.21em;"><span class="pdf24_104 pdf24_06 pdf24_115"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:43.0283em;top:19.2133em;"><span class="pdf24_99 pdf24_06 pdf24_111">X</span><sup style="top: -0.21em;"><span class="pdf24_104 pdf24_06 pdf24_113"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.002em;top:20.0045em;"><span class="pdf24_41 pdf24_06 pdf24_84" style="word-spacing:-0.0053em;">* continuar con IMFINZI hasta progresin de la enfermedad o toxicidad intolerable. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.9545em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:-0.0059em;">$ Tenga en cuenta el cambio del intervalo de dosificacin de cada 3 semanas a cada 4 semanas a partir del ciclo 5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.9145em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0037em;"> perfusin intravenosa durante 60 minutos [</span><span class="pdf24_117 pdf24_06 pdf24_118" style="word-spacing:0.0003em;">consulte Dosis y administracin</span><span class="pdf24_41 pdf24_06 pdf24_119">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8845em;"><span class="pdf24_41 pdf24_06 pdf24_91" style="word-spacing:-0.0225em;"># si los pacientes reciben menos de 4 ciclos de quimioterapia basada en platino, los ciclos restantes de tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8345em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0227em;">actl (hasta un total de 5) deben administrarse despus de la fase de quimioterapia basada en platino, en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.7945em;"><span class="pdf24_41 pdf24_06 pdf24_120" style="word-spacing:0.0041em;">con IMFINZI, cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.7545em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0473em;"> terapia opcional con pemetrexed desde la semana 12 hasta la progresin de la enfermedad o toxicidad intolerable &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.7145em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0001em;">para pacientes con enfermedad no escamosa que recibieron tratamiento con pemetrexed y carboplatino/cisplatino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.7143em;"><span class="pdf24_05 pdf24_06 pdf24_96" style="word-spacing:-0.0233em;">Tabla 3. Rgimen y dosis recomendados para CPCNP metastsico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:29.8043em;"><span class="pdf24_05 pdf24_06 pdf24_122">Histologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:30.8643em;"><span class="pdf24_05 pdf24_06 pdf24_123">tumoral &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:31.9643em;"><span class="pdf24_05 pdf24_06 pdf24_124">No &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7617em;top:29.8043em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.0592em;">Peso del &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7617em;top:30.8643em;"><span class="pdf24_05 pdf24_06 pdf24_123">paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7617em;top:31.9543em;"><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0054em;"> </span><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0109em;">30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:29.8043em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0036em;">Dosis de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:30.8643em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:31.9543em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0241em;">1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:29.8043em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0036em;">Dosis de &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:30.8643em;"><span class="pdf24_05 pdf24_06 pdf24_127">tremelimumab-actl* &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:31.9543em;"><span class="pdf24_14 pdf24_06 pdf24_128" style="word-spacing:0.017em;">75 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:29.8043em;"><span class="pdf24_05 pdf24_06 pdf24_71" style="word-spacing:-0.0589em;">Rgimen de quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:30.8643em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:0.0021em;">basada en platino* &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:30.8758em;top:31.9292em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:32.3758em;top:32.0343em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0589em;">carboplatino y nab-paclitaxel &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:33.0243em;"><span class="pdf24_05 pdf24_06 pdf24_122">escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:33.0843em;"><span class="pdf24_14 pdf24_06 pdf24_15">O</span></div>
					<div class="pdf24_01 pdf24_28" style="left:30.8758em;top:34.0309em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:11.7617em;top:34.026em;"><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0115em;">&lt; 30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7617em;top:36.336em;"><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0054em;"> </span><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0109em;">30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7617em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0115em;">&lt; 30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:34.026em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:0.007em;">20 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:36.336em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0241em;">1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.1742em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:0.007em;">20 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:34.026em;"><span class="pdf24_14 pdf24_06 pdf24_79" style="word-spacing:0.006em;">1 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:36.336em;"><span class="pdf24_14 pdf24_06 pdf24_128" style="word-spacing:0.017em;">75 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.3758em;top:34.136em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0607em;">carboplatino o cisplatino y &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.3758em;top:35.196em;"><span class="pdf24_14 pdf24_06 pdf24_123">pemetrexed &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:36.336em;"><span class="pdf24_05 pdf24_06 pdf24_127">Escamoso &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:30.8758em;top:36.3109em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:32.3758em;top:36.416em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0589em;">carboplatino y nab-paclitaxel &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:37.466em;"><span class="pdf24_14 pdf24_06 pdf24_15">O</span></div>
					<div class="pdf24_01 pdf24_28" style="left:30.8758em;top:38.4109em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:32.3758em;top:38.516em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0607em;">carboplatino o cisplatino y &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.3758em;top:39.576em;"><span class="pdf24_14 pdf24_06 pdf24_23">gemcitabina &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1242em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_79" style="word-spacing:0.006em;">1 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.7462em;"><span class="pdf24_41 pdf24_06 pdf24_129" style="word-spacing:-0.003em;">* Consulte el prospecto para obtener informacin sobre la dosis. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.272em;top:43.756em;"><span class="pdf24_12 pdf24_06 pdf24_26">5.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5717em;top:43.756em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.025em;">Modificaciones de Dosis por Reacciones Adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.306em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1222em;">No se recomienda reducir la dosis de IMFINZI. En general, suspenda IMFINZI en caso de reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.356em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0996em;">adversas graves (grado 3) mediadas por el sistema inmunitario. Interrumpir permanentemente IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.416em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0624em;">para el caso de reacciones adversas mediadas por el sistema inmunitario potencialmente mortales (grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4685em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.018em;">4), reacciones graves recurrentes (grado 3) mediadas por el sistema inmunitario que requieren tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5285em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0894em;">inmunosupresor sistmico, o la incapacidad de reducir la dosis de corticosteroides a 10 mg o menos de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5785em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0021em;">prednisona o equivalente al da en las 12 semanas siguientes al inicio de los corticosteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.6885em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1162em;">En la Tabla 4 se resumen las modificaciones de la dosis de IMFINZI o IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7485em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0508em;">tremelimumab-actl o quimioterapia para las reacciones adversas que requieren un tratamiento diferente a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.7985em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0031em;">estas pautas generales. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.9082em;"><span class="pdf24_05 pdf24_06 pdf24_96" style="word-spacing:-0.0235em;">Tabla 4. Modificaciones de Dosis Recomendadas por Reacciones Adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">5 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_5" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_130" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.862em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.8842em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_132">Severidad</span><sup style="top: -0.3317em;"><span class="pdf24_70 pdf24_06 pdf24_133">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.3458em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0277em;">Modificacin de Dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:7.0118em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.032em;">Reacciones Adversas Mediadas por el Sistema Inmunitario </span><span class="pdf24_55 pdf24_06 pdf24_131" style="word-spacing:-0.0243em;">[consulte Advertencias y Precauciones] &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:8.1018em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0268em;">Grade 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0125em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:10.2918em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0268em;">Grade 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:8.1018em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.552em;top:8.7218em;"><span class="pdf24_14 pdf24_06 pdf24_57">Neumonitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:0.2156em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:10.2918em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2858em;top:11.4618em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0649em;">Suspender o interrumpir &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:12.5218em;"><span class="pdf24_14 pdf24_06 pdf24_138">permanentemente</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.432em;top:11.9918em;"><span class="pdf24_14 pdf24_06 pdf24_17">Colitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:11.9818em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0286em;">Grado 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0286em;">Grado 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.432em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0402em;">Perforacin intestinal &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0395em;">Cualquier grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0453em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:15.7918em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1443em;">ALT o AST aumenta a ms de 3 y &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:16.8518em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0014em;">hasta 8 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:17.9018em;"><span class="pdf24_14 pdf24_06 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:17.9018em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:16.5042em;top:18.9418em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0564em;">la bilirrubina total aumenta a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:19.9343em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0058em;">1.5 y hasta 3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:21.1143em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0618em;">ALT o AST aumenta a ms de 8 veces &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0084em;">el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:20.0343em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0601em;">Hepatitis sin afectacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:21.0843em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0091em;">tumoral del hgado &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:23.2043em;"><span class="pdf24_14 pdf24_06 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:23.2143em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0453em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:24.2643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.001em;">la bilirrubina total aumenta a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:25.3243em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0066em;">3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:26.4143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1726em;">AST o ALT es ms de 1 y hasta 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:27.4743em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0267em;">veces el ULN basal y aumentan a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:28.5243em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:0.0057em;">de 5 y hasta 10 veces el ULN o &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:29.5743em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:16.5042em;top:30.5543em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.1729em;">AST o ALT es ms de 3 y hasta 5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:31.6043em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0218em;">veces el ULN basal y aumentan a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:32.6543em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0048em;">de 8 y hasta</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.1894em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_142" style="word-spacing:0.0065em;">10 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:31.7043em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0604em;">Hepatitis con afectacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:32.7543em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0084em;">tumoral del hgado</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_143" style="word-spacing:0.0134em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:16.5042em;top:33.836em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.1874em;">AST o ALT aumenta a ms de 10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:34.886em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0003em;">veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:35.936em;"><span class="pdf24_14 pdf24_06 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:35.946em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0453em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:36.996em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.001em;">la bilirrubina total aumenta a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:38.046em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0066em;">3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:39.146em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.1819em;">Suspender hasta</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.0011em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0045em;">que est &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:40.206em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0592em;">clnicamente estable o interrumpir &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:41.266em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0015em;">permanentemente segn la &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:42.326em;"><span class="pdf24_14 pdf24_06 pdf24_144">gravedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:40.726em;"><span class="pdf24_14 pdf24_06 pdf24_57">Endocrinopatas &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:40.726em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0089em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:43.396em;"><span class="pdf24_14 pdf24_06 pdf24_145" style="word-spacing:-0.0107em;">Aumento de la creatinina en sangre de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:44.386em;"><span class="pdf24_14 pdf24_06 pdf24_146" style="word-spacing:-0.0188em;">grado 2 o 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:45.556em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0626em;">Aumento de la creatinina en sangre de &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:46.616em;"><span class="pdf24_14 pdf24_06 pdf24_146" style="word-spacing:-0.0106em;">grado 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:43.926em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:44.476em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0611em;">Nefritis con disfuncin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.536em;"><span class="pdf24_14 pdf24_06 pdf24_100">renal &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:46.076em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:47.6385em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.3325em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:16.5042em;top:47.6385em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0099em;">SJS, TEN o DRESS sospechosos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.7185em;"><span class="pdf24_14 pdf24_06 pdf24_138">Condiciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:48.7785em;"><span class="pdf24_14 pdf24_06 pdf24_57">dermatolgicas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:49.8285em;"><span class="pdf24_14 pdf24_06 pdf24_61">exfoliativas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.432em;top:50.8485em;"><span class="pdf24_14 pdf24_06 pdf24_57">Miocarditis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.0085em;"><span class="pdf24_14 pdf24_06 pdf24_144">Toxicidades &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_57">neurolgicas &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:49.3085em;"><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.0113em;">SJS, TEN o DRESS confirmados &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:49.3085em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:50.8485em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.017em;">Grade 2, 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:51.9385em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0177em;">Grado 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:53.0285em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0089em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:50.8485em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:51.9385em;"><span class="pdf24_14 pdf24_06 pdf24_72">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2858em;top:53.0285em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.652em;top:54.1185em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0215em;">Reacciones adversas no inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.652em;top:55.2785em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0577em;">Aplasia eritrocitaria pura &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:55.8085em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0395em;">Cualquier grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.652em;top:56.3385em;"><span class="pdf24_14 pdf24_06 pdf24_87">(AEP)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_148">i &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2858em;top:55.8085em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0453em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:57.3682em;"><span class="pdf24_05 pdf24_06 pdf24_149" style="word-spacing:-0.0277em;">Otras Reacciones Adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">6 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_6" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_150" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.862em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.9742em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_132">Severidad</span><sup style="top: -0.3317em;"><span class="pdf24_70 pdf24_06 pdf24_133">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.3458em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0277em;">Modificacin de Dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0585em;">Reacciones relacionadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:8.1318em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0027em;">a la perfusin [</span><span class="pdf24_55 pdf24_06 pdf24_39">consulte &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:9.1918em;"><span class="pdf24_55 pdf24_06 pdf24_67" style="word-spacing:-0.0079em;">Advertencias y &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:7.2518em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0375em;">Interrumpir o bajar la velocidad de &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:8.3018em;"><span class="pdf24_14 pdf24_06 pdf24_100">perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5942em;top:7.7418em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0125em;">Grado 1 o 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5942em;top:9.8618em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0125em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2858em;top:9.8618em;"><span class="pdf24_14 pdf24_06 pdf24_137" style="word-spacing:-0.0344em;">Interrumpir permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:10.1718em;"><span class="pdf24_55 pdf24_06 pdf24_123">Precauciones</span><span class="pdf24_14 pdf24_06 pdf24_123">] &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.432em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.2781em;">ALT = alanina aminotransferasa, AST = aspartato aminotransferasa, DRESS = erupcin medicamentosa con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.392em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:0.0361em;">eosinofilia y sntomas sistmicos, SJS = sndrome de Stevens Johnson, TEN = necrlisis epidrmica txica, ULN = &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.352em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.0007em;">lmite superior normal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.312em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:0.0152em;">* Basado en los Criterios de Terminologa Comn para Eventos Adversos del Instituto Nacional del Cncer, versin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.272em;"><span class="pdf24_41 pdf24_06 pdf24_51">4.03. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.232em;"><span class="pdf24_152 pdf24_06 pdf24_153" style="word-spacing:0.1069em;"> Reanudar en pacientes con resolucin completa o parcial (Grado 0 a 1) despus de la reduccin gradual de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.182em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:0.0367em;">corticosteroides. Suspender permanentemente si no hay una resolucin completa o parcial dentro de las 12 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.142em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0173em;">posteriores al inicio de los corticosteroides o si no se puede reducir la dosis de corticosteroides a 10 mg de prednisona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.102em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0004em;">o menos por da (o equivalente) dentro de las 12 semanas posteriores al inicio de los corticosteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.0645em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0201em;">Suspender IMFINZI de forma permanente para la colitis de grado 3 cuando se administre como parte de un rgimen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.0245em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0005em;">que contenga tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.9845em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.033em;"> Si AST y ALT son inferiores o iguales al ULN al inicio del estudio en pacientes con compromiso heptico, suspenda &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9445em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0em;">o interrumpa permanentemente IMFINZI segn las recomendaciones para la hepatitis sin compromiso heptico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9045em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1944em;">i </span></sup><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0367em;">La reaccin adversa al medicamento solo se asocia cuando el tratamiento de mantenimiento con olaparib se utiliza &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.8545em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.0565em;">en combinacin con IMFINZI, despus del tratamiento con IMFINZI en combinacin con quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.8145em;"><span class="pdf24_41 pdf24_06 pdf24_144">platino. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.272em;top:28.7243em;"><span class="pdf24_12 pdf24_06 pdf24_26">5.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5717em;top:28.7243em;"><span class="pdf24_05 pdf24_06 pdf24_156" style="word-spacing:-0.02em;">Preparacin y Administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8243em;"><span class="pdf24_14 pdf24_06 pdf24_52">Preparacin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:32.8992em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:33.0043em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0005em;">Inspeccione visualmente el medicamento para detectar partculas y decoloracin antes de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:34.056em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0169em;">administracin, siempre que la solucin y el recipiente lo permitan. Deseche el vial si la solucin est &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:35.106em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0049em;">turbia, descolorida o si se observan partculas visibles. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:36.1109em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:37.2509em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.216em;"><span class="pdf24_14 pdf24_06 pdf24_131" style="word-spacing:-0.0007em;">No agite el vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:37.356em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0155em;">Extraiga el volumen requerido de los frascos de IMFINZI y transfiralos a una bolsa intravenosa que &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.406em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0002em;">contenga una inyeccin de cloruro de sodio al 0.9%, USP o una inyeccin de dextrosa al 5%, USP. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:39.456em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0004em;">Mezcle la solucin diluida por inversin suave. No agite la solucin. La concentracin final de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:40.516em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0052em;">solucin diluida debe estar entre 1 mg / mL y 15 mg / mL. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:41.5109em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:41.616em;"><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0247em;">Deseche los viales de IMFINZI parcialmente usados o vacos.. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.736em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0198em;">Almacenamiento de la Solucin de Perfusin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:45.7909em;"><span class="pdf24_158 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:46.9309em;"><span class="pdf24_158 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.896em;"><span class="pdf24_159 pdf24_06 pdf24_73" style="word-spacing:-0.0206em;">IMFINZI no contiene preservantes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.036em;"><span class="pdf24_159 pdf24_06 pdf24_19" style="word-spacing:-0.0004em;">Administre la solucin de perfusin inmediatamente despus de preparada. Si la solucin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:48.0885em;"><span class="pdf24_159 pdf24_06 pdf24_35" style="word-spacing:-0.0191em;">perfusin no se administra inmediatamente y </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0101em;">es necesario </span><span class="pdf24_159 pdf24_06 pdf24_38" style="word-spacing:-0.0201em;">almacenarla, el tiempo desde la preparacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:49.1385em;"><span class="pdf24_159 pdf24_06 pdf24_94" style="word-spacing:0.0035em;">hasta la finalizacin de la perfusin no debe exceder: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:9.0017em;top:50.2624em;"><span class="pdf24_160 pdf24_161 pdf24_15">o</span></div>
					<div class="pdf24_01 pdf24_28" style="left:9.0017em;top:51.3224em;"><span class="pdf24_160 pdf24_161 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:50.2085em;"><span class="pdf24_159 pdf24_06 pdf24_58" style="word-spacing:-0.017em;">28 das en el refrigerador de 2C a 8C. &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:51.2685em;"><span class="pdf24_159 pdf24_06 pdf24_143" style="word-spacing:-0.0192em;">8 horas a temperatura ambiente hasta 25C. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:52.2534em;"><span class="pdf24_158 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:53.3634em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.3585em;"><span class="pdf24_159 pdf24_06 pdf24_54" style="word-spacing:0.0059em;">No congelar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:53.4685em;"><span class="pdf24_159 pdf24_06 pdf24_162" style="word-spacing:0.0039em;">No agitar</span><span class="pdf24_14 pdf24_06 pdf24_162" style="word-spacing:0.0039em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5885em;"><span class="pdf24_14 pdf24_06 pdf24_23">Administracin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:57.6631em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:57.7682em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.014em;">Administre la solucin de perfusin por va intravenosa durante 60 minutos a travs de una lnea &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:58.8182em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0102em;">intravenosa que contenga un filtro en lnea estril de baja unin a protenas de 0.2 o 0.22 micras. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">7 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_7" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANcklEQVR4nO3RsQnCYBSF0beGgiS9nQOIgwhWQnZIkT1sXNVX2KYI5McXcw58A1xuBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACwvi7rJalRxwAAWNGYTZLUqCEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA4Eeu2U2SCncKAICve/aQpMKdAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA9mfMpuI9m60HAAA2pcv64h0WrwIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAP/bK3irdZfY9AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADYgA+T6MPBxSsNigAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_163" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:5.9967em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:6.1018em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:-0.0207em;">Utilice bolsas de infusin y filtros separados para cada medicamento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.2018em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0225em;">IMFINZI en combinacin con otros productos &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:9.1967em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:10.3167em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:11.4667em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:9.3018em;"><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:-0.0298em;">Administre todos los medicamentos intravenosos en infusiones separadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:10.4218em;"><span class="pdf24_14 pdf24_06 pdf24_56" style="word-spacing:-0.023em;">No coadministrar otros medicamentos intravenosos a travs de la misma lnea de perfusin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:11.5718em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0128em;">Para la quimioterapia basada en platino, consulte la informacin de administracin en la Informacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:12.6218em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0082em;">para prescribir. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:13.6367em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:15.7867em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:13.7418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0153em;">Para el tratamiento con pemetrexed, consulte la informacin de administracin en la Informacin para &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:14.7918em;"><span class="pdf24_14 pdf24_06 pdf24_122">prescribir. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:15.8918em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:-0.0271em;">Para Olaparib, consulte la informacin de administracin en la Informacin para prescribir. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0118em;"><span class="pdf24_14 pdf24_06 pdf24_48" style="word-spacing:-0.022em;">Regmenes combinados: Orden de las infusiones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1143em;"><span class="pdf24_55 pdf24_06 pdf24_58" style="word-spacing:-0.035em;">IMFINZI en combinacin con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:21.1392em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:21.2443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0255em;">Infundir tremelimumab-actl, seguido de IMFINZI el mismo da de la dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.3543em;"><span class="pdf24_55 pdf24_06 pdf24_164" style="word-spacing:-0.0272em;">IMFINZI en combinacin con tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:24.3692em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:24.4743em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0011em;">Infundir primero tremelimumab-actl, seguido de IMFINZI y luego quimioterapia basada en platino el &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:-0.0071em;">mismo da de la dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.6243em;"><span class="pdf24_55 pdf24_06 pdf24_165" style="word-spacing:-0.0244em;">IMFINZI en combinacin con terapia con tremelimumab-actl y pemetrexed &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:28.6392em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:28.7443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1593em;">Infundir primero tremelimumab-actl, seguido de IMFINZI y luego tratamiento con pemetrexed el &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:29.7943em;"><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:-0.0071em;">mismo da de la dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.9043em;"><span class="pdf24_55 pdf24_06 pdf24_37" style="word-spacing:-0.032em;">IMFINZI en combinacin con quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:33.0243em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0249em;">Infundir primero IMFINZI, seguido de quimioterapia basada en platino el mismo da de la dosis. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:32.9192em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.126em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:-0.0368em;">Regmenes combinados: Instrucciones de perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.246em;"><span class="pdf24_55 pdf24_06 pdf24_98" style="word-spacing:-0.0378em;">IMFINZI en combinacin con tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:38.2609em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.366em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.197em;">Administrar tremelimumab-actl durante 60 minutos seguido de un perodo de observacin de 60 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:39.416em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0004em;">minutos. Luego administre IMFINZI como una perfusin intravenosa separada durante 60 minutos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.516em;"><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:0.3253em;">IMFINZI en combinacin con tremelimumab-actl y quimioterapia basada en platino /terapia con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.566em;"><span class="pdf24_55 pdf24_06 pdf24_144">pemetrexed &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.676em;"><span class="pdf24_55 pdf24_06 pdf24_82" style="word-spacing:-0.0334em;">Ciclo 1 &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:45.7009em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.806em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0345em;">Infundir tremelimumab-actl durante 60 minutos. Una o dos horas despus de finalizar la perfusin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:46.856em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1122em;">tremelimumab-actl, infundir IMFINZI durante 60 minutos. Una o dos horas despus de finalizar la &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.9085em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0036em;">perfusin de IMFINZI, administrar quimioterapia basada en platino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.0185em;"><span class="pdf24_55 pdf24_06 pdf24_166" style="word-spacing:-0.0146em;">Ciclos posteriores &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:51.0334em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:51.1385em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.088em;">Si no hay reacciones a la perfusin durante el ciclo 1, se los ciclos posteriores de IMFINZI pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.1885em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0437em;">administrarse inmediatamente despus de tremelimumab-actl. El tiempo entre el final de la perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:53.2385em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0013em;">de IMFINZI y el inicio de la quimioterapia puede reducirse a 30 minutos. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:55.3485em;"><span class="pdf24_12 pdf24_06 pdf24_13">6. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:55.3485em;"><span class="pdf24_05 pdf24_06 pdf24_145">CONTRAINDICACIONES &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.4582em;"><span class="pdf24_14 pdf24_06 pdf24_167">Ninguna. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">8 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_8" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANOklEQVR4nO3DMQkAIBAAwG9gDyO7mMPJan4AQdwU7uAiAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHZGnvrIGgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPC7lruqxyUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAuLUAu/5IzhLOdpoAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_168" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:6.0318em;"><span class="pdf24_12 pdf24_06 pdf24_13">7. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:6.0318em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0359em;">ADVERTENCIAS Y PRECAUCIONES &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5717em;top:8.0818em;"><span class="pdf24_05 pdf24_06 pdf24_170" style="word-spacing:-0.0252em;">Reacciones Adversas Inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:8.0818em;"><span class="pdf24_12 pdf24_06 pdf24_26">7.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.6418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.007em;">IMFINZI es un anticuerpo monoclonal que pertenece a una clase de frmacos que se unen al receptor de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.6918em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0858em;">protena de la muerte programada (PD-1) o al ligando PD-L1 (PD-L1), bloqueando la va PD-1/PD-L1, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.7418em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0031em;">eliminando as la inhibicin de la respuesta inmunitaria, rompiendo potencialmente la tolerancia perifrica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.8018em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0048em;">e induciendo reacciones adversas inmunomediadas. Las reacciones adversas importantes inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.8518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.017em;">son enumeradas en Advertencias y Precauciones y pueden no incluir todas las posibles reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.9018em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.003em;">inmunomedidas graves y mortales. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.0218em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.018em;">La incidencia y gravedad de las reacciones adversas inmunomediadas fueron similares cuando IMFINZI se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0718em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0161em;">administr como agente nico o en combinacin con quimioterapia o en combinacin con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.1218em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0392em;">actl y quimioterapia basada en platino, o en combinacin con quimioterapia basada en platino seguida de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1843em;"><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:-0.0214em;">IMFINZI como monoterapia, o IMFINZI en combinacin con olaparib, a menos que se indique lo contrario. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.2843em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1555em;">Las reacciones adversas inmunomediadas que puedan ser severas o fatales puede ocurrir en cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.2093em;">rgano o tejido, que pueden ser graves o fatales. Las reacciones adversas inmuno mediadas pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.3943em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0583em;">producirse en cualquier momento despus de iniciar el tratamiento con un anticuerpo bloqueante de PD- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.4543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2493em;">1/PD-L1. Aunque las reacciones adversas inmuno mediadas se manifiestan normalmente durante el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.5043em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.053em;">tratamiento con anticuerpos anti-PD-1/PD-L1, las reacciones adversas inmuno mediadas tambin pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.5543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0014em;">manifestarse despus de la interrupcin del tratamiento con anticuerpos anti PD-1/PD-L1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.6743em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0925em;">La identificacin y el tratamiento temprano de las reacciones adversas inmuno mediadas son esenciales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.7243em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0247em;">para garantizar un uso seguro de anticuerpos anti PD-1/PD-L1. Monitorizar estrechamente a los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.7743em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0465em;">para detectar sntomas y signos que puedan ser manifestaciones clnicas de reacciones adversas subyacentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.8343em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0028em;">mediadas por el sistema inmune. Evaluar las enzimas hepticas, la creatinina y la funcin tiroidea al inicio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.886em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.047em;">y de forma peridica durante el tratamiento. En casos de sospecha de reacciones adversas inmuno mediadas, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.946em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.08em;">iniciar un tratamiento adecuado para excluir etiologas alternativas, incluyendo la infeccin. Instituir sin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.996em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0001em;">demora la gestin mdica, incluida la consulta especializada, segn proceda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.096em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.256em;">Suspender o Interrumpir permanentemente IMFINZI dependiendo de la gravedad [</span><span class="pdf24_55 pdf24_06 pdf24_50" style="word-spacing:0.2546em;">consulte Dosis y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.156em;"><span class="pdf24_55 pdf24_06 pdf24_35">Administracin</span><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0533em;">]. En general, si IMFINZI requiere suspensin o interrupcin permanente del tratamiento, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.206em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0551em;">administrar tratamiento sistmico con corticosteroides (1 mg a 2 mg/kg/da de prednisona o equivalente) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.266em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0535em;">hasta mejora al grado 1 o menos. Tras la mejora al Grado 1 o menos, inicie la reduccin de la dosis de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.316em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0535em;">corticosteroides y contine disminuyendo durante al menos 1 mes. Considerar la administracin de otros &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.366em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.123em;">inmunosupresores sistmicos en pacientes cuyas reacciones adversas inmuno mediadas no se controlen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.426em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0016em;">con el tratamiento con corticosteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.486em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1283em;">A continuacin se describen las pautas de manejo de la toxicidad para las reacciones adversas que no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.536em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.7723em;">requieren necesariamente esteroides sistmicos (por ejemplo, endocrinopatas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.5985em;"><span class="pdf24_14 pdf24_06 pdf24_138">dermatolgicas). &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6942em;top:46.536em;"><span class="pdf24_14 pdf24_06 pdf24_15">y</span></div>
					<div class="pdf24_01" style="left:41.0936em;top:46.536em;"><span class="pdf24_14 pdf24_06 pdf24_94">reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.7085em;"><span class="pdf24_14 pdf24_06 pdf24_171" style="word-spacing:-0.0476em;">Neumonitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.8085em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0006em;">IMFINZI puede causar neumonitis inmunomediada. La incidencia de neumonitis es mayor en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.8685em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0008em;">que han recibido previamente radiacin torcica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.9785em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0272em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.0782em;"><span class="pdf24_55 pdf24_06 pdf24_98" style="word-spacing:-0.0228em;">En pacientes que no recibieron radiacin previa reciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_15" style="word-spacing:-0.003em;">9 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_9" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANSUlEQVR4nO3DQQ2AMBAAsHPBh2RThhEeCMABn1nlBEwAO9qkEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKzjzJdq8UcAACW03FWL3wIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA4Gda7jq5BwAAfMyTh07eAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUNILnrIpf9u/pQQAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_172" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0748em;">En pacientes que recibieron IMFINZI en estudios clnicos en los que la radioterapia generalmente no se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2086em;">administraba inmediatamente antes del inicio de IMFINZI, la incidencia de neumonitis mediada por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0005em;">inmunes fue del 2.4% (34/1414), incluidos reacciones adversas mortales (&lt;0.1%) y Grado 3-4 (0.4%). Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1528em;">acontecimientos se resolvieron en 19 de los 34 pacientes y resultaron en suspensin permanente en 5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.2284em;">pacientes. Se requirieron corticosteroides sistmicos en 19 pacientes (19/34) con neumonitis que no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0007em;">recibieron quimioradiacin antes del inicio de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.4083em;">La frecuencia y la severidad de la neumonitis inmunomediada en pacientes que no recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_72" style="word-spacing:0.009em;">quimiorradiacin definitiva antes de IMFINZI fueron similares tanto si IMFINZI se administr como agente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0098em;">nico en pacientes con varios tipos de cncer en un conjunto de datos agrupados o en pacientes con CPCP- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0026em;">EE o CVB cuando se administra en combinacin con quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_55 pdf24_06 pdf24_141" style="word-spacing:-0.0245em;">En Pacientes que recibieron radiacin previa reciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0147em;">La incidencia de neumonitis (incluyendo neumonitis por radiacin) en pacientes con CPCNP estado III no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0545em;">resecable tras la quimioradiacin definitiva en los 42 das previos al inicio de IMFINZI en PACIFIC fue &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0239em;">del 18.3% (87/475) en pacientes tratados con IMFINZI, y del 12.8% (30/234) en pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0286em;">placebo. De los pacientes que recibieron IMFINZI (475), el 1.1% tuvieron una reaccin adversa fatal y el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.04em;">2.7% tuvieron reacciones adversas de grado 3-4. Los eventos se resolvieron en 50 de los 87 pacientes (57%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.3446em;">y resultaron en la discontinuacin permanente en 27 de los 87 pacientes (31%). Se necesitaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0489em;">corticosteroides sistmicos en 64 pacientes (64/87) con neumonitis que haban recibido quimiorradiacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1643em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0576em;">antes del inicio de IMFINZI, mientras que 2 pacientes requirieron el uso de infliximab con esteroides en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0024em;">dosis altas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2389em;">La incidencia de neumonitis (incluyendo neumonitis por radiacin) en pacientes con CPCP-EL tras &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1659em;">quimiorradiacin en los 42 das previos al inicio de IMFINZI en el estudio ADRIATIC fue del 14% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4343em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0049em;">(37/262) en pacientes que recibieron IMFINZI y del 6% (16/ 265) en pacientes que recibieron placebo. De &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0278em;">los pacientes que recibieron IMFINZI (262), el 0.4% tuvieron una reaccin adversa fatal y el 2.7% tuvieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0086em;">reacciones adversas de grado 3. Los eventos se resolvieron en 19 de los 37 pacientes (51%) y resultaron en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3249em;">la discontinuacin permanente en 18 de los 37 pacientes (49%). Todos los pacientes requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.055em;">corticosteroides sistmicos, mientras que 1 paciente requiri el uso de infliximab con esteroides en dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_119">altas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.886em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.071em;">Se produjo neumonitis inmunomediada en el 1.3 % (5/388) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.936em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0073em;">combinacin con tremelimumab-actl, incluidas reacciones adversas mortales (0.3 %) y de grado 3 (0.2 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.986em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0098em;">Los eventos se resolvieron en 3 de los 5 pacientes y resultaron en la suspensin permanente en 1 paciente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.046em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0452em;">Se requirieron corticoides sistmicos en todos los pacientes; de estos, 4 pacientes requirieron tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0385em;">con corticoides a dosis altas (al menos 40 mg de prednisona o equivalente al da). Un paciente (1/5) requiri &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0033em;">otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2585em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0278em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.3085em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0351em;">Se produjo neumonitis inmunomediada en el 3.5 % (21/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3685em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1787em;">combinacin con tremelimumab-actl y quimioterapia basada en platino, incluidas reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0022em;">mortales (0.5 %) y de Grado 3 (1 %). Los eventos se resolvieron en 11 de los 21 pacientes y dieron lugar a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0256em;">la interrupcin permanente en 7 pacientes. Se requirieron corticosteroides sistmicos en todos los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.001em;">con neumonitis inmunomediada, mientras que 1 paciente (1/21) requiri otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6385em;"><span class="pdf24_14 pdf24_06 pdf24_119" style="word-spacing:-0.0138em;">Colitis Inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">10 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_10" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANL0lEQVR4nO3DwQkAMAgEsBveKfrpqnWJgkgCSQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAANjn96qcVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIBpHpFrXugWl+AMAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_174" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0496em;">IMFINZI puede causar colitis inmunomediada que es asociado frecuentemente con diarrea. Se ha notificado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.4136em;">infeccin/reactivacin por citomegalovirus (CMV) en pacientes con colitis inmune mediada por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0125em;">corticosteroides refractaria. En casos de colitis refractaria con corticosteroides, considere repetir el examen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_67" style="word-spacing:-0.0048em;">infeccioso para excluir etiologas alternativas</span><span class="pdf24_55 pdf24_06 pdf24_67" style="word-spacing:-0.0048em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0236em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2612em;">Colitis inmuno mediada se produjo en el 2% (37/1889) de los pacientes que recibieron IMFINZI, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0185em;">incluyendo reacciones adversas de Grado 4 </span><span class="pdf24_20 pdf24_06 pdf24_71" style="word-spacing:-0.0117em;">(0.1%) </span><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0193em;">y Grado 3 (0.4%). Los eventos se resolvieron en 27 de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0385em;">los 37 pacientes y dieron lugar a la interrupcin permanente en 8 pacientes. Se requeran corticosteroides &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0462em;">sistmicos en todos los pacientes con colitis inmuno mediada, mientras que dos pacientes (2/37) necesitaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0017em;">otros inmunosupresores (por ejemplo, infliximab, micofenolato). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6718em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0449em;">Se produjo colitis o diarrea inmunomediada en el 6 % (23/388) de los pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0181em;">en combinacin con tremelimumab-actl, incluidas reacciones adversas de grado 3 (3.6 %). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0413em;">resolvieron en 22 de los 23 pacientes y resultaron en la suspensin permanente en 5 pacientes. Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2388em;">pacientes recibieron corticosteroides sistmicos y 20 de los 23 pacientes recibieron tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0505em;">corticosteroides en dosis altas (al menos 40 mg de prednisona o equivalente por da). Tres pacientes tambin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0083em;">recibieron otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.023em;">Se ha observado perforacin intestinal en otros estudios de IMFINZI en combinacin con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_169">actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2843em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1714em;">Se produjo colitis inmunomediada en el 6.5 % (39/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0245em;">combinacin con tremelimumab-actl, incluidas reacciones adversas mortales (0.2 %) y de Grado 3 (2.5 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1758em;">Los eventos se resolvieron en 33 de 39 pacientes y dieron lugar a la interrupcin permanente en 11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1165em;">pacientes. Se requirieron corticosteroides sistmicos en todos los pacientes con colitis inmunomediada, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0026em;">mientras que 4 pacientes (4/39) requirieron otros corticosteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1888em;">Se inform perforacin intestinal y perforacin del intestino grueso en el 0.1% de los pacientes que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.606em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0015em;">recibieron IMFINZI en combinacin con tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_96" style="word-spacing:-0.0332em;">Hepatitis inmuno mediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_165" style="word-spacing:-0.0289em;">IMFINZI puede causar hepatitis inmuno mediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.926em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0272em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.976em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1521em;">La Hepatitis inmuno mediada se produjo en el 2.8% (52/1889) de pacientes que recibieron IMFINZI, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.2131em;">incluyendo reacciones adversas mortales (0.2%), Grado 4 (0.3%) y Grade 3 (1.4%). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.086em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.0404em;">resolvieron en 21 de los 52 pacientes y dieron lugar a la suspensin permanente de IMFINZI en 6 pacientes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.0549em;">Se requirieron corticosteroides sistmicos en todos los pacientes con hepatitis inmune mediada, mientras &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1985em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0021em;">que 2 pacientes (2/52) requirieron el uso de</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.1906em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0021em;">micofenolato con dosis altas de esteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.3085em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3685em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1072em;">Se produjo hepatitis inmunomediada en el 7.5 % (29/388) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0073em;">combinacin con tremelimumab-actl, incluidas reacciones adversas mortales (0.8 %), de grado 4 (0.3 %) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0037em;">de grado 3 (4.1 %). Los eventos se resolvieron en 12 de los 29 pacientes y resultaron en la discontinuacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0304em;">permanente en 9 pacientes. Se requirieron corticosteroides sistmicos en los 29 pacientes y los 29 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5785em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0373em;">requirieron tratamiento con corticosteroides en dosis altas (al menos 40 mg de prednisona o equivalente por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6385em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0013em;">da). Ocho pacientes (8/29) requirieron otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.7382em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">11 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_11" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANMElEQVR4nO3DsQ0AMAgDsEj8/0CXvlqmXgCbLTkBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAANh1+lX/CgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAnAe1HXpawuqZ8gAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_175" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1311em;">Se produjo hepatitis inmunomediada en el 3.9% (23/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1224em;">combinacin con tremelimumab-actl, incluidas reacciones adversas mortales (0.3%), Grado 4 (0.5%) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1208em;">Grado 3 (2.0%). Los eventos se resolvieron en 12 de los 23 pacientes y dieron lugar a la interrupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0166em;">permanente en 10 pacientes. Todos los pacientes con hepatitis inmunomediada requirieron corticosteroides &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0031em;">sistmicos, mientras que 2 pacientes (2/23) requirieron el uso de otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_176" style="word-spacing:0.0771em;">Endocrinopatas Inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_55 pdf24_06 pdf24_74" style="word-spacing:-0.0409em;">Insuficiencia Suprarrenal</span><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0409em;">: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.232em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0636em;">IMFINZI puede causar insuficiencia suprarrenal primaria o secundaria. Para la insuficiencia suprarrenal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0328em;">de Grado 2 o superior, inicie un tratamiento sintomtico, incluyendo el reemplazo hormonal como se indica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1218em;">clnicamente. Suspender o interrumpir permanentemente IMFINZI en funcin de la gravedad [</span><span class="pdf24_55 pdf24_06 pdf24_164">consulte &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6718em;"><span class="pdf24_55 pdf24_06 pdf24_39" style="word-spacing:-0.0021em;">Dosis y Administracin</span><span class="pdf24_14 pdf24_06 pdf24_177">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0272em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8544em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0482em;">La insuficiencia suprarrenal inmuno mediada se produjo en el 0.5% (9/1889) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1047em;">IMFINZI, incluyendo reacciones adversas de grado 3 (&lt; 0.1%). Los eventos resueltos en 1 de 9 de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2283em;">pacientes no llevaron a la interrupcin permanente de IMFINZI en ningn paciente. Se necesitaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.0433em;">corticosteroides sistmicos en todos los pacientes con insuficiencia suprarrenal; de los cuales, la mayora &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0003em;">permaneci en corticosteroides sistmicos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0619em;">Se produjo insuficiencia suprarrenal inmunomediada en el 1.5 % (6/388) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0592em;">IMFINZI en combinacin con tremelimumab-actl, incluidas las reacciones adversas de Grado 3 (0.3 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.1259em;">Los eventos se resolvieron en 2 de los 6 pacientes. Se requirieron corticosteroides sistmicos en los 6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0236em;">pacientes, y de estos, 1 paciente requiri tratamiento con corticosteroides en dosis altas (al menos 40 mg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0044em;">prednisona o equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.536em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0231em;">Se produjo insuficiencia suprarrenal inmunomediada en el 2.2 % (13/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0282em;">IMFINZI en combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.8 %). Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0271em;">eventos se resolvieron en 2 de los 13 pacientes y dieron lugar a la interrupcin permanente en 1 paciente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0188em;">Se requirieron corticosteroides sistmicos en todos los pacientes con insuficiencia suprarrenal. Un paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0006em;">tambin requiri terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.926em;"><span class="pdf24_55 pdf24_06 pdf24_61">Hipofisitis: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.046em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0299em;">IMFINZI puede causar hipofisitis inmuno mediada. La hipofisitis puede presentarse con sntomas agudos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0394em;">asociados con efecto masivo como dolor de cabeza, fotofobia o cortes de campo visual. La hipofisitis puede &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0254em;">causar hipopituitarismo. Iniciar un tratamiento sintomtico, incluyendo el reemplazo hormonal segn est &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1985em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0674em;">clnicamente indicado. Suspender o interrumpir permanentemente IMFINZI dependiendo de la gravedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2585em;"><span class="pdf24_14 pdf24_06 pdf24_178">[</span><span class="pdf24_55 pdf24_06 pdf24_22" style="word-spacing:-0.0001em;">consulte Dosis y Administracin</span><span class="pdf24_14 pdf24_06 pdf24_177">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3685em;"><span class="pdf24_55 pdf24_06 pdf24_143" style="word-spacing:-0.0282em;">IMFINZI como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1733em;">Hipofisis/hipopituitarismo de grado 3 se produjo en &lt; 0.1% (1/1889) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0236em;">IMFINZI. En este paciente se administr tratamiento con corticosteroides sistmicos. El evento no condujo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0003em;">a la interrupcin permanente de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6385em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6882em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">Se produjo hipofisitis/hipopituitarismo inmunomediado en el 1 % (4/388) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.7382em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0257em;">IMFINZI en combinacin con tremelimumab-actl. Los eventos se resolvieron en 2 de los 4 pacientes. Se &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">12 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_12" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2037em;">requirieron corticosteroides sistmicos en 3 pacientes, y de estos, 1 paciente recibi tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0137em;">corticosteroides a dosis altas (al menos 40 mg de prednisona o equivalente por da). Dos pacientes tambin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0016em;">requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0278em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0993em;">Se produjo hipofisitis inmunomediada en el 1.3 % (8/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.192em;">combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.5 %). Los eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.127em;">resultaron en la interrupcin permanente en 1 paciente. Se requirieron corticosteroides sistmicos en 6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.256em;">pacientes con hipofisitis inmunomediada; de estos, 2 de los 8 pacientes recibieron tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1084em;">corticosteroides en dosis altas (al menos 40 mg de prednisona o equivalente por da). Cuatro pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0002em;">tambin requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_55 pdf24_06 pdf24_10" style="word-spacing:-0.0227em;">Trastornos de la tiroides: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1172em;">IMFINZI puede causar trastornos tiroideos inmuno mediados. La tiroiditis puede presentarse con o sin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0054em;">endocrinopata. El hipotiroidismo puede seguir al hipertiroidismo. Inicie la terapia de reemplazo hormonal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1234em;">para el hipotiroidismo o instituya el manejo mdico del hipertiroidismo como se indique clnicamente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:-0.0002em;">Suspender o interrumpir permanentemente IMFINZI segn la severidad </span><span class="pdf24_55 pdf24_06 pdf24_132" style="word-spacing:-0.0054em;">[consulte Dosis y Administracin]</span><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:-0.0054em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_55 pdf24_06 pdf24_23">Tiroiditis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0236em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.175em;">Tiroiditis inmuno mediada se produjo en el 0.5% (9/1889) de los pacientes que recibieron IMFINZI, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_20 pdf24_06 pdf24_18" style="word-spacing:0.0399em;">incluyendo reacciones adversas grado 3 (0.1%) Los eventos se resolvieron en 4 de los 9 pacientes y dio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0147em;">lugar a la interrupcin permanente en 1 paciente. Se requirieron corticosteroides sistmicos en 3 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0014em;">(3/9) con tiroiditis inmuno mediada, mientras que 8 pacientes (8/9) requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1392em;">Se produjo tiroiditis inmunomediada en el 1.5 % (6/388) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.606em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0877em;">combinacin con tremelimumab-actl. Los eventos se resolvieron en 2 de los 6 pacientes. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.005em;">corticosteroides sistmicos en 2 pacientes (2/6) con tiroiditis inmunomediada; de estos, 1 paciente requiri &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0054em;">tratamiento con corticosteroides a dosis altas (al menos 40 mg de prednisona o equivalente por da). Todos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.117em;">los pacientes requirieron otra terapia, incluida la terapia de reemplazo hormonal, tiamazol, carbimazol, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0009em;">propiltiouracilo, perclorato, bloqueadores de los canales de calcio o bloqueadores beta. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.936em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.986em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.137em;">Se produjo tiroiditis inmunomediada en el 1.2 % (7/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0132em;">combinacin con tremelimumab-actl. Los eventos se resolvieron en 2 de los 7 pacientes y uno result en la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1936em;">interrupcin permanente. Se requirieron corticosteroides sistmicos en 2 pacientes (2/7) con tiroiditis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0016em;">inmunomediada, mientras que todos los pacientes requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2585em;"><span class="pdf24_55 pdf24_06 pdf24_72">Hipertiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3685em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0236em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0144em;">Hipertiroidismo inmuno mediado se produjo en 2.1% (39/1889) de pacientes que recibieron IMFINZI. Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0389em;">eventos se resolvieron en 30 de los 39 pacientes y no llevaron a la descontinuacin permanente de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0418em;">en ningn paciente. Corticosteroides sistmicos fueron requeridos en 9 pacientes (9/39) con hipertiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5785em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0029em;">inmuno mediada, mientras que 35 pacientes (35/39) requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6882em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">13 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_13" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0002em;">Se produjo hipertiroidismo inmunomediado en el 4.6 % (18/388) de los pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.017em;">en combinacin con tremelimumab-actl, incluidas las reacciones adversas de Grado 3 (0.3 %). Los eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0926em;">se resolvieron en 15 de los 18 pacientes. Dos pacientes (2/18) requirieron tratamiento con corticoides a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0406em;">dosis altas (al menos 40 mg de prednisona o equivalente al da). Diecisiete pacientes requirieron otra terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.067em;">(tiamazol, carbimazol, propiltiouracilo, perclorato, bloqueadores de los canales de calcio o bloqueadores &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_68">beta). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4018em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0166em;">Se produjo hipertiroidismo inmunomediado en el 5% (30/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1209em;">combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.2%). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0131em;">resolvieron en 21 de los 30 pacientes. Se necesitaron corticosteroides sistmicos en 5 pacientes (5/30) con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0036em;">hipertiroidismo inmunomediado, mientras que 28 pacientes (28/30) requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_55 pdf24_06 pdf24_127">Hipotiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_55 pdf24_06 pdf24_143" style="word-spacing:-0.0282em;">IMFINZI como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0415em;">El hipotiroidismo mediado inmune ocurri en el 8.3% (156/1889) de los pacientes que recibieron IMFINZI, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.0179em;">incluyendo reacciones adversas de grado 3 (&lt; 0.1%). Los eventos se resolvieron en 31 de los 156 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3544em;">y no llevaron a la descontinuacin permanente de IMFINZI en ningn paciente. Se necesitaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1742em;">corticosteroides sistmicos en 11 pacientes (11/156) y la mayora de los pacientes (152/156) requiri &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.001em;">reemplazo de la hormona tiroidea a largo plazo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2843em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0362em;">Se produjo hipotiroidismo inmunomediado en el 11 % (42/388) de los pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.03em;">en combinacin con tremelimumab-actl. Los eventos se resolvieron en 5 de los 42 pacientes. Un paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0719em;">recibi tratamiento con corticosteroides en dosis altas (al menos 40 mg de prednisona o equivalente por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.2588em;">da). Todos los pacientes requirieron otra terapia (tiamazol, carbimazol, propiltiouracilo, perclorato, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0022em;">bloqueadores de los canales de calcio o bloqueadores beta). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0347em;">Se produjo hipotiroidismo inmunomediado en el 8.6% (51/596) de los pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0396em;">en combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.5%). Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0009em;">corticosteroides sistmicos en 2 pacientes (2/51) y todos los pacientes requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.876em;"><span class="pdf24_55 pdf24_06 pdf24_22" style="word-spacing:-0.0267em;">Diabetes Mellitus Tipo </span><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0186em;">1, que puede presentar cetoacidosis diabtica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.976em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1405em;">Monitoree a los pacientes para detectar hiperglucemia u otros signos y sntomas de diabetes. Inicie el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0461em;">tratamiento con insulina segn est clnicamente indicado. Suspender o s permanentemente IMFINZI segn &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.086em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0053em;">la severidad </span><span class="pdf24_55 pdf24_06 pdf24_31" style="word-spacing:0.0043em;">[consulte Dosis y Administracin]</span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0043em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1985em;"><span class="pdf24_55 pdf24_06 pdf24_143" style="word-spacing:-0.0282em;">IMFINZI como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2485em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0557em;">Diabetes mellitus tipo 1 de Inmuno mediada de Grado 3 ocurri en &lt;0.1% (1/1889) de los pacientes que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.3085em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.2913em;">recibieron IMFINZI. Este paciente requiri tratamiento con insulina a largo plazo y se suspendi &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3585em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0035em;">permanentemente IMFINZI. 2 pacientes adicionales (0.1%, 2/1889) presentaron eventos de hiperglicemia, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0001em;">requiriendo terapia con insulina, que no se haba resolvido en el tiempo de reporte. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5185em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5785em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0024em;">Dos pacientes (0.5%, 2/388) tuvieron eventos de hiperglucemia que requirieron tratamiento con insulina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6285em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0005em;">que no se resolvieron en el ltimo seguimiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.7382em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">14 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_14" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANSklEQVR4nO3DMQ2AQAwAwApAABs/IAAFBCEkL4QB61RA2TvcJRcBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAB/znypFtcAAGjmzlO1uAcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQB9PflWLRwAANLPloVpcAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOjoA4pWSG71VPTWAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_179" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0895em;">Se produjo diabetes mellitus tipo 1 inmunomediada en el 0.5 % (3/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0284em;">IMFINZI en combinacin con tremelimumab-actl, incluidas reacciones adversas de grado 3 (0.3 %). Todos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0021em;">los pacientes requirieron terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:-0.029em;">Nefritis Inmunomediada con disfuncin renal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0203em;">IMFINZI puede causar nefritis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0272em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.045em;">Nefritis inmunomediadase produjo en el 0.5% (10/1889) de los pacientes que recibieron IMFINZI incluidos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0041em;">reacciones adversas de grado 3 </span><span class="pdf24_20 pdf24_06 pdf24_31" style="word-spacing:-0.0054em;">(0.1%). </span><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0081em;">Los eventos se resolvieron en 5 de los 10 pacientes y dieron lugar &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0164em;">a la suspensn permanente en 3 pacientes. Se requirieron corticosteroides sistmicos en todos los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6718em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0005em;">con nefritis immuno mediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8544em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2257em;">Se produjo nefritis inmunomediada en el 1 % (4/388) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1092em;">combinacin con tremelimumab-actl, incluidas reacciones adversas de grado 3 (0.5 %). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0003em;">resolvieron en 3 de los 4 pacientes y resultaron en la suspensin permanente en 2 pacientes. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2209em;">corticosteroides sistmicos en todos los pacientes con nefritis inmunomediada; de estos, 3 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0002em;">requirieron tratamiento con corticosteroides a dosis altas (al menos 40 mg de prednisona o equivalente por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_17">da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2077em;">Se produjo nefritis inmunomediada en el 0.7% (4/596) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1231em;">combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.2%). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0506em;">resolvieron en 1 de los 4 pacientes y dieron lugar a la interrupcin permanente en 3 pacientes. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0017em;">corticosteroides sistmicos en todos los pacientes con nefritis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0427em;">Reacciones Dermatolgicas Inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0032em;">IMFINZI puede causar erupcin cutnea o dermatitis inmunomediadas. Dermatitis exfoliativa, incluyendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1871em;">el sndrome de Stevens Johnson (SJS), erupcin farmacolgica con eosinofilia y sntomas sistmicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.3532em;">(DRESS),y necrlisis epidrmica txica (TEN), se ha producido con anticuerpos anti- PD-1/L-1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2603em;">Emolientes tpicos y/o los corticosteroides tpicos pueden ser adecuados para tratar erupciones no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.876em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0754em;">exfoliativas leves a moderadas. Suspender o interrumpir permanentemente IMFINZI, segn la severidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.926em;"><span class="pdf24_55 pdf24_06 pdf24_38" style="word-spacing:0.0002em;">[consulte Dosis y Administracin]</span><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0002em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_55 pdf24_06 pdf24_143" style="word-spacing:-0.0282em;">IMFINZI como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0246em;">En 1.8% (34/1889) de los pacientes que recibieron IMFINZI, presentaron erupciones o dermatitis inmune &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.087em;">mediada incluyendo reacciones adversas de grado 3 (0.4%). Los eventos se resolvieron en 19 de los 34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1985em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1868em;">pacientes y dieron lugar a la interrupcin permanente en 2 pacientes. Se necesitaron corticosteroides &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2585em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0008em;">sistmicos en todos los pacientes con erupcin o dermatitis inmuno mediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3685em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2123em;">Ocurri erupcin o dermatitis inmunomediada en el 4.9 % (19/388) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1243em;">IMFINZI en combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 4 (0.3 %) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.1534em;">Grado 3 (1.5 %). Los eventos se resolvieron en 13 de los 19 pacientes y resultaron en la suspensin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5785em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0228em;">permanente en 2 pacientes. Se requirieron corticosteroides sistmicos en todos los pacientes con erupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6385em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0538em;">o dermatitis inmunomediada; de estos, 12 pacientes requirieron tratamiento con corticosteroides en dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6882em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0011em;">altas (al menos 40 mg de prednisona o equivalente por da). Un paciente recibi otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">15 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_15" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANSklEQVR4nO3DwQmAMBAAsFuluIEDiIMI7uIY/XRV7+EIV7CQQCIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAObqeehPbgEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAANTpeah+nwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAlnXlW1XV8nsA5Y58qqpavgUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAALC6F81ifuWYHJj7AAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_180" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1395em;">Se produjo erupcin o dermatitis inmunomediada en el 7.2% (43/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0508em;">IMFINZI en combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.3%). Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0176em;">eventos se resolvieron en 32 de los 43 pacientes y dieron lugar a la interrupcin permanente en 2 pacientes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_57" style="word-spacing:-0.0055em;">Se requirieron corticosteroides sistmicos en todos los pacientes con erupcin o dermatitis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.05em;">Pancreatitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_143" style="word-spacing:-0.0293em;">IMFINZI en combinacin con tremelimumab-actl puede causar pancreatitis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_55 pdf24_06 pdf24_53" style="word-spacing:-0.0445em;">IMFINZI con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0631em;">Se produjo pancreatitis inmunomediada en el 2.3 % (9/388) de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0064em;">combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 4 (0.3 %) y Grado 3 (1.5 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.1264em;">Los eventos se resolvieron en 6 de los 9 pacientes. Se requirieron corticosteroides sistmicos en los 9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.062em;">pacientes, y de estos 7 pacientes requirieron tratamiento con corticosteroides en dosis altas (al menos 40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0012em;">mg de prednisona o equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0239em;">Otras Reacciones Adversas Inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0005em;">Las siguientes reacciones adversas clnicamente significativas, mediadas por el sistema inmunitario, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0017em;">ocurrieron con una incidencia de menos del 1% en pacientes que recibieron IMFINZI o IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1643em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0162em;">combinacin con tremelimumab-actl, o fueron notificados con el uso de otros anticuerpos bloqueantes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_182">PD-1/PD-L1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_183 pdf24_06 pdf24_31" style="word-spacing:-0.044em;">Cardiaca/vascular: </span><span class="pdf24_14 pdf24_06 pdf24_48" style="word-spacing:-0.0452em;">Miocarditis, pericarditis, vasculitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_183 pdf24_06 pdf24_94" style="word-spacing:0.1921em;">Sistema nervioso: </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1827em;">Meningitis, encefalitis, mielitis y desmielinizacin, sndrome miastnico/miastenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4343em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0016em;">gravis (incluida la exacerbacin), Sndrome de Guillain-Barr, paresia nerviosa, neuropata autoinmune. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_183 pdf24_06 pdf24_18" style="word-spacing:0.0084em;">Ocular: </span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0014em;">Pueden ocurrir Uvetis, iritis y otras toxicidades inflamatorias oculares. Algunos casos pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0035em;">asociarse con desprendimiento de retina. Pueden ocurrir varios grados de discapacidad visual para incluir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1581em;">la ceguera. Si la uvetis se produce en combinacin con otras reacciones adversas inmuno mediadas, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1836em;">considere un sndrome similar a Vogt-Koyanagi-Harada, ya que esto puede requerir tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0003em;">esteroides sistmicos para reducir el riesgo de prdida permanente de la visin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_183 pdf24_06 pdf24_39" style="word-spacing:0.1196em;">Gastrointestinal: </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0009em;">Pancreatitis incluyendo aumentos en los niveles sricos de amilasa y lipasa, gastritis, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_184">duodenitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.886em;"><span class="pdf24_183 pdf24_06 pdf24_31" style="word-spacing:0.1367em;">Trastornos musculoesquelticos y del tejido conectivo: </span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1315em;">Miositis/polimiositis, rabdomilisis y secuelas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.936em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0061em;">asociadas incluyendo insuficiencia renal, artritis, polimialgia reumtica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.976em;"><span class="pdf24_183 pdf24_06 pdf24_39" style="word-spacing:-0.036em;">Endocrino: </span><span class="pdf24_14 pdf24_06 pdf24_145">Hipoparatiroidismo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_183 pdf24_06 pdf24_50" style="word-spacing:0.2638em;">Otros (hematolgica/inmune): </span><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.2426em;">anemia hemoltica, anemia aplsica, linfohistiocitosis hemofagoctica, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0717em;">sndrome de respuesta inflamatoria sistmica, linfadenitis necrotizante histioctica (linfadenitis Kikuchi), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.146em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0289em;">sarcoidosis, trombocitopenia inmune, rechazo de trasplante de rganos slidos, rechazo de otros trasplantes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1985em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0017em;">(incluido el injerto de crnea). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.3085em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.0281em;">Precaucin especfica del tratamiento (IMFINZI en combinacin con olaparib en cncer de endometrio) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4185em;"><span class="pdf24_55 pdf24_06 pdf24_170" style="word-spacing:-0.0305em;">Toxicidad hematolgica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4685em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0055em;">Se notific aplasia eritrocitaria pura (AEP) cuando el tratamiento de mantenimiento con olaparib se us en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1718em;">combinacin con IMFINZI, despus del tratamiento con IMFINZI en combinacin con quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5785em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0017em;">basada en platino. Si se confirma AEP, se debe suspender el tratamiento con IMFINZI y olaparib. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6385em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.055em;">Se notific anemia hemoltica autoinmune (AHAI) cuando el tratamiento de mantenimiento con olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6882em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.2677em;">se us en combinacin con IMFINZI, despus del tratamiento con IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">16 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_16" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0004em;">quimioterapia basada en platino. Si se confirma AHAI, se debe suspender el tratamiento con IMFINZI y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_185">olaparib. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:10.1918em;"><span class="pdf24_12 pdf24_06 pdf24_26">7.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:10.1918em;"><span class="pdf24_05 pdf24_06 pdf24_143" style="word-spacing:-0.0264em;">Reacciones relacionadas con la Infusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.7518em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0015em;">IMFINZI puede causar reacciones graves o potencialmente mortales relacionadas con la infusin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.8018em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1022em;">Monitoree los signos y sntomas de las reacciones relacionadas con la infusin. Interrumpa, reduzca la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.8518em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.003em;">velocidad o suspenda permanentemente IMFINZI segn la gravedad </span><span class="pdf24_55 pdf24_06 pdf24_39" style="word-spacing:-0.0006em;">[consulte Dosis y Administracin]</span><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0006em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.9119em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0043em;">Para las reacciones relacionadas con la infusin de Grado 1 o 2, considere usar medicamentos previos con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.9618em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:0.0015em;">dosis posteriores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0718em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0272em;">IMFINZI como Agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.1218em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0259em;">Se produjeron reacciones relacionadas con la infusin en el 2.2% (42/1889) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0014em;">IMFINZI, incluido reacciones adversas de Grado 3 (0.3%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.2843em;"><span class="pdf24_55 pdf24_06 pdf24_58" style="word-spacing:-0.0373em;">IMFINZI en Combinacin con Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.3543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0013em;">Se produjeron reacciones relacionadas con la infusin en 2.6 % (10/388) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.4043em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0004em;">IMFINZI en combinacin con tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.5043em;"><span class="pdf24_55 pdf24_06 pdf24_07" style="word-spacing:-0.0294em;">IMFINZI con Tremelimumab-actl y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.5543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0154em;">Se produjeron reacciones relacionadas con la infusin en el 2.9 % (17/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.6143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0em;">IMFINZI en combinacin con tremelimumab-actl, incluidas reacciones adversas de Grado 3 (0.3 %). &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:31.7243em;"><span class="pdf24_12 pdf24_06 pdf24_26">7.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:31.7243em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0279em;">Complicaciones de HSCT alognico despus de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2743em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0218em;">Pueden ocurrir complicaciones fatales y otras complicaciones graves en pacientes que reciben trasplante de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.336em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0139em;">clulas madre hematopoyticas alognicas (HSCT) antes o despus de ser tratados con un anticuerpo anti- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.386em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:0.0636em;">PD-1/L-1. Las complicaciones relacionadas con el trasplante incluyen la enfermedad hiperaguda injerto- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.446em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0213em;">contra-husped (EICH), EICH aguda, EICH crnica, enfermedad venoclusiva heptica (VOD) despus de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.496em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2634em;">acondicionamiento de intensidad reducida y sndrome febril que requiere esteroides (sin una causa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.546em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0203em;">infecciosa identificada). Estas complicaciones pueden ocurrir a pesar de la intervencin teraputica entre el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.606em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0049em;">bloqueo PD-1/L-1 y el HSCT alognico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.2159em;">Monitorear de cerca a los pacientes para evidenciar complicaciones relacionadas con el trasplante e &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.716em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0004em;">intervenir con prontitud. Considere el beneficio frente a los riesgos del tratamiento con un anticuerpo anti- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.766em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.001em;">PD-1/L-1 antes o despus de un TSCT alognico. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:45.886em;"><span class="pdf24_12 pdf24_06 pdf24_26">7.4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:45.886em;"><span class="pdf24_05 pdf24_06 pdf24_57" style="word-spacing:0.073em;">Toxicidad Embrio-fetal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.436em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1154em;">Segn su mecanismo de accin y los datos de estudios en animales, IMFINZI puede causar dao fetal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4885em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0149em;">cuando se administra a una mujer embarazada. En estudios de reproduccin en animales, la administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5385em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0134em;">de durvalumab a monos cynomolgus desde el inicio de la organognesis hasta el parto dio como resultado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2299em;">un aumento del parto prematuro, prdida fetal y muerte neonatal prematura. Informe a las mujeres &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.6485em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0025em;">embarazadas sobre el riesgo potencial para un feto. Aconseje a las mujeres con potencial reproductivo que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.6985em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0074em;">usen mtodos anticonceptivos efectivos durante el tratamiento con IMFINZI y durante 3 meses despus de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7585em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0005em;">la ltima dosis de IMFINZI </span><span class="pdf24_55 pdf24_06 pdf24_38" style="word-spacing:0.0004em;">[consulte Uso en Poblaciones Especficas]</span><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0004em;">. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:55.8685em;"><span class="pdf24_12 pdf24_06 pdf24_13">8. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:55.8685em;"><span class="pdf24_05 pdf24_06 pdf24_107" style="word-spacing:0.0307em;">REACCIONES ADVERSAS &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.9282em;"><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0212em;">Las siguientes reacciones adversas se analizan con mayor detalle en otras secciones del etiquetado. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">17 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_17" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANL0lEQVR4nO3DQQ0AMAgEsLOE/L1mbTjYG9ImTQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYJrTr7p+BQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIC/B26Xu3ECEIyMAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_186" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:5.9767em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:7.0967em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:6.0818em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:-0.0365em;">Reacciones Adversas Inmunomediadas </span><span class="pdf24_55 pdf24_06 pdf24_147" style="word-spacing:-0.0278em;">[consulte Advertencias y Precauciones]</span><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.0278em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:7.2018em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0282em;">Reacciones Relacionadas con la Perfusin </span><span class="pdf24_55 pdf24_06 pdf24_74" style="word-spacing:-0.025em;">[consulte Advertencias y Precauciones]</span><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.025em;">. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:9.2508em;"><span class="pdf24_12 pdf24_06 pdf24_26" style="word-spacing:0.2079em;">8.1. </span><span class="pdf24_05 pdf24_06 pdf24_142" style="word-spacing:-0.0231em;">Experiencia en Estudios Clnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.8218em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0424em;">Debido a que los estudios clnicos se llevan a cabo en condiciones muy variables, las tasas de reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.8818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.016em;">adversas observadas en los estudios clnicos de un medicamento no se pueden comparar directamente con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.9318em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1373em;">las tasas en los estudios clnicos de otro medicamento y pueden no reflejar las tasas observadas en la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.9818em;"><span class="pdf24_14 pdf24_06 pdf24_144">prctica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.0918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0287em;">Los datos descritos en la seccin de Advertencias y Precauciones reflejan la exposicin a IMFINZI como &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.1518em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0949em;">agente nico con un total de 1889 pacientes enrolados en el estudio PACIFIC (un estudio aleatorizado, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.2018em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.039em;">controlado con placebo que inscribi a 475 pacientes con CPCNP no resecable en estado III), Estudio 1108 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.2518em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0676em;">(un estudio de etiqueta abierta, de un solo brazo, estudio multicohorte que inscribi a 970 pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.3143em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2887em;">tumores slidos avanzados), y un estudio de etiqueta abierta, de un solo brazo adicional (estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.3643em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0443em;">ATLANTIC) que inscribi a 444 pacientes con tumores slidos avanzados, incluido el CPCNP. En estos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.4243em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0319em;">estudios, IMFINZI se administr a una dosis de 10 mg/kg cada 2 semanas. Entre los 1889 pacientes, el 38% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.4743em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1239em;">estuvo expuesto durante 6 meses o ms y el 18% estuvo expuesto durante 12 meses o ms. Los datos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.5243em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0478em;">tambin reflejan la exposicin a IMFINZI 1500 mg cada 4 semanas como agente nico en 262 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.5843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.006em;">del estudio ADRIATIC (un estudio aleatorizado, doble ciego en pacientes con CPCP-EL) y a IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.6343em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2091em;">combinacin con quimioterapia en 265 pacientes del estudio CASPIAN (un estudio aleatorizado, de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.6943em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.2595em;">etiqueta abierta en pacientes con CPCP-EE) y en 338 pacientes del estudio TOPAZ-1 (un estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.7443em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0663em;">aleatorizado y doble ciego en pacientes con CVB). En los estudios CASPIAN y TOPAZ-1, IMFINZI se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.7943em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0013em;">administr a una dosis de 1500 mg cada 3 o 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.9043em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0051em;">Los datos tambin reflejan la exposicin a IMFINZI 1500 mg en combinacin con tremelimumab-actl 300 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.9643em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0136em;">mg en 388 pacientes en HIMALAYA. En el estudio HIMALAYA, los pacientes recibieron IMFINZI 1500 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.016em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.0611em;">mg en combinacin con tremelimumab-actl como una nica infusin intravenosa de 300 mg, seguida de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.076em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0317em;">IMFINZI 1500 mg cada 4 semanas. La poblacin de seguridad agrupada (N = 596) descrita en la seccin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.126em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0409em;">Advertencias y Precauciones refleja la exposicin a IMFINZI 1500 mg en combinacin con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.176em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0362em;">actl 75 mg y la histologa en regmenes de quimioterapia basada en platino en 330 pacientes en POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.236em;"><span class="pdf24_14 pdf24_06 pdf24_178">[</span><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:-0.0164em;">consulte Estudios clnicos</span><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.02em;">] y 266 pacientes con CPCP-EE en CASPIAN que recibieron hasta cuatro ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.286em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.095em;">de platino-etopsido ms IMFINZI 1500 mg con tremelimumab-actl 75 mg cada 3 semanas seguido de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.346em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0167em;">IMFINZI 1500 mg cada 4 semanas (un rgimen no aprobado para el cncer de pulmn de clulas pequeas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.396em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0056em;">en estado extenso). Entre los 596 pacientes, el 55 % estuvo expuesto a IMFINZI durante 6 meses o ms y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.446em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0007em;">el 24 % estuvo expuesto durante 12 meses o ms. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.566em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.3032em;">Los datos descritos en esta seccin reflejan la exposicin en pacientes tratados con IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.616em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1943em;">combinacin con quimioterapia basada en platino seguida de IMFINZI en combinacin con olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0016em;">(quimioterapia basada en platino + IMFINZI + olaparib) (N=238). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.7785em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0252em;">Los datos descritos en esta seccin reflejan la exposicin a IMFINZI en pacientes con CPCNP no resecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.8285em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1323em;">en estado III enrolados en el estudio PACIFIC, en pacientes con CPCNP metastsico enrolados en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.8885em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1183em;">estudio POSEIDON, en pacientes con CPCP-EL enrolados en el estudio ADRIATIC, en pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.9385em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0001em;">CPCP-EE enrolados en el estudio CASPIAN, en pacientes con CVB enrolados en el estudio TOPAZ-1, en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.9885em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0665em;">pacientes con CHC irresecable incluidos en el estudio HIMALAYA, en pacientes con CPCNP resecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.0485em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0062em;">enrolados en el estudio AEGEAN, y en pacientes con cncer de endometrio enrolados en el estudio DUO- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.0985em;"><span class="pdf24_14 pdf24_06 pdf24_187">E. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.2082em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0157em;">Cncer de Pulmn de Clulas No Pequeas &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">18 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_18" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_188" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_55 pdf24_06 pdf24_165" style="word-spacing:-0.0248em;">Tratamiento neoadyuvante y adyuvante del CPCNP resecable - AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1318em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0254em;">La seguridad de IMFINZI en combinacin con quimioterapia neoadyuvante con platino seguido de ciruga, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0279em;">y tratamiento adyuvante continuado con IMFINZI como agente nico despus de la ciruga, se investig en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0207em;">AEGEAN, un estudio aleatorizado, doble ciego, controlado con placebo, multicntrico para pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0374em;">CPCNP resecable (estado IIA a estado IIIB seleccionado [AJCC, 8 edicin]); escamoso o no escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_55 pdf24_06 pdf24_34" style="word-spacing:0.0041em;">[consulte Estudios Clnicos]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.3119em;">Se encuentran disponibles datos de seguridad para los 799 pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0003em;">combinacin con quimioterapia (n = 401) o placebo en combinacin con quimioterapia (n = 398). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0409em;">La mediana de la duracin de la exposicin a 1500 mg de IMFINZI cada 3 semanas en la fase neoadyuvante &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0322em;">fue de 12 semanas (rango: de 0 a 19 semanas). La mediana de la duracin de la exposicin a 1500 mg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0055em;">IMFINZI cada 4 semanas en la fase adyuvante fue de 37 semanas (rango: de 4 a 67 semanas). La mediana &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0096em;">de la edad de los pacientes que recibieron IMFINZI fue de 65 aos (rango: de 30 a 88), 52 % de 65 aos o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0106em;">ms, 12 % de 75 aos o ms; 65 % hombres; 54 % de raza blanca, 41 % asiticos, 1 % de raza negra, 3 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0011em;">de otras razas; y 17 % hispanos o latinos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_20 pdf24_06 pdf24_50" style="word-spacing:0.0911em;">Las reacciones adversas ms frecuentes (que se produjeron en  20 % de los pacientes) fueron anemia, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0003em;">nuseas, estreimiento, fatiga, dolor musculoesqueltico y erupcin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_20 pdf24_06 pdf24_50" style="word-spacing:0.1623em;">La Tabla 5 resume las reacciones adversas que ocurrieron en ( 10 %) de los pacientes tratados con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0005em;">IMFINZI en combinacin con quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0211em;">Tabla 5. Reacciones adversas que ocurrieron en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_05 pdf24_06 pdf24_24" style="word-spacing:-0.0219em;">10 % de los pacientes en el estudio AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.8442em;top:32.4143em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.0601em;">IMFINZI con quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.1442em;top:33.4643em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=401 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.1058em;top:32.4143em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0671em;">Placebo con quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0458em;top:33.4643em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=398 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:32.4343em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0329em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.5442em;top:34.576em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1942em;top:35.636em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.4842em;top:34.576em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0629em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0358em;top:35.636em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2358em;top:34.576em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8758em;top:35.636em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.2683em;top:34.576em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8183em;top:35.636em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:36.656em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:38.846em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:39.936em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:41.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:38.846em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:39.936em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:41.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:38.846em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:39.936em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:41.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3683em;top:38.846em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:39.936em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:41.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:38.846em;"><span class="pdf24_14 pdf24_06 pdf24_23">Constipacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:39.936em;"><span class="pdf24_14 pdf24_06 pdf24_192" style="word-spacing:-0.0581em;">Diarrea </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128" style="word-spacing:-0.0921em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:41.026em;"><span class="pdf24_14 pdf24_06 pdf24_184">Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.126em;"><span class="pdf24_05 pdf24_06 pdf24_71" style="word-spacing:-0.0338em;">Trastornos generales y condiciones administrativas del sitio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0569em;">Fatiga </span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_108" style="word-spacing:-0.0903em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.9542em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5858em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:44.306em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0136em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.406em;"><span class="pdf24_14 pdf24_06 pdf24_127" style="word-spacing:-0.0009em;">Erupcin cutnea </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_193" style="word-spacing:-0.0015em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:46.496em;"><span class="pdf24_14 pdf24_06 pdf24_54">Pirexia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:45.406em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:46.496em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:45.406em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:46.496em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:45.406em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8658em;top:46.496em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:45.406em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3683em;top:46.496em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.5885em;"><span class="pdf24_05 pdf24_06 pdf24_143" style="word-spacing:-0.0294em;">Trastornos musculoesquelticos y del tejido conectivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:48.6785em;"><span class="pdf24_14 pdf24_06 pdf24_97" style="word-spacing:-0.0227em;">Dolor musculoesqueltico</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_194" style="word-spacing:-0.036em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:49.7785em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.0237em;">Trastornos del metabolismo y nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:50.8685em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0251em;">Disminucion del apetito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:51.9585em;"><span class="pdf24_05 pdf24_06 pdf24_196" style="word-spacing:-0.0276em;">Trastornos del sistema nervioso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.0291em;">Neuropata perifrica</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_23" style="word-spacing:-0.0461em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:54.1485em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0391em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.2385em;"><span class="pdf24_14 pdf24_06 pdf24_122" style="word-spacing:-0.026em;">Hipotiroidismo </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_197" style="word-spacing:-0.0413em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.9542em;top:48.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:48.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:50.8685em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5858em;top:55.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:48.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:50.8685em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5358em;top:55.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:48.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:50.8685em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3683em;top:55.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:50.8685em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:53.0585em;"><span class="pdf24_14 pdf24_06 pdf24_64">16 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:55.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.3285em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0324em;">Trastornos respiratorios, torcicos y mediastnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.4282em;"><span class="pdf24_14 pdf24_06 pdf24_17" style="word-spacing:0.0039em;">Tos / Tos productiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:57.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:58.5182em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5858em;top:57.4282em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:27.2558em;top:58.5182em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:57.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:58.5182em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3683em;top:57.4282em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:58.5182em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:58.5182em;"><span class="pdf24_14 pdf24_06 pdf24_138">Neumona</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_198">#, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">19 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_19" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_199" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.492em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0329em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.8442em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.0601em;">IMFINZI con quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.1442em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=401 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.1058em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0671em;">Placebo con quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0458em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=398 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.5442em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1942em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.4842em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0629em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0358em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2358em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8758em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8658em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:38.2683em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8183em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_200">COVID-19</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_201"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:27.2558em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.3118em;"><span class="pdf24_05 pdf24_06 pdf24_59" style="word-spacing:-0.0378em;">Trastornos psiquitricos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_132">Insomnio &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9542em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5858em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3683em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.672em;"><span class="pdf24_41 pdf24_06 pdf24_18" style="word-spacing:0.0006em;">* incluye colitis, diarrea, enteritis y proctitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.632em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_141" style="word-spacing:0.0019em;">incluye fatiga y astenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.592em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0327em;"> incluye dermatitis, dermatitis acneiforme, erupcin farmacolgica, eccema, eccema esteattico, eritema, sndrome &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.552em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.2663em;">palmar-eritrodisestesia, penfigoide, erupcin, erupcin eritematosa, erupcin macular, erupcin maculopapular, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.502em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:-0.0011em;">erupcin papular, erupcin prurtica y erupcin pustulosa, exfoliacin cutnea y dermatitis urticarial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.462em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:0.1201em;"> incluye artralgia, artritis, dolor de espalda, dolor seo, dolor torcico, dolor torcico musculoesqueltico, dolor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.422em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.242em;">musculoesqueltico, molestias musculoesquelticas, rigidez musculoesqueltica, mialgia, dolor de cuello, dolor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.3845em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0002em;">torcico no cardaco, dolor en las extremidades y dolor espinal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.3445em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.3021em;"> incluye disestesia, hipoestesia, neuralgia, neuropata perifrica, parestesia, neuropata sensorial perifrica y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.3045em;"><span class="pdf24_41 pdf24_06 pdf24_100">polineuropata. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.2545em;"><span class="pdf24_41 pdf24_06 pdf24_36" style="word-spacing:-0.0018em;"> incluye aumento de la hormona estimulante de la tiroides en sangre e hipotiroidismo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.2245em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.0069em;"># Incluye infeccin del tracto respiratorio inferior, absceso pulmonar, neumona paracancerosa, neumona, neumona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.1745em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:0.2887em;">por aspiracin, neumona bacteriana, neumona por clamidias, neumona criptoccica, neumona por hongos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.1345em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0018em;">neumona por pseudomonas, neumona estreptoccica, neumona vrica y neumona posterior al procedimiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0745em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_202" style="word-spacing:-0.0031em;">Cinco eventos de grado 5 en el brazo de IMFINZI y cuatro eventos de grado 5 en el brazo de placebo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.0545em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0214em;"> Incluye COVID-19 y neumona por COVID-19. Cinco eventos de grado 5 en el brazo de IMFINZI y un evento de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.0045em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0024em;">grado 5 en el brazo de placebo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.0143em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0357em;">La Tabla 6 resume las anormalidades de laboratorio en los pacientes tratados con IMFINZI en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.0643em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0029em;">con quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.186em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:-0.0372em;">Tabla 6. Anormalidades de Laboratorio seleccionadas (&gt; 20 %) que empeoraron en comparacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.236em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:0.0541em;">los valores iniciales en pacientes con la enfermedad que recibieron IMFINZI con quimioterapia en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.286em;"><span class="pdf24_05 pdf24_06 pdf24_190">AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:37.396em;"><span class="pdf24_05 pdf24_06 pdf24_80" style="word-spacing:0.0156em;">Anormalidad de Laboratorio </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203" style="word-spacing:0.0247em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:25.4742em;top:37.376em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:0.0031em;">IMFINZI con &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0658em;top:37.376em;"><span class="pdf24_05 pdf24_06 pdf24_204" style="word-spacing:-0.0119em;">Placebo con &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.2442em;top:38.426em;"><span class="pdf24_05 pdf24_06 pdf24_72">quimioterapia</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_206"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.4458em;top:38.426em;"><span class="pdf24_05 pdf24_06 pdf24_138">quimioterapia</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:23.3642em;top:39.526em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.0142em;top:40.576em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.5258em;top:39.526em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0758em;top:40.576em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5958em;top:39.526em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2358em;top:40.576em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7783em;top:39.526em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0629em;">Grade 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:40.576em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:41.616em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:42.716em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.02em;">Disminucin de la hemoglobina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:43.806em;"><span class="pdf24_14 pdf24_06 pdf24_208" style="word-spacing:-0.0236em;">Disminucin de los leucocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:44.896em;"><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0257em;">Disminucin de Neutrofilos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0319em;">Disminucin de plaquetas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:47.076em;"><span class="pdf24_14 pdf24_06 pdf24_16" style="word-spacing:-0.024em;">Disminucin de los linfocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:48.1785em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:42.716em;"><span class="pdf24_14 pdf24_06 pdf24_64">78 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:43.806em;"><span class="pdf24_14 pdf24_06 pdf24_64">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:44.896em;"><span class="pdf24_14 pdf24_06 pdf24_64">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_64">46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:47.076em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.3958em;top:42.716em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.3958em;top:43.806em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.3958em;top:44.896em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.6258em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:42.716em;"><span class="pdf24_14 pdf24_06 pdf24_64">75 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:43.806em;"><span class="pdf24_14 pdf24_06 pdf24_64">64 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:44.896em;"><span class="pdf24_14 pdf24_06 pdf24_64">56 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_64">44 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:47.076em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:42.716em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:43.806em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:44.896em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:30.3958em;top:47.076em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:47.076em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:6.482em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0201em;">Calcio corregido, disminuido &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_64">51 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_64">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:51.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">47 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:53.0885em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:54.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:55.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.6258em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_64">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_64">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:51.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:53.0885em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:54.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:55.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_15">2</span></div>
					<div class="pdf24_01" style="left:6.482em;top:50.5985em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0169em;">Aumento de la alanina aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:51.8385em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0232em;">Aumento de aspartato aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:53.0885em;"><span class="pdf24_14 pdf24_06 pdf24_48" style="word-spacing:-0.0224em;">Aumento de potasio &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:51.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:53.0885em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.6258em;top:54.3385em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:51.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:53.0885em;"><span class="pdf24_14 pdf24_06 pdf24_15">2</span></div>
					<div class="pdf24_01" style="left:6.482em;top:54.3385em;"><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0354em;">Disminucin de sodio &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:54.3385em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.482em;top:55.6085em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0229em;">Aumento de la gamma glutamil &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:56.8185em;"><span class="pdf24_14 pdf24_06 pdf24_23">transferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:55.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:55.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:58.0682em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:-0.0223em;">Aumento de la creatinina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:58.0682em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:58.0682em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:58.0682em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:58.0682em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">20 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_20" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_211" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.482em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0218em;">Aumento de amilasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:7.2318em;"><span class="pdf24_14 pdf24_06 pdf24_138">Hipomagnesemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:7.2318em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:8.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:7.2318em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:8.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:7.2318em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0058em;top:8.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:5.9818em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:7.2318em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:8.4918em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:6.482em;top:8.4918em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0163em;">Lipasa aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.842em;"><span class="pdf24_41 pdf24_06 pdf24_39" style="word-spacing:0.0003em;">* Clasificado segn NCI CTCAE V5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.802em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.0018em;">El denominador utilizado para calcular la tasa vari de 349 a 399 segn el nmero de pacientes con un valor inicial &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.762em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.004em;">y, al menos, un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.722em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0017em;"> El denominador utilizado para calcular la tasa vari de 333 a 398 segn el nmero de pacientes con un valor inicial &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.682em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.004em;">y, al menos, un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.6818em;"><span class="pdf24_55 pdf24_06 pdf24_213" style="word-spacing:-0.0215em;">Fase neoadyuvante de AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.7818em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0136em;">Un total de 401 pacientes recibieron al menos 1 dosis de IMFINZI en combinacin con quimioterapia con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.8418em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.229em;">platino como tratamiento neoadyuvante y 398 pacientes recibieron al menos 1 dosis de placebo en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.8943em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0018em;">combinacin con quimioterapia con platino como tratamiento neoadyuvante. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.0043em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.2331em;">Se produjeron reacciones adversas graves en el 21 % de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0484em;">combinacin con quimioterapia con platino como tratamiento neoadyuvante; las reacciones adversas graves &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.1143em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0372em;">ms frecuentes </span><span class="pdf24_20 pdf24_06 pdf24_22" style="word-spacing:-0.0283em;">(1 </span><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0326em;">%) fueron neumona (2.7 %), anemia (1.5 %), mielosupresin (1.5 %), vmitos (1.2 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.1643em;"><span class="pdf24_14 pdf24_06 pdf24_67" style="word-spacing:-0.0486em;">neutropenia (1 %) y lesin renal aguda (1 %). Hubo reacciones adversas mortales en el 2 % de los pacientes, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.2243em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.0077em;">incluida la muerte por neumona por COVID-19 (0.5 %), sepsis (0.5 %), miocarditis (0.2 %), disminucin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.2743em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0035em;">del apetito (0.2 %), hemoptisis (0.2 %) y muerte no especificada de otra manera (0.2 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.3843em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0133em;">Se produjo la discontinuacin permanente de cualquier frmaco del estudio debido a una reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4343em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0222em;">en el 14 % de los pacientes que recibieron IMFINZI en combinacin con quimioterapia con platino como &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.4943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.3649em;">tratamiento neoadyuvante; las reacciones adversas ms frecuentes (&gt;0.5 %) que derivaron en la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5443em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0024em;">discontinuacin permanente de cualquier frmaco del estudio fueron anemia (1.5 %), neutropenia (0.7 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5943em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0391em;">mielosupresin (0.7 %) y neuropata sensorial perifrica (0.7 %). Se produjo la discontinuacin permanente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.656em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1576em;">de IMFINZI debido a una reaccin adversa en el 6.7 % de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.706em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0384em;">combinacin con quimioterapia con platino como tratamiento neoadyuvante; las reacciones adversas ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.766em;"><span class="pdf24_20 pdf24_06 pdf24_19" style="word-spacing:0.2178em;">frecuentes (0.5 %) que derivaron en la discontinuacin permanente de IMFINZI fueron neuropata &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.816em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0007em;">sensorial perifrica (0.7 %) y neumonitis (0.5 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.926em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.184em;">De los 401 pacientes tratados con IMFINZI y los 398 pacientes tratados con placebo que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.976em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0066em;">tratamiento neoadyuvante, el 1.7 % (n = 7) y el 1 % (n = 4), respectivamente, no recibieron ciruga debido &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.036em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0056em;">a reacciones adversas. Las reacciones adversas que derivaron en la cancelacin de la ciruga en el brazo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.086em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0445em;">IMFINZI fueron neumona por COVID-19, infeccin por VIH, neumonitis, cncer de prstata, cncer de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.146em;"><span class="pdf24_14 pdf24_06 pdf24_129" style="word-spacing:-0.0069em;">colon, prurito y colitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.256em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0111em;">De los 325 pacientes tratados con IMFINZI que recibieron ciruga, el 4 % (n = 15) experiment retraso de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.306em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0574em;">la ciruga (un retraso quirrgico se define como una ciruga en el estudio que se produce ms de 40 das &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3685em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0983em;">despus de la ltima dosis del tratamiento del estudio en el perodo neoadyuvante) debido a reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4185em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.014em;">adversas. De los 326 pacientes tratados con placebo que recibieron ciruga, el 4 % (n = 16) experiment un &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4685em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0002em;">retraso de la ciruga debido a reacciones adversas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5785em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0173em;">De los 325 pacientes tratados con IMFINZI que recibieron ciruga, el 6.5 % (n = 21) no recibi tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6385em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0051em;">adyuvante debido a reacciones adversas. De los 326 pacientes tratados con placebo que recibieron ciruga, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6885em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">el 5.8 % (n = 19) no recibi tratamiento adyuvante debido a reacciones adversas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7985em;"><span class="pdf24_55 pdf24_06 pdf24_27" style="word-spacing:-0.0178em;">Fase adyuvante de AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">21 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_21" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAV0UlEQVR4nO3av86lZRXG4X0EtLQTG1p6iaHiEAANCYHeRtAOjYVWNsQhMoaEgImKf2pLT82XDM2EYnzeVax1s64rufuV2Zlv9m+e7/EAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADg8sm1982stPeuvT3gDrOUvXPt3QF3mCXul9defcBi31x708xKe+vapwPuMEvZx9c+GHCHWeKeXnvtAYv9pfsA+AF45dpn3UdAkA8fz7+IAed+e+1H3UdAJwEDdQIGzggYuE/AsJ6AgToBA2cEDNwnYFhPwECdgIEzAgbuEzCsJ2CgTsDAGQED9wkY1hMwUCdg4IyAgfsEDOsJGKgTMHBGwMB9Aob1BAzUCRg4I2DgPgHDegIG6gQMnBEwcJ+AYT0BA3UCBs4IGLhPwLCegIE6AQNnBAzcJ2BYT8BAnYCBMwIG7hMwrCdgoE7AwBkBA/cJGNYTMFAnYOCMgIH7BAzrCRioEzBwRsDAfQKG9QQM1AkYOCNg4D4Bw3oCBuoEDJwRMHCfgGE9AQN1AgbOCBi4T8CwnoCBOgEDZwQM3CdgWE/AQJ2AgTMCBu4TMKwnYKBOwMAZAQP3CRjWEzBQJ2DgjICB+wQM6wkYqBMwcEbAwH0ChvUEDNQJGDgjYOA+AcN6AgbqBAycETBwn4BhPQEDdQIGzggYuE/AsJ6AgToBA2cEDNwnYFhPwECdgIEzAgbuEzCsJ2CgTsDAGQED9wkY1hMwUCdg4IyAgfsEDOsJGKgTMHBGwMB9Aob1BAzUCRg4I2DgPgHDegIG6gQMnBEwcJ+AYb1/XvuvmZX2n2v/GHCHne2v1/494I6N+9u1bwbcYS/fvwbcYC/u79eePGAxLzBQ5wUm00fXXu8+YikvMDm+7j6A7/ECw3oCBuoETCYB00fA5BAw8wgY1hMwUCdgMgmYPgImh4CZR8CwnoCBOgGTScD0ETA5BMw8Aob1BAzUCZhMAqaPgMkhYOYRMKwnYKBOwGQSMH0ETA4BM4+AYT0BA3UCJpOA6SNgcgiYeQQM6wkYqBMwmQRMHwGTQ8DMI2BYT8BAnYDJJGD6CJgcAmYeAcN6AgbqBEwmAdNHwOQQMPMIGNYTMFAnYDIJmD4CJoeAmUfAsJ6AgToBk0nA9BEwOQTMPAKG9QQM1AmYTAKmj4DJIWDmETCsJ2CgTsBkEjB9BEwOATOPgGE9AQN1AiaTgOkjYHIImHkEDOsJGKgTMJkETB8Bk0PAzCNgWE/AQJ2AySRg+giYHAJmHgHDegIG6gRMJgHTR8DkEDDzCBjWEzBQJ2AyCZg+AiaHgJlHwLCegIE6AZNJwPQRMDkEzDwChvUEDNQJmEwCpo+AySFg5hEwrCdgoE7AZBIwfQRMDgEzj4BhPQEDdQImk4DpI2ByCJh5BAzrCRioEzCZBEwfAZNDwMwjYFhPwECdgMkkYPoImBwCZh4Bw3oCBuoETCYB00fA5BAw8wgY1hMwUCdgMgmYPgImh4CZR8CwnoCBOgGTScD0ETA5BMw8Aob1BAzUCZhMAqaPgMkhYOYRMKwnYKBOwGQSMH0ETA4BM4+AYT0BA3UCJpOA6SNgcgiYeQQM6wkYqBMwmQRMHwGTQ8DMI2BYT8BAnYDJJGD6CJgcAmYeAcN6AgbqBEwmAdNHwOQQMPMIGNYTMFAnYDIJmD4CJoeAmUfAsJ6AgToBk0nA9BEwOQTMPAKG9QQM1AmYTAKmj4DJIWDmETCsJ2CgTsBkEjB9BEwOATOPgGE9AQN1AiaTgOkjYHIImHkEDOsJGKgTMJkETB8Bk0PAzCNgWE/AQJ2AySRg+giYHAJmHgHDegIG6gRMJgHTR8DkEDDzCBjWEzBQJ2AyCZg+AiaHgJlHwLCegIE6AZNJwPQRMDkEzDwChvUEDNQJmEwCpo+AySFg5hEwrCdgoE7AZBIwfQRMDgEzj4BhPQEDdQImk4DpI2ByCJh5BAzrCRioEzCZBEwfAZNDwMwjYFhPwECdgMkkYPoImBwCZh4Bw3oCBuoETCYB00fA5BAw8wgY1vvq2pdmVtqz79Z9h53t6eN5eHbfsXF//G7dd9jL52fbvH1x7ckDFvMCAwCQwwsM6wkYAIAcAob1BAwAQA4Bw3oCBgAgh4BhPQEDAJBDwLCegAEAyCFgWE/AAADkEDCsJ2AAAHIIGNYTMAAAOQQM6wkYAIAcAob1BAwAQA4Bw3oCBgAgh4BhPQEDAJBDwLCegAEAyCFgWE/AAADkEDCsJ2AAAHIIGNb7/NqbZlbaT679eMAddrY3Hs8/u+47Nu7bvy9vDLjD/r/PqvsGe3G/u/bkAYs9u/a+mZX2wbWnA+6ws/3+2s8H3LFxv7n2iwF32Mvne8K8/eEhYFjOr5BB3SvXPus+gmMfXXu9+4ilPnw8/59k5vu6+wC+x6+QsZ6AgToBk0nA9BEwOQTMPAKG9QQM1AmYTAKmj4DJIWDmETCsJ2CgTsBkEjB9BEwOATOPgGE9AQN1AiaTgOkjYHIImHkEDOsJGKgTMJkETB8Bk0PAzCNgWE/AQJ2AySRg+giYHAJmHgHDegIG6gRMJgHTR8DkEDDzCBjWEzBQJ2AyCZg+AiaHgJlHwLCegIE6AZNJwPQRMDkEzDwChvUEDNQJmEwCpo+AySFg5hEwrCdgoE7AZBIwfQRMDgEzj4BhPQEDdQImk4DpI2ByCJh5BAzrCRioEzCZBEwfAZNDwMwjYFhPwECdgMkkYPoImBwCZh4Bw3oCBuoETCYB00fA5BAw8wgY1vvq2pdmVtqzATfY+f587U8D7ti4z/3Zx8z3hHn74tqTByzmBQbqvMBk8gLTxwtMDi8w83iBYT0BA3UCJpOA6SNgcgiYeQQM6wkYqBMwmQRMHwGTQ8DMI2BYT8BAnYDJJGD6CJgcAmYeAcN6AgbqBEwmAdNHwOQQMPMIGNYTMFAnYDIJmD4CJoeAmUfAsJ6AgToBk0nA9BEwOQTMPAKG9QQM1AmYTAKmj4DJIWDmETCsJ2CgTsBkEjB9BEwOATOPgGE9AQN1AiaTgOkjYHIImHkEDOsJGKgTMJkETB8Bk0PAzCNgWE/AQJ2AySRg+giYHAJmHgHDegIG6gRMJgHTR8DkEDDzCBjWEzBQJ2AyCZg+AiaHgJlHwLCegIE6AZNJwPQRMDkEzDwChvUEDNQJmEwCpo+AySFg5hEwrCdgoE7AZBIwfQRMDgEzj4BhPQEDdQImk4DpI2ByCJh5BAzrCRioEzCZBEwfAZNDwMwjYFhPwECdgMkkYPoImBwCZh4Bw3oCBuoETCYB00fA5BAw8wgY1hMwUCdgMgmYPgImh4CZR8CwnoCBOgGTScD0ETA5BMw8Aob1BAzUCZhMAqaPgMkhYOYRMKwnYKBOwGQSMH0ETA4BM4+AYT0BA3UCJpOA6SNgcgiYeQQM6wkYqBMwmQRMHwGTQ8DMI2BYT8BAnYDJJGD6CJgcAmYeAcN6AgbqBEwmAdNHwOQQMPMIGNYTMFAnYDIJmD4CJoeAmUfAsJ6AgToBk0nA9BEwOQTMPAKG9QQM1AmYTAKmj4DJIWDmETCsJ2CgTsBkEjB9BEwOATOPgGG9bx7P/xExs/t769qnA+6ws/362k8H3LFxH1/7YMAd9vI9G3CDvbin1157wGKfXHvfzEp779rbA+6ws337mf1swB0b9861dwfcYS+fn23z9qtrrz4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADgB+p/tRhLKAKiZ2cAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_214" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0869em;">Un total de 265 pacientes en el brazo de IMFINZI y 254 pacientes en el brazo de placebo recibieron al &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0005em;">menos 1 dosis de tratamiento adyuvante. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2122em;">De los pacientes que recibieron IMFINZI como agente nico como tratamiento adyuvante, el 13 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2418em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0162em;">experiment reacciones adversas graves. Las reacciones adversas graves ms frecuentes que se informaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0384em;">en &gt;1 % de los pacientes fueron neumona (1.9 %), neumonitis (1.1 %) y COVID-19 (1.1 %). Durante la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0734em;">fase adyuvante del estudio, se produjeron cuatro reacciones adversas mortales, entre las que se incluyen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4018em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0198em;">neumona por COVID-19, neumona por aspiracin, enfermedad pulmonar intersticial y aneurisma artico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0124em;">Se produjo la discontinuacin permanente de IMFINZI adyuvante debido a una reaccin adversa en el 8 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0056em;">de los pacientes. La reaccin adversa ms frecuente </span><span class="pdf24_20 pdf24_06 pdf24_66" style="word-spacing:-0.0062em;">(0.5 </span><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0006em;">%) que deriv en la discontinuacin permanente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0005em;">de IMFINZI adyuvante fue neumonitis (1.1 %) y erupcin (0.8 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_55 pdf24_06 pdf24_140" style="word-spacing:-0.0143em;">CPCNP no resecable en estado III - PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1002em;">En el estudio PACIFIC, un estudio multicntrico, aleatorizado, doble ciego, controlado con placebo, se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.5222em;">evalu la seguridad de IMFINZI en pacientes con CPCNP en estado III que completaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0511em;">quimiorradioterapia concurrente basada en platino dentro de los 42 das previos al inicio del frmaco del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0519em;">estudio. Un total de 475 pacientes recibieron IMFINZI 10 mg/kg por va intravenosa cada 2 semanas. El &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0372em;">estudio excluy a los pacientes que tenan progresin de la enfermedad despus de la quimiorradiacin, con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2051em;">enfermedad autoinmune activa o previa dentro de los 2 aos posteriores al inicio del estudio o con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0037em;">afecciones mdicas que requeran inmunosupresin sistmica </span><span class="pdf24_55 pdf24_06 pdf24_31" style="word-spacing:-0.0013em;">[consulte Estudios Clnicos]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0334em;">Las caractersticas de la poblacin del estudio fueron: mediana de edad de 64 aos (rango: 23 a 90), 45% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0962em;">de edad de 65 aos o ms, 70% masculino, 69% blanco, 27% asitico, 75% ex fumador, 16% fumador &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0176em;">actual, y el 51% tena un estado de desempeo de la OMS de 1. Todos los pacientes recibieron radioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0328em;">definitiva segn el protocolo, de los cuales el 92% recibi una dosis de radiacin total de 54 Gy a 66 Gy. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0009em;">La mediana de la duracin de la exposicin a IMFINZI fue de 10 meses (rango: 0.2 a 12.6). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0438em;">IMFINZI se suspendi debido a reacciones adversas en el 15% de los pacientes. Las reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.606em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0425em;">ms comunes que condujeron a la suspensin de IMFINZI fueron neumonitis o neumonitis por radiacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1612em;">en el 6% de los pacientes. Se produjeron reacciones adversas graves en el 29% de los pacientes que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0081em;">recibieron IMFINZI. Las reacciones adversas severas ms frecuentes notificadas en al menos el 2% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0571em;">pacientes fueron neumonitis o neumonitis por radiacin (7%) y neumona (6%). La neumonitis fatal o la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0471em;">neumonitis por radiacin y la neumona mortal ocurrieron en &lt;2% de los pacientes y fueron similares en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.876em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0032em;">todos los brazos. Las reacciones adversas ms comunes (que ocurrieron en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:0.0055em;"> </span><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0057em;">20% de los pacientes) fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.926em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.106em;">tos, fatiga, neumonitis o neumonitis por radiacin, infecciones del tracto respiratorio superior, disnea y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.986em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.0095em;">erupcin cutnea. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0179em;">La Tabla 7 resume las reacciones adversas que ocurrieron en al menos el 10% de los pacientes tratados con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.096em;"><span class="pdf24_14 pdf24_06 pdf24_25">IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.2085em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0224em;">Tabla 7. Reaccin Adversas que Ocurren en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_05 pdf24_06 pdf24_27" style="word-spacing:-0.014em;">10% de los Pacientes en el Estudio PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.8242em;top:49.2885em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1742em;top:50.3385em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.005em;">N = 475 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0758em;top:49.2885em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1058em;top:50.3385em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0293em;">N = 234 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.8342em;top:51.4585em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.2342em;top:52.5085em;"><span class="pdf24_05 pdf24_06 pdf24_72">Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.9242em;top:53.4885em;"><span class="pdf24_05 pdf24_06 pdf24_114">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5058em;top:51.4585em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8958em;top:52.5085em;"><span class="pdf24_05 pdf24_06 pdf24_72">Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5958em;top:53.4885em;"><span class="pdf24_05 pdf24_06 pdf24_114">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8458em;top:51.9785em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0615em;">Grados 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2658em;top:53.0285em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6583em;top:51.9785em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0615em;">Grados 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.5085em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0783em;top:53.0285em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.5785em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.035em;">Trastornos Respiratorios, Torcicos, y Mediastinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.6685em;"><span class="pdf24_14 pdf24_06 pdf24_215" style="word-spacing:-0.0273em;">Tos/Tos Productiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:55.6685em;"><span class="pdf24_14 pdf24_06 pdf24_64">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:56.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:55.6685em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:56.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:55.6685em;"><span class="pdf24_14 pdf24_06 pdf24_64">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:56.8385em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:55.6685em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:56.8385em;"><span class="pdf24_14 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.8285em;"><span class="pdf24_14 pdf24_06 pdf24_62">Neumonitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">*</span></sup><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0576em;">/Neumonitis por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.8782em;"><span class="pdf24_14 pdf24_06 pdf24_23">Radiacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">22 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_22" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_216" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:23.8242em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1742em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.005em;">N = 475 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0658em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0958em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0293em;">N = 234 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.8342em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.2242em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_72">Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.9142em;top:10.2618em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5058em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8958em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_72">Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5858em;top:10.2618em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8458em;top:8.6718em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0615em;">Grados 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2658em;top:9.7218em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6583em;top:8.6718em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0615em;">Grados 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0783em;top:9.7218em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.2718em;"><span class="pdf24_14 pdf24_06 pdf24_72">Disnea</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_136"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.2142em;top:11.2718em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:11.2718em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:11.2718em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:11.2718em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.3718em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0397em;">Trastornos Generales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_52">Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_217"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_54">Pirexia &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:15.6418em;"><span class="pdf24_05 pdf24_06 pdf24_144">Infecciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:16.8018em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0599em;">Infecciones de tracto respiratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:16.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:18.8818em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:16.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8158em;top:18.8818em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:16.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:18.8818em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:16.8118em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:18.8818em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.492em;top:17.8518em;"><span class="pdf24_14 pdf24_06 pdf24_192">superior</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_218"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:18.8818em;"><span class="pdf24_14 pdf24_06 pdf24_138">Neumonia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:19.9843em;"><span class="pdf24_05 pdf24_06 pdf24_149" style="word-spacing:-0.0077em;">Trastornos de Piel y Tejido Subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:21.0743em;"><span class="pdf24_14 pdf24_06 pdf24_138">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.2142em;top:21.0743em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:21.0743em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8158em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:21.0743em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:21.0743em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:22.1643em;"><span class="pdf24_14 pdf24_06 pdf24_185">Prurito</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_219"># &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:23.2643em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.036em;">Trastornos Gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:24.3543em;"><span class="pdf24_14 pdf24_06 pdf24_192">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:24.3543em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2142em;top:25.4443em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:24.3543em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:25.4443em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.8858em;top:24.3543em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:25.4443em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:24.3543em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:25.4443em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.4443em;"><span class="pdf24_14 pdf24_06 pdf24_220" style="word-spacing:-0.0122em;">Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_221" style="word-spacing:-0.0194em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:26.5343em;"><span class="pdf24_05 pdf24_06 pdf24_147" style="word-spacing:-0.0275em;">Trastornos Endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:27.6343em;"><span class="pdf24_14 pdf24_06 pdf24_144">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_222"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.2142em;top:27.6343em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4858em;top:27.6343em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7858em;top:27.6343em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6183em;top:27.6343em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9245em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:-0.0093em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_223" style="word-spacing:-0.0068em;">Incluye neumonitis intersticial aguda, enfermedad pulmonar intersticial, neumonitis, fibrosis pulmonar &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.8945em;"><sup style="top: -0.29em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:0.0833em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_91" style="word-spacing:-0.0349em;">Incluye disnea y disnea de esfuerzo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8545em;"><span class="pdf24_41 pdf24_06 pdf24_225" style="word-spacing:0.1995em;"> Incluye</span><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:0.0009em;">&nbsp;</span><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:-0.0028em;">astenia y fatiga &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.8145em;"><span class="pdf24_41 pdf24_06 pdf24_225" style="word-spacing:0.1351em;"> Incluye</span><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0305em;">&nbsp;</span><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0171em;">laringitis, nasofaringitis, absceso periamigdalino, faringitis, rinitis, sinusitis, amigdalitis, traqueobronquitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:32.7745em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0007em;">e infeccin del tracto respiratorio superior &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.7362em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.0044em;"> Incluye infeccin pulmonar, neumona por pneumocystis jirovecii, neumona, neumona adenoviral, neumona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:34.6862em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0021em;">bacteriana, neumona por citomegalovirus, neumona por haemophilus, neumona por klebsiella, neumona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:35.6462em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0001em;">necrotizante, neumona neumoccica y neumona estreptoccica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.6062em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0165em;"> Incluye erupcin eritematosa, erupcin generalizada, erupcin macular, erupcin maculopapular, erupcin papular, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:37.5662em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0002em;">erupcin pruriginosa, erupcin pustulosa, eritema, eccema, erupcin y dermatitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.5162em;"><span class="pdf24_41 pdf24_06 pdf24_81" style="word-spacing:-0.0049em;"># Incluye prurito generalizado y prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.4862em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_85" style="word-spacing:-0.0048em;">Incluye dolor abdominal, dolor abdominal inferior, dolor abdominal superior y dolor en el costado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.4462em;"><span class="pdf24_41 pdf24_06 pdf24_94" style="word-spacing:-0.0072em;"> Incluye hipotiroidismo autoinmune e hipotiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.446em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0119em;">Otras reacciones adversas que ocurrieron en menos del 10% de los pacientes tratados con IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.496em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0008em;">fueron disfona, disuria, sudores nocturnos, edema perifrico y una mayor susceptibilidad a las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.556em;"><span class="pdf24_14 pdf24_06 pdf24_123">infecciones. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.616em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0134em;">La Tabla 8 resume las anormalidades de laboratorio que ocurrieron en al menos el 20% de los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0051em;">tratados con IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.7685em;"><span class="pdf24_189 pdf24_06 pdf24_32" style="word-spacing:0.0021em;">Tabla 8. Anormalidades de Laboratorio que Empeoran desde el Inicio del Estudio en  20% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.8285em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:0.0034em;">Pacientes en el Estudio PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.1642em;top:50.8485em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.7683em;top:50.8485em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:51.9985em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.0442em;top:52.0085em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.0958em;top:52.0085em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6458em;top:53.0685em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5058em;top:52.0085em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:52.0085em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2883em;top:53.0685em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.2842em;top:53.0685em;"><span class="pdf24_05 pdf24_06 pdf24_66">Grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.0431em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_35">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_31"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:34.7558em;top:53.0685em;"><span class="pdf24_05 pdf24_06 pdf24_122">Grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_226">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:35.4558em;top:54.1285em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:55.1485em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_61">Hiperglicemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.3282em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:58.4282em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0201em;">ALT Incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:57.3282em;"><span class="pdf24_14 pdf24_06 pdf24_64">46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:58.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.1958em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:57.3282em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:58.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8858em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">51 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8858em;top:57.3282em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8858em;top:58.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8383em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:41.8383em;top:57.3282em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:58.4282em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">23 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_23" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_230" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:25.1642em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.7683em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:7.0718em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.0442em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.0958em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6458em;top:8.1318em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5058em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0647em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2883em;top:8.1318em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.2842em;top:8.1318em;"><span class="pdf24_05 pdf24_06 pdf24_66">Grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.0431em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_35">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_31"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:34.7558em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_122">Grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_226">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:35.4558em;top:9.1918em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:35.8858em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0085em;">AST Incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.4018em;"><span class="pdf24_14 pdf24_06 pdf24_23">Hipercalemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:13.4918em;"><span class="pdf24_14 pdf24_06 pdf24_192" style="word-spacing:-0.0175em;">GGT Incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:14.5918em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:12.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:13.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:12.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8658em;top:13.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5083em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5083em;top:12.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5083em;top:13.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8858em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8758em;top:12.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8758em;top:13.4918em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_23">Linfopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4542em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.9658em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8758em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6083em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.942em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_36" style="word-spacing:0.0059em;">Clasificado de acuerdo a NCI CTCAE versin 4.0. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.912em;"><sup style="top: -0.29em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:-0.0093em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_13" style="word-spacing:-0.0144em;">La incidencia de cada prueba se basa en el nmero de pacientes que tenan disponible una medicin de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.8721em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0002em;">inicial y al menos una en el laboratorio: IMFINZI (rango: 464 a 470) y placebo (rango: 224 a 228). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.8843em;"><span class="pdf24_55 pdf24_06 pdf24_118" style="word-spacing:-0.0207em;">CPCNP metastsico - POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9843em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0793em;">La seguridad de IMFINZI en combinacin con tremelimumab-actl y quimioterapia basada en platino en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.0343em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.133em;">pacientes con CPCNP metastsico se evalu en POSEIDON (NCT03164616), un estudio aleatorizado, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0199em;">abierto, multicntrico y controlado con activo. Un total de 330 pacientes recibieron IMFINZI 1500 mg en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.1443em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0336em;">combinacin con tremelimumab-actl </span><span class="pdf24_20 pdf24_06 pdf24_49" style="word-spacing:-0.0241em;">( </span><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0343em;">30 kg de peso corporal recibieron 75 mg y &lt; 30 kg de peso corporal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.2043em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.1039em;">recibieron 1 mg/kg) y regmenes de quimioterapia con platino basados en histologa [</span><span class="pdf24_55 pdf24_06 pdf24_33" style="word-spacing:0.1139em;">consulte Estudios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.2543em;"><span class="pdf24_55 pdf24_06 pdf24_84">clnicos</span><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0132em;">]. De estos pacientes, el 66% recibi el mximo de 5 dosis de tremelimumab-actl y el 79% recibi &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.3043em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.2399em;">al menos 4 dosis. El tratamiento se continu con IMFINZI como agente nico (o con IMFINZI y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.3643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0296em;">pemetrexed basado histolgicamente para pacientes no escamosos segn la decisin del investigador) hasta &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.4143em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0185em;">la progresin de la enfermedad o una toxicidad inaceptable. El estudio excluy a pacientes con enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.4743em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.3153em;">autoinmune activa o previa o con afecciones mdicas que requeran corticosteroides sistmicos o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0061em;">inmunosupresores [</span><span class="pdf24_55 pdf24_06 pdf24_18" style="word-spacing:0.0034em;">consulte Estudios clnicos</span><span class="pdf24_14 pdf24_06 pdf24_177">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.636em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0702em;">La mediana de edad de los pacientes que recibieron IMFINZI en combinacin con tremelimumab-actl y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.696em;"><span class="pdf24_14 pdf24_06 pdf24_231" style="word-spacing:-0.0247em;">quimioterapia basada en platino fue de 63 aos (rango: 27 a 87); 80% hombres; 61% blancos, 29% asiticos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.746em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:-0.0234em;">58% exfumadores, 25% fumadores actuales y 68% con un desempeo ECOG de 1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.856em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2724em;">Se produjeron reacciones adversas graves en el 44% de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.906em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0993em;">combinacin con tremelimumab-actl y quimioterapia basada en platino. Las reacciones adversas graves &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.966em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.074em;">ms frecuentes notificadas en al menos el 2 % de los pacientes fueron neumona (11 %), anemia (5 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.016em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1404em;">diarrea (2.4 %), trombocitopenia (2.4 %), pirexia (2.4 %) y neutropenia febril (2.1 %). Se produjeron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.076em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0356em;">reacciones adversas mortales en un total del 4.2% de los pacientes que recibieron IMFINZI en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.126em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0865em;">con tremelimumab-actl y quimioterapia basada en platino. Estos incluyen hepatitis, nefritis, miocarditis, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.176em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2453em;">pancreatitis (todas en el mismo paciente), muerte (2 pacientes), sepsis (2 pacientes), neumonitis (2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.236em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3075em;">pacientes), lesin renal aguda (2 pacientes), neutropenia febril (1 paciente), enfermedad pulmonar &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.2885em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.208em;">obstructiva crnica (EPOC) (1 paciente), disnea (1 paciente), muerte sbita (1 paciente) y accidente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3485em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.001em;">cerebrovascular isqumico (1 paciente). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4485em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0203em;">La interrupcin permanente de IMFINZI o tremelimumab-actl debido a una reaccin adversa se produjo en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5085em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0167em;">el 17% de los pacientes. Las reacciones adversas que resultaron en la interrupcin permanente de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.5585em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0001em;">o tremelimumab-actl en &gt; 2% de los pacientes incluyeron neumona. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6785em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0508em;">La interrupcin o retraso de la dosificacin de IMFINZI y tremelimumab-actl debido a una reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7285em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0825em;">ocurri en el 41% de los pacientes. Las reacciones adversas que requirieron interrupcin o retraso de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.7782em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.7158em;">dosis de IMFINZI y tremelimumab-actl en &gt; 1% de los pacientes incluyeron anemia, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.8382em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:-0.0468em;">leucopenia/disminucin del recuento de glbulos blancos, neumona, neumonitis, colitis, diarrea, hepatitis, &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">24 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_24" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAtKElEQVR4nO3aMa+d55We4d2x1h9I2LDkHxgdcQxMMS2beNJkDMsdGwqWOwGiGtkG5IQBjQHJUDRteTJBkNTTZIAB8svybdB9Bjjr1fPu57suYPUvcBZ51n32vlwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAUv9yzAdjCua/HPPfNniHMeb/P//5mP+6wTuM+bHmfxzz9AKM+HP6ATDk1TGfpB8B/Jt8fsxP0o+AH5Gdh0EChhYCBm6HY46zsfMwSMDQQsDA7XDMcTZ2HgYJGFoIGLgdjjnOxs7DIAFDCwEDt8Mxx9nYeRgkYGghYOB2OOY4GzsPgwQMLQQM3A7HHGdj52GQgKGFgIHb4ZjjbOw8DBIwtBAwcDscc5yNnYdBAoYWAgZuh2OOs7HzMEjA0ELAwO1wzHE2dh4GCRhaCBi4HY45zsbOwyABQwsBA7fDMcfZ2HkYJGBoIWDgdjjmOBs7D4MEDC0EDNwOxxxnY+dhkIChhYCB2+GY42zsPAwSMLQQMHA7HHOcjZ2HQQKGFgIGbodjjrOx8zBIwNBCwMDtcMxxNnYeBgkYWggYuB2OOc7GzsMgAUMLAQO3wzHH2dh5GCRgaCFg4HY45jgbOw+DBAwtBAzcDsccZ2PnYZCAoYWAgdvhmONs7DwMEjC0EDBwOxxznI2dh0EChhYCBm6HY46zsfMwSMDQQsDA7XDMcTZ2HgYJGFoIGLgdjjnOxs7DIAFDCwEDt8Mxx9nYeRgkYGghYOB2OOY4GzsPgwQMLQQM3A7HHGdj52GQgKGFgIHb4ZjjbOw8DBIwtBAwcDscc5yNnYdBAoYWAgZuh2OOs7HzMEjA0ELAwO1wzHE2dh4GCRhaCBi4HY45zsbOwyABQwsBA7fDMcfZ2HkYJGBoIWDgdjjmOBs7D4MEDC0EDNwOxxxnY+dhkIChhYCB2+GY42zsPAwSMLQQMHA7HHOcjZ2HQQKGFgIGbodjjrOx8zBIwNBCwMDtcMxxNnYeBgkYWggYuB2OOc7GzsMgAUMLAQO3wzHH2dh5GCRgaCFg4HY45jgbOw+DBAwtBAzcDsccZ2PnYZCAoYWAgdvhmONs7DwMEjC0EDBwOxxznI2dh0EChhYCBm6HY46zsfMwSMDQQsDA7XDMcTZ2HgYJGFoIGLgdjjnOxs7DIAFDCwEDt8Mxx9nYeRgkYGghYOB2OOY4GzsPgwQMLQQM3A7HHGdj52GQgKGFgIHb4ZjjbOw8DBIwtBAwcDscc5yNnYdBAoYWAgZuh2OOs7HzMEjA0ELAwO1wzHE2dh4GCRhaCBi4HY45zsbOwyABQwsBA7fDMcfZ2HkY9PaYnxlTML8/5hcbvMOsm7875u83eIe5/3xzzC83eMcZ56cbvOGM8+KYuwsw4howPzGmYF4e87cbvMOsm3845m82eIe5//zqmJ9v8I4zjt/7mbnu/GcXYISvkNHCV8j6fX/Mg/QjGPH55eNRx4/vh/QDTsrOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOw6A/HfPBmIJ5fcy7Dd5h1s3bY95v8A5z//n9Xyb9jjPO2w3ecMa5/o769AKM8AkMAMBaPoGBQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgYJGAAANYSMDBIwAAArCVgYJCAAQBYS8DAIAEDALCWgIFBAgYAYC0BA4MEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBgkYAAA1hIwMEjAAACsJWBgkIABAFhLwMCg7495YUzBPD/mqw3eYdbNF8d8vcE7zMzP8ssN3nHGeb7BG8443x1zdwFGXAPmoTEF8/KYxxu8w6yb18c82uAd5v7z7JinG7zjjPNugzecca47/+QCjPAVMlq8OuaT9CNY6voHlwfpRzDC12lyfkg/4KTsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+D/nTMB2MK5g+Xjwdu+h1m3fzxmPcbvMPcf94c83qDd5xx/N7PzHXf7y7ACJ/A0MInMP18AtPDX6NzfAKTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GHQ9CF4YUzBvjvlmg3eYdeP/q5757phvN3jHGef9Bm8441x3/u4CjLgeBA+NKZiXxzze4B1m3bw+5tEG7zD3n2fHPN3gHWecdxu84Yxz3fknF2CEr5DRwlfI+vkKWQ9fp8nxFbIMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DoOt/ZB+MKZl3G7zBrJvr/1d/2OAd5v7z9pjXG7zjjPPnDd5wxnlzzN0FGOETGFr4BKafT2B6+Gt0jk9gMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4OuAfPBmIL54+XjgZt+h1k318Pr/QbvMPeft8e83uAdZxy/9zPz5pi7CzDievA9NKZgXh7zeIN3mHVzPXgfbfAOc/95dszTDd5xxnm3wRvOONedf3IBRvgKGS18hayfr5D18HWaHF8hy7DzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DrgfBQ2MK5uUxjzd4h1k3r495tME7zP3n2TFPN3jHGefdBm8441x3/skFGHENmBfGFMzzY77a4B1m3XxxzNcbvMPM/Cy/3OAdZ5znG7zhjPPdMXcXYISvkAEArOUrZDBIwAAArCVgYJCAAQBYS8DAIAEDALCWgIFBAgYAYC0BA4MEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBgkYAAA1hIwMEjAAACsJWBgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGPT9MS+MKZjnx3y1wTvMuvnimK83eIeZ+Vl+ucE7zjjPN3jDGee7Y+4uwIhrwDw0pmBeHvN4g3eYdfP6mEcbvMPcf54d83SDd5xx3m3whjPOdeefXIARvkJGi1fHfJJ+BEtd/+DyIP0IRvg6Tc4P6QeclJ2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYdCfjvlgTMH84fLxwE2/w6ybPx7zfoN3mPvPm2Neb/COM47f+5m57vvdBRjhExha+ASmn09gevhrdI5PYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DrgfBC2MK5s0x32zwDrNu/H/VM98d8+0G7zjjvN/gDWec687fXYAR14PgoTEF8/KYxxu8w6yb18c82uAd5v7z7JinG7zjjPNugzecca47/+QCjPAVMlr4Clk/XyHr4es0Ob5ClmHnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRh0/Y/sgzEF8+0xbzd4h1k3vznm/QbvMPef3x7zuw3eccb59QZvOOO8OebuAozwCQwAwFo+gYFBAgYAYC0BA4MEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBgkYAAA1hIwMEjAAACsJWBgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGCRgAADWEjAwSMAAAKwlYGCQgAEAWEvAwKBrwHwwpmC+PebtBu8w6+Y3x7zf4B3m/vPbY363wTvOOL/e4A1nnDfH3F2AET6BocWrYz5JP4Klvj/mQfoRjPDX6Jwf0g84KTsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPg67/kX0wpmC+PebtBu8w6+Y3x7zf4B3m/vPbY363wTvOOL/e4A1nnDfH3F2AET6BAQBYyycwMEjAAACsJWBgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGCRgAADWEjAwSMAAAKwlYGCQgAEAWEvAwCABAwCwloCBQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgY9P0xL4wpmOfHfLXBO8y6+eKYrzd4h5n5WX65wTvOOM83eMMZ57tj7i7AiGvAPDSmYF4e83iDd5h18/qYRxu8w9x/nh3zdIN3nHHebfCGM851559cgBG+QkaLV8d8kn4ES13/4PIg/QhG+DpNzg/pB5yUnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedh0P865l+NKZh3x/zzBu8w6+b9Mf9ng3eY+88fLh//gJZ+xxnn/QZvOOP80zGfXYARPoEBAFjLJzAwSMAAAKwlYGCQgAEAWEvAwCABAwCwloCBQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgYJGAAANYSMDBIwAAArCVgYJCAAQBYS8DAIAEDALCWgIFBAgYAYC0BA4MEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBj0/TEvjCmY58d8tcE7zLr54pivN3iHmflZfrnBO844zzd4wxnnu2PuLsCIa8A8NKZgXh7zeIN3mHXz+phHG7zD3H+eHfN0g3eccd5t8IYzznXnn1yAEb5CRotXx3ySfgRLXf/g8iD9CEb4Ok3OD+kHnJSdh0EChhYCpp+A6eGYyxEwGXYeBgkYWgiYfgKmh2MuR8Bk2HkYJGBoIWD6CZgejrkcAZNh52GQgKGFgOknYHo45nIETIadh0EChhYCpp+A6eGYyxEwGXYeBgkYWgiYfgKmh2MuR8Bk2HkYJGBoIWD6CZgejrkcAZNh52GQgKGFgOknYHo45nIETIadh0EChhYCpp+A6eGYyxEwGXYeBgkYWgiYfgKmh2MuR8Bk2HkYJGBoIWD6CZgejrkcAZNh52GQgKGFgOknYHo45nIETIadh0EChhYCpp+A6eGYyxEwGXYeBgkYWgiYfgKmh2MuR8Bk2HkYdD0IHhpTMC+PebzBO8y6eX3Mow3eYe4/z455usE7zjjvNnjDGee6808uwIjrX2I+GFMy7zZ4g1k31/+v/rDBO8z95+3lY5Cm33HG+fMGbzjjvDnm7gKM8BUyWvgKWT9fIevh6zQ5vkKWYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GCRgaCFg+gmYHo65HAGTYedhkIChhYDpJ2B6OOZyBEyGnYdBAoYWAqafgOnhmMsRMBl2HgYJGFoImH4CpodjLkfAZNh5GHQNmA/GFMwfLx8P3PQ7zLq5Hl7vN3iHuf+8Peb1Bu844/i9n5k3x9xdgBE+gaGFT2D6+QSmh79G5/gEJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zBIwNBCwPQTMD0cczkCJsPOwyABQwsB00/A9HDM5QiYDDsPgwQMLQRMPwHTwzGXI2Ay7DwMEjC0EDD9BEwPx1yOgMmw8zDoehA8NKZgXh7zeIN3mHXz+phHG7zD3H+eHfN0g3eccd5t8IYzznXnn1yAEdeAeWFMwTw/5qsN3mHWzRfHfL3BO8zMz/LLDd5xxnm+wRvOON8dc3cBRvgKGQDAWr5CBoMEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBgkYAAA1hIwMEjAAACsJWBgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGCRgAADWEjAwSMAAAKwlYGCQgAEAWEvAwCABAwCwloCBQdeA+WBMwXx7zNsN3mHWzW+Oeb/BO8z957fH/G6Dd5xxfr3BG844b465uwAjfAJDi1fHfJJ+BEt9f8yD9CMY4a/ROT+kH3BSdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQdeD4KExBfPymMcbvMOsm9fHPNrgHeb+8+yYpxu844zzboM3nHGuO//kAoy4BswLYwrmzQZvMGvn+v/VNxu8w9x/vjvm2w3eccZ5v8EbzjjXnb+7ACN8hYwWvkLWz1fIevg6TY6vkGXYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRh0PQheGFMwb475ZoN3mHXj/6ue+e6Ybzd4xxnn/QZvOONcd/7uAoy4HgQPjSmYf7fBG4yfsfm3/yz//QbvOOP4d5SZZ8c8uQAjfIUMAGAtXyGDQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgYJGAAANYSMDBIwAAArCVgYJCAAQBYS8DAIAEDALCWgIFBAgYAYC0BA4MEDADAWgIGBgkYAIC1BAwMEjAAAGsJGBgkYAAA1hIwMEjAAACsJWBg0JvLx39Qxtz6/NUxTzZ4h1k3nx7z1xu8w8z8LO82eMcZ59MN3nDG+dUxn12AEW+P+ZkxBfPqmF9s8A6zbl4f8/MN3mHuPy+O+eUG7zjj+L2fmReXj9EODPAVMlpcA+aT9CNY6vtjHqQfwYjPLx//Ks2P74f0A07KzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMwSMDQQsD0EzA9HHM5AibDzsMgAUMLAdNPwPRwzOUImAw7D4MEDC0ETD8B08MxlyNgMuw8DBIwtBAw/QRMD8dcjoDJsPMw6H8e86/GFMz1l/I/b/AOs27+8Zh/2eAd5v5z/ff6Txu844zzjxu84Yzz34+5uwAjfAIDALCWT2BgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGCRgAADWEjAwSMAAAKwlYGCQgAEAWEvAwCABAwCwloCBQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgYJGAAANYSMDDozeXjPyhjbn3+6pgnG7zDrJtPj/nrDd5hZn6Wdxu844zz6QZvOOP86pjPLsCIt8f8zJiCeXXMLzZ4h1k3r4/5+QbvMPefF8f8coN3nHH83s/Mi8vHaAcG+AoZLa4B80n6ESz1/TEP0o9gxOeXj3+V5sf3Q/oBJ2XnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRgkYGghYPoJmB6OuRwBk2HnYZCAoYWA6SdgejjmcgRMhp2HQQKGFgKmn4Dp4ZjLETAZdh4GCRhaCJh+AqaHYy5HwGTYeRj0p2M+GFMwr495t8E7zLp5e8z7Dd5h7j+//8uk33HGebvBG844199Rn16AET6BAQBYyycwMEjAAACsJWBgkIABAFhLwMAgAQMAsJaAgUECBgBgLQEDgwQMAMBaAgYGCRgAgLUEDAwSMAAAawkYGCRgAADWEjAwSMAAAKwlYGCQgAEAWEvAwCABAwCwloCBQQIGAGAtAQODBAwAwFoCBgYJGACAtQQMDBIwAABrCRgY9PaYnxlTMD895j9t8A6zbv7umL/f4B1m5mf5Hzd4xxnnpxu84Yzz4pi7CzDiGjA/MaZgXh7ztxu8w6ybfzjmbzZ4h7n//OqYn2/wjjOO3/uZue78ZxdghK+Q0eLVMZ+kH8FS3x/zIP0IRnx++XjU8eP7If2Ak7LzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAwSMLQQMP0ETA/HXI6AybDzMEjA0ELA9BMwPRxzOQImw87DIAFDCwHTT8D0cMzlCJgMOw+DBAwtBEw/AdPDMZcjYDLsPAz6v8d8MKZgXh/zboN3mHXz9pj3G7zD3H9+/5dJv+OM83aDN5xx/vcx/+ECAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADfh/wHkuLyMyJrEOwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_232" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0745em;">erupcin cutnea, astenia, aumento de amilasa, alanina aminotransferasa. aument, aument el aspartato &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1654em;">aminotransferasa, aument la lipasa, disminuy el recuento de neutropenia/neutrfilos y disminuy el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0075em;">recuento de trombocitopenia/plaquetas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_20 pdf24_06 pdf24_32" style="word-spacing:0.0405em;">Las reacciones adversas ms comunes (que ocurrieron en  20% de los pacientes) fueron nuseas, fatiga, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:0.0178em;">dolor musculoesqueltico, disminucin del apetito, erupcin cutnea y diarrea. Las anomalas de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_20 pdf24_06 pdf24_31" style="word-spacing:0.2277em;">de grado 3 o 4 ( 10%) fueron neutropenia, anemia, leucopenia, linfocitopenia, aumento de lipasa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0018em;">hiponatremia y trombocitopenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_142" style="word-spacing:-0.0174em;">La Tabla 9 resume las reacciones adversas de POSEIDON. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6318em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.0461em;">Tabla 9. Reacciones adversas </span><span class="pdf24_189 pdf24_06 pdf24_49" style="word-spacing:-0.035em;">( </span><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.0482em;">10%) en pacientes con CPCNP que recibieron IMFINZI en el estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_05 pdf24_06 pdf24_233">POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.7942em;top:20.1243em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0562em;">IMFINZI con tremelimumab-actl y &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.3042em;top:21.1743em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0022em;">quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.1642em;top:22.2343em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0279em;">N = 330 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.0358em;top:20.1243em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0668em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.5758em;top:21.1743em;"><span class="pdf24_05 pdf24_06 pdf24_122">platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4558em;top:22.2343em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0293em;">N = 333 &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.222em;top:23.6643em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0329em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.7442em;top:23.6743em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.067em;">Todos los grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:24.7343em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1042em;top:23.6743em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0629em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6558em;top:24.7343em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.1158em;top:23.6743em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.7658em;top:24.7343em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.5983em;top:23.6743em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0665em;">Grade 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.1083em;top:24.7343em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.7543em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:26.8543em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:27.9443em;"><span class="pdf24_14 pdf24_06 pdf24_192">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:26.8543em;"><span class="pdf24_14 pdf24_06 pdf24_64">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:27.9443em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:29.0343em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:30.1243em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:31.2143em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:26.8543em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:27.9443em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:29.0343em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:30.1243em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:31.2143em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:26.8543em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:27.9443em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:29.0343em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:30.1243em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:31.2143em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:26.8543em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:27.9443em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:29.0343em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:30.1243em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:31.2143em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:29.0343em;"><span class="pdf24_14 pdf24_06 pdf24_23">Constipacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:30.1243em;"><span class="pdf24_14 pdf24_06 pdf24_184">Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:31.2143em;"><span class="pdf24_14 pdf24_06 pdf24_138">Estomatitis</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:32.3043em;"><span class="pdf24_05 pdf24_06 pdf24_71" style="word-spacing:-0.0338em;">Trastornos generales y condiciones administrativas del sitio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:33.4043em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0127em;">Fatiga / Astenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_100" style="word-spacing:-0.0201em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:34.506em;"><span class="pdf24_14 pdf24_06 pdf24_202" style="word-spacing:-0.0303em;">Pirexia </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_86" style="word-spacing:-0.0481em;"># &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.5942em;top:33.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:34.506em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:35.596em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:33.4043em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:34.506em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:35.596em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:33.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:34.506em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:35.596em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:33.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6683em;top:34.506em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:35.596em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:35.596em;"><span class="pdf24_14 pdf24_06 pdf24_123">Edema</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_234"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:36.686em;"><span class="pdf24_05 pdf24_06 pdf24_143" style="word-spacing:-0.0294em;">Trastornos musculoesquelticos y del tejido conectivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:37.786em;"><span class="pdf24_14 pdf24_06 pdf24_97" style="word-spacing:-0.0118em;">Dolor musculoesqueltico</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_194" style="word-spacing:-0.0187em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:38.876em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.0237em;">Trastornos del metabolismo y nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:39.966em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0251em;">Disminucion del apetito</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:5.6261em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:37.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:37.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:39.966em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:37.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:39.966em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:37.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:39.966em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:41.066em;"><span class="pdf24_05 pdf24_06 pdf24_196" style="word-spacing:-0.0132em;">Trastornos de la piel y del tejido subcutneo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_138">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:43.246em;"><span class="pdf24_14 pdf24_06 pdf24_68">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:44.336em;"><span class="pdf24_14 pdf24_06 pdf24_144">Alopecia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:43.246em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:44.336em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:43.246em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:44.336em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4258em;top:43.246em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:44.336em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6683em;top:43.246em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:40.6683em;top:44.336em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.436em;"><span class="pdf24_05 pdf24_06 pdf24_78" style="word-spacing:-0.0167em;">Infecciones e infestaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:46.526em;"><span class="pdf24_14 pdf24_06 pdf24_75" style="word-spacing:-0.0558em;">Neumona </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_235" style="word-spacing:-0.0886em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.5942em;top:46.526em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:47.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:46.526em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:27.8758em;top:47.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:46.526em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:47.6785em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:46.526em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:47.6785em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.6885em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0628em;">Infecciones del tracto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:48.7485em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0398em;">respiratorio superior</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_169" style="word-spacing:-0.0631em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:49.7685em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0391em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:50.8585em;"><span class="pdf24_14 pdf24_06 pdf24_144">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_222"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:51.9585em;"><span class="pdf24_05 pdf24_06 pdf24_142" style="word-spacing:-0.0322em;">Trastornos respiratorios, torcicos y mediastnicos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.0485em;"><span class="pdf24_14 pdf24_06 pdf24_17" style="word-spacing:0.004em;">Tos / Tos productiva* &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:50.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:50.8585em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:53.0485em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:28.2058em;top:55.2285em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.4258em;top:50.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:53.0485em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:40.6683em;top:50.8585em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:20.5942em;top:53.0485em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:53.0485em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:55.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.1385em;"><span class="pdf24_05 pdf24_06 pdf24_196" style="word-spacing:-0.0276em;">Trastornos del sistema nervioso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.2285em;"><span class="pdf24_14 pdf24_06 pdf24_236" style="word-spacing:-0.0042em;">Dolor de cabeza</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_237" style="word-spacing:-0.0066em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.5942em;top:55.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7558em;top:55.2285em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4787em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_32" style="word-spacing:-0.0051em;">Incluye inflamacin de las mucosas y estomatitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.4384em;"><span class="pdf24_41 pdf24_06 pdf24_34" style="word-spacing:-0.0004em;"> Incluye astenia y fatiga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.3984em;"><span class="pdf24_41 pdf24_06 pdf24_202" style="word-spacing:-0.0041em;"># Incluye aumento de la temperatura corporal, hiperpirexia, hipertermia y pirexia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">25 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_25" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAsvUlEQVR4nO3asY6l53Em4P8W9ga8ugBdgSNmBKRroBpjKtlIGmxCbCABhAg4sEzuJjM9kjAckjBg2PE6cOBb89/dDCo+jcJbdf7nAQqTfgDZb9V7zjkOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADgav7/OR+NMdH5ZsAbjNk6/zjgDcZ0z1/P+d8H8OzH9AOA44f0A2Axe4wr+Ptz/lf6ETCF4Ic8BQZuZ49xBQoMFIIf8hQYuJ09xhUoMFAIfshTYOB29hhXoMBAIfghT4GB29ljXIECA4XghzwFBm5nj3EFCgwUgh/yFBi4nT3GFSgwUAh+yFNg4Hb2GFegwEAh+CFPgYHb2WNcgQIDheCHPAUGbmePcQUKDBSCH/IUGLidPcYVKDBQCH7IU2DgdvYYV6DAQCH4IU+BgdvZY1yBAgOF4Ic8BQZuZ49xBQoMFIIf8hQYuJ09xhUoMFAIfshTYOB29hhXoMBAIfghT4GB29ljXIECA4XghzwFBm5nj3EFCgwUgh/yFBi4nT3GFSgwUAh+yFNg4Hb2GFegwEAh+CFPgYHb2WNcgQIDheCHPAUGbmePcQUKDBSCH/IUGLidPcYVKDBQCH7IU2DgdvYYV6DAQCH4IU+BgdvZY1yBAgOF4Ic8BQZuZ49xBQoMFIIf8hQYuJ09xhUoMFAIfshTYOB29hhXoMBAIfghT4GB29ljXIECA4XghzwFBm5nj3EFCgwUgh/yFBi4nT3GFSgwUAh+yFNg4Hb2GFegwEAh+CFPgYHb2WNcgQIDheCHPAUGbmePcQUKDBSCH/IUGLidPcYVKDBQCH7IU2DgdvYYV6DAQCH4IU+BgdvZY1yBAgOF4Ic8BQZuZ49xBQoMFIIf8hQYuJ09xhUoMFAIfshTYOB29hhXoMBAIfghT4GB29ljXIECA4XghzwFBm5nj3EFCgwUgh/yFBi4nT3GFSgwUAh+yFNg4Hb2GFegwEAh+CFPgYHb2WNcgQIDheCHPAUGbmePcQUKDBSCH/IUGLidPcYVKDBQCH7IU2DgdvYYV6DAQCH4IU+BgdvZY1yBAgOF4Ic8BQZuZ49xBQoMFO/TDwCOd+f8wqye/3nO3w14xxXnLwPeYPwNdM+vzvntATz7x/QDgOOfzvmjWT3fnPPPA95xxfnbgDeY4/jDOY8D3nGv86dzHg7gma/eIc9PyPbz844ce2yG/3HO/0s/4o7JGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgong6nj8aY6Pg73D/vznkc8I4rzk8D3mBe/v//NOAd9zpPGfNwAM98cgV5voHZz6ejOfbYDL6B6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yB4vGcB2NMdPwd7p+353w94B1XnA8D3mCO48vjpcCk33Gv8/bnf4Hj5XD6zBgTnfcD3mBeN1+c89WAd1xx7LEZ8/k53w14x73OU8a8OYBnvnqHvB/SD+DV/Lwjxx6bwU/IeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgeDqcPhpjouPvcP+8O+dxwDuuOD8NeIN5+f//04B33Os8ZczDATzzyRXk+QZmP5+O5thjM/gGppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGir+e80djTHT+NuAN5nXzzTl/HvCOK46/nxnzh3MeB7zjXudP5zwcwLOnAvMLY0x0/jLgDeZ18+tzfjfgHVcce2zG/PKcbwe8417nV+f89gCe+eod8vyEbD8/78ixx2bwE7JeMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6D46zm/MMZE5y8D3mBeN78+53cD3nHF8fczY355zrcD3nGv86tzfnsAz54KzB+NMdH524A3mNfNN+f884B3XHH8/cyYP5zzOOAd9zp/OufhAJ756h3y/IRsPz/vyLHHZvATsl4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKJ6C/6MxJjr+DvfP+3MeB7zjivPTgDeY4/hwzvcD3nGv8+6chwN45pMryPMNzH4+Hc2xx2bwDUwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA8XT4fTRGBMdf4f75905jwPeccX5acAbzMv//58GvONe5yljHg7gmU+uIM83MPv5dDTHHpvBNzC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVA8Bf9HY0x0/B3un/fnPA54xxXnpwFvMMfx4ZzvB7zjXufdOQ8H8MwnV5DnG5j9fDqaY4/N4BuYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgaKp8PpozEmOv4O98+7cx4HvOOK89OAN5iX//8/DXjHvc5TxjwcwDOfXEGeb2D28+lojj02g29geskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOg+Os5fzTGROdvA95gXjffnPPnAe+44vj7mTF/OOdxwDvudf50zsMBPHsqML8wxkTnLwPeYF43vz7ndwPeccWxx2bML8/5dsA77nV+dc5vD+CZr94hz0/I9vPzjhx7bAY/IeslY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgeDqcPhpjouPvcP+8O+dxwDuuOD8NeIN5+f//04B33Os8ZczDATzzyRXk+QZmP5+O5thjM/gGppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGik/nfDTGROf7AW8wr5v35zwOeMcV58cBbzDH8WHAG+553p3zmwN45pMryPMNzH4+Hc2xx2bwDUwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBTvz/nMGBMdf4f754tzvhrwjivO44A3mOP4/JxvB7zjXucpY94cwLOn4H8wxkTn/YA3mNfN78/5esA7rjgfBrzBHMc/HC/fwKTfca/z+5//BQ5fvcMEP6QfwKv5eUeOPTaDn5D1kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkDxr+f8lzEmOv824A3m9f8N/2XAO644/z7gDeY4/uNwU3TOU8a8OYBnPrmCPN/A7OfT0Rx7bAbfwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQPH+nM+MMdHxd7h/vjjnqwHvuOI8DniDOY7Pz/l2wDvudZ4y5s0BPHsK/gdjTHTeD3iDed38/pyvB7zjivNhwBvMcfzD8fINTPod9zq///lf4PDVO0zwQ/oBvJqfd+TYYzP4CVkvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSfzvlojInO9wPeYF437895HPCOK86PA95gjuPDgDfc87w75zcH8MwnV5DnG5j9fDqaY4/N4BuYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoHs95MMZEx9/h/nl7ztcD3nHF+TDgDeY4vjxeCkz6Hfc6b3/+FzheDqfPjDHReT/gDeZ188U5Xw14xxXHHpsxn5/z3YB33Os8ZcybA3jmq3fI+yH9AF7Nzzty7LEZ/ISsl4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgaKT+d8NMZEx9/h/nl/zuOAd1xxfhzwBnMcH875fsA77nXenfObA3jmkyvI8w3Mfj4dzbHHZvANTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFI/nPBhjouPvcP+8PefrAe+44nwY8AZzHF8eLwUm/Y57nbc//wscL4fTZ8aY6Lwf8AbzuvninK8GvOOKY4/NmM/P+W7AO+51njLmzQE889U75P2QfgCv5ucdOfbYDH5C1kvGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDxb+e81/GmOj824A3mNf/N/yXAe+44vz7gDeY4/iPw03ROU8Z8+YAnvnkCvJ8A7OfT0dz7LEZfAPTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQPF4zkPxpjo+DvcP2/P+XrAO644Hwa8wRzHl8dLgUm/417n7c//AsfL4fSZMSY67we8wbxuvjjnqwHvuOLYYzPm83O+G/COe52njHlzAM989Q55P6QfwKv5eUeOPTaDn5D1kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkAh+CFPgdnPcZFjj82gwPSSMVAIfshTYPZzXOTYYzMoML1kDBSCH/IUmP0cFzn22AwKTC8ZA4XghzwFZj/HRY49NoMC00vGQCH4IU+B2c9xkWOPzaDA9JIxUAh+yFNg9nNc5NhjMygwvWQMFIIf8hSY/RwXOfbYDApMLxkDheCHPAVmP8dFjj02gwLTS8ZAIfghT4HZz3GRY4/NoMD0kjFQCH7IU2D2c1zk2GMzKDC9ZAwUgh/yFJj9HBc59tgMCkwvGQOF4Ic8BWY/x0WOPTaDAtNLxkDx6ZyPxpjofD/gDeZ18/6cxwHvuOL8OOAN5jg+DHjDPc+7c35zAM98cgV5voHZz6ejOfbYDL6B6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yB4vGcB2NMdPwd7p+353w94B1XnA8D3mCO48vjpcCk33Gv8/bnf4Hj5XD6zBgTnfcD3mBeN1+c89WAd1xx7LEZ8/k53w14x73OU8a8OYBnvnqHvB/SD+DV/Lwjxx6bwU/IeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOgEPyQp8Ds57jIscdmUGB6yRgoBD/kKTD7OS5y7LEZFJheMgYKwQ95Csx+josce2wGBaaXjIFC8EOeArOf4yLHHptBgeklY6AQ/JCnwOznuMixx2ZQYHrJGCgEP+QpMPs5LnLssRkUmF4yBgrBD3kKzH6Oixx7bAYFppeMgULwQ54Cs5/jIscem0GB6SVjoBD8kKfA7Oe4yLHHZlBgeskYKAQ/5Ckw+zkucuyxGRSYXjIGCsEPeQrMfo6LHHtsBgWml4yBQvBDngKzn+Mixx6bQYHpJWOg+M9zPhpjovPtgDeY183T4fbnAe+44vzfAW8wx/H+nO8GvONe59M5/+cAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGv03qAEosEGQB2EAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_238" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.032em;"><span class="pdf24_41 pdf24_06 pdf24_08" style="word-spacing:0.0002em;"> Incluye edema facial, edema localizado y edema perifrico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.002em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.4049em;"> Incluye artralgia, artritis, dolor de espalda, dolor de huesos, dolor torcico musculoesqueltico, dolor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.952em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0024em;">musculoesqueltico, mialgia, dolor de cuello, dolor torcico no cardaco y dolor espinal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.912em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0039em;"> Incluye eccema, eritema, dermatitis, erupcin farmacolgica, eritema multiforme, penfigoide, erupcin cutnea, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.882em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.001em;">erupcin maculopapular, erupcin papular, erupcin pruriginosa y erupcin pustulosa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.832em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0034em;"> Incluye infeccin del tracto respiratorio inferior, neumona por Pneumocystis jirovecii, neumona, neumona por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.792em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0007em;">aspiracin y neumona bacteriana. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.752em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0006em;"> Incluye laringitis, nasofaringitis, faringitis, rinitis, sinusitis, amigdalitis, traqueobronquitis e infeccin del tracto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.712em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0034em;">respiratorio superior. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.662em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_35" style="word-spacing:-0.0008em;">Incluye aumento de la hormona estimulante de la tiroides en sangre e hipotiroidismo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.622em;"><span class="pdf24_41 pdf24_06 pdf24_164" style="word-spacing:0.0039em;">* Incluye tos y tos productiva. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.592em;"><span class="pdf24_41 pdf24_06 pdf24_32" style="word-spacing:0.0018em;"> Incluye dolor de cabeza y migraa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.5818em;"><span class="pdf24_14 pdf24_06 pdf24_96" style="word-spacing:-0.0181em;">La Tabla 10 resume las anomalas de laboratorio en POSEIDON. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7043em;"><span class="pdf24_05 pdf24_06 pdf24_18" style="word-spacing:0.1839em;">Tabla 10. Anomalas de laboratorio seleccionadas </span><span class="pdf24_189 pdf24_06 pdf24_49" style="word-spacing:0.206em;">( </span><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.1824em;">10%) que empeoraron desde el inicio en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7543em;"><span class="pdf24_05 pdf24_06 pdf24_19" style="word-spacing:-0.0012em;">pacientes con CPCNP que recibieron IMFINZI en el estudio POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:22.8443em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0037em;">IMFINZI con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:23.3743em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0668em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:23.9043em;"><span class="pdf24_05 pdf24_06 pdf24_19" style="word-spacing:-0.0491em;">actl y quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:24.4243em;"><span class="pdf24_05 pdf24_06 pdf24_144">platino</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_239"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.6342em;top:24.9643em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.001em;">platino </span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_15" style="word-spacing:-0.0016em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:24.9843em;"><span class="pdf24_05 pdf24_06 pdf24_59" style="word-spacing:-0.0188em;">Anomala de laboratorio</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_72" style="word-spacing:-0.0299em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.6342em;top:26.0443em;"><span class="pdf24_05 pdf24_06 pdf24_236" style="word-spacing:-0.0177em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:27.0343em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:26.0443em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.02em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:27.0343em;"><span class="pdf24_05 pdf24_06 pdf24_114">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:26.0443em;"><span class="pdf24_05 pdf24_06 pdf24_236" style="word-spacing:-0.0178em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:27.0343em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0268em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:26.0443em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.029em;">Grado 3 o &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:27.0343em;"><span class="pdf24_05 pdf24_06 pdf24_114" style="word-spacing:0.0401em;">4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:28.1343em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:-0.0223em;">Aumento de la creatinina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:30.3143em;"><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0188em;">Aumento de ALT &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:31.4043em;"><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.019em;">Aumento de AST &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:33.5843em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_60">Hiperpotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_64">89 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:30.3143em;"><span class="pdf24_14 pdf24_06 pdf24_64">64 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:31.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_64">58 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:33.5843em;"><span class="pdf24_14 pdf24_06 pdf24_64">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_64">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:35.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:36.876em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:30.3143em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:31.4043em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:33.5843em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:35.786em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_64">83 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:30.3143em;"><span class="pdf24_14 pdf24_06 pdf24_64">56 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:31.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_64">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:33.5843em;"><span class="pdf24_14 pdf24_06 pdf24_64">50 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:35.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:36.876em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:30.3143em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:31.4043em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:33.5843em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:35.786em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:36.876em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.492em;top:35.786em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiperglucemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:36.876em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0218em;">Aumento de amilasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:36.876em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:6.492em;top:38.036em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0463em;">Aumento de la gamma glutamil &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:39.096em;"><span class="pdf24_14 pdf24_06 pdf24_23">transferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:38.566em;"><span class="pdf24_14 pdf24_06 pdf24_64">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:38.566em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:38.566em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:38.566em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:40.116em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0163em;">Lipasa aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0232em;">Aumento de la fosfatasa alcalina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_59" style="word-spacing:-0.039em;">Albmina disminuida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_72">Hipopotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:44.486em;"><span class="pdf24_14 pdf24_06 pdf24_75">Bilirrubinemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.576em;"><span class="pdf24_14 pdf24_06 pdf24_122">Hipernatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:40.116em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:44.486em;"><span class="pdf24_14 pdf24_06 pdf24_64">16 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:45.576em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:40.116em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:44.486em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:45.576em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:40.116em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_64">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:44.486em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:40.116em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:42.296em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:44.486em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:45.576em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:45.576em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_138">Hipomagnesemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.7585em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:46.666em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:48.8585em;"><span class="pdf24_14 pdf24_06 pdf24_122">Anemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:49.9485em;"><span class="pdf24_14 pdf24_06 pdf24_138">Leucopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:51.0385em;"><span class="pdf24_14 pdf24_06 pdf24_60">Neutropenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.1385em;"><span class="pdf24_14 pdf24_06 pdf24_75">Linfocitopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:48.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">84 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:49.9485em;"><span class="pdf24_14 pdf24_06 pdf24_64">77 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:51.0385em;"><span class="pdf24_14 pdf24_06 pdf24_64">71 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:52.1385em;"><span class="pdf24_14 pdf24_06 pdf24_64">67 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6342em;top:53.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">53 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:48.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:49.9485em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:51.0385em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:52.1385em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7358em;top:53.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:48.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">84 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:49.9485em;"><span class="pdf24_14 pdf24_06 pdf24_64">81 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:51.0385em;"><span class="pdf24_14 pdf24_06 pdf24_64">69 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:52.1385em;"><span class="pdf24_14 pdf24_06 pdf24_64">60 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6358em;top:53.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">54 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:48.8585em;"><span class="pdf24_14 pdf24_06 pdf24_64">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:49.9485em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:51.0385em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:52.1385em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7983em;top:53.2285em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.2285em;"><span class="pdf24_14 pdf24_06 pdf24_75">Trombocitopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.4587em;"><span class="pdf24_41 pdf24_06 pdf24_31" style="word-spacing:0.0032em;">* Clasificado segn NCI CTCAE versin 4.03. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4287em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0196em;">El denominador utilizado para calcular la tasa vari de 45 a 326 segn el nmero de pacientes con un valor inicial y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.3887em;"><span class="pdf24_41 pdf24_06 pdf24_240" style="word-spacing:-0.0064em;">al menos un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.3484em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0222em;"> El denominador utilizado para calcular la tasa vari de 43 a 323 segn el nmero de pacientes con un valor inicial y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.3084em;"><span class="pdf24_41 pdf24_06 pdf24_240" style="word-spacing:-0.0064em;">al menos un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">26 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_26" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAVnklEQVR4nO3av8pmZxnF4d2lTiUImfk+IWgTyCEEklMQ0UJb+yApRObPCWTIKHE0Y9AQiMmklUCKnFqeF2sLi3nW3ve6Llj9JsWT+zfvdxwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMBED9fuzOw0++kBAMD/9Me1R2Z2mv3+AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABo9qe135nZyP1y7Tcn+A6z17nfrv3qBN9htmt/WPvJAcX+vfaemY3c7R8ofn2C7zB7nXt/7S8n+A6zXfvz2s8PKPZF+gOA1+bDtXfTHwGv2Rtrn6U/AjZ6svaz9EdAkoCBuQQMDQQMbQQM9QQMzCVgaCBgaCNgqCdgYC4BQwMBQxsBQz0BA3MJGBoIGNoIGOoJGJhLwNBAwNBGwFBPwMBcAoYGAoY2AoZ6AgbmEjA0EDC0ETDUEzAwl4ChgYChjYChnoCBuQQMDQQMbQQM9QQMzCVgaCBgaCNgqCdgYC4BQwMBQxsBQz0BA3MJGBoIGNoIGOoJGJhLwNBAwNBGwFBPwMBcAoYGAoY2AoZ6AgbmEjA0EDC0ETDUEzAwl4ChgYChjYChnoCBuQQMDQQMbQQM9QQMzCVgaCBgaCNgqCdgYC4BQwMBQxsBQz0BA3MJGBoIGNoIGOoJGJhLwNBAwNBGwFBPwMBcAoYGAoY2AoZ6AgbmEjA0EDC0ETDUEzAwl4ChgYChjYChnoCBuQQMDQQMbQQM9QQMzCVgaCBgaCNgqCdgYC4BQwMBQxsBQz0BA3MJGBoIGNoIGOoJGJhLwNBAwNBGwFBPwMBcAoYGAoY2AoZ6AgbmEjA0EDC0ETDUEzAwl4ChgYChjYCh3jdrP5jZyH259u0JvqNh3619fYLvaNz3a69O8B2Nc0Nk9tXa3QHF/AIDc/kFZp831z5Jf0Qpv8DkuCEy/AJDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnoeH5hLwOwjYHIETI4bIkPAUM/jA3MJmH0ETI6AyXFDZAgY6nl8YC4Bs4+AyREwOW6IDAFDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnoeH5hLwOwjYHIETI4bIkPAUM/jA3MJmH0ETI6AyXFDZAgY6nl8YC4Bs4+AyREwOW6IDAFDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnoeH5hLwOwjYHIETI4bIkPAUM/jA3MJmH0ETI6AyXFDZAgY6nl8YC4Bs4+AyREwOW6IDAFDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnoeH5hLwOwjYHIETI4bIkPAUM/jA3MJmH0ETI6AyXFDZAgY6nl8YC4Bs4+AyREwOW6IDAFDvduj/8jMRu7Z2tMTfEfLXpzgGxr3+PD/stRenuAbGvd87f6AYrdH/87MRu7B2sMTfEfLHpzgG1rnv31mb53gGxp3+4ep+wOK+fkXAOA6nhz+hIxyAgYA4DoEDPUEDADAdQgY6gkYAIDrEDDUEzAAANchYKgnYAAArkPAUE/AAABch4ChnoABALgOAUM9AQMAcB0ChnoCBgDgOgQM9QQMAMB1CBjqCRgAgOsQMNQTMAAA1yFgqCdgAACuQ8BQT8AAAFyHgKGegAEAuA4BQ71v1n4ws5H7cu3bE3xHw75b+/oE39G479deneA7GueGyOyrtbsDivkFBub6cO3d9EeUeHPtk/RHlHpj7bP0R5RyQ2T4BYZ6Hh+YS8DsI2ByBEyOGyJDwFDP4wNzCZh9BEyOgMlxQ2QIGOp5fGAuAbOPgMkRMDluiAwBQz2PD8wlYPYRMDkCJscNkSFgqOfxgbkEzD4CJkfA5LghMgQM9Tw+MJeA2UfA5AiYHDdEhoChnscH5hIw+wiYHAGT44bIEDDU8/jAXAJmHwGTI2By3BAZAoZ6Hh+YS8DsI2ByBEyOGyJDwFDP4wNzCZh9BEyOgMlxQ2QIGOp5fGAuAbOPgMkRMDluiAwBQz2PD8wlYPYRMDkCJscNkSFgqOfxgbkEzD4CJkfA5LghMgQM9Tw+MJeA2UfA5AiYHDdEhoChnscH5hIw+wiYHAGT44bIEDDUuz36j8xs5J6tPT3Bd7TsxQm+oXGPD/8vS+3lCb6hcc/X7g8odnv078xs5D5a++AE39Gwd9Y+PsF3NO7ttU9P8B2Nc0NkdvuHqfsDivn5F+byJ2T7+BOyHH9CluOGyHhy+BMyynl8YC4Bs4+AyREwOW6IDAFDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnoeH5hLwOwjYHIETI4bIkPAUM/jA3MJmH0ETI6AyXFDZAgY6nl8YC4Bs4+AyREwOW6IDAFDPY8PzCVg9hEwOQImxw2RIWCo5/GBuQTMPgImR8DkuCEyBAz1PD4wl4DZR8DkCJgcN0SGgKGexwfmEjD7CJgcAZPjhsgQMNTz+MBcAmYfAZMjYHLcEBkChnq3R//OzEbuo7UPTvAdDXtn7eMTfEfj3l779ATf0Tg3RGZP1u4PKPavtc/NbOT+tvbXE3xHw/6+9s8TfEfj/nH4f1lqX5zgGxr38vhvyEAtP//CXP6EbB9/QpbjT8hy3BAZt19g/AkZ1Tw+MJeA2UfA5AiYHDdEhoChnscH5hIw+wiYHAGT44bIEDDU8/jAXAJmHwGTI2By3BAZAoZ6Hh+YS8DsI2ByBEyOGyJDwFDP4wNzCZh9BEyOgMlxQ2QIGOp5fGAuAbOPgMkRMDluiAwBQz2PD8wlYPYRMDkCJscNkSFgqOfxgbkEzD4CJkfA5LghMgQM9Tw+MJeA2UfA5AiYHDdEhoChnscH5hIw+wiYHAGT44bIEDDU8/jAXAJmHwGTI2By3BAZAoZ6Hh+YS8DsI2ByBEyOGyJDwFDP4wNzCZh9BEyOgMlxQ2QIGOp5fGAuAbOPgMkRMDluiAwBQz2PD8wlYPYRMDkCJscNkSFgqHd79B+Z2cg9W3t6gu9o2YsTfEPjHh/+X5bayxN8Q+Oer90fUOz26N+Z2cg9WHt4gu9o2YMTfEPr/LfP7K0TfEPjbv8wdX9AMT//AgBcx5PDn5BRTsAAAFyHgKGegAEAuA4BQz0BAwBwHQKGegIGAOA6BAz1BAwAwHUIGOoJGACA6xAw1BMwAADXIWCoJ2AAAK5DwFBPwAAAXIeAoZ6AAQC4DgFDPQEDAHAdAoZ6AgYA4DoEDPUEDADAdQgY6gkYAIDrEDDUEzAAANchYKj3n7XPzczMzOwSe7X2iwMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD+Pz8C5C1PrWEOsqQAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_241" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:8.1318em;"><span class="pdf24_14 pdf24_06 pdf24_134" style="word-spacing:-0.0164em;">Cncer de Pulmn de Clulas Pequeas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_55 pdf24_06 pdf24_22" style="word-spacing:-0.0239em;">Cncer de Pulmn de Clulas Pequeas en Estado Limitado </span><span class="pdf24_242 pdf24_06 pdf24_15" style="word-spacing:-0.0217em;"> </span><span class="pdf24_55 pdf24_06 pdf24_109">ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0125em;">La seguridad de IMFINZI como agente nico en pacientes con CPCP-EL sin progresin de la enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.167em;">tras completar quimiorradioterapia concurrente basada en platino (60-66 Gy una vez al da durante 6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0609em;">semanas o 45 Gy dos veces al da durante 3 semanas) dentro de los 42 das previos al inicio del medicamento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1707em;">en estudio, se evalu en el estudio ADRIATIC, un estudio multicntrico, aleatorizado, doble ciego y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:0.0298em;">controlado con placebo [</span><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:0.0366em;">consulte Estudios Clnicos</span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.034em;">]. Un total de 262 pacientes recibieron IMFINZI 1500 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6318em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0042em;">mg cada 4 semanas hasta la progresin de la enfermedad, toxicidad inaceptable o un mximo de 24 meses. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0083em;">El estudio excluy a pacientes con CPCP-EL en etapa I o II que se consideraron mdicamente operables y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.2824em;">a pacientes con enfermedad autoinmune activa o previa o con condiciones mdicas que requeran &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0003em;">corticosteroides sistmicos o inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0153em;">Las caractersticas de la poblacin del estudio fueron: edad media de 62 aos (rango: 28 a 84); 39% de 65 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0254em;">aos o ms, 6% de 75 aos o ms; 69% hombres; 50% blancos, 48% asiticos, 1.3% de otras razas; 4.2% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0067em;">hispanos o latinos; 68% exfumadores, 22% fumadores actuales; y 51% tuvo un estado de desempeo de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0113em;">OMS de 1. El sesenta y siete por ciento de los pacientes recibi una dosis total de radiacin de 60 Gy a 66 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0149em;">Gy una vez al da y el 27% de los pacientes recibi una dosis total de radiacin de 45 Gy dos veces al da. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_14 pdf24_06 pdf24_165" style="word-spacing:-0.056em;">La duracin media de la exposicin a IMFINZI fue de 9.2 meses (rango: 0.92 a 25) en el brazo de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0161em;">Reacciones adversas graves ocurrieron en el 30% de los pacientes que recibieron IMFINZI. Las reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_20 pdf24_06 pdf24_18" style="word-spacing:0.1825em;">adversas graves ms frecuentes reportadas en  1% de los pacientes que recibieron IMFINZI fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0022em;">neumonitis o neumonitis por radiacin (12%) y neumona (5%). Reacciones adversas fatales ocurrieron en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1095em;">el 2.7% de los pacientes que recibieron IMFINZI, incluyendo neumona (1.5%), insuficiencia cardaca, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2493em;">encefalopata y neumonitis (0.4% cada uno). La discontinuacin permanente de IMFINZI debido a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.546em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1642em;">reacciones adversas ocurri en el 16% de los pacientes. Las reacciones adversas que resultaron en la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.606em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0173em;">discontinuacin permanente de IMFINZI en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0203em;">1% de los pacientes incluyeron neumonitis o neumonitis por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0491em;">radiacin (9%) y neumona (1.5%). Las interrupciones en la dosificacin de IMFINZI debido a una reaccin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.716em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0329em;">adversa ocurrieron en el 35% de los pacientes. Las reacciones adversas que requirieron la interrupcin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.766em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0004em;">la dosis en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0054em;"> </span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0023em;">5% de los pacientes incluyeron neumonitis o neumonitis por radiacin (17%). Las reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:0.0005em;">adversas ms comunes que ocurrieron en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_72" style="word-spacing:-0.0022em;">20% de los pacientes que recibieron IMFINZI fueron neumonitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.876em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0013em;">o neumonitis por radiacin (38%) y fatiga (21%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.986em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.038em;">La Tabla 11 resume las reacciones adversas que ocurrieron en pacientes tratados con IMFINZI en el estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.036em;"><span class="pdf24_14 pdf24_06 pdf24_243">ADRIATIC. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.156em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0026em;">Tabla 11. Reacciones Adversas </span><span class="pdf24_189 pdf24_06 pdf24_49" style="word-spacing:0.0085em;">( </span><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0007em;">10%) en Pacientes con Cncer de Pulmn de Clulas Pequeas en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.2085em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:0.0038em;">Estadio Limitado (CPCP-EL) que Recibieron IMFINZI en el Estudio ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5442em;top:49.2885em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.9142em;top:50.3385em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=262) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6283em;top:49.2885em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6483em;top:50.3385em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=265) &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.5842em;top:51.4385em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.1042em;top:52.4885em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.5285em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0292em;">Trastornos respiratorios, torcicos y mediastnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9458em;top:51.4385em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4858em;top:52.4885em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3258em;top:51.4385em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8358em;top:52.4885em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:51.4385em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:52.4885em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:51.4585em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.6285em;"><span class="pdf24_14 pdf24_06 pdf24_244" style="word-spacing:-0.0151em;">Neumonitis o neumonitis por radiacin* &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:-0.0021em;">Tos / tos productiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.8085em;"><span class="pdf24_20 pdf24_06 pdf24_75">Disnea &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:54.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:56.8085em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.7158em;top:54.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:29.7158em;top:56.8085em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:54.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9558em;top:56.8085em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:54.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:56.8085em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.9082em;"><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.0262em;">Trastornos generales &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">27 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_27" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_245" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:25.5442em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.9142em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=262) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6283em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6483em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=265) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:8.1318em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.5842em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.1042em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9458em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4858em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3258em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8358em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_52">Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_217"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:23.9942em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.7158em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_134" style="word-spacing:-0.012em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0418em;">Erupcin </span><span class="pdf24_20 pdf24_06 pdf24_09">cutnea &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:13.5018em;"><span class="pdf24_14 pdf24_06 pdf24_68">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:13.5018em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.7158em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:13.5018em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9558em;top:13.5018em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:13.5018em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0263em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_144">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_222"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:23.9942em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.6258em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6258em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_72">Hipertiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_136"># &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:17.8718em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0199em;">Trastornos del metabolismo y la nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0251em;">Disminucin del apetito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0197em;">Trastornos del sistema nervioso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:21.1443em;"><span class="pdf24_14 pdf24_06 pdf24_52">Mareos</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_108"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:23.9942em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:21.1443em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:21.1443em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9558em;top:21.1443em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:21.1443em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_59" style="word-spacing:-0.0115em;">Infecciones e infestaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_138">Neumona</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:29.7158em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9558em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.5183em;top:23.3443em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_246" style="word-spacing:-0.0226em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_192">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.9942em;top:27.7043em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:29.7158em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0358em;top:27.7043em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9558em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:35.7258em;top:27.7043em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:25.5243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.8483em;top:27.7043em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:27.7043em;"><span class="pdf24_14 pdf24_06 pdf24_72">Estreimiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.0145em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.1878em;">* Incluye neumonitis, enfermedad pulmonar inmunomediada, enfermedad pulmonar intersticial, neumonitis por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9745em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.0057em;">radiacin y fibrosis pulmonar por radiacin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.9345em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0341em;">Incluye disnea y disnea de esfuerzo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.8945em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0015em;"> Incluye fatiga y astenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.8545em;"><span class="pdf24_152 pdf24_06 pdf24_121" style="word-spacing:0.0029em;"> Incluye dermatitis, dermatitis acneiforme, eczema, erupcin cutnea, erupcin maculopapular, erupcin papular, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.8062em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0036em;">erupcin pruriginosa y exfoliacin de la piel. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.7662em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0em;"> Incluye hipotiroidismo, aumento de la hormona estimulante de la tiroides en sangre y disminucin de la tiroxina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.7262em;"><span class="pdf24_41 pdf24_06 pdf24_138">libre. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.6862em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.009em;"># Incluye hipertiroidismo, disminucin de la hormona estimulante de la tiroides en sangre, aumento de tiroxina libre, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.6462em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0013em;">aumento de tiroxina, aumento de triyodotironina libre y aumento de triyodotironina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.6062em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0031em;"> Incluye neumona, neumona atpica, infeccin del tracto respiratorio inferior, neumona bacteriana, neumona por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.5662em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.001em;">Pneumocystis jirovecii, neumona por legionella y neumona viral. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.5162em;"><span class="pdf24_41 pdf24_06 pdf24_62" style="word-spacing:-0.0033em;"> Incluye mareos, mareos posturales, vrtigo y vrtigo posicional. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.526em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0008em;">La Tabla 12 resume las anomalas de laboratorio que se presentaron en al menos el 20% de los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.576em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0051em;">tratados con IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.686em;"><span class="pdf24_189 pdf24_06 pdf24_71" style="word-spacing:0.1649em;">Tabla 12. Anomalas de Laboratorio Seleccionadas ( 20%) que Empeoraron desde el Inicio en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.736em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.0198em;">Pacientes con Cncer de Pulmn de Clulas Pequeas en Etapa Limitada (CPCP-EL) que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.7985em;"><span class="pdf24_05 pdf24_06 pdf24_07" style="word-spacing:0.0036em;">IMFINZI en el Estudio ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.6642em;top:48.8185em;"><span class="pdf24_05 pdf24_06 pdf24_233">IMFINZI</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_247"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.8758em;top:48.8185em;"><span class="pdf24_05 pdf24_06 pdf24_75">Placebo</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_235"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:48.8785em;"><span class="pdf24_05 pdf24_06 pdf24_170" style="word-spacing:-0.019em;">Anomala de Laboratorio</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_75" style="word-spacing:-0.0302em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:21.8842em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4142em;top:51.0385em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.3458em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8958em;top:51.0385em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.2358em;top:51.0385em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.1683em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.7083em;top:51.0385em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.0585em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.1585em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.2485em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiperglucemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.3385em;"><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0188em;">Aumento de ALT &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.4385em;"><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.019em;">Aumento de AST &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:53.1585em;"><span class="pdf24_14 pdf24_06 pdf24_64">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:54.2485em;"><span class="pdf24_14 pdf24_06 pdf24_64">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:55.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:56.4385em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:57.5882em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:53.1585em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:53.1585em;"><span class="pdf24_14 pdf24_06 pdf24_64">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:54.2485em;"><span class="pdf24_14 pdf24_06 pdf24_64">45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:55.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:56.4385em;"><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:57.5882em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:53.1585em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:54.2485em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:55.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:56.4385em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:57.5882em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:54.2485em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:55.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:56.4385em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:57.5882em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.5982em;"><span class="pdf24_14 pdf24_06 pdf24_60">Aumento &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.0317em;top:57.5982em;"><span class="pdf24_14 pdf24_06 pdf24_248">de &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.0317em;top:57.5982em;"><span class="pdf24_14 pdf24_06 pdf24_100">Gamma &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.0742em;top:57.5982em;"><span class="pdf24_14 pdf24_06 pdf24_138">Glutamil &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:58.6582em;"><span class="pdf24_14 pdf24_06 pdf24_57">Transferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">28 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_28" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_249" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:24.6642em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_233">IMFINZI</span><sup style="top: -0.3317em;"><span class="pdf24_205 pdf24_06 pdf24_247"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.8758em;top:5.9218em;"><span class="pdf24_05 pdf24_06 pdf24_75">Placebo</span><sup style="top: -0.3317em;"><span class="pdf24_205 pdf24_06 pdf24_235"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_170" style="word-spacing:-0.019em;">Anomala de Laboratorio</span><sup style="top: -0.3317em;"><span class="pdf24_70 pdf24_06 pdf24_75" style="word-spacing:-0.0302em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:21.8842em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.3458em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.1683em;top:7.0818em;"><span class="pdf24_05 pdf24_06 pdf24_121" style="word-spacing:-0.0635em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4142em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8958em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:9.1618em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.2358em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.7083em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:9.1618em;"><span class="pdf24_14 pdf24_06 pdf24_64">6.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:9.1618em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_23">Hipercalemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_53" style="word-spacing:-0.0199em;">Aumento de Creatinina en sangre* &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.4518em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:9.1618em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:9.1618em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_16" style="word-spacing:-0.0204em;">Disminucin de los linfocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_208" style="word-spacing:-0.0236em;">Disminucin de los leucocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2942em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_64">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1258em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_64">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0283em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:14.6318em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.902em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.021em;">* Clasificado segn los criterios de toxicidad comunes del Instituto Nacional del Cncer (NCI CTCAE, por sus siglas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.862em;"><span class="pdf24_41 pdf24_06 pdf24_250" style="word-spacing:0.0042em;">en ingls) versin 4.03, excepto el aumento de creatinina, que est clasificado segn NCI CTCAE versin 5.0. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.822em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_13" style="word-spacing:-0.0277em;">El denominador utilizado para calcular la tasa vari de 63 a 259, dependiendo del nmero de pacientes con un valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.782em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0019em;">inicial y al menos un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.742em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_13" style="word-spacing:-0.0277em;">El denominador utilizado para calcular la tasa vari de 65 a 262, dependiendo del nmero de pacientes con un valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7045em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0019em;">inicial y al menos un valor posterior al tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.7543em;"><span class="pdf24_55 pdf24_06 pdf24_22" style="word-spacing:-0.0236em;">Cncer de pulmn de clulas pequeas en estado extenso </span><span class="pdf24_242 pdf24_06 pdf24_15" style="word-spacing:-0.0217em;"> </span><span class="pdf24_55 pdf24_06 pdf24_251">CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.8643em;"><span class="pdf24_14 pdf24_06 pdf24_138" style="word-spacing:-0.0023em;">La seguridad de IMFINZI en combinacin con etopsido y carboplatino o cisplatino en CPCP-EE no tratado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.9143em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0298em;">previamente se evalu en CASPIAN, un estudio aleatorizado, abierto, multicntrico, controlado con activo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.9743em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0168em;">Un total de 265 pacientes recibieron IMFINZI 1500 mg en combinacin con quimioterapia cada 3 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.0243em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0749em;">durante 4 ciclos seguidos de IMFINZI 1500 mg cada 4 semanas hasta la progresin de la enfermedad o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.0743em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1439em;">toxicidad inaceptable. El estudio excluy pacientes con enfermedad autoinmune activa o previa o con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.1343em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:0.1672em;">afecciones mdicas que requirieron corticosteroides o inmunosupresores sistmicos [</span><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:0.1672em;">consulte Estudios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.1843em;"><span class="pdf24_55 pdf24_06 pdf24_35">Clnicos</span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0297em;">]. Entre 265 pacientes que recibieron IMFINZI, el 49% estuvo expuesto durante 6 meses o ms y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2443em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0032em;">el 19% estuvo expuesto durante 12 meses o ms. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.356em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2345em;">Entre 266 pacientes que recibieron quimioterapia sola, el 57% de los pacientes recibi 6 ciclos de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.406em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.2646em;">quimioterapia y el 8% de los pacientes recibi irradiacin cranial profilctica (PCI) despus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.466em;"><span class="pdf24_14 pdf24_06 pdf24_138">quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.576em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0376em;">IMFINZI se suspendi debido a reacciones adversas en el 7% de los pacientes que recibieron IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.626em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0545em;">quimioterapia. Estos incluyen neumonitis, hepatotoxicidad, neurotoxicidad, sepsis, cetoacidosis diabtica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.676em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0042em;">y pancitopenia (1 paciente cada uno). Se produjeron reacciones adversas graves en el 31% de los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.736em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0157em;">que recibieron IMFINZI ms quimioterapia. Las reacciones adversas severas ms frecuentes notificadas en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.786em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1764em;">al menos el 1% de los pacientes fueron neutropenia febril (4.5%), neumona (2.3%), anemia (1.9%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.846em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0203em;">pancitopenia (1.5%), neumonitis (1.1%) y EPOC (1.1%) ) Se produjeron reacciones adversas fatales en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.896em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1087em;">4.9% de los pacientes que recibieron IMFINZI ms quimioterapia. Estos incluyen pancitopenia, sepsis, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.946em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1234em;">shock sptico, trombosis de la arteria pulmonar, embolia pulmonar y hepatitis (1 paciente cada uno) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.0085em;"><span class="pdf24_20 pdf24_06 pdf24_38" style="word-spacing:0.1866em;">muerte sbita (2 pacientes). Las reacciones adversas ms comunes (que ocurrieron en  20% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.0585em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0018em;">pacientes) fueron nuseas, fatiga / astenia y alopecia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.1185em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1964em;">La Tabla 13 resume las reacciones adversas que ocurrieron en pacientes tratados con IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.1685em;"><span class="pdf24_14 pdf24_06 pdf24_138">quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.2785em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0223em;">Tabla 13. Reaccin Adversas que Ocurren en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_05 pdf24_06 pdf24_27" style="word-spacing:-0.0151em;">10% de Pacientes en el Estudio CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">29 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_29" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_252" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:18.2142em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0582em;">IMFINZI con etopsido y &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.2942em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:0.0028em;">carboplatino o cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.6342em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.005em;">N = 265 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.1458em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0659em;">Etopsido y carboplatino o &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.4758em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_57">cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8558em;top:8.0318em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0293em;">N = 266 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.522em;top:9.1818em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.7642em;top:9.1818em;"><span class="pdf24_05 pdf24_06 pdf24_236" style="word-spacing:-0.0177em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.2742em;top:10.1818em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.8642em;top:9.1818em;"><span class="pdf24_05 pdf24_06 pdf24_208" style="word-spacing:-0.022em;">Grado 3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9358em;top:9.1818em;"><span class="pdf24_05 pdf24_06 pdf24_236" style="word-spacing:-0.0178em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.4558em;top:10.1818em;"><span class="pdf24_05 pdf24_06 pdf24_68" style="word-spacing:-0.0241em;">Grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0383em;top:9.1818em;"><span class="pdf24_05 pdf24_06 pdf24_253" style="word-spacing:-0.0134em;">Grado 3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:11.2718em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.3618em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_72">Estreimiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_184">Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:12.3618em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:15.6418em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:12.3618em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4842em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:12.3618em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_64">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:15.6418em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:12.3618em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6583em;top:13.4618em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:14.5518em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:15.6418em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:15.6418em;"><span class="pdf24_14 pdf24_06 pdf24_192">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:15.6418em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:16.7318em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.021em;">Desordenes generales y condiciones del sitio de administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:17.8318em;"><span class="pdf24_14 pdf24_06 pdf24_123">Fatiga/Astenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:17.8318em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:17.8318em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:17.8318em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:17.8318em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:18.9218em;"><span class="pdf24_05 pdf24_06 pdf24_208" style="word-spacing:-0.0148em;">Trastornos de piel y tejidos subcutneos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:20.0143em;"><span class="pdf24_14 pdf24_06 pdf24_144">Alopecia &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:20.0143em;"><span class="pdf24_14 pdf24_06 pdf24_64">31 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:21.1044em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:20.0143em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4842em;top:21.1044em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:20.0143em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5758em;top:21.1044em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:20.0143em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6583em;top:21.1044em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:21.1044em;"><span class="pdf24_14 pdf24_06 pdf24_138">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:22.1943em;"><span class="pdf24_05 pdf24_06 pdf24_96" style="word-spacing:-0.0271em;">Trastornos de metabolism y nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:23.2943em;"><span class="pdf24_14 pdf24_06 pdf24_253" style="word-spacing:-0.0176em;">Apetito disminuido</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:5.9117em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:24.3843em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0324em;">Trastornos respiratorios, torcicos y mediastinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:23.2943em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1542em;top:25.4743em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4842em;top:27.6643em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.3458em;top:23.2943em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5758em;top:25.4743em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:40.3283em;top:23.2943em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6583em;top:25.4743em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.4743em;"><span class="pdf24_14 pdf24_06 pdf24_68" style="word-spacing:0.0079em;">Tos / Tos Productiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:26.5643em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0391em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:27.6643em;"><span class="pdf24_14 pdf24_06 pdf24_75">Hipertiroidismo* &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:25.4743em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:27.6643em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.2458em;top:27.6643em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.6583em;top:27.6643em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9745em;"><span class="pdf24_152 pdf24_06 pdf24_82" style="word-spacing:0.003em;">Incluye erupcin eritematosa, erupcin </span><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:-0.0003em;">generalizada, erupcin macular, erupcin maculopapular, erupcin papular, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9345em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0002em;">erupcin pruriginosa, erupcin pustulosa, eritema, eccema, erupcin y dermatitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8745em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:-0.0093em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_81" style="word-spacing:-0.0047em;">Incluye hipertiroidismo y enfermedad de Basedow &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.8943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0005em;">La Tabla 14 resume las anormalidades de laboratorio que ocurrieron en al menos el 20% de los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.946em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0015em;">tratados con IMFINZI ms quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.056em;"><span class="pdf24_05 pdf24_06 pdf24_18" style="word-spacing:-0.0124em;">Tabla 14. Anormalidades de Laboratorio que Empeoran desde la Lnea Base que Ocurren en </span><span class="pdf24_189 pdf24_06 pdf24_18" style="word-spacing:-0.0124em;"> &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.106em;"><span class="pdf24_05 pdf24_06 pdf24_15">20%</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.146em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_37" style="word-spacing:0.0043em;">de Pacientes en el Estudio CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1242em;top:38.206em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0608em;">IMFINZI con Etopsido &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5258em;top:39.256em;"><span class="pdf24_05 pdf24_06 pdf24_18" style="word-spacing:0.0035em;">y Carboplatino o &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8658em;top:40.306em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.9783em;top:38.206em;"><span class="pdf24_05 pdf24_06 pdf24_21" style="word-spacing:0.0018em;">Etopsido y &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3458em;top:39.256em;"><span class="pdf24_05 pdf24_06 pdf24_67" style="word-spacing:-0.061em;">Carboplatino o &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.3183em;top:40.306em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:41.426em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.526em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4158em;top:41.426em;"><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.1121em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_227" style="word-spacing:0.0201em;">3 o 4 (%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228" style="word-spacing:0.0319em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.8758em;top:41.426em;"><span class="pdf24_05 pdf24_06 pdf24_92">Grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.1121em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_227" style="word-spacing:0.0201em;">3 o 4 (%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228" style="word-spacing:0.0319em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:43.616em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:44.706em;"><span class="pdf24_14 pdf24_06 pdf24_138">Hipomagnesemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4058em;top:43.616em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4058em;top:44.706em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:43.616em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0783em;top:44.706em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.796em;"><span class="pdf24_14 pdf24_06 pdf24_61">Hiperglicemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.6258em;top:45.796em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:40.0783em;top:45.796em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:6.492em;top:46.886em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0296em;">Fosfatasa alcalina incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.9885em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0201em;">ALT Incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:49.0785em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0085em;">AST Incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:50.1685em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:46.886em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:47.9885em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:49.0785em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:50.1685em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:51.2685em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.2958em;top:52.3585em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.1958em;top:53.4485em;"><span class="pdf24_14 pdf24_06 pdf24_254">NA &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:46.886em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:47.9885em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:49.0785em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:50.1685em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:51.2685em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7483em;top:52.3585em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6483em;top:53.4485em;"><span class="pdf24_14 pdf24_06 pdf24_254">NA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:51.2685em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0349em;">Creatinina sangunea incrementada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.3585em;"><span class="pdf24_14 pdf24_06 pdf24_23">Hipercalemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.4485em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0192em;">TSH disminuida &lt; LLN</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.1121em;"> </span></sup><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:-0.019em;">y </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0129em;">LLN en la lnea base &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.5385em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:55.6285em;"><span class="pdf24_14 pdf24_06 pdf24_60">Neutropenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:56.7285em;"><span class="pdf24_14 pdf24_06 pdf24_23">Linfopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.8282em;"><span class="pdf24_14 pdf24_06 pdf24_122">Anemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4058em;top:55.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4058em;top:56.7285em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4058em;top:57.8282em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:55.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">48 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:56.7285em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:57.8282em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">30 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_30" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAbZ0lEQVR4nO3azcvt11nH4f0XZJxRCQgROpFOTcRAOFU0OAn4UgpnkEltQUNHCobUqm1J2kEwr23KoaeG4kiKozqwQ/8tf4c4WCDx+dV9P89e9/e+LvjOFzw5a+Wz975cAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgP/ta8deMTML20vHXt7gHGZ37aUNzmD77LULcKdfHntsZha27x57c4NzmN21H29wBttnv7gAd/r5rQ8AcA/+8tjv3voQcIJ3mNXTWx8AOnBxAokEDF14h1kJGDjBxQkkEjB04R1mJWDgBBcnkEjA0IV3mJWAgRNcnEAiAUMX3mFWAgZOcHECiQQMXXiHWQkYOMHFCSQSMHThHWYlYOAEFyeQSMDQhXeYlYCBE1ycQCIBQxfeYVYCBk5wcQKJBAxdeIdZCRg4wcUJJBIwdOEdZiVg4AQXJ5BIwNCFd5iVgIETXJxAIgFDF95hVgIGTnBxAokEDF14h1kJGDjBxQkkEjB04R1mJWDgBBcnkEjA0IV3mJWAgRNcnEAiAUMX3mFWAgZOcHECiQQMXXiHWQkYOMHFCSQSMHThHWYlYOAEFyeQSMDQhXeYlYCBE1ycQCIBQxfeYVYCBk5wcQKJBAxdeIdZCRg4wcUJJBIwdOEdZiVg4AQXJ5BIwNCFd5iVgIETXJxAIgFDF95hVgIGTnBxAokEDF14h1kJGDjBxQkkEjB04R1mJWDgBBcnkEjA0IV3mJWAgRNcnEAiAUMX3mFWAgZOcHECiQQMXXiHWQkYOMHFCSQSMHThHWYlYOAEFyeQSMDQhXeYlYCBE1ycQCIBQxfeYVYCBk5wcQKJBAxdeIdZCRg4wcUJJBIwdOEdZiVg4AQXJ5BIwNCFd5iVgIETXJxAIgFDF95hVgIGTnBxAokEDF14h1kJGDjBxQkkEjB04R1mJWDgBBcnkEjA0IV3mJWAgRNcnEAiAUMX3mFWAgZOcHECiQQMXXiHWQkYOMHFCSQSMHThHWYlYOAEFyeQSMDQhXeYlYCBE1ycQCIBQxfeYVYCBk5wcQKJBAxdeIdZCRg4wcUJJBIwdOEdZiVg4AQXJ5BIwNCFd5iVgIETXJxAIgFDF95hVgIGTnBxAokEDF14h1kJGDjBxQkkEjB04R1mJWDghGcX5xMzs7B9cuyjDc5hdtc+2+AMts9+dAHu5JMfIJFvYOjCO8zKNzBwgosTSCRg6MI7zErAwAkuTiCRgKEL7zArAQMnuDiBRAKGLrzDrAQMnODiBBIJGLrwDrMSMHCCixNIJGDowjvMSsDACS5OIJGAoQvvMCsBAye4OIFEAoYuvMOsBAyc4OIEEgkYuvAOsxIwcIKLE0gkYOjCO8xKwMAJLk4gkYChC+8wKwEDJ7g4gUQChi68w6wEDJzg4gQSCRi68A6zEjBwgosTSCRg6MI7zErAwAkuTiCRgKEL7zArAQMnuDiBRAKGLrzDrAQMnPDpsRfMzML25rE/3uAcZnfNO2zrProAd3p2cb5tZha2Hx37xw3OYXbXfrrBGWyfvXsB7uSrayCRn5DRhXeYlZ+QwQkuTiCRgKEL7zArAQMnuDiBRAKGLrzDrAQMnODiBBIJGLrwDrMSMHCCixNIJGDowjvMSsDACS5OIJGAoQvvMCsBAye4OIFEAoYuvMOsBAyc4OIEEgkYuvAOsxIwcIKLE0gkYOjCO8xKwMAJLk4gkYChC+8wKwEDJ7g4gUQChi68w6wEDJzg4gQSCRi68A6zEjBwgosTSCRg6MI7zErAwAkuTiCRgKEL7zArAQMnuDiBRAKGLrzDrAQMnODiBBIJGLrwDrMSMHDCfx17YmYWtk+OfbTBOczu2mcbnMH22X9cgDv9zrEXzMzC9qX/2a3PYXbX/Hdq6377AgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA3Navjv3a7Av2nxcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPhiXzv2ilnhfv/YSxucw8x+8/3exb9fs9332rHfusBgvzz22Kxwbxx7f4NzmNlvvm8ee2eDc5jZF++Hx/7iAoP9/NYHIM5zxz649SGA/5cXj71160MA/6c/P/ZHtz4E3JKAoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8AwnoChmoCBvgQM7E/AMJ6AoZqAgb4EDOxPwDCegKGagIG+BAzsT8Aw3ifHHpsV7o1j729wDnvYff3Yn25wDrtu3zr2zgbnsPvZn10+/5/fW5/DrtvfHXt0gcGeBcwrZoX7g2PvbXAOe9i9duyHG5zDrtvrx/5hg3PY/ezZB0zf3uAcdt3+6thXLzCYn5BRzU/IZnr+2Lu3PgRX8xOybK9ePv8En978hIzxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxnh57Yla4nxz7/gbnsIfdh8e+t8E57Lq97+8YvWcfMvxgg3PYdfv42KMLDOYbGACAPnwDw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3gCBgCgDwHDeAIGAKAPAcN4AgYAoA8Bw3j/euzXZoX71eXzML71Oexh9+/Hnm5wDrtu/3bsZxucw+5nn138O03YL4599QKD+QaGas8d++DWh+DBPX/s3Vsfgqu9eOytWx+Ce/Pqsce3PgRX8w0M4wkYqgmYmQRMBgGTTcBkEDCMJ2CoJmBmEjAZBEw2AZNBwDCegKGagJlJwGQQMNkETAYBw3gChmoCZiYBk0HAZBMwGQQM4wkYqgmYmQRMBgGTTcBkEDCMJ2CoJmBmEjAZBEw2AZNBwDCegKGagJlJwGQQMNkETAYBw3gChmoCZiYBk0HAZBMwGQQM4wkYqgmYmQRMBgGTTcBkEDCMJ2CoJmBmEjAZBEw2AZNBwDCegKGagJlJwGQQMNkETAYBw3gChmoCZiYBk0HAZBMwGQQM4wkYqgmYmQRMBgGTTcBkEDCMJ2CoJmBmEjAZBEw2AZNBwDCegKGagJlJwGQQMNkETAYBw3gChmoCZiYBk0HAZBMwGQQM4wkYqgmYmQRMBgGTTcBkEDCM9+mxF8wK9+Vj721wDnvYfeXYOxucw67by8e+s8E57H72+rFvbHAOu25vHPvDCwz2LGDeNivc3x/7ZINz2MPvww3OYNftu8f+eYNz2P3sny6ff1N663PYdXv2YdGjCwzmJ2RU8xOymfyELIOfkGXzE7IMfkLGeAKGagJmJgGTQcBkEzAZBAzjCRiqCZiZBEwGAZNNwGQQMIwnYKgmYGYSMBkETDYBk0HAMJ6AoZqAmUnAZBAw2QRMBgHDeAKGagJmJgGTQcBkEzAZBAzjCRiqCZiZBEwGAZNNwGQQMIwnYKgmYGYSMBkETDYBk0HAMJ6AoZqAmUnAZBAw2QRMBgHDeAKGagJmJgGTQcBkEzAZBAzjCRiqCZiZBEwGAZNNwGQQMIwnYKgmYGYSMBkETDYBk0HAMJ6AoZqAmUnAZBAw2QRMBgHDeAKGagJmJgGTQcBkEzAZBAzjCRiqCZiZBEwGAZNNwGQQMIwnYKgmYGYSMBkETDYBk0HAMJ6AoZqAmUnAZBAw2QRMBgHDeAKGagJmJgGTQcBkEzAZBAzjCRiqCZiZBEwGAZNNwGQQMIz39NgTs8L95Nj3NziHPew+PPa9Dc5h1+19f8foPfuQ4QcbnMOu28fHHl1gMN/AAAD04RsYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxhMwAAB9CBjGEzAAAH0IGMYTMAAAfQgYxnt67IlZ4X567GcbnMMedj/e4AxW83f8dINz2P3sw2OfbHAOu24fH3t0gcF8A0O15459cOtD8OCeP/burQ/B1V489tatD8G9efXY41sfgqv5BobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMYTMFQTMDMJmAwCJpuAySBgGE/AUE3AzCRgMgiYbAImg4BhPAFDNQEzk4DJIGCyCZgMAobxBAzVBMxMAiaDgMkmYDIIGMb7l2MvmBXuy8fe2+Ac9rD7yrF3NjiHXbeXj31ng3PY/ez1Y9/Y4Bx23b557E8uMNinx942K9yzT2/f3OAc9rD722N/vcE57Lr9jb9j9L59cT8n7NmHRY8uAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPfovwFDBgiE3vBjEwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_255" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:26.1242em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0608em;">IMFINZI con Etopsido &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5258em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_18" style="word-spacing:0.0035em;">y Carboplatino o &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.8658em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.9783em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_21" style="word-spacing:0.0018em;">Etopsido y &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3458em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_67" style="word-spacing:-0.061em;">Carboplatino o &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.3183em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:9.2118em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.3018em;"><span class="pdf24_14 pdf24_06 pdf24_75">Trombocitopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4158em;top:9.2118em;"><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.1121em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_227" style="word-spacing:0.0201em;">3 o 4 (%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228" style="word-spacing:0.0319em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:30.4058em;top:10.3018em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.8758em;top:9.2118em;"><span class="pdf24_05 pdf24_06 pdf24_92">Grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.1121em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_227" style="word-spacing:0.0201em;">3 o 4 (%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228" style="word-spacing:0.0319em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:39.8483em;top:10.3018em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.572em;"><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0031em;">* El corte de frecuencia se basa en cualquier cambio de grado desde la lnea de base &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.532em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_18" style="word-spacing:0.004em;">Calificacin segn NCI CTCAE versin 4.03 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.482em;"><span class="pdf24_152 pdf24_06 pdf24_42" style="word-spacing:0.0171em;"> La incidencia de cada prueba se basa en el nmero de pacientes que tenan disponible una medicin </span><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.0131em;">de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.442em;"><span class="pdf24_41 pdf24_06 pdf24_256" style="word-spacing:0.0356em;">inicial y al menos una en el laboratorio: IMFINZI (rango: 258 a 263) y quimioterapia (rango: 253 a 262) excepto el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.402em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0026em;">magnesio de IMFINZI con quimioterapia (18) y quimioterapia (16) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.362em;"><span class="pdf24_41 pdf24_06 pdf24_22" style="word-spacing:0.001em;"> LLN = lmite inferior de lo normal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.4118em;"><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0116em;">Cncer de Vas Biliares &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.5343em;"><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:-0.0328em;">CVB localmente avanzado o metastsico - TOPAZ-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.6343em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0058em;">La seguridad de IMFINZI en combinacin con gemcitabina y cisplatino en el CVB localmente avanzado o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.6843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0996em;">metastsico se evalu en TOPAZ-1, un estudio multicntrico, aleatorizado, doble ciego, controlado con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.7443em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0864em;">placebo. Un total de 338 pacientes recibieron 1500 mg de IMFINZI en combinacin con gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.7943em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1552em;">cisplatino cada 3 semanas hasta 8 ciclos, seguidos de 1500 mg de IMFINZI cada 4 semanas hasta la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.8543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3037em;">progresin de la enfermedad o toxicidad inaceptable. Los pacientes con trastornos autoinmunes o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9043em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0098em;">inflamatorios activos o previamente documentados, infeccin por VIH u otras infecciones activas, incluida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9543em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0013em;">la tuberculosis o la hepatitis C, no fueron elegibles [</span><span class="pdf24_55 pdf24_06 pdf24_164">consult</span><a href="#55_0"><span class="pdf24_55 pdf24_06 pdf24_31" style="word-spacing:0.0007em;">e Estudios clnicos</span></a><a href="#55_0"><span class="pdf24_14 pdf24_06 pdf24_177">]. &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:6.002em;top:32.0743em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0369em;">IMFINZI se interrumpi debido a reacciones adversas en el 6% de los pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.1243em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0168em;">ms quimioterapia. Los eventos notificados con mayor frecuencia que dieron lugar a la interrupcin fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.176em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2944em;">sepsis (3 pacientes) y accidente cerebrovascular isqumico (2 pacientes). Los eventos restantes se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.236em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1728em;">dispersaron por clases de rganos y sistemas y se notificaron en 1 paciente cada uno. Se produjeron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.286em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0973em;">reacciones adversas graves en el 47% de los pacientes que recibieron IMFINZI ms quimioterapia. Las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.346em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0142em;">reacciones adversas graves ms frecuentes notificadas en al menos el 2% de los pacientes fueron colangitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.396em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.01em;">(7%), pirexia (3.8%), anemia (3.6%), sepsis (3.3%) y lesin renal aguda (2.4%). Se produjeron reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.446em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0573em;">adversas mortales en el 3.6% de los pacientes que recibieron IMFINZI ms quimioterapia. Entre ellas se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.506em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.3323em;">incluyen accidente cerebrovascular isqumico o hemorrgico (4 pacientes), sepsis (2 pacientes) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.556em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0419em;">hemorragia gastrointestinal alta (2 pacientes). Las reacciones adversas ms frecuentes (ocurrieron en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.038em;"> </span><span class="pdf24_14 pdf24_06 pdf24_149">20% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.616em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0054em;">de los pacientes) fueron fatiga, nuseas, estreimiento, disminucin del apetito, dolor abdominal, erupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.666em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0498em;">cutnea y pirexia. En la Tabla 15 se resumen las reacciones adversas que se produjeron en pacientes tratados &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.716em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0014em;">con IMFINZI ms quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.836em;"><span class="pdf24_05 pdf24_06 pdf24_18" style="word-spacing:-0.0337em;">Tabla 15. Reacciones Adversas que se Produjeron en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:-0.0253em;"> </span><span class="pdf24_05 pdf24_06 pdf24_141" style="word-spacing:-0.0272em;">10% de los Pacientes del Estudio TOPAZ-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.3542em;top:47.9285em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0563em;">IMFINZI con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9742em;top:48.9785em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5258em;top:47.9385em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0732em;">Placebo con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7758em;top:48.9885em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4642em;top:50.0385em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0388em;">N = 338 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.2758em;top:50.0385em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0401em;">N = 342 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.652em;top:51.6185em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0329em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.9242em;top:51.6085em;"><span class="pdf24_05 pdf24_06 pdf24_66" style="word-spacing:-0.0676em;">Todos los grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:1.3707em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.1494em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_257" style="word-spacing:-0.0145em;">3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.6042em;top:52.6585em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:51.6085em;"><span class="pdf24_05 pdf24_06 pdf24_66" style="word-spacing:-0.0676em;">Todos los grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:1.1336em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.1293em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_25" style="word-spacing:-0.0199em;">3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5458em;top:52.6585em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:53.7685em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0215em;">Trastornos generales y condiciones del lugar de administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:55.0085em;"><span class="pdf24_14 pdf24_06 pdf24_52">Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_108"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:18.9042em;top:55.0085em;"><span class="pdf24_14 pdf24_06 pdf24_64">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6342em;top:55.0085em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:55.0085em;"><span class="pdf24_14 pdf24_06 pdf24_64">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">16 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:55.0085em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.062em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_54">Pirexia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:56.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:57.5182em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:58.7682em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:58.7682em;"><span class="pdf24_14 pdf24_06 pdf24_64">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:58.7682em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:58.7682em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:58.7682em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">31 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_31" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_258" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:17.3542em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0563em;">IMFINZI con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9742em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5258em;top:6.0018em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0732em;">Placebo con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7758em;top:7.0518em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4642em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0388em;">N = 338 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.2758em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_64" style="word-spacing:0.0401em;">N = 342 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.652em;top:9.6818em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0329em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.9242em;top:9.6718em;"><span class="pdf24_05 pdf24_06 pdf24_66" style="word-spacing:-0.0676em;">Todos los grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:1.3707em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.1494em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_257" style="word-spacing:-0.0145em;">3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.6042em;top:10.7218em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.8758em;top:9.6718em;"><span class="pdf24_05 pdf24_06 pdf24_66" style="word-spacing:-0.0676em;">Todos los grados</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:1.1336em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_15" style="word-spacing:0.1293em;">* </span></sup><span class="pdf24_05 pdf24_06 pdf24_25" style="word-spacing:-0.0199em;">3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5458em;top:10.7218em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:11.8118em;"><span class="pdf24_14 pdf24_06 pdf24_72">Estreimiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:13.0718em;"><span class="pdf24_14 pdf24_06 pdf24_220" style="word-spacing:-0.0122em;">Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_221" style="word-spacing:-0.0194em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.062em;top:14.3218em;"><span class="pdf24_14 pdf24_06 pdf24_184">Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:11.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:13.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:14.3218em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:11.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:13.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:14.3218em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:11.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:13.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:14.3218em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:11.8118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:13.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:14.3218em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_192">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:16.8318em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0199em;">Trastornos del metabolismo y la nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:18.0718em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0251em;">Disminucin del apetito</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:4.2565em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_64">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3242em;top:18.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:18.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9283em;top:18.0718em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:19.3518em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0136em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:20.5743em;"><span class="pdf24_14 pdf24_06 pdf24_138">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_139"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:18.9042em;top:20.5743em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:21.8243em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3142em;top:20.5743em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6342em;top:21.8243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:20.5743em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9358em;top:21.8243em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:20.5743em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:21.8243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.062em;top:21.8243em;"><span class="pdf24_14 pdf24_06 pdf24_68">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:23.1043em;"><span class="pdf24_05 pdf24_06 pdf24_59" style="word-spacing:-0.0378em;">Trastornos psiquitricos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:24.3243em;"><span class="pdf24_14 pdf24_06 pdf24_132">Insomnio &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.9042em;top:24.3243em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6342em;top:24.3243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:33.7158em;top:24.3243em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:24.3243em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.6945em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_62" style="word-spacing:0.0015em;">Clasificado segn NCI CTCAE versin 5.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.6545em;"><sup style="top: -0.29em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:0.1204em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_66" style="word-spacing:-0.0032em;">Incluye fatiga, malestar general, fatiga por cncer y astenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.6045em;"><sup style="top: -0.29em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:0.1204em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0034em;">Incluye dolor abdominal, dolor abdominal inferior, dolor abdominal superior y dolor de costado. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.5745em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1389em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0018em;">Incluye erupcin macular, erupcin maculopapular, erupcin morbiliforme, erupcin papular, erupcin pruriginosa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.5345em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.3103em;">erupcin pustulosa, erupcin eritematosa, dermatitis acneiforme, dermatitis bullosa, erupcin medicamentosa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4845em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0011em;">eccema, eritema, dermatitis y erupcin cutnea. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.4943em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1758em;">En la Tabla 16 se resumen las anomalas de laboratorio en los pacientes tratados con IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5443em;"><span class="pdf24_14 pdf24_06 pdf24_138">quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.656em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:-0.0138em;">Tabla 16. Anomalas de Laboratorio que Empeoran con Respecto a la Lnea Basal y que Ocurren &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.716em;"><span class="pdf24_189 pdf24_06 pdf24_32" style="word-spacing:0.0025em;">en  20%* de los Pacientes del Estudio TOPAZ</span><span class="pdf24_05 pdf24_06 pdf24_49">-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:37.806em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0563em;">IMFINZI con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.6642em;top:38.866em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2258em;top:37.806em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0655em;">Placebo con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5283em;top:38.866em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:40.556em;"><span class="pdf24_05 pdf24_06 pdf24_74" style="word-spacing:-0.038em;">Anormalidad de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.5042em;top:40.556em;"><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_15" style="word-spacing:0.0948em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_114" style="word-spacing:0.0371em;">3 o 4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4258em;top:40.556em;"><span class="pdf24_05 pdf24_06 pdf24_92">Grado</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_15" style="word-spacing:0.0948em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_114" style="word-spacing:0.0329em;">3 o 4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:42.346em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:43.596em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:43.596em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:44.856em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:43.596em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:44.856em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:44.866em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0614em;">Aumento de gamma- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:45.926em;"><span class="pdf24_14 pdf24_06 pdf24_75">glutamiltransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_156" style="word-spacing:-0.0184em;">Aumento de bilirrubina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:48.6185em;"><span class="pdf24_14 pdf24_06 pdf24_72">Hipopotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7958em;top:48.6185em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.1483em;top:48.6185em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.4783em;top:49.8485em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:6.062em;top:49.8485em;"><span class="pdf24_14 pdf24_06 pdf24_147" style="word-spacing:-0.019em;">Aumento de AST &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7958em;top:49.8485em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:6.062em;top:51.1085em;"><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0188em;">Aumento de ALT &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7958em;top:51.1085em;"><span class="pdf24_14 pdf24_06 pdf24_15">7</span></div>
					<div class="pdf24_01" style="left:39.4783em;top:51.1085em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:6.062em;top:52.3785em;"><span class="pdf24_14 pdf24_06 pdf24_141" style="word-spacing:-0.0223em;">Aumento de la creatinina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:53.6285em;"><span class="pdf24_14 pdf24_06 pdf24_138">Hipomagnesemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:52.3785em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:52.3785em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:53.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:54.8785em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:56.1185em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:57.3882em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0983em;top:58.6282em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2442em;top:53.6285em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2442em;top:54.8785em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2442em;top:56.1185em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2442em;top:57.3882em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2442em;top:58.6282em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:54.8785em;"><span class="pdf24_14 pdf24_06 pdf24_132">Hipoalbuminemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:56.1185em;"><span class="pdf24_14 pdf24_06 pdf24_60">Hiperpotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:57.3882em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0232em;">Aumento de la fosfatasa alcalina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:58.6282em;"><span class="pdf24_14 pdf24_06 pdf24_123">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">32 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_32" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_259" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:21.0042em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.0563em;">IMFINZI con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.6642em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2258em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0655em;">Placebo con Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5283em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:8.7418em;"><span class="pdf24_05 pdf24_06 pdf24_74" style="word-spacing:-0.038em;">Anormalidad de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.5042em;top:8.7418em;"><span class="pdf24_05 pdf24_06 pdf24_121">Grado</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_15" style="word-spacing:0.0948em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_114" style="word-spacing:0.0371em;">3 o 4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4258em;top:8.7418em;"><span class="pdf24_05 pdf24_06 pdf24_92">Grado</span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_15" style="word-spacing:0.0948em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_114" style="word-spacing:0.0329em;">3 o 4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:10.5518em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:11.7818em;"><span class="pdf24_14 pdf24_06 pdf24_60">Neutropenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:13.0418em;"><span class="pdf24_14 pdf24_06 pdf24_122">Anemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:11.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">48 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:13.0418em;"><span class="pdf24_14 pdf24_06 pdf24_64">31 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:14.3018em;"><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:15.5318em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:16.7919em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:11.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:13.0418em;"><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:14.3018em;"><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:15.5318em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:16.7919em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:14.3018em;"><span class="pdf24_14 pdf24_06 pdf24_138">Leucopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:15.5318em;"><span class="pdf24_14 pdf24_06 pdf24_23">Linfopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:16.7919em;"><span class="pdf24_14 pdf24_06 pdf24_75">Trombocitopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.152em;"><span class="pdf24_41 pdf24_06 pdf24_62" style="word-spacing:-0.0005em;">* El corte de frecuencia se basa en cualquier cambio de grado con respecto a la lnea basal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.1221em;"><span class="pdf24_152 pdf24_06 pdf24_151" style="word-spacing:0.0503em;"> Calificado segn la versin 5.0 de NCI CTCAE. La incidencia de cada prueba se basa en el nmero de pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.0845em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0466em;">que disponan tanto de una medicin basal como de al menos una medicin de laboratorio durante el estudio: IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.0345em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0002em;">con gemcitabina / cisplatino (rango: 312 a 335) y Placebo con gemcitabina / cisplatino (rango: 319 a 341). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.0943em;"><span class="pdf24_14 pdf24_06 pdf24_166" style="word-spacing:-0.0271em;">Carcinoma Hepatocelular &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.2043em;"><span class="pdf24_55 pdf24_06 pdf24_65" style="word-spacing:-0.0168em;">CHC irresecable - HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.3043em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0429em;">La seguridad de IMFINZI en combinacin con tremelimumab-actl se evalu en un total de 388 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.3643em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0276em;">con CHC irresecable en HIMALAYA, un estudio multicntrico, abierto y aleatorizado [</span><span class="pdf24_55 pdf24_06 pdf24_37" style="word-spacing:0.0281em;">consulte Estudios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4143em;"><span class="pdf24_55 pdf24_06 pdf24_84">clnicos</span><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1171em;">]. Los pacientes recibieron 1500 mg de IMFINZI administrados como una infusin intravenosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.4743em;"><span class="pdf24_14 pdf24_06 pdf24_57" style="word-spacing:-0.0062em;">nica en combinacin con 300 mg de tremelimumab-actl el mismo da, seguido de IMFINZI cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5243em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0015em;">o 400 mg de sorafenib administrados por va oral dos veces al da. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.636em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.2331em;">Se produjeron reacciones adversas graves en el 41 % de los pacientes que recibieron IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.696em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0064em;">combinacin con tremelimumab-actl. Las reacciones adversas graves en &gt; 1 % de los pacientes incluyeron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.746em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:-0.0322em;">hemorragia (6 %), diarrea (4 %), sepsis (2.1 %), neumona (2.1 %), erupcin cutnea (1.5 %), vmitos (1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.806em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0149em;">%), lesin renal aguda ( 1.3%) y anemia (1.3%). Se produjeron reacciones adversas mortales en el 8 % de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.856em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.056em;">los pacientes que recibieron IMFINZI en combinacin con tremelimumab-actl, incluida la muerte (1 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.916em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0492em;">hemorragia intracraneal (0.5 %), paro cardaco (0.5 %), neumonitis (0.5 %), insuficiencia heptica (0.5 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.966em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0117em;">%) y hepatitis inmunomediada (0.5%). Las reacciones adversas ms comunes (que ocurrieron en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:-0.0178em;">20% de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.026em;"><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:-0.0132em;">los pacientes) fueron erupcin cutnea, diarrea, fatiga, prurito, dolor musculoesqueltico y dolor abdominal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.126em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0339em;">La interrupcin permanente del rgimen de tratamiento debido a una reaccin adversa ocurri en el 14 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.186em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.013em;">de los pacientes; las reacciones adversas ms comunes que llevaron a la interrupcin del tratamiento </span><span class="pdf24_20 pdf24_06 pdf24_49" style="word-spacing:0.0194em;">( </span><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:0.0194em;">1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.226em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:-0.0191em;">%) fueron hemorragia (1.8 %), diarrea (1.5 %), aumento de AST (1 %) y hepatitis (1 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3485em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1663em;">Las interrupciones de la dosis o el retraso del rgimen de tratamiento debido a una reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3985em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0176em;">ocurrieron en el 35% de los pacientes. Las reacciones adversas que requirieron la interrupcin o el retraso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4485em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0195em;">de la dosificacin en </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0203em;">1 % de los pacientes incluyeron aumento de ALT (3.6 %), diarrea (3.6 %), erupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.5085em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1624em;">cutnea (3.6 %), aumento de amilasa (3.4 %), aumento de AST (3.1 %), aumento de lipasa (2.8 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5585em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:0.3665em;">neumona (1.5 %), hepatitis (1.5 %), pirexia (1.5 %), anemia (1.3 %), trombocitopenia (1 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6185em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0017em;">hipertiroidismo (1 %), neumonitis (1 %) y creatinina en sangre aument (1%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.7285em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2449em;">La Tabla 17 resume las reacciones adversas que ocurrieron en pacientes tratados con IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7785em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0022em;">combinacin con tremelimumab-actl en el estudio HIMALAYA. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.8882em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:-0.026em;">Tabla 17. Reacciones adversas que ocurrieron en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.0248em;">10 % de los pacientes en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">33 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_33" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_260" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:17.8442em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_50" style="word-spacing:-0.0598em;">IMFINZI y Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.2842em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 388) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8458em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_138">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9058em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 374) &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0342em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0681em;">Todos los Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6842em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1642em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0619em;">Grado 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4158em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.5558em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_62" style="word-spacing:-0.0681em;">Todos los Grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_81" style="word-spacing:-0.0637em;">Grado 3-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0783em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:8.6718em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0322em;">Reaccin Adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2058em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_102">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:10.2118em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0136em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_81" style="word-spacing:-0.0418em;">Erupcin </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_08" style="word-spacing:-0.0663em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_68">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9558em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">57 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7458em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.4083em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:12.4119em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:13.5018em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_52">Diarrea</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_217">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:21.0042em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9558em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9558em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_64">45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_64">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6383em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01" style="left:41.6383em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.472em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_220" style="word-spacing:-0.0122em;">Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_221" style="word-spacing:-0.0194em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:16.7818em;"><span class="pdf24_14 pdf24_06 pdf24_132">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:17.8718em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0207em;">Trastornos generales y alteraciones en el lugar de administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_52">Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_217">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:21.0042em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_64">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_64">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_64">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7458em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.6383em;top:18.9618em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:20.0543em;"><span class="pdf24_14 pdf24_06 pdf24_185">Pirexia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:21.1443em;"><span class="pdf24_05 pdf24_06 pdf24_58" style="word-spacing:-0.0317em;">Trastornos Musculoesquelticos y del Tejido Conectivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_97" style="word-spacing:-0.0227em;">Dolor musculoesqueltico</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_194" style="word-spacing:-0.036em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:23.3443em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.016em;">Trastornos del metabolismo y de la nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0264em;">Disminucion del apetito &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_64">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9558em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.5258em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.7458em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:22.2443em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2983em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6383em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:24.4343em;"><span class="pdf24_14 pdf24_06 pdf24_64">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.0042em;top:28.7943em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:25.5243em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0391em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.2517em;top:26.5873em;"><span class="pdf24_261 pdf24_06 pdf24_15">*</span></div>
					<div class="pdf24_01" style="left:6.472em;top:26.6143em;"><span class="pdf24_14 pdf24_06 pdf24_122">Hipotiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:27.7043em;"><span class="pdf24_05 pdf24_06 pdf24_59" style="word-spacing:-0.0378em;">Trastornos psiquitricos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:28.7943em;"><span class="pdf24_14 pdf24_06 pdf24_132">Insomnio &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.6358em;top:28.7943em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4258em;top:28.7943em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.6383em;top:28.7943em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.1145em;"><span class="pdf24_41 pdf24_06 pdf24_08" style="word-spacing:-0.0066em;">* Representa un compuesto de mltiples trminos relacionados. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.1143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.031em;">La Tabla 18 resume las anomalas de laboratorio que ocurrieron en pacientes tratados con IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.1643em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0022em;">combinacin con tremelimumab-actl en el estudio HIMALAYA. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.286em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:0.1152em;">Tabla 18. Anomalas de laboratorio que empeoran desde el inicio que ocurren en </span><span class="pdf24_189 pdf24_06 pdf24_15" style="word-spacing:0.1251em;"> </span><span class="pdf24_05 pdf24_06 pdf24_250" style="word-spacing:0.1081em;">20 % de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.336em;"><span class="pdf24_05 pdf24_06 pdf24_07" style="word-spacing:0.0043em;">pacientes en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5442em;top:37.426em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.0591em;">IMFINZI y Tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3842em;top:38.476em;"><span class="pdf24_05 pdf24_06 pdf24_102">actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6358em;top:37.436em;"><span class="pdf24_05 pdf24_06 pdf24_138">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1642em;top:39.566em;"><span class="pdf24_05 pdf24_06 pdf24_176">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2058em;top:39.566em;"><span class="pdf24_05 pdf24_06 pdf24_146" style="word-spacing:-0.0663em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.0603em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0543em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.7458em;top:40.616em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:33.5558em;top:39.566em;"><span class="pdf24_05 pdf24_06 pdf24_176">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0083em;top:39.566em;"><span class="pdf24_05 pdf24_06 pdf24_146" style="word-spacing:-0.0663em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.0603em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0544em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.5483em;top:40.616em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:39.586em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:41.656em;"><span class="pdf24_05 pdf24_06 pdf24_60">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.8742em;top:40.616em;"><span class="pdf24_05 pdf24_06 pdf24_80">grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:-0.0086em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_17">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_106"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:33.2758em;top:40.616em;"><span class="pdf24_05 pdf24_06 pdf24_80">grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:-0.0086em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_169">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_109"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:42.826em;"><span class="pdf24_14 pdf24_06 pdf24_60">Aumento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:43.886em;"><span class="pdf24_14 pdf24_06 pdf24_75">aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_194" style="word-spacing:1.6549em;">Aumento de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:46.026em;"><span class="pdf24_14 pdf24_06 pdf24_75">aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.4217em;top:42.826em;"><span class="pdf24_14 pdf24_06 pdf24_248">de &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.8417em;top:42.826em;"><span class="pdf24_14 pdf24_06 pdf24_144">aspartato &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:42.816em;"><span class="pdf24_14 pdf24_06 pdf24_64">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_64">56 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:42.816em;"><span class="pdf24_14 pdf24_06 pdf24_64">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_64">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:42.816em;"><span class="pdf24_14 pdf24_06 pdf24_64">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_64">53 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0183em;top:42.816em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0183em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_64">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:14.1417em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_262">la &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5042em;top:44.976em;"><span class="pdf24_14 pdf24_06 pdf24_54">alanina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0354em;">Disminucin de sodio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_263" style="word-spacing:-0.0122em;">Aumento de la bilirrubina &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_64">46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:49.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:50.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_64">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:52.5185em;"><span class="pdf24_14 pdf24_06 pdf24_64">31 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:54.7085em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:49.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:50.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:52.5185em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:54.7085em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_64">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_64">47 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:49.2385em;"><span class="pdf24_14 pdf24_06 pdf24_64">44 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:50.3385em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_64">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:52.5185em;"><span class="pdf24_14 pdf24_06 pdf24_64">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:54.7085em;"><span class="pdf24_14 pdf24_06 pdf24_64">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0183em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0183em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:49.2385em;"><span class="pdf24_14 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:6.472em;top:49.2385em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0232em;">Aumento de la fosfatasa alcalina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:50.3385em;"><span class="pdf24_14 pdf24_06 pdf24_16" style="word-spacing:-0.014em;">Aumento de la glucosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_53" style="word-spacing:-0.0268em;">Disminucin del calcio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:52.5185em;"><span class="pdf24_14 pdf24_06 pdf24_53" style="word-spacing:-0.0266em;">Disminucin de la albmina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_48" style="word-spacing:-0.0224em;">Aumento de potasio &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:50.3385em;"><span class="pdf24_14 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01" style="left:40.9183em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9183em;top:52.5185em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9183em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_64">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9183em;top:54.7085em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:54.7085em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0125em;">Aumento de la creatinina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:55.7985em;"><span class="pdf24_05 pdf24_06 pdf24_144">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:56.8882em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0236em;">Disminucin de la hemoglobina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:57.9882em;"><span class="pdf24_14 pdf24_06 pdf24_16" style="word-spacing:-0.024em;">Disminucin de los linfocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:56.8882em;"><span class="pdf24_14 pdf24_06 pdf24_64">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:57.9882em;"><span class="pdf24_14 pdf24_06 pdf24_64">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:56.8882em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2158em;top:57.9882em;"><span class="pdf24_14 pdf24_06 pdf24_64">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:56.8882em;"><span class="pdf24_14 pdf24_06 pdf24_64">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:57.9882em;"><span class="pdf24_14 pdf24_06 pdf24_64">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2483em;top:56.8882em;"><span class="pdf24_14 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:41.0183em;top:57.9882em;"><span class="pdf24_14 pdf24_06 pdf24_64">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">34 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_34" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_264" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:20.5442em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.0591em;">IMFINZI y Tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3842em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_102">actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6358em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_138">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:8.1318em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0317em;">Anormalidad de Laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1642em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_176">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2058em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_146" style="word-spacing:-0.0663em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.0603em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0543em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5558em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_176">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0083em;top:8.1418em;"><span class="pdf24_05 pdf24_06 pdf24_146" style="word-spacing:-0.0663em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.0603em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.0544em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.8742em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_80">grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:-0.0086em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_17">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_106"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.7458em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:29.1158em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.2758em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_80">grado</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:-0.0086em;"> </span></sup><span class="pdf24_05 pdf24_06 pdf24_169">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_109"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:40.5483em;top:9.2018em;"><span class="pdf24_05 pdf24_06 pdf24_227">(%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_228"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:40.9183em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0319em;">Disminucin de plaquetas &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0246em;">Disminucin de los leucocitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.7142em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.1158em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1158em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9183em;top:11.3118em;"><span class="pdf24_14 pdf24_06 pdf24_64">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.582em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_34" style="word-spacing:0.0068em;">Clasificado segn NCI CTCAE versin 4.03. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.532em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.0038em;">La incidencia de cada prueba se basa en la cantidad de pacientes que tenan disponible una medicin de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4921em;"><span class="pdf24_41 pdf24_06 pdf24_91" style="word-spacing:-0.0121em;">inicial y al menos una durante el estudio: IMFINZI con tremelimumab-actl (rango: 367-378) y sorafenib (rango: 344- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.452em;"><span class="pdf24_41 pdf24_06 pdf24_171">352). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.3118em;"><span class="pdf24_14 pdf24_06 pdf24_263" style="word-spacing:-0.0222em;">Cncer de endometrio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.4343em;"><span class="pdf24_55 pdf24_06 pdf24_31" style="word-spacing:0.0358em;">IMFINZI en combinacin con quimioterapia basada en platino seguida de IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.4843em;"><span class="pdf24_55 pdf24_06 pdf24_34" style="word-spacing:0.0031em;">olaparib 300 mg dos veces al da &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.5843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0673em;">La seguridad de IMFINZI administrado en combinacin con quimioterapia basada en platino seguida de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.6443em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0228em;">IMFINZI en combinacin con olaparib 300 mg dos veces al da se basa en los datos de 238 pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.6943em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0719em;">cncer de endometrio. Las reacciones adversas ms frecuentes (&gt; 20%) fueron anemia (61.8%), nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.7543em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.4522em;">(54.6%), fatiga (54.2%), neuropata perifrica (51.7%), alopecia (50.8%), neutropenia (39.5%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.7943em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.1293em;">estreimiento (32.8%), trombocitopenia (29.8%), diarrea (28.2%), vmitos (25.6%), artralgia (24.4%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.8443em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:-0.0311em;">erupcin (23.5%), dolor abdominal (23.5%), apetito disminuido (23.1%) y leucopenia (20.2%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.9643em;"><span class="pdf24_20 pdf24_06 pdf24_34" style="word-spacing:0.0752em;">Las reacciones adversas ms frecuentes (&gt; 2%) de Grado NCI CTCAE  3 fueron neutropenia (25.2%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.0143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.161em;">anemia (23.5%), leucopenia (6.7%), trombocitopenia (5.9%), fatiga (5.5%), neutropenia febril (3.4%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.0743em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.026em;">nuseas (2.9%), aspartato aminotransferasa elevada/alanina aminotransferasa elevada (2.9%) y neuropata &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.126em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0049em;">perifrica (2.5%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.186em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1036em;">IMFINZI se suspendi en el 4.6% de las pacientes. La reaccin adversa ms comn que dio lugar a la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.236em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0004em;">interrupcin del tratamiento fue neumonitis (1.7%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.346em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0247em;">IMFINZI se interrumpi en el 38.2% de las pacientes. Las reacciones adversas ms frecuentes que dieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.396em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0149em;">lugar a la interrupcin de la dosis fueron anemia (13.4%), trombocitopenia (11.8%), neutropenia (10.1%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.456em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0003em;">leucopenia (2.9%), hipotiroidismo (2.1%) e infeccin del tracto respiratorio superior (2.1%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.566em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0356em;">En la Tabla 19 se muestra la incidencia de las reacciones adversas en pacientes tratados con IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.616em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.2383em;">combinacin con quimioterapia (N=838) y en pacientes tratados con IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.676em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0283em;">quimioterapia basada en platino seguida de IMFINZI en combinacin con olaparib (quimioterapia basada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.726em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0005em;">en platino + IMFINZI + olaparib) (N=238). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.8385em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:0.4995em;">Tabla 19. Reacciones adversas en pacientes tratados con IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.8885em;"><span class="pdf24_05 pdf24_06 pdf24_22" style="word-spacing:-0.0015em;">quimioterapia y Quimioterapia basada en platino + IMFINZI + olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_141" style="word-spacing:-0.0394em;">IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:49.9785em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0358em;">Quimioterapia basada en platino + &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:51.1985em;"><span class="pdf24_05 pdf24_06 pdf24_49" style="word-spacing:-0.014em;">IMFINZI + olaparib</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_80" style="word-spacing:-0.0221em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:51.1985em;"><span class="pdf24_05 pdf24_06 pdf24_57">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.4385em;"><span class="pdf24_05 pdf24_06 pdf24_78" style="word-spacing:-0.0221em;">Infecciones e infestaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.6885em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.9485em;"><span class="pdf24_14 pdf24_06 pdf24_123">Common &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:53.6885em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:-0.0242em;">Infecciones del tracto respiratorio superior</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_210" style="word-spacing:-0.0384em;">a &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:54.9685em;"><span class="pdf24_14 pdf24_06 pdf24_15">Neumona</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_22">b,c</span></sup><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0067em;">, Infecciones del tracto &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:56.1785em;"><span class="pdf24_14 pdf24_06 pdf24_129" style="word-spacing:-0.0107em;">respiratorio superior</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_265">a</span></sup><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.005em;">, Infecciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:57.3882em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0273em;">dentales y de los tejidos blandos de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:58.5882em;"><span class="pdf24_14 pdf24_06 pdf24_72">boca</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_136">d &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:55.5685em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0549em;">Neumona, Candidiasis oral, Infecciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:56.7785em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0002em;">dentales y de los tejidos blandos de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:57.9982em;"><span class="pdf24_14 pdf24_06 pdf24_72">boca</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_136">d &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">35 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_35" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_266" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:13.5517em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_141" style="word-spacing:-0.0394em;">IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:7.2018em;"><span class="pdf24_05 pdf24_06 pdf24_57">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0358em;">Quimioterapia basada en platino + &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:7.2018em;"><span class="pdf24_05 pdf24_06 pdf24_49" style="word-spacing:-0.014em;">IMFINZI + olaparib</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_80" style="word-spacing:-0.0221em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:8.4618em;"><span class="pdf24_14 pdf24_06 pdf24_75">Gripe &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:8.4618em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:8.4618em;"><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:-0.0268em;">Candidiasis oral, Gripe &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:9.7018em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0154em;">Trastornos de la sangre y del sistema linftico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0342em;">Anemia, Leucopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_265">e</span></sup><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0223em;">, Neutropenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_268">f</span></sup><span class="pdf24_14 pdf24_06 pdf24_217">, &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:12.1718em;"><span class="pdf24_14 pdf24_06 pdf24_123">Trombocitopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_269">g &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_74" style="word-spacing:-0.0285em;">Neutropenia febril, Pancitopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_79" style="word-spacing:-0.0452em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_62">Anemia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.052em;">, Leucopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.0776em;">h </span></sup><span class="pdf24_14 pdf24_06 pdf24_132">Neutropenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_80">, &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:12.1718em;"><span class="pdf24_14 pdf24_06 pdf24_75">Trombocitopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_235">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0275em;">Aplasia eritrocitaria pura, Neutropenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:14.6418em;"><span class="pdf24_14 pdf24_06 pdf24_204" style="word-spacing:-0.0927em;">febril </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_167" style="word-spacing:-0.0117em;">, Linfopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_270" style="word-spacing:-0.0185em;">i &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:15.8918em;"><span class="pdf24_14 pdf24_06 pdf24_57">Pancitopenia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_271">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:15.8918em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:15.8918em;"><span class="pdf24_14 pdf24_06 pdf24_127" style="word-spacing:0.0677em;">Trombocitopenia inmune &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:17.1318em;"><span class="pdf24_05 pdf24_06 pdf24_209" style="word-spacing:-0.0262em;">Trastornos del sistema inmunolgico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:18.3818em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:18.3818em;"><span class="pdf24_14 pdf24_06 pdf24_60">Hipersensibilidad</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128">i,j &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:19.6418em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0391em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:20.9043em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:22.1443em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:20.9043em;"><span class="pdf24_14 pdf24_06 pdf24_122">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_197">k &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:20.9043em;"><span class="pdf24_14 pdf24_06 pdf24_122">Hipotiroidismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:22.1443em;"><span class="pdf24_14 pdf24_06 pdf24_84">Hipertiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_34">l</span></sup><span class="pdf24_14 pdf24_06 pdf24_132" style="word-spacing:-0.0447em;">, Tiroiditis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_272" style="word-spacing:-0.0709em;">m &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:23.4043em;"><span class="pdf24_14 pdf24_06 pdf24_143" style="word-spacing:-0.0369em;">Insuficiencia suprarrenal, Diabetes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:24.6243em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0268em;">mellitus tipo 1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:22.1443em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0542em;">Hipertiroidismo, Tiroiditis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:23.4043em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.8643em;"><span class="pdf24_05 pdf24_06 pdf24_149" style="word-spacing:-0.0395em;">Trastornos oculares &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_192">Uveitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_192">Uveitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:28.3743em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.016em;">Trastornos del metabolismo y de la nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:29.6343em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:29.6343em;"><span class="pdf24_14 pdf24_06 pdf24_253" style="word-spacing:-0.0146em;">Apetito disminuido &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:29.6343em;"><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:-0.0168em;">Apetito disminuido</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_233" style="word-spacing:-0.0266em;">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:30.8743em;"><span class="pdf24_05 pdf24_06 pdf24_196" style="word-spacing:-0.0276em;">Trastornos del sistema nervioso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:32.1243em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:34.596em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:32.1243em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.0369em;">Neuropata perifrica</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_23" style="word-spacing:-0.0585em;">n &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:32.1243em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0315em;">Neuropata perifrica, Mareo</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_34">i</span></sup><span class="pdf24_14 pdf24_06 pdf24_61" style="word-spacing:-0.0252em;">, Cefalea</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_273">i</span></sup><span class="pdf24_14 pdf24_06 pdf24_105">, &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:33.3543em;"><span class="pdf24_14 pdf24_06 pdf24_144">Disgeusia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128">i,o &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:34.596em;"><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:-0.0413em;">Miastenia grave &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:35.846em;"><span class="pdf24_05 pdf24_06 pdf24_78" style="word-spacing:-0.0385em;">Trastornos vasculares &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:37.106em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:37.106em;"><span class="pdf24_14 pdf24_06 pdf24_138" style="word-spacing:0.0634em;">Acontecimientos tromboemblicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:38.326em;"><span class="pdf24_14 pdf24_06 pdf24_72">venosos</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128">i,s &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:39.566em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0324em;">Trastornos respiratorios, torcicos y mediastnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_274" style="word-spacing:-0.0037em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:42.086em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0246em;">Tos/Tos productiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:42.086em;"><span class="pdf24_14 pdf24_06 pdf24_57">Neumonitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:40.816em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0267em;">Tos/Tos productiva, Disnea</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_128">i,t &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:42.086em;"><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0394em;">Neumonitis, Disfona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:43.336em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:43.336em;"><span class="pdf24_14 pdf24_06 pdf24_65" style="word-spacing:-0.0328em;">Enfermedad pulmonar intersticial, &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:44.546em;"><span class="pdf24_14 pdf24_06 pdf24_122">Disfona &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:43.336em;"><span class="pdf24_14 pdf24_06 pdf24_65" style="word-spacing:-0.0342em;">Enfermedad pulmonar intersticial &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:45.806em;"><span class="pdf24_05 pdf24_06 pdf24_191" style="word-spacing:-0.0354em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0223em;">Diarrea, Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">u</span></sup><span class="pdf24_14 pdf24_06 pdf24_80">, &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:47.056em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.037em;">Diarrea, Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">u</span></sup><span class="pdf24_14 pdf24_06 pdf24_57" style="word-spacing:-0.0232em;">, Estreimiento</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_80">, &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:48.2685em;"><span class="pdf24_14 pdf24_06 pdf24_08">Nuseas</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_85" style="word-spacing:-0.0546em;">, Vmitos</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0222em;">, Estomatitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_275" style="word-spacing:-0.0353em;">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:49.5185em;"><span class="pdf24_14 pdf24_06 pdf24_202">Dispepsia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_34">i</span></sup><span class="pdf24_14 pdf24_06 pdf24_138" style="word-spacing:-0.0453em;">, Colitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_136" style="word-spacing:-0.0719em;">w &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:48.2685em;"><span class="pdf24_14 pdf24_06 pdf24_143" style="word-spacing:-0.0382em;">Estreimiento, Nuseas, Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:49.5185em;"><span class="pdf24_14 pdf24_06 pdf24_60">Estomatitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_269">v &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:50.7585em;"><span class="pdf24_14 pdf24_06 pdf24_90">Colitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_13">w</span></sup><span class="pdf24_14 pdf24_06 pdf24_233" style="word-spacing:-0.0105em;">, Pancreatitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_276" style="word-spacing:-0.0167em;">x &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:52.0085em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0371em;">Enfermedad celaca</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_192" style="word-spacing:-0.0589em;">r &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:49.5185em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:50.7585em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:52.0085em;"><span class="pdf24_14 pdf24_06 pdf24_277">Rare &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:53.2685em;"><span class="pdf24_05 pdf24_06 pdf24_171" style="word-spacing:-0.0374em;">Trastornos hepatobiliares &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:54.5385em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:54.5385em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0493em;">Aspartato aminotransferasa elevada o &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:54.5385em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0499em;">Aspartato aminotransferasa elevada o &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:55.7385em;"><span class="pdf24_14 pdf24_06 pdf24_53" style="word-spacing:-0.0411em;">Alanina aminotransferasa elevada &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:55.7385em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0407em;">Alanina aminotransferasa elevada</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_59" style="word-spacing:-0.0645em;">y &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:56.9882em;"><span class="pdf24_14 pdf24_06 pdf24_144">Hepatitis</span><sup style="top: -0.3297em;"><span class="pdf24_70 pdf24_06 pdf24_80">c,z &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:56.9882em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:58.2482em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:58.2482em;"><span class="pdf24_14 pdf24_06 pdf24_75">Hepatitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_235">z &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">36 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_36" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_278" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:13.5517em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_141" style="word-spacing:-0.0394em;">IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:7.2018em;"><span class="pdf24_05 pdf24_06 pdf24_57">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0358em;">Quimioterapia basada en platino + &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:7.2018em;"><span class="pdf24_05 pdf24_06 pdf24_49" style="word-spacing:-0.014em;">IMFINZI + olaparib</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_80" style="word-spacing:-0.0221em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:8.4618em;"><span class="pdf24_05 pdf24_06 pdf24_134" style="word-spacing:-0.0136em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:9.7018em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:9.7018em;"><span class="pdf24_14 pdf24_06 pdf24_15">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_265">aa</span></sup><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0352em;">, Alopecia, Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:9.7018em;"><span class="pdf24_14 pdf24_06 pdf24_84">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_265">aa</span></sup><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0515em;">, Alopecia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_110" style="word-spacing:-0.0195em;">, Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_184">Dermatitis</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">bb &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:13.5517em;top:10.9518em;"><span class="pdf24_14 pdf24_06 pdf24_100">Dermatitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:12.2018em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:12.2018em;"><span class="pdf24_14 pdf24_06 pdf24_62">Penfigoide</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_265">cc</span></sup><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0243em;">, Sudores nocturnos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:13.4318em;"><span class="pdf24_14 pdf24_06 pdf24_57">Psoriasis &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:12.2018em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0293em;">Sudores nocturnos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:14.6718em;"><span class="pdf24_05 pdf24_06 pdf24_140" style="word-spacing:-0.0289em;">Trastornos musculoesquelticos y del tejido conjuntivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:15.9218em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:17.1918em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:15.9218em;"><span class="pdf24_14 pdf24_06 pdf24_123">Artralgia &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:15.9218em;"><span class="pdf24_14 pdf24_06 pdf24_279">Artralgia</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_40" style="word-spacing:-0.021em;">, Mialgia &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:18.4218em;"><span class="pdf24_14 pdf24_06 pdf24_184">Miositis &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:17.1918em;"><span class="pdf24_14 pdf24_06 pdf24_60">Mialgia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:18.4218em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:18.4218em;"><span class="pdf24_14 pdf24_06 pdf24_98" style="word-spacing:-0.0484em;">Artritis inmunomediada, Miositis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:19.6843em;"><span class="pdf24_05 pdf24_06 pdf24_118" style="word-spacing:-0.0205em;">Trastornos renales y urinarios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:20.9343em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:20.9343em;"><span class="pdf24_14 pdf24_06 pdf24_134" style="word-spacing:-0.0213em;">Creatinina en sangre elevada &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:22.2043em;"><span class="pdf24_14 pdf24_06 pdf24_52">Disuria &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:23.4443em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0132em;">Cistitis no infecciosa</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_60" style="word-spacing:-0.0209em;">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:22.2043em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:22.2043em;"><span class="pdf24_14 pdf24_06 pdf24_98" style="word-spacing:-0.0252em;">Creatinina en sangre elevada, Disuria &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:23.4443em;"><span class="pdf24_14 pdf24_06 pdf24_263" style="word-spacing:-0.0123em;">Cistitis no infecciosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:23.4443em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.0183em;">Poco frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:24.6943em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0223em;">Trastornos generales y alteraciones en el lugar de administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:25.9543em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0017em;">Muy frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:25.9543em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0364em;">Pirexia, Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">gg</span></sup><span class="pdf24_14 pdf24_06 pdf24_220" style="word-spacing:-0.0153em;">, Edema perifrico</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">hh &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:25.9543em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0392em;">Pirexia, Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15">h</span></sup><span class="pdf24_14 pdf24_06 pdf24_119" style="word-spacing:-0.0157em;">, Edema perifrico</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_203">hh &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:27.2143em;"><span class="pdf24_05 pdf24_06 pdf24_48" style="word-spacing:-0.028em;">Injury, poisoning and procedural complications &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:28.4743em;"><span class="pdf24_14 pdf24_06 pdf24_122">Frecuentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.5517em;top:28.4743em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0178em;">Reaccin asociada a la perfusion</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_273">ii &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.4758em;top:28.4743em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0189em;">Reaccin asociada a la perfusion &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.8245em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0002em;">Las frecuencias de las reacciones adversas no se pueden atribuir exclusivamente a durvalumab, sino tambin pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.7845em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.0043em;">incluir contribuciones de la enfermedad subyacente o de otros medicamentos usados en combinacin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.7445em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.0833em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0431em;">el tratamiento global del estudio con hasta seis ciclos de 21 das con quimioterapia basada en platino en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.7045em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:0.0008em;">con IMFINZI, seguido de IMFINZI en combinacin con olaparib. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.6645em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1395em;">a </span></sup><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0014em;">incluye laringitis, nasofaringitis, absceso periamigdalar, faringitis, rinitis, sinusitis, amigdalitis, traqueobronquitis e &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.6262em;"><span class="pdf24_41 pdf24_06 pdf24_256" style="word-spacing:0.0038em;">infeccin del tracto respiratorio superior. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.5862em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">b </span></sup><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0143em;">incluye neumona por pneumocystis jirovecii, neumona, neumona por adenovirus, neumona bacteriana, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.5362em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0036em;">neumona por citomegalovirus, neumona por haemophilus, neumona neumoccica, neumona &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.4962em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0039em;">estreptoccica, neumona por cndida y neumona por legionela. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.4562em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.121em;">c </span></sup><span class="pdf24_41 pdf24_06 pdf24_21" style="word-spacing:-0.0015em;">incluye desenlace mortal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.4062em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">d </span></sup><span class="pdf24_41 pdf24_06 pdf24_250" style="word-spacing:-0.0077em;">incluye gingivitis, infeccin oral, periodontitis, pulpitis dental, absceso dental e infeccin dental. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.3662em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.121em;">e </span></sup><span class="pdf24_41 pdf24_06 pdf24_38" style="word-spacing:0.0002em;">incluye leucopenia y recuento de leucocitos disminuido. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.3262em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1207em;">f </span></sup><span class="pdf24_41 pdf24_06 pdf24_21" style="word-spacing:-0.0038em;">incluye neutropenia y recuento de neutrfilos disminuido. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.2762em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">g </span></sup><span class="pdf24_41 pdf24_06 pdf24_67" style="word-spacing:-0.0061em;">incluye trombocitopenia y recuento de plaquetas disminuido. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.2462em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">h </span></sup><span class="pdf24_41 pdf24_06 pdf24_146" style="word-spacing:-0.0021em;">la reaccin adversa solo aplica a las reacciones adversas de la quimioterapia en el estudio DUO-E. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.1962em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1388em;">i </span></sup><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:-0.0056em;">la reaccin adversa solo aplica a las reacciones adversas de olaparib en el estudio DUO-E. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.1562em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1203em;">j </span></sup><span class="pdf24_41 pdf24_06 pdf24_31" style="word-spacing:-0.0068em;">incluye hipersensibilidad al medicamento e hipersensibilidad. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.1262em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.0833em;">k </span></sup><span class="pdf24_41 pdf24_06 pdf24_250" style="word-spacing:-0.0266em;">incluye hipotiroidismo autoinmune, hipotiroidismo, hipotiroidismo inmunomediado y tirotropina en sangre elevada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.0546em;"><span class="pdf24_88 pdf24_06 pdf24_15">l</span></div>
					<div class="pdf24_01" style="left:6.532em;top:47.0862em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.2074em;">incluye hipertiroidismo y enfermedad de Basedow, hipertiroidismo inmunomediado y tirotropina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.0487em;"><span class="pdf24_41 pdf24_06 pdf24_144">disminuida. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.9987em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1018em;">m </span></sup><span class="pdf24_41 pdf24_06 pdf24_202" style="word-spacing:-0.0088em;">incluye tiroiditis autoinmune, tiroiditis inmunomediada, tiroiditis y tiroiditis subaguda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.9587em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">n </span></sup><span class="pdf24_41 pdf24_06 pdf24_66" style="word-spacing:-0.0066em;">incluye neuropata perifrica, parestesia y neuropata sensorial perifrica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.9187em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">o </span></sup><span class="pdf24_41 pdf24_06 pdf24_81" style="word-spacing:0.0002em;">incluye disgeusia y trastorno del gusto. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.8571em;"><span class="pdf24_88 pdf24_06 pdf24_15">s</span></div>
					<div class="pdf24_01" style="left:6.592em;top:51.8887em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.2058em;">incluye trombosis venosa profunda, embolia, embolia venosa, trombosis venosa plvica, trombosis de vena &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.8487em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0031em;">superficial y trombosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7987em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1388em;">t </span></sup><span class="pdf24_41 pdf24_06 pdf24_31" style="word-spacing:-0.0012em;">incluye disnea y disnea de esfuerzo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.7587em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1389em;">u </span></sup><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0032em;">incluye dolor abdominal, dolor en la zona inferior del abdomen, dolor en la zona superior del abdomen y dolor en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.7187em;"><span class="pdf24_41 pdf24_06 pdf24_192">flanco. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6787em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">v </span></sup><span class="pdf24_41 pdf24_06 pdf24_129" style="word-spacing:-0.0047em;">incluye estomatitis e inflamacin de mucosa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6384em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">w </span></sup><span class="pdf24_41 pdf24_06 pdf24_31" style="word-spacing:-0.0013em;">incluye colitis, enteritis, enterocolitis y proctitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.5984em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">x </span></sup><span class="pdf24_41 pdf24_06 pdf24_67" style="word-spacing:-0.005em;">incluye pancreatitis y pancreatitis aguda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">37 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_37" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANaklEQVR4nO3DsQmDQBQA0A/WyQIptBXrtCGDCBnEwj1sXNU/Qoh35JD34EUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAB8Y8u7NrQLAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADgn+b80cLHAACACl75rYU/AgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAoElLXtXTnwEAQHV9HtTTbwEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEBVS1618HsAAEAFfR608C4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACatOXdy58CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA+MUBwwDwXu0UNVAAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_280" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0088em;"><span class="pdf24_88 pdf24_06 pdf24_15">y</span></div>
					<div class="pdf24_01" style="left:6.652em;top:6.042em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.2083em;">incluye alanina aminotransferasa elevada, aspartato aminotransferasa elevada, enzimas hepticas elevadas y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.002em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0044em;">transaminasas elevadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.9205em;"><span class="pdf24_88 pdf24_06 pdf24_15">z</span></div>
					<div class="pdf24_01" style="left:6.582em;top:7.952em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.1514em;">incluye hepatitis, hepatitis autoinmune, hepatitis txica, dao hepatocelular, hepatitis aguda, hepatotoxicidad y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.912em;"><span class="pdf24_41 pdf24_06 pdf24_13" style="word-spacing:-0.0072em;">hepatitis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.872em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_250" style="word-spacing:0.1383em;">aa </span></sup><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0012em;">incluye erupcin eritematosa, erupcin macular, erupcin maculopapular, erupcin papular, erupcin pruriginosa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.832em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:0.0006em;">erupcin pustular, eritema, eccema y erupcin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.782em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">bb </span></sup><span class="pdf24_41 pdf24_06 pdf24_32" style="word-spacing:-0.0062em;">incluye dermatitis y dermatitis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.7205em;"><span class="pdf24_88 pdf24_06 pdf24_250">cc &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.832em;top:12.752em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.1663em;">incluye penfigoide, dermatitis bullosa y pnfigo. La frecuencia notificada de los ensayos clnicos en curso y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.712em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0048em;">finalizados es poco frecuente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.662em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">gg </span></sup><span class="pdf24_41 pdf24_06 pdf24_141" style="word-spacing:0.0059em;">incluye fatiga y astenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.622em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">hh </span></sup><span class="pdf24_41 pdf24_06 pdf24_39" style="word-spacing:-0.0023em;">incluye edema perifrico e hinchazn perifrico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.592em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_279" style="word-spacing:0.1204em;">ii </span></sup><span class="pdf24_41 pdf24_06 pdf24_84" style="word-spacing:0em;">incluye reaccin asociada a la perfusin y urticaria con inicio en el da de la administracin o 1 da despus. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.5918em;"><span class="pdf24_55 pdf24_06 pdf24_18" style="word-spacing:-0.0436em;">Descripcin de reacciones adversas seleccionadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7043em;"><span class="pdf24_55 pdf24_06 pdf24_50" style="word-spacing:-0.0056em;">Neumonitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0528em;">En el estudio DUO-E, de las 238 pacientes tratadas con quimioterapia basada en platino en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8643em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.0572em;">con IMFINZI, seguida de IMFINZI en combinacin con olaparib (brazo de quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0299em;">+ IMFINZI + olaparib), se produjo neumonitis inmunomediada en 5 (2,1%) pacientes, que fueron de Grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.9743em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0223em;">3 en 3 (1,3%) pacientes. La mediana del tiempo hasta la aparicin fue de 85 das (intervalo: 65-321 das). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0131em;">Cinco pacientes recibieron corticosteroides sistmicos, de las cuales 4 pacientes recibieron tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.0743em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0352em;">corticosteroides en dosis altas (al menos 40 mg de prednisona o equivalente por da). Hubo resolucin en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1343em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0021em;">las 5 pacientes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2443em;"><span class="pdf24_55 pdf24_06 pdf24_215" style="word-spacing:-0.0295em;">Erupcin inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0528em;">En el estudio DUO-E, de las 238 pacientes tratadas con quimioterapia basada en platino en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.406em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:-0.0584em;">con IMFINZI, seguida de IMFINZI en combinacin con olaparib (brazo de quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.456em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.031em;">+ IMFINZI + olaparib), se produjo erupcin inmunomediada en 8 (3,4%) pacientes, que fueron de Grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.516em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.0213em;">3 en 2 (0,8%) pacientes. La mediana del tiempo hasta la aparicin fue de 155 das (intervalo: 2-308 das). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.566em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2589em;">Todas las pacientes recibieron tratamiento con corticosteroides en dosis altas (al menos 40 mg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.626em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0022em;">prednisona o equivalente por da). Hubo resolucin en las 8 pacientes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.736em;"><span class="pdf24_55 pdf24_06 pdf24_140" style="word-spacing:-0.0266em;">Reacciones asociadas a la perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.836em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0013em;">En el estudio DUO-E, de las 238 pacientes tratadas con quimioterapia basada en platino en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.896em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.057em;">con IMFINZI, seguida de IMFINZI en combinacin con olaparib (brazo de quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.946em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0044em;">+ IMFINZI + olaparib), se produjeron reacciones asociadas a la perfusin en 13 (5,5%) pacientes, que fue &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.996em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0031em;">de Grado 3 en 1 (0,4%) paciente. No hubo acontecimientos de Grado 4 o 5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1085em;"><span class="pdf24_55 pdf24_06 pdf24_96" style="word-spacing:-0.0347em;">Aplasia eritrocitaria pura &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2185em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0449em;">La aplasia eritrocitaria pura (AEP) se ha notificado cuando IMFINZI se ha utilizado en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.2685em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.317em;">olaparib. En un ensayo clnico de pacientes con cncer de endometrio tratadas con IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.3285em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0546em;">combinacin con olaparib, la incidencia de AEP fue del 1,6%. Todos los acontecimientos fueron de CTCAE &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.3785em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0599em;">Grado 3 o 4. Los acontecimientos fueron manejables tras la interrupcin de IMFINZI y olaparib. La mayora &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.4385em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0337em;">de los acontecimientos fueron tratados con transfusin de sangre e inmunosupresin y se recuperaron; no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4885em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0019em;">hubo acontecimientos mortales. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5982em;"><span class="pdf24_55 pdf24_06 pdf24_210" style="word-spacing:-0.0409em;">Anomalas analticas &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">38 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_38" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANiUlEQVR4nO3VMQoCQQxA0dgIYmcpgmJjZWUvexBhzyEWnsvKo41zhC2U2YnvwT9AICERAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAZGWQJHXVJgDgP5VFbZQkddWu9fcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD4rnKrjVLCVq2vi56U0wx2VsrYpfV1A+mUa22QErYMmKxsZ7CzUsaOAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD0YF87KG3rAACARB61p9J2DgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgtVft3bj7z6cEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKC9D7TfN/tnOYY3AAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_281" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0678em;">En las pacientes tratadas con quimioterapia basada en platino en combinacin con IMFINZI, seguida de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0088em;">IMFINZI, ya sea en monoterapia (brazo de quimioterapia basada en platino + IMFINZI) o en combinacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0059em;">con olaparib (brazo de quimioterapia basada en platino + IMFINZI + olaparib), la proporcin de pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1015em;">que experimentaron un cambio desde el valor basal hasta una anomala analtica de Grado 3 o 4 fue la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0315em;">siguiente en el brazo de quimioterapia basada en platino + IMFINZI: 3,5% para la alanina aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0191em;">elevada, 3,0% para la aspartato aminotransferasa elevada y 0,4% para la creatinina en sangre elevada, y fue &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0764em;">la siguiente en el brazo de quimioterapia basada en platino + IMFINZI + olaparib: 3,8% para la alanina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0952em;">aminotransferasa elevada, 3,4% para la aspartato aminotransferasa elevada y 1,7% para la creatinina en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0167em;">sangre elevada. La proporcin de pacientes que presentaron una variacin de la TSH con respecto al valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:-0.0128em;">basal que fue de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0101em;">LSN a &gt; LSN correspondi al 27,2% y los que presentaron una variacin de la TSH con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0207em;">respecto al valor basal que fue de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:-0.017em;">LIN a &lt; LIN fue 24,3% en el brazo de quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0774em;">+ IMFINZI y la proporcin de pacientes que presentaron una variacin de la TSH con respecto al valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0157em;">basal que fue de </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0151em;">LSN a &gt; LSN fue del 28,6% y los que presentaron una variacin de la TSH con respecto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_20 pdf24_06 pdf24_71" style="word-spacing:0.0689em;">al valor basal que fue de  LIN a &lt; LIN fue de 20,1% en el brazo de quimioterapia basada en platino + &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0025em;">IMFINZI + olaparib. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:23.9043em;"><span class="pdf24_12 pdf24_06 pdf24_26">8.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.3617em;top:23.9043em;"><span class="pdf24_05 pdf24_06 pdf24_140" style="word-spacing:-0.0207em;">Reporte de sospecha de eventos adversos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0043em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0832em;">Para Per: Reportar a travs de la website </span><a href="https://contactazmedical.astrazeneca.com/content/astrazeneca-champion/br/pt/amp-form.html" target="_blank"><span class="pdf24_282 pdf24_06 pdf24_22">https://contactazmedical.astrazeneca.com/content/astrazeneca- &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0543em;"><a href="https://contactazmedical.astrazeneca.com/content/astrazeneca-champion/br/pt/amp-form.html" target="_blank"><span class="pdf24_282 pdf24_06 pdf24_39">champion/br/pt/amp-form.html</span></a><a href="https://contactazmedical.astrazeneca.com/content/astrazeneca-champion/br/pt/amp-form.html" target="_blank"><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0em;">, </span></a><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0084em;">por correo electrnico </span><a href="mailto:patientsafety.peru@astrazeneca.com" target="_blank"><span class="pdf24_282 pdf24_06 pdf24_19" style="word-spacing:0.0195em;">patientsafety.peru@astrazeneca.com </span></a><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0057em;">o por telfono &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1143em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0007em;">al 6101515 (presione 1 y luego presione 3). &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:30.2243em;"><span class="pdf24_12 pdf24_06 pdf24_13">9. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.272em;top:32.2743em;"><span class="pdf24_12 pdf24_06 pdf24_26">9.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:30.2243em;"><span class="pdf24_05 pdf24_06 pdf24_137" style="word-spacing:-0.0261em;">USO EN POBLACIONES ESPECFICAS &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5717em;top:32.2743em;"><span class="pdf24_05 pdf24_06 pdf24_231">Embarazo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.386em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0186em;">Resumen de Riesgos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.496em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1148em;">Segn su mecanismo de accin y los datos de estudios en animales, IMFINZI puede causar dao fetal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.546em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0028em;">cuando se administra a una mujer embarazada </span><span class="pdf24_55 pdf24_06 pdf24_31" style="word-spacing:0.0067em;">[consulte Farmacologa Clnica]</span><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0033em;">. No hay datos disponibles &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.606em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0003em;">sobre el uso de IMFINZI en mujeres embarazadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.656em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0035em;">En estudios de reproduccin en animales, la administracin de durvalumab a monas cynomolgus preadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.716em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0239em;">desde la confirmacin del embarazo hasta el parto a niveles de exposicin aproximadamente 6 a 20 veces &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.766em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0426em;">superiores a los observados a la dosis clnica de 10 mg/kg basada en el rea bajo la curva (AUC, por sus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.816em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0762em;">siglas en ingls), dio como resultado un aumento en el parto prematuro, prdida fetal y muerte neonatal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.876em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0276em;">prematura </span><span class="pdf24_55 pdf24_06 pdf24_71" style="word-spacing:-0.0259em;">(ver Datos). </span><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0276em;">Se sabe que la inmunoglobulina humana G1 (IgG1) cruza la barrera placentaria; por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.926em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1048em;">lo tanto, durvalumab tiene el potencial de transmitirse de la madre al feto en desarrollo. Advierta a las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.986em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.003em;">mujeres embarazadas del riesgo potencial para el feto. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.036em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0838em;">En la poblacin general de los EE. UU., el riesgo de fondo estimado de defectos congnitos mayores y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.0985em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0063em;">aborto involuntario en embarazos clnicamente reconocidos es de 2 a 4% y de 15 a 20%, respectivamente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2085em;"><span class="pdf24_14 pdf24_06 pdf24_127">Datos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.3085em;"><span class="pdf24_55 pdf24_06 pdf24_78" style="word-spacing:-0.0075em;">Datos de Animales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.3685em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0945em;">Como se reporta en la literatura, la va PD-1/PD-L1 desempea un papel central en la preservacin del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.4185em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.017em;">embarazo al mantener la tolerancia inmune materna al feto. En modelos de embarazo alognico en ratones, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4685em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0342em;">se demostr que la interrupcin de la sealizacin de PD-L1 produce un aumento de la prdida fetal. Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.5285em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0717em;">efectos de durvalumab en el desarrollo prenatal y postnatal se evaluaron en estudios de reproduccin en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5782em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0254em;">monos cynomolgus. Durvalumab se administr desde la confirmacin del embarazo hasta el parto a niveles &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.6382em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0033em;">de exposicin aproximadamente 6 a 20 veces ms altos que los observados a la dosis clnica de 10 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">39 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
					<div style="position:absolute;left:0em;top:0em;width:0em;height:0em;">
						<a href="https://contactazmedical.astrazeneca.com/content/astrazeneca-champion/br/pt/amp-form.html" target="_blank">
							<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAAC0lEQVR4nGNgAAIAAAUAAXpeqz8AAAAASUVORK5CYII=" class="pdf24_grlink" />
						</a>
					</div>
				</div>
			</div>
		</div>
		<div id="page_39" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANa0lEQVR4nO3RwQkCQRBE0cabePU+k4C5GI4wh8nDi6naIQiLO0vve/ADKCoCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOK6WdZXtFgAAUMjIpsr2CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAWGFkc3HPv68EAABKaFlf3H3zCgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgMN7Zx+V7xUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAnFzLunbpEgAAwCYjm9ql64+fAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAwMl9AT+U5F4wjqShAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_283" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1407em;">(segn el AUC). La administracin de durvalumab result en parto prematuro, prdida fetal (aborto y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0204em;">muerte fetal) y un aumento de las muertes neonatales. Durvalumab se detect en suero infantil en el da 1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0571em;">posparto, lo que indica la presencia de transferencia placentaria de durvalumab. Segn su mecanismo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.4903em;">accin, la exposicin fetal al durvalumab puede aumentar el riesgo de desarrollar trastornos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.5114em;">inmunomediados o alterar la respuesta inmunitaria normal, y se ha informado de trastornos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.001em;">inmunomediados en ratones knockout PD-1. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:14.4119em;"><span class="pdf24_12 pdf24_06 pdf24_26">9.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:14.4119em;"><span class="pdf24_05 pdf24_06 pdf24_57">Lactancia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5118em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0186em;">Resumen de Riesgos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.5718em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0397em;">No hay informacin sobre la presencia de durvalumab en la leche humana, los efectos sobre el lactante o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6218em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0078em;">los efectos sobre la produccin de leche. La IgG humana se excreta en la leche humana. Se desconocen los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.6843em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1577em;">efectos de la exposicin local gastrointestinal y la exposicin sistmica limitada en el nio lactante a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7343em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0046em;">IMFINZI. Durvalumab estuvo presente en la leche de monos cynomolgus lactantes y se asoci con muerte &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7943em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0026em;">neonatal prematura </span><span class="pdf24_55 pdf24_06 pdf24_38" style="word-spacing:-0.0065em;">(ver Datos). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9043em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0553em;">Debido a la posibilidad de reacciones adversas en lactantes amamantados, aconseje a las mujeres que no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9543em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0em;">amamanten durante el tratamiento con IMFINZI y durante 3 meses despus de la ltima dosis. Consulte la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0043em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0647em;">informacin para prescribir de los agentes administrados en combinacin con IMFINZI para la duracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0643em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0002em;">recomendada de no amamantar, segn sea apropiado. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1743em;"><span class="pdf24_14 pdf24_06 pdf24_127">Datos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0631em;">En monos cynomolgus lactantes, durvalumab estuvo presente en la leche materna a aproximadamente el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2743em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1848em;">0.15% de las concentraciones sricas maternas despus de la administracin de durvalumab desde la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3343em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0059em;">confirmacin del embarazo hasta el parto a niveles de exposicin aproximadamente 6 a 20 veces ms altos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0324em;">que los observados en la dosis clnica recomendada de 10 mg/kg (basado en AUC). La administracin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.446em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0018em;">durvalumab result en muerte neonatal prematura. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:37.546em;"><span class="pdf24_12 pdf24_06 pdf24_26">9.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:37.546em;"><span class="pdf24_05 pdf24_06 pdf24_48" style="word-spacing:-0.0218em;">Mujeres y Hombres de Potencial Reproductivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.656em;"><span class="pdf24_14 pdf24_06 pdf24_65" style="word-spacing:-0.0196em;">Pruebas de embarazo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.716em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0003em;">Verificar el estado de embarazo de las mujeres con potencial reproductivo antes de iniciar el tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.766em;"><span class="pdf24_14 pdf24_06 pdf24_164" style="word-spacing:0.0056em;">con IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.886em;"><span class="pdf24_14 pdf24_06 pdf24_144">Anticoncepcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.986em;"><span class="pdf24_55 pdf24_06 pdf24_79">Mujeres &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.036em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2466em;">IMFINZI puede causar dao fetal cuando se administra a una mujer embarazada [</span><span class="pdf24_55 pdf24_06 pdf24_143" style="word-spacing:0.2523em;">consulte Uso en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.0985em;"><span class="pdf24_55 pdf24_06 pdf24_39" style="word-spacing:0.3953em;">poblaciones especficas</span><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.3914em;">]. Aconsejar a las mujeres con potencial reproductivo que usen mtodos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.1485em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0303em;">anticonceptivos efectivos durante el tratamiento con IMFINZI y durante 3 meses despus de la ltima dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.1985em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1014em;">de IMFINZI. Consulte la informacin para prescribir de los agentes administrados en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.2585em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0002em;">IMFINZI para la duracin recomendada de la anticoncepcin, segn sea apropiado. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:54.3685em;"><span class="pdf24_12 pdf24_06 pdf24_26">9.4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:54.3685em;"><span class="pdf24_05 pdf24_06 pdf24_52" style="word-spacing:-0.0011em;">Uso Peditrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4785em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1203em;">La seguridad y efectividad de IMFINZI no ha sido establecida en pacientes peditricos. En un estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5282em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.064em;">multicntrico, abierto (NCT03837899) en 45 pacientes peditricos de 1 a &lt; 17 aos con tumores slidos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.5882em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0269em;">avanzados, se evalu la seguridad y la eficacia, pero esta no fue establecida. Los 45 pacientes recibieron al &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">40 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_40" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0487em;">menos una dosis nica de IMFINZI y 41 pacientes recibieron IMFINZI en combinacin con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.001em;">actl. No se observaron nuevas seales de seguridad en pacientes peditricos en este estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_20 pdf24_06 pdf24_33" style="word-spacing:0.054em;">La exposicin sistmica a durvalumab en pacientes peditricos que pesan  35 kg se encontr dentro del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1319em;">rango de valores observados previamente en adultos que recibieron la misma dosis basada en el peso, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.042em;">mientras que la exposicin sistmica en pacientes peditricos que pesan &lt; 35 kg fue menor que la observada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0029em;">en adultos. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:14.4119em;"><span class="pdf24_12 pdf24_06 pdf24_26">9.5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:14.4119em;"><span class="pdf24_05 pdf24_06 pdf24_100" style="word-spacing:-0.0012em;">Uso Geritrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5118em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0164em;">De los 401 pacientes con CPCNP resecable tratados con IMFINZI en combinacin con quimioterapia en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.5718em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0189em;">estudio AEGEAN, 209 (52 %) pacientes tenan 65 aos o ms, y 49 (12 %) pacientes tenan 75 aos o ms. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6218em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:-0.0201em;">No hubo diferencias generales clnicamente significativas en la seguridad o efectividad entre los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.6843em;"><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0112em;">65 aos y los pacientes ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7843em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0207em;">De los 476 pacientes con CPCNP no resecable en estadio III tratados con IMFINZI en el estudio PACIFIC, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8443em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.1286em;">el 45% tena 65 aos o ms, mientras que el 7.6% tena 75 aos o ms. No se observaron diferencias &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8943em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.012em;">generales en seguridad o efectividad entre pacientes de 65 aos o ms y pacientes ms jvenes. El estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9543em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0154em;">PACIFIC no incluy un nmero suficiente de pacientes de 75 aos o ms para determinar si responden de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0043em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0025em;">manera diferente a los pacientes ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1143em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0295em;">De los 330 pacientes con CPCNP metastsico tratados con IMFINZI en combinacin con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1643em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0771em;">actl y quimioterapia basada en platino, 143 (43%) pacientes tenan 65 aos o ms y 35 (11%) pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2243em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2065em;">tenan 75 aos o ms. No hubo diferencias clnicamente significativas en seguridad o eficacia entre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2743em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.001em;">pacientes de 65 aos o ms y pacientes ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3843em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0836em;">De los 262 pacientes con CPCP-EL tratados con IMFINZI, 103 (39%) tenan 65 aos o ms y 15 (6%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.446em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.098em;">tenan 75 aos o ms. No hubo diferencias clnicamente significativas en seguridad y eficacia entre los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.496em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0004em;">pacientes de 65 aos o ms y los pacientes ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.596em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0041em;">De los 265 pacientes con CPCP-EE tratados con IMFINZI en combinacin con quimioterapia, 101 (38 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.656em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2049em;">pacientes tenan 65 aos o ms y 19 (7.2 %) pacientes tenan 75 aos o ms. No hubo diferencias &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.706em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0064em;">clnicamente significativas en la seguridad o eficacia entre los pacientes de 65 aos o ms y pacientes mas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.766em;"><span class="pdf24_14 pdf24_06 pdf24_23">jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.886em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.11em;">De los 338 pacientes con CVB tratados con IMFINZI en combinacin con quimioterapia en el estudio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.936em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0502em;">TOPAZ-1, 158 (47%) pacientes tenan 65 aos o ms y 38 (11%) pacientes tenan 75 aos o ms. No se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.986em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0393em;">han observado diferencias globales en la seguridad o efectividad de IMFINZI entre los pacientes de 65 aos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.046em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0029em;">o ms y los pacientes adultos ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1485em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0105em;">De los 393 pacientes con CHC irresecable tratados con IMFINZI en combinacin con tremelimumab-actl, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.1985em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0204em;">el 50 % de los pacientes tenan 65 aos o ms y el 13 % de los pacientes tenan 75 aos o ms. No se han &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2585em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0051em;">observado diferencias generales en la seguridad o eficacia de IMFINZI entre pacientes de 65 aos de edad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3085em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0005em;">y pacientes adultos mayores y jvenes. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:53.3975em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.4665em;">10. </span><span class="pdf24_05 pdf24_06 pdf24_109">DESCRIPCIN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4785em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.3694em;">Durvalumab es un anticuerpo bloqueador del ligando 1 de muerte celular programada (PD-L1). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.5285em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0284em;">Durvalumab es </span><span class="pdf24_20 pdf24_06 pdf24_33" style="word-spacing:0.0235em;">un anticuerpo monoclonal de inmunoglobulina humana G1 kappa (IgG1) que se produce &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5882em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0393em;">mediante tecnologa de ADN recombinante en cultivos en suspensin de clulas de ovario de hmster chino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.6382em;"><span class="pdf24_14 pdf24_06 pdf24_251">(CHO). &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">41 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_41" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:7.0918em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.2078em;">IMFINZI (durvalumab) Inyectable para uso intravenoso es una solucin estril, sin conservantes, de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.001em;">transparente a opalescente, de incolora a ligeramente amarilla, libre de partculas visibles. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0069em;">Cada vial de 500 mg de IMFINZI contiene 500 mg de durvalumab en 10 ml de solucin. Cada ml contiene &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.1145em;">durvalumab, 50 mg, L-histidina (2 mg), clorhidrato de L-</span><span class="pdf24_20 pdf24_06 pdf24_62" style="word-spacing:0.1121em;">histidina monohidrato (2,7 mg), ,</span><span class="pdf24_14 pdf24_06 pdf24_140">-trehalosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0004em;">dihidrato (104 mg), polisorbato 80 (0,2 mg) y agua para inyeccin, USP . &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:-0.017em;">Cada vial de 120 mg de IMFINZI contiene 120 mg de durvalumab en 2,4 ml de solucin. Cada ml contiene &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.1145em;">durvalumab, 50 mg, L-histidina (2 mg), clorhidrato de L-</span><span class="pdf24_20 pdf24_06 pdf24_62" style="word-spacing:0.1121em;">histidina monohidrato (2,7 mg), ,</span><span class="pdf24_14 pdf24_06 pdf24_140">-trehalosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0004em;">dihidrato (104 mg), polisorbato 80 (0,2 mg) y agua para inyeccin, USP . &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:19.4908em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.4665em;">11. </span><span class="pdf24_05 pdf24_06 pdf24_40" style="word-spacing:0.0258em;">FARMACOLOGA CLNICA &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:21.5743em;"><span class="pdf24_12 pdf24_06 pdf24_240">11.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:21.5743em;"><span class="pdf24_05 pdf24_06 pdf24_73" style="word-spacing:-0.0195em;">Mecanismo de Accin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.1243em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2668em;">La expresin del ligando-1 de muerte celular programada (PD-L1) puede ser inducida por seales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.1743em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0735em;">inflamatorias (por ejemplo, IFN-gamma) y puede expresarse tanto en clulas tumorales como en clulas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.2343em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0219em;">inmunes asociadas a tumores en el microambiente tumoral. PD-L1 bloquea la funcin y la activacin de las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.2843em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0285em;">clulas T a travs de la interaccin con PD-1 y CD80 (B7.1). Al unirse a sus receptores, PD-L1 reduce la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.3443em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.001em;">actividad de las clulas T citotxicas, la proliferacin y la produccin de citocinas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.4543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0317em;">Durvalumab es un anticuerpo monoclonal de inmunoglobulina G1 kappa </span><span class="pdf24_20 pdf24_06 pdf24_83" style="word-spacing:-0.0337em;">(IgG1) </span><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0333em;">humana que se une a PD- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.5043em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0439em;">L1 y bloquea la interaccin de PD-L1 con PD-1 y CD80 (B7.1). El bloqueo de las interacciones PD-L1 / &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.5543em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1339em;">PD-1 y PD-L1 / CD80 libera la inhibicin de las respuestas inmunes, sin inducir citotoxicidad celular &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.6143em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0004em;">dependiente de anticuerpos (ADCC). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.726em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0174em;">El bloqueo de PD-L1 con durvalumab condujo a un aumento de la activacin de las clulas T in vitro y una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.776em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.066em;">disminucin del tamao del tumor en modelos de ratn xenoinjerto de clulas inmunes y tumor humano &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.826em;"><span class="pdf24_14 pdf24_06 pdf24_60">coinjerto. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:39.936em;"><span class="pdf24_12 pdf24_06 pdf24_240">11.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:39.936em;"><span class="pdf24_05 pdf24_06 pdf24_167">Farmacodinmica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.496em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0102em;">El AUC, Cvalle (o Ctrough en ingls)</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.1824em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0068em;">y Cmax en estado estacionario en pacientes administrados con 1500 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.546em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0382em;">mg cada 4 semanas son 6% ms altos, 19% menores y 55% superiores a los administrados con 10 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.596em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0164em;">cada 2 semanas, respectivamente. Basndose en el modelado de los datos farmacocinticos y las relaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1595em;">de exposicin para la seguridad, no hay diferencias clnicamente significativas en cuanto a eficacia y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.706em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0836em;">seguridad para las dosis de 1500 mg cada 4 semanas en comparacin con 10 mg/kg cada 2 semanas en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.766em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.003em;">pacientes que pesan &gt; 30 kg</span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.1937em;">&nbsp;</span><span class="pdf24_14 pdf24_06 pdf24_165">CPCNP. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:49.8685em;"><span class="pdf24_12 pdf24_06 pdf24_240">11.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:49.8685em;"><span class="pdf24_05 pdf24_06 pdf24_72">Farmacocintica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4285em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0039em;">La farmacocintica de durvalumab como agente nico se estudi en pacientes con dosis que van desde 0.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4785em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1171em;">mg/kg (0.01 veces la dosis recomendada recomendada) hasta 20 mg/kg (2 veces la dosis recomendada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.5285em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0016em;">aprobada) administrados una vez cada dos, tres o cuatro semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6385em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.2248em;">La exposicin a PK aument ms de una dosis proporcional a dosis &lt;3 mg/kg (0.3 veces la dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6985em;"><span class="pdf24_20 pdf24_06 pdf24_18" style="word-spacing:0.0215em;">recomendada aprobada) y dosis proporcional a dosis  3 mg/kg cada 2 semanas. El estado estacionario se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.7482em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0001em;">logr aproximadamente a las 16 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">42 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_42" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANWElEQVR4nO3QsQmAQBAAwQtNTE19sCtbMfi6jGzNyxUUHlFwBraBjQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAoMGSVZ02N3wFAAAeMGZFpw0BAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAFfGrOhQFwAAwOcsWdWhqWUqAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA8GNrtkk36gMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAXrUD2XW/4QKHHhkAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_284" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0229em;">La farmacocintica de durvalumab es similar cuando se evala como un agente nico, cuando se combina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.065em;">con quimioterapia, cuando se combina con tremelimumab-actl y cuando se combina con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.1516em;">actl y en combinacin con quimioterapia basada en platino seguido de IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_185">olaparib. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_75">Distribucin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.001em;">La media geomtrica (% coeficiente de variacin [CV%]) volumen de distribucin en estado estacionario &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.002em;">(Vss) fue 5.6 (18%) L. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_122">Eliminacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0134em;">El aclaramiento de durvalumab disminuye con el tiempo, con una reduccin mxima media (CV%) de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1631em;">valores basales de aproximadamente el 23% (57%) que resulta en un aclaramiento medio geomtrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1319em;">(CV%) de estado estacionario (CLss) de 8 ml / h (39%) en el da 365; la disminucin de CLss no se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0086em;">considera clnicamente relevante. La vida media terminal geomtrica media (CV%), basada en la CL basal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.002em;">fue de aproximadamente 21 (26%) das. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0377em;">Poblaciones Especficas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0367em;">No hubo diferencias clnicamente significativas en la farmacocintica de durvalumab en funcin del peso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0024em;">corporal (31 a 175 kg), la edad (18 a 96 aos), el sexo, la raza (blanca, negra, asitica, nativa de Hawai, de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1329em;">las islas del Pacfico o nativo americano), los niveles de albmina (4 a 57 g/L), los niveles de lactato &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0056em;">deshidrogenasa (18 a 15800 U/L), PD-L1 soluble (67 a 3470 pg/mL), tipo de tumor (CPCNP, CPCP, CVB &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0191em;">y CHC),insuficiencia renal de leve omoderada (CLcr de 30 a 89 ml/min)e insuficiencia heptica de leve a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_20 pdf24_06 pdf24_50" style="word-spacing:0.0458em;">moderada (bilirrubina  3x ULN y cualquier AST).Se desconoce el efecto de la insuficiencia renal grave &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0219em;">(CLcr 15 a 29 ml/min) o de la insuficiencia heptica grave (bilirrubina &gt; 3x ULN y cualquier AST) sobre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3343em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.005em;">la farmacocintica de durvalumab &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:34.446em;"><span class="pdf24_12 pdf24_06 pdf24_240">11.4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:34.446em;"><span class="pdf24_05 pdf24_06 pdf24_132">Inmunogenicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.996em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0317em;">La incidencia observada de anticuerpos anti-frmaco (ADA) depende en gran medida de la sensibilidad y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.046em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0076em;">especificidad del ensayo. Las diferencias en los mtodos de ensayo impiden una comparacin significativa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.106em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0522em;">de la incidencia de ADA en los estudios descritos a continuacin con la incidencia de ADA en otros estudios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.156em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0056em;">incluyendo los de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.266em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.1647em;">Durante el perodo de tratamiento de 10 a 48 semanas en los estudios clnicos PACIFIC, CASPIAN, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.316em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0436em;">TOPAZ-1, HIMALAYA, POSEIDON, DUO-E, AEGEAN y otros, en pacientes que recibieron IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.376em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0516em;">en dosis de 1500 mg cada 4 semanas, 10 mg/kg cada 2 semanas, 20 mg/kg cada 4 semanas como agente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.426em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0326em;">nico, 1120 mg cada 3 semanas o 1500 mg cada 3 semanas en las terapias combinadas, el 3.2 % (151/4668) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.486em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0421em;">de los pacientes evaluados dieron positivo para anticuerpos anti-durvalumab, y el 19.2 % (29/151) de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.536em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.097em;">pacientes con ADA positivo tuvieron anticuerpos neutralizantes contra durvalumab. No se identificaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.5985em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.005em;">efectos clnicamente significativos de los ADA sobre la farmacocintica o la seguridad de durvalumab; sin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.6485em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0014em;">embargo, se desconoce el efecto de estos ADA sobre la eficacia de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:50.7375em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.7231em;">12. </span><span class="pdf24_05 pdf24_06 pdf24_147" style="word-spacing:-0.0335em;">TOXICOLOGA NO CLNICA &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:52.8085em;"><span class="pdf24_12 pdf24_06 pdf24_240">12.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:52.8085em;"><span class="pdf24_05 pdf24_06 pdf24_143" style="word-spacing:-0.0288em;">Carcinognesis, Mutagnesis, deterioro de la fertilidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.3685em;"><span class="pdf24_14 pdf24_06 pdf24_143" style="word-spacing:-0.0174em;">No se ha evaluado el potencial carcinognico y genotxico de durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4185em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1102em;">No se han realizado estudios de fertilidad animal con durvalumab. En estudios de toxicologa de dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4685em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0465em;">repetidas con durvalumab en monos cynomolgus sexualmente maduros de hasta 3 meses de duracin, no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5282em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0001em;">hubo efectos notables en los rganos reproductores masculinos y femeninos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">43 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_43" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:6.0318em;"><span class="pdf24_12 pdf24_06 pdf24_240">12.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:6.0318em;"><span class="pdf24_05 pdf24_06 pdf24_98" style="word-spacing:-0.0385em;">Toxicologa y/o Farmacologa Animal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.5818em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.1416em;">En modelos animales, la inhibicin de la sealizacin PD-L1 / PD-1 aument la gravedad de algunas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.6418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.3329em;">infecciones y mejor las respuestas inflamatorias. Los ratones knockout PD-1 infectados con M. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.6918em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0472em;">tuberculosis presentan una supervivencia marcadamente disminuida en comparacin con los controles de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.7518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0609em;">tipo salvaje, lo que se correlacion con una mayor proliferacin bacteriana y respuestas inflamatorias en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.8018em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.029em;">estos animales. El bloqueo de PD-1 usando un primate anti-PD-1 tambin mostr que exacerba la infeccin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.8518em;"><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.0474em;">por </span><span class="pdf24_55 pdf24_06 pdf24_18" style="word-spacing:0.0603em;">M. tuberculosis </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0545em;">en macacos rhesus.Los ratones knockout PD-L1 y PD-1 y los ratones que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.9119em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0301em;">anticuerpos bloqueantes PD-L1 tambin han mostrado una disminucin de la supervivencia despus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.9618em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0009em;">infeccin con el virus de la coriomeningitis linfoctica. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:17.0508em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.4665em;">13. </span><span class="pdf24_05 pdf24_06 pdf24_166" style="word-spacing:-0.0402em;">ESTUDIOS CLNICOS &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:19.1218em;"><span class="pdf24_12 pdf24_06 pdf24_240">13.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:19.1218em;"><span class="pdf24_05 pdf24_06 pdf24_142" style="word-spacing:-0.0178em;">Cncer de Pulmn de Clulas No Pequeas (CPCNP) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7343em;"><span class="pdf24_55 pdf24_06 pdf24_164" style="word-spacing:-0.0253em;">Tratamiento neoadyuvante y adyuvante del CPCNP resecable - Estudio AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0281em;">La eficacia de IMFINZI en combinacin con quimioterapia neoadyuvante, seguido de ciruga y tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9043em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1072em;">adyuvante continuado con IMFINZI como agente nico se investig en AEGEAN (NCT03800134), un &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.9543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0547em;">estudio aleatorizado, doble ciego, controlado con placebo y multicntrico realizado en 802 pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0043em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2943em;">CPCNP escamoso o no escamoso no tratado previamente y resecable (estado IIA a estado IIIB &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.0643em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0419em;">seleccionado [AJCC, 8a edicin]). Los pacientes se inscribieron independientemente de la expresin PD- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0451em;">L1 del tumor. Los pacientes elegibles no tenan exposicin previa a la terapia inmunomediada, un estado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.1743em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0359em;">funcional del Eastern Cooperative Oncology Group (ECOG)/OMS de 0 o 1 y, al menos, una lesin diana &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2243em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0017em;">de RECIST 1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3343em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2576em;">Los pacientes con enfermedad autoinmunitaria previa o activa documentada, o el uso de cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.386em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0408em;">medicamento inmunosupresor en el plazo de los 14 das siguientes a la primera dosis de IMFINZI no fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.446em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1169em;">elegibles. La poblacin para los anlisis de eficacia fue modificada por intencin de tratar [mITT] que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.496em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.001em;">excluy a los pacientes con mutaciones EGFR conocidas o reordenamientos ALK. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.596em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0851em;">No se permiti el cruce entre los brazos del estudio. La aleatorizacin se estratific por el estado de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.656em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0832em;">enfermedad (estado II vs. estado III) y por expresin PD-</span><span class="pdf24_20 pdf24_06 pdf24_50" style="word-spacing:0.0825em;">L1 (TC &lt; 1 % vs. TC  1 %). Los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.706em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.001em;">fueron aleatorizados a uno de los siguientes brazos de tratamiento con una proporcin de 1:1: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:42.7809em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:42.886em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0188em;">Brazo 1: Neoadyuvante, IMFINZI 1500 mg una vez cada 3 semanas, durante un mximo de 4 ciclos en &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:43.936em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0038em;">combinacin con: &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:44.996em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.019em;">Histologa del tumor escamoso: carboplatino AUC 6 y paclitaxel 200 mg/m2 en el da 1 de cada ciclo &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:46.046em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0328em;">de 3 semanas, O cisplatino 75 mg/m2 en el da 1 y gemcitabina 1250 mg/m2 en el da 1 y el da 8 de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.106em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0025em;">cada ciclo de 3 semanas, durante 4 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:48.1585em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0379em;">Histologa de tumores no escamosos: pemetrexed 500 mg/m2 y cisplatino 75 mg/m2 en el da 1 de cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:49.2085em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0612em;">ciclo de 3 semanas, durante 4 ciclos O pemetrexed 500 mg/m2 y carboplatino AUC 5 en el da 1 de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:50.2685em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0023em;">cada ciclo de 3 semanas, durante 4 ciclos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:51.3185em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1177em;">Seguido de IMFINZI 1500 mg como agente nico en adyuvancia durante un mximo de 12 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.3785em;"><span class="pdf24_14 pdf24_06 pdf24_67" style="word-spacing:-0.0044em;">despus de la ciruga. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:53.3934em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:53.4985em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0348em;">Brazo 2: Neoadyuvante placebo en combinacin con 4 ciclos de quimioterapia (ver ms arriba) antes &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:54.5485em;"><span class="pdf24_14 pdf24_06 pdf24_62" style="word-spacing:-0.0036em;">de la ciruga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:55.5985em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.0218em;">Seguido de placebo durante un mximo de 12 ciclos despus de la ciruga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.7082em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0899em;">Todos los medicamentos del estudio se administraron mediante infusin intravenosa. En el caso de una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.7582em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.236em;">tolerabilidad desfavorable, los pacientes que cumplieron los criterios de elegibilidad cambiaron del &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">44 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_44" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAXgklEQVR4nO3aQWpk2RUE0FyJ6X14ok0YD7UEe+aR6SW4KUQjlQuXVTaG3qVTK8jgQqRe9j0HYv4HN1A8SZcLAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPCwvl3zs4jU8pcDvkHkUfPXA75B5J55uQA3/fean0Sklm8HfIPIo+afB3yDyD3zfgFu+s9nfwD8zukYzP347A+AO3PzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPAeMKunQM5ow5tnHzEDCuoEvHYM6YYxs3DwHjCrp0DOaMObZx8xAwrqBLx2DOmGMbNw8B4wq6dAzmjDm2cfMQMK6gS8dgzphjGzcPgW/X/CwiteiYyDz/OuAbRO6Zlwtw08e4+klEavnDAd8g8qjRH9mWrxfgJv/eAgBwBv9CBgEPGACAM3jAQMADBgDgDB4wEPCAAQA4gwcMBDxgAADO4AEDAQ8YAIAzeMBAwAMGAOAMHjAQ8IABADiDBwwEPGAAAM7gAQMBDxgAgDN4wEDAAwYA4AweMBDwgAEAOIMHDAQ8YAAAzuABAwEPGACAM3jAQMADBgDgDB4wEPCAAQA4gwcMBDxgAADO4AEDAQ8YAIAzeMBA4PWaJxGp5Y8HfIPIo0Z/ZFteLsBNb9c8i0gtOiYyz9cDvkHknvlyAW7yL2TQpWMw9+OzPwDuzM1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEXq95EpFa3g74BpFHjf7ItrxcgJs+fjg8i0gtOiYyz9cDvkHknvlyAW7y7y3QpWMw9+OzPwDuzM1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BIwr6NIxmDPm2MbNQ8C4gi4dgzljjm3cPASMK+jSMZgz5tjGzUPAuIIuHYM5Y45t3DwEjCvo0jGYM+bYxs1DwLiCLh2DOWOObdw8BN6v+S4iteiYyDy/HPANIvfMrxfgJr8dhi4dAyDlLzAQMK6gS8cASHnAQMC4gi4dAyDlAQMB4wq6dAyAlAcMBIwr6NIxAFIeMBAwrqBLxwBIecBAwLiCLh0DIOUBAwHjCrp0DICUBwwEjCvo0jEAUh4wEDCuoEvHAEh5wEDAuIIuHQMg5QEDAeMKunQMgJQHDASMK+jSMQBSHjAQMK6gS8cASHnAQMC4gi4dAyDlAQMB4wq6dAyAlAcMBIwr6NIxAFIeMBAwrqBLxwBIecBAwLiCLh0DIOUBA4H3a76LSC3/PuAbRETkMfJ6AW7y22Ho0jEAUv4CAwHjCrp0DICUBwwEjCvo0jEAUh4wEDCuoEvHAEh5wEDAuIIuHQMg5QEDAeMKunQMgJQHDASMK+jSMQBSHjAQMK6gS8cASHnAQMC4gi4dAyDlAQMB4wq6dAyAlAcMBIwr6NIxAFIeMBAwrqBLxwBIecBAwLiCLh0DIOUBAwHjCrp0DICUBwwEjCvo0jEAUh4wEDCuoEvHAEh5wEDAuIIuHQMg5QEDAeMKunQMgJQHDASMK+jSMQBSHjAQeL/mu4jU8nrAN4iIyGPk42cGcIPfDgMAnMFfYCDgAQMAcAYPGAh4wAAAnMEDBgIeMAAAZ/CAgYAHDADAGTxgIOABAwBwBg8YCHjAAACcwQMGAh4wAABn8ICBgAcMAMAZPGAg4AEDAHAGDxgIeMAAAJzBAwYCHjAAAGfwgIGABwwAwBk8YCDgAQMAcAYPGAh4wAAAnMEDBgIeMAAAZ/CAgYAHDADAGTxgIOABAwBwBg8YCHjAAACcwQMGAu/XfBeRWv5xwDeIPGp+OeAbRO6ZXy/ATf4CA106BnN+G802bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+Yh8HrNk4jU8nbAN4g8avRHtuXlAtz08cPhWURq0TGReb4e8A0i98yXC3CTf2+BLh2DuR+f/QFwZ24eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+YhYFxBl47BnDHHNm4eAsYVdOkYzBlzbOPmIWBcQZeOwZwxxzZuHgLGFXTpGMwZc2zj5iFgXEGXjsGcMcc2bh4CxhV06RjMGXNs4+Yh8HrNk4jU8nbAN4g8avRHtuXlAtz08cPhWURq0TGRef58wDeI3DNfLsBN/r0FunQMgNSPz/4AeATGFXTpGAApDxgIGFfQpWMApDxgIGBcQZeOAZDygIGAcQVdOgZAygMGAsYVdOkYACkPGAgYV9ClYwCkPGAgYFxBl44BkPKAgYBxBV06BkDKAwYCxhV06RgAKQ8YCBhX0KVjAKQ8YCBgXEGXjgGQ8oCBgHEFXToGQMoDBgLGFXTpGAApDxgIGFfQpWMApDxgIGBcQZeOAZDygIGAcQVdOgZAygMGAsYVdOkYACkPGAj8ds2TiNTydsA3iIjIY+R/F+Cmv1/zLCK1/OmAbxARkcfI3y4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA/A79H5kP1Ol9+lmWAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_285" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0982em;">tratamiento con cisplatino al tratamiento con carboplatino en cualquier momento durante el estudio. En &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.022em;">pacientes con comorbilidades o que no pueden tolerar el cisplatino segn el criterio de los investigadores, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0382em;">podan administrar carboplatino AUC 5 a partir del ciclo 1. El tratamiento con IMFINZI o placebo continu &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2589em;">hasta la finalizacin del tratamiento, evolucin de la enfermedad que impida la ciruga definitiva, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0379em;">imposibilidad de completar la ciruga definitiva, recurrencia de la enfermedad en la fase adyuvante o una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1017em;">toxicidad inaceptable. Se realiz una evaluacin del tumor segn los criterios RECIST 1.1 al inicio del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0031em;">estudio y tras la finalizacin del perodo neoadyuvante (antes de la ciruga). Las evaluaciones del tumor se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1204em;">realizaron a las 5 semanas despus de la operacin, antes del inicio de la terapia adyuvante y cada 12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0397em;">semanas hasta la semana 48, cada 24 semanas durante aproximadamente 4 aos y, a partir de entonces, cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0009em;">48 semanas hasta la evolucin de la enfermedad, la retirada del consentimiento o la muerte. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.1107em;">El estudio no se dise para aislar el efecto de IMFINZI en cada fase (neoadyuvante o adyuvante) del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_123">tratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0897em;">Las medidas principales del resultado de la eficacia del estudio fueron la respuesta patolgica completa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0402em;">(pCR) mediante revisin patolgica central ciega y la supervivencia libre de eventos (EFS) mediante una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.214em;">revisin central independiente y ciega (BICR). Otras mediciones de resultados de eficacia fueron la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0012em;">respuesta patolgica mayor (MPR) mediante revisin patolgica central ciega, la DFS por BICR y la OS. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1858em;">Las caractersticas demogrficas e iniciales de la enfermedad fueron las siguientes: hombres (72 %); &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0031em;">mediana de edad de 65 aos (rango: de 30 a 88); edad </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0053em;"> </span><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0023em;">65 aos (52 %); OMS/ ECOG PS 0 (68 %), OMS/ &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1643em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0096em;">ECOG PS 1 (32); blancos (54 %), asiticos (41 %), negros o afroamericanos (0.9 %), indios americanos o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.191em;">nativos de Alaska (1.4 %), otras razas (2.6 %); no hispanos o latinos (84 %); fumadores actuales o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.059em;">exfumadores (86 %); histologa escamosa (49 %) e histologa no escamosa (51 %); estado II (28 %), estado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.001em;">III (71 %); estado de expresin PD-</span><span class="pdf24_20 pdf24_06 pdf24_36" style="word-spacing:-0.0017em;">L1 TC  1 % (67 %), estado de expresin PD</span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0001em;">-L1 TC &lt; 1 % (33 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0166em;">En la poblacin por intencin de tratar (mITT), el 78 % de los pacientes en el Brazo 1 finalizaron la ciruga &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0013em;">definitiva en comparacin con el 77 % de los pacientes en el Brazo 2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0297em;">El estudio mostr mejoras estadsticamente significativas en la EFS y la tasa de pCR (ver Tabla 18 y Figura &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.656em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0221em;">1) en el brazo de IMFINZI en combinacin con quimioterapia en comparacin con el brazo de placebo en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.706em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0031em;">combinacin con quimioterapia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.816em;"><span class="pdf24_05 pdf24_06 pdf24_164" style="word-spacing:-0.0229em;">Tabla 20. Resultados de la eficacia del estudio AEGEAN (mITT) &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1642em;top:41.916em;"><span class="pdf24_05 pdf24_06 pdf24_129" style="word-spacing:-0.05em;">IMFINZI 1500 mg cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1858em;top:42.436em;"><span class="pdf24_05 pdf24_06 pdf24_204" style="word-spacing:-0.0119em;">Placebo con &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.6542em;top:42.966em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0036em;">semanas con &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.1758em;top:43.496em;"><span class="pdf24_05 pdf24_06 pdf24_167">quimioterapia/Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4042em;top:44.016em;"><span class="pdf24_05 pdf24_06 pdf24_80">quimioterapia/IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.7058em;top:44.546em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 374) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.2942em;top:45.066em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 366) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:46.176em;"><span class="pdf24_05 pdf24_06 pdf24_286">EFS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_287">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.232em;top:47.416em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.014em;">Nmero de eventos, n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:48.6685em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0093em;">Mediana de EFS (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:49.8985em;"><span class="pdf24_14 pdf24_06 pdf24_75">(meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8042em;top:47.416em;"><span class="pdf24_14 pdf24_06 pdf24_288" style="word-spacing:0.0201em;">98 (27) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.9858em;top:47.416em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">138 (37) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4242em;top:48.6685em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0141em;">NR (31.9, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6258em;top:48.6685em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0133em;">25.9 (18.9, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:51.1385em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0094em;">Razn de Riesgo (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:52.3885em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0195em;">Valor p bilateral </span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_290">, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:53.5885em;"><span class="pdf24_05 pdf24_06 pdf24_226">pCR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_291">*</span></sup><sup style="top: -0.29em;"><span class="pdf24_207 pdf24_06 pdf24_54">,</span></sup><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_203"></span></sup><sup style="top: -0.29em;"><span class="pdf24_207 pdf24_06 pdf24_54">,</span></sup><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_54"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.9658em;top:51.1385em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.68 (0.53, 0.88) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.7758em;top:52.3885em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0039 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:54.9085em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0217em;">Nmero de pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:56.1185em;"><span class="pdf24_14 pdf24_06 pdf24_100">respuesta &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.6642em;top:54.9085em;"><span class="pdf24_14 pdf24_06 pdf24_64">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0783em;top:54.9085em;"><span class="pdf24_14 pdf24_06 pdf24_64">16 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:57.3682em;"><span class="pdf24_14 pdf24_06 pdf24_210" style="word-spacing:-0.0064em;">Tasa pCR , % (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:58.6282em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0248em;">valor p &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.0442em;top:57.3682em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">17.2 (13.5, 21.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1458em;top:57.3682em;"><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:-0.0061em;">4.3 (2.5, 6.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.4158em;top:58.6282em;"><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0121em;">&lt; 0.0001 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">45 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_45" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_292" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:21.1642em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_129" style="word-spacing:-0.05em;">IMFINZI 1500 mg cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.6442em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0036em;">semanas con &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.4042em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_80">quimioterapia/IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.2942em;top:9.1618em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 366) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1858em;top:6.5218em;"><span class="pdf24_05 pdf24_06 pdf24_204" style="word-spacing:-0.0119em;">Placebo con &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.1758em;top:7.5718em;"><span class="pdf24_05 pdf24_06 pdf24_167">quimioterapia/Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.7058em;top:8.6318em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 374) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:10.2418em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0412em;">Diferencia en proporciones, % &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.232em;top:11.4618em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0139em;">(CI del 95%) </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_34" style="word-spacing:-0.022em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:29.1858em;top:10.2418em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0118em;">13.0 (8.7, 17.6) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.802em;"><span class="pdf24_41 pdf24_06 pdf24_256" style="word-spacing:0.1046em;">* Los resultados se basan en el anlisis interino de la EFS planificado y el anlisis final de la pCR (DCO: 10 de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.762em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0009em;">noviembre de 2022) que se produjeron 46.3 meses despus del inicio del estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.712em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_62" style="word-spacing:0.0002em;">En comparacin con un lmite de valor de p bilateral de 0.00989. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.682em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0206em;">Segn un anlisis interino de pCR especificado previamente (DCO: 14 de enero de 2022) en n = 402, la tasa de pCR &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.642em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:-0.0004em;">fue estadsticamente significativa (p = 0.000036) en comparacin con el nivel de significancia del 0.0082 %. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.602em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0129em;"> El valor de p bilateral de la pCR se calcul sobre la base de una prueba de CMH estratificada. El valor de p bilateral &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.562em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:0.0591em;">para la EFS se calcul en funcin de una prueba del orden logartmico estratificada. Los factores de estratificacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.522em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0005em;">incluyen el PD-L1 y el estadio de la enfermedad. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.4845em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0192em;"> Se calcul el intervalo de confianza para la diferencia de proporciones con base en el mtodo Miettinen y Nurminen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.4346em;"><span class="pdf24_41 pdf24_06 pdf24_144">estratificado. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.4343em;"><span class="pdf24_05 pdf24_06 pdf24_157" style="word-spacing:-0.0188em;">Figura 1. Curvas de Kaplan-Meier de la EFS en el estudio AEGEAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.296em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0639em;">En el anlisis interino, el estudio mostr una diferencia estadsticamente significativa en la tasa de MPR &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3485em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0887em;">(34 % vs. 14 %; p &lt; 0,0001). En el momento de los anlisis interinos especificados previamente, no se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4085em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0009em;">analiz formalmente la significacin estadstica de la supervivencia general (OS). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5685em;"><span class="pdf24_55 pdf24_06 pdf24_140" style="word-spacing:-0.0127em;">CPCNP no resecable en estado III - PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6885em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1641em;">La eficacia de IMFINZI se evalu en el estudio PACIFIC (NCT02125461), un estudio multicntrico, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.7385em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0026em;">aleatorizado, doble ciego, controlado con placebo en pacientes con CPCNP en estado III no resecable que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7885em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0051em;">completaron al menos 2 ciclos de quimioterapia simultnea basada en platino y radiacin definitiva dentro &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.8382em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0047em;">de 42 das antes del inicio del frmaco del estudio y tena un estado de rendimiento de la OMS de 0 o 1. El &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.8982em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0018em;">estudio excluy a pacientes que haban progresado despus de la quimiorradiacin concurrente, pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">46 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_46" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_293" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1041em;">con enfermedad autoinmune documentada activa o previa dentro de los 2 aos posteriores al inicio del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0164em;">estudio o pacientes con condiciones mdicas que requirieron inmunosupresin sistmica. La aleatorizacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_20 pdf24_06 pdf24_94" style="word-spacing:0.0329em;">se estratific por sexo, edad (&lt;65 aos frente a  65 aos) y antecedentes de tabaquismo (fumador versus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.108em;">no fumador). Los pacientes fueron aleatorizados 2:1 para recibir IMFINZI 10 mg/kg o placebo por va &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0319em;">intravenosa cada 2 semanas durante un mximo de 12 meses o hasta una toxicidad inaceptable o progresin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0144em;">confirmada definida por RECIST v1.1. La evaluacin del estado del tumor se realiz cada 8 semanas. Las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0953em;">principales medidas de resultado de eficacia fueron la supervivencia libre de progresin (PFS) segn la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.027em;">evaluacin de un BICR RECIST v1.1, y la supervivencia global (OS). Las medidas de resultado de eficacia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0041em;">adicionales incluyeron ORR y DoR evaluados por BICR. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0298em;">Un total de 713 pacientes fueron asignados al azar: 476 pacientes al brazo IMFINZI y 237 al brazo placebo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0443em;">Las caractersticas de la poblacin de estudio fueron: mediana de edad de 64 aos (rango: 23 a 90); 70% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_14 pdf24_06 pdf24_57" style="word-spacing:0em;">hombres; 69% blancos y 27% asiticos; 16% fumadores actuales, 75% exfumadores y 9% nunca fumadores; &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:0.058em;">51% del estado de desempeo de la OMS de 1; 53% con estado IIIA y 45% eran estado IIIB; 46% con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2282em;">histologa escamosa y 54% con histologa no escamosa. Todos los pacientes recibieron radioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0323em;">definitiva segn el protocolo, de los cuales el 92% recibi una dosis de radiacin total de 54 Gy a 66 Gy; &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.067em;">el 99% de los pacientes recibi quimioterapia concomitante a base de platino (55% a base de cisplatino, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.001em;">42% a base de carboplatino y 2% cambi entre cisplatino y carboplatino). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1825em;">En un anlisis interino preespecificado para la OS basado en 299 eventos (61% del total de eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2819em;">planificados), el estudio demostr una mejora estadsticamente significativa en la OS en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1643em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0164em;">asignados al azar a IMFINZI en comparacin con placebo. El anlisis interino previamente especificado de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0129em;">PFS basado en 371 eventos (81% del total de eventos planificados) demostr una mejora estadsticamente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0131em;">significativa en PFS en pacientes asignados al azar a IMFINZI en comparacin con placebo. La Tabla 21 y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0032em;">la Figura 2 resumen los resultados de eficacia para PACIFIC. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4443em;"><span class="pdf24_05 pdf24_06 pdf24_140" style="word-spacing:-0.017em;">Tabla 21. Resultados de Eficacia para el Estudio PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.502em;top:34.496em;"><span class="pdf24_05 pdf24_06 pdf24_208" style="word-spacing:-0.0203em;">Punto final &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4042em;top:34.496em;"><span class="pdf24_05 pdf24_06 pdf24_119" style="word-spacing:-0.0076em;">IMFINZI (N = 476)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_182" style="word-spacing:-0.012em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.3958em;top:34.496em;"><span class="pdf24_05 pdf24_06 pdf24_49" style="word-spacing:-0.0099em;">Placebo (N = 237)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_80" style="word-spacing:-0.0157em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.502em;top:35.626em;"><span class="pdf24_05 pdf24_06 pdf24_19" style="word-spacing:-0.033em;">Supervivencia Global (OS) </span><sup style="top: -0.33em;"><span class="pdf24_205 pdf24_06 pdf24_33" style="word-spacing:-0.0523em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.502em;top:36.746em;"><span class="pdf24_14 pdf24_06 pdf24_65" style="word-spacing:-0.0154em;">Nmero de muertes &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.3758em;top:36.746em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0097em;">183 (38%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0183em;top:36.746em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0097em;">116 (49%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6058em;top:37.916em;"><span class="pdf24_14 pdf24_06 pdf24_124">NR &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.3258em;top:38.966em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0624em;">(34.7, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.502em;top:37.946em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.021em;">Mediana en meses (95% IC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.1083em;top:37.946em;"><span class="pdf24_14 pdf24_06 pdf24_64">28.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0083em;top:38.926em;"><span class="pdf24_14 pdf24_06 pdf24_166" style="word-spacing:-0.0174em;">(22.9, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.222em;top:40.056em;"><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0063em;">Tasa de Peligro (95% IC)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_75" style="word-spacing:-0.01em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.222em;top:41.176em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0058em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_290">, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.8358em;top:40.056em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.68 (0.53, 0.87) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.6558em;top:41.176em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.382em;top:42.306em;"><span class="pdf24_05 pdf24_06 pdf24_141" style="word-spacing:-0.0328em;">Supervivencia Libre de Progresin (PFS)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_294"></span><span class="pdf24_207 pdf24_06 pdf24_54">,</span><span class="pdf24_70 pdf24_06 pdf24_54"># &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.502em;top:43.426em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0159em;">Nmero (%) de pacientes con evento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.502em;top:44.546em;"><span class="pdf24_14 pdf24_06 pdf24_118" style="word-spacing:-0.0196em;">Mediana en meses (95% IC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.222em;top:45.676em;"><span class="pdf24_14 pdf24_06 pdf24_134" style="word-spacing:-0.0104em;">Tasa de Peligro (95% IC)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_198">, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.222em;top:46.796em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0058em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_290">, &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.3258em;top:43.426em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0097em;">214 (45%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1858em;top:44.546em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">16.8 (13.0, 18.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.9583em;top:43.426em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0097em;">157 (66%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5083em;top:44.546em;"><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:-0.0074em;">5.6 (4.6, 7.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.7658em;top:45.676em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.52 (0.42, 0.65) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.2358em;top:46.796em;"><span class="pdf24_14 pdf24_06 pdf24_80" style="word-spacing:0.0121em;">&lt; 0.0001 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.9787em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_91" style="word-spacing:-0.0128em;">Entre la poblacin de ITT, el 7% en el brazo IMFINZI y el 10% en el brazo placebo tenan una enfermedad no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.712em;top:48.9387em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0004em;">medible segn lo evaluado por BICR de acuerdo con RECIST v1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.8987em;"><span class="pdf24_295 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0108em;">Los resultados de OS se basan en el anlisis interino de OS realizado en 299 eventos de OS que ocurrieron 46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.712em;top:50.8487em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0002em;">meses despus del inicio del estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.7987em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_279" style="word-spacing:-0.0012em;">Valor p de dos lados basado en una prueba de log-rank estratificada por sexo, edad e historial de tabaquismo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7687em;"><span class="pdf24_41 pdf24_06 pdf24_204" style="word-spacing:-0.0043em;"> En comparacin con el </span><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0028em;"> </span><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:-0.0115em;">asignado de 0.00274 (funcin de gasto de Lan DeMets que se aproxima al lmite de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.712em;top:53.7287em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.002em;">O'Brien Fleming) para el anlisis interino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6787em;"><span class="pdf24_41 pdf24_06 pdf24_37" style="word-spacing:0.0043em;"> Segn lo evaluado por BICR RECIST v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6487em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0119em;"># Los resultados de PFS se basan en el anlisis interino de PFS realizado en 371 eventos de PFS que ocurrieron 33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.712em;top:56.5987em;"><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0002em;">meses despus del inicio del estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5584em;"><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:0.2386em;"> Estimador</span><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:0.0094em;">&nbsp;</span><span class="pdf24_41 pdf24_06 pdf24_267" style="word-spacing:0.0076em;">de Pike. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">47 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_47" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_296" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.042em;"><span class="pdf24_41 pdf24_06 pdf24_204" style="word-spacing:-0.0043em;"> En comparacin con el </span><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0028em;"> </span><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0088em;">asignado de 0.011035 (funcin de gasto de Lan DeMets que se aproxima al lmite de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.712em;top:7.002em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.002em;">O'Brien Fleming) para el anlisis interino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.0018em;"><span class="pdf24_05 pdf24_06 pdf24_165" style="word-spacing:-0.0242em;">Figura 2 Curvas Kaplan-Meier de Supervivencia Global en Estudio PACIFIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.6142em;top:29.3243em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:-0.0233em;">Tiempo de la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:31.8445em;"><span class="pdf24_41 pdf24_06 pdf24_38" style="word-spacing:0.0037em;">Nmero de pacientes en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_297">Mes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:33.9162em;"><span class="pdf24_41 pdf24_06 pdf24_133" style="word-spacing:0.9134em;">IMFINZI 476 464 431 415 385 364 343 319 274 210 115 57 23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:34.9462em;"><span class="pdf24_41 pdf24_06 pdf24_182" style="word-spacing:1.5508em;">Placebo 237</span><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:0.8888em;">&nbsp;</span><span class="pdf24_41 pdf24_06 pdf24_45" style="word-spacing:0.9178em;">220 198 178 170 155 141 130 117 78</span><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:1.3765em;">&nbsp;</span><span class="pdf24_41 pdf24_06 pdf24_45" style="word-spacing:1.3946em;">42 21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5317em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:12.6817em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:14.8317em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:16.9842em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:19.1642em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.3142em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4342em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5842em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7658em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.9158em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.0658em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2158em;top:32.8445em;"><span class="pdf24_41 pdf24_06 pdf24_45" style="word-spacing:0.8863em;">33 36 39 42 45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6583em;top:33.9162em;"><span class="pdf24_41 pdf24_06 pdf24_15">2</span></div>
					<div class="pdf24_01" style="left:37.6583em;top:34.9462em;"><span class="pdf24_41 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:39.4083em;top:33.9162em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:39.4083em;top:34.9462em;"><span class="pdf24_41 pdf24_06 pdf24_15">1</span></div>
					<div class="pdf24_01" style="left:41.1283em;top:33.9162em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:41.1283em;top:34.9462em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:35.9458em;top:34.9462em;"><span class="pdf24_41 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.176em;"><span class="pdf24_55 pdf24_06 pdf24_118" style="word-spacing:-0.0207em;">CPCNP metastsico - POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.286em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1394em;">La eficacia de IMFINZI en combinacin con tremelimumab-actl y quimioterapia basada en platino en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.336em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0507em;">pacientes con CPCNP metastsico no tratados previamente y sin mutacin sensibilizante del receptor del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.386em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2653em;">factor de crecimiento epidrmico (EGFR) o aberraciones tumorales genmicas del linfoma quinasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.446em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.098em;">anaplsico (ALK) se investig en POSEIDON, un estudio aleatorizado, estudio multicntrico, abierto y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.496em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1445em;">controlado con activo (NCT03164616). Los pacientes elegibles tenan un estado funcional del Eastern &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.556em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0087em;">Cooperative Oncology Group (ECOG) de 0 o 1 y no deban haber recibido quimioterapia previa ni ningn &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.6085em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.038em;">otro tratamiento sistmico para el CPCNP metastsico. La eleccin de la quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.6585em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0175em;">qued a criterio del investigador, teniendo en cuenta el aclaramiento de creatinina calculado. Pacientes con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.7185em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0238em;">metstasis cerebrales activas y/o no tratadas; antecedentes de inmunodeficiencia primaria activa; trastornos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.7685em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0066em;">autoinmunes que incluyen trastornos autoinmunes o inflamatorios activos o previamente documentados; el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.8285em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0976em;">uso de inmunosupresores sistmicos dentro de los 14 das anteriores a la primera dosis del tratamiento, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.8785em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0026em;">excepto la dosis fisiolgica de corticosteroides sistmicos, no fue elegible. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.9985em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.047em;">La aleatorizacin se estratific segn la expresin de PD-L1 de las clulas tumorales (TC) (TC </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0488em;"> </span><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0588em;">50% frente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.0485em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0388em;">a TC &lt; 50%), estadio de la enfermedad (Estadio IVA frente a Estadio IVB) e histologa (no escamosa frente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.0982em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0032em;">a escamosa). &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">48 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_48" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0498em;">Los pacientes fueron aleatorizados 1:1:1 para recibir IMFINZI en combinacin con tremelimumab-actl y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.1175em;">quimioterapia basada en platino de acuerdo con los regmenes enumerados a continuacin, IMFINZI y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1005em;">quimioterapia basada en platino (un rgimen no aprobado para el CPCNP metastsico) o quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.0519em;">basada en platino. La evaluacin de la eficacia para el CPCNP metastsico se bas en la comparacin entre: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:10.2167em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:10.3218em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0121em;">IMFINZI 1500 mg con tremelimumab-actl 75 mg (o 1 mg/kg para pacientes &lt; 30 kg) y quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:11.3718em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0358em;">basada en platino cada 3 semanas durante 4 ciclos, seguido de IMFINZI 1500 mg cada 4 semanas como &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:12.4218em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0464em;">agente nico. Se administr una quinta dosis de tremelimumab-actl de 75 mg (o 1 mg/kg para pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:13.4718em;"><span class="pdf24_14 pdf24_06 pdf24_142" style="word-spacing:-0.0106em;">&lt; 30 kg) en la semana 16 en combinacin con la dosis 6 de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:14.4967em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:14.6018em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1002em;">Quimioterapia a base de platino cada 3 semanas como monoterapia durante 4 ciclos. Los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:15.6518em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1563em;">podran recibir 2 ciclos adicionales (un total de 6 ciclos despus de la aleatorizacin), segn est &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:16.7018em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0002em;">clnicamente indicado, a criterio del investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.8118em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.1853em;">Los pacientes recibieron IMFINZI en combinacin con tremelimumab-actl con uno de los siguientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.8643em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0034em;">regmenes de quimioterapia basados en platino: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:20.8692em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:20.9743em;"><span class="pdf24_14 pdf24_06 pdf24_156" style="word-spacing:-0.0096em;">CPCNP no escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:22.0343em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0868em;">Pemetrexed 500 mg/m2 con carboplatino AUC 5-6 o cisplatino 75 mg/m2 cada 3 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:23.0143em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0024em;">durante 4 ciclos. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:9.0017em;top:22.0883em;"><span class="pdf24_298 pdf24_161 pdf24_15">o</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:23.9992em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:24.1043em;"><span class="pdf24_14 pdf24_06 pdf24_215" style="word-spacing:-0.0199em;">CPCNP escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:25.1843em;"><span class="pdf24_299 pdf24_161 pdf24_15" style="word-spacing:0.1802em;">o </span><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0041em;">Gemcitabina 1000 o 1250 mg/m2 los das 1 y 8 con cisplatino 75 mg/m2 o carboplatino AUC &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:26.2443em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0012em;">5-6 el da 1 cada 3 semanas durante 4 ciclos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:27.3443em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0164em;">CPCNP no escamoso y escamoso &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:27.2392em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:9.0017em;top:28.4683em;"><span class="pdf24_298 pdf24_161 pdf24_15">o</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:28.4143em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.088em;">Nab-paclitaxel 100 mg/m2 los das 1, 8 y 15 con AUC 5-6 de carboplatino el da 1 cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:29.3943em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0007em;">semanas durante 4 ciclos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.4843em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0408em;">Se administr tremelimumab-actl hasta un mximo de 5 dosis. IMFINZI y pemetrexed basado en histologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5443em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0018em;">continuaron cada 4 semanas hasta la progresin de la enfermedad o una toxicidad inaceptable. Se permiti &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5943em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0687em;">la administracin de IMFINZI en monoterapia ms all de la progresin de la enfermedad si el paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.656em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.0174em;">estaba clnicamente estable y obtena un beneficio clnico segn lo determinado por el investigador. A los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.706em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0727em;">pacientes con progresin de la enfermedad durante la monoterapia con IMFINZI se les dio la opcin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.756em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0239em;">volver a recibir 4 ciclos adicionales de tremelimumab-actl en combinacin con IMFINZI. Las evaluaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.816em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0015em;">del tumor se realizaron en la semana 6, la semana 12 y luego cada 8 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.926em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0958em;">Las principales medidas de resultado de eficacia fueron la supervivencia libre de progresin (PFS) y la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.986em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0074em;">supervivencia global (OS) de IMFINZI y tremelimumab-actl en combinacin con quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.036em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0295em;">platino en comparacin con la quimioterapia basada en platino sola. Las medidas de resultado de eficacia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.086em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0332em;">adicionales fueron la tasa de respuesta objetiva (ORR) y la duracin de la respuesta (DoR). La PFS, la ORR &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.146em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0108em;">y la DoR se evaluaron mediante una Revisin central independiente ciega (BICR) de acuerdo con RECIST &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.196em;"><span class="pdf24_14 pdf24_06 pdf24_80">v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.306em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.3651em;">Un total de 675 pacientes fueron aleatorizados para recibir IMFINZI con tremelimumab-actl y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3585em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0319em;">quimioterapia basada en platino (n = 338) o quimioterapia basada en platino (n = 337). La mediana de edad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4085em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0002em;">fue de 63 aos (rango: 27 a 87), el 46 % </span><span class="pdf24_20 pdf24_06 pdf24_18" style="word-spacing:0.0003em;">de los pacientes tenan  65 aos, el 77 % eran hombres, el 57 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4685em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0005em;">eran blancos, el 34 % eran asiticos, el 0.3 % eran nativos de Hawi o de otras islas del Pacfico, el 3 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.5185em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0205em;">eran indios americanos o de Alaska. Nativo, 2% negro o afroamericano, 4% otra raza, 79% fumador actual &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5785em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0021em;">o exfumador, 34% ECOG PS 0 y 66% ECOG PS 1. Treinta y seis por ciento tena histologa escamosa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6285em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0019em;">63% histologa no escamosa, 29 % expresin de PD-</span><span class="pdf24_20 pdf24_06 pdf24_56" style="word-spacing:0.0059em;">L1 TC  50%, 71% expresin de PD</span><span class="pdf24_14 pdf24_06 pdf24_165" style="word-spacing:0.0049em;">-L1 TC &lt; 50%. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6785em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.001em;">Los resultados de eficacia se resumen en la Tabla 22 y la Figura 3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7985em;"><span class="pdf24_05 pdf24_06 pdf24_96" style="word-spacing:-0.0197em;">Tabla 22. Resultados de eficacia del estudio POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">49 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_49" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_300" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:20.9742em;top:6.0118em;"><span class="pdf24_05 pdf24_06 pdf24_32" style="word-spacing:0.0037em;">IMFINZI con tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9042em;top:7.0718em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.0395em;">actl y quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.6042em;top:8.1218em;"><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:-0.005em;">platino (n = 338) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.1158em;top:6.0118em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0668em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6583em;top:7.0618em;"><span class="pdf24_05 pdf24_06 pdf24_122">platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1958em;top:8.0518em;"><span class="pdf24_05 pdf24_06 pdf24_269" style="word-spacing:0.0179em;">(n = 337) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.092em;top:9.1618em;"><span class="pdf24_05 pdf24_06 pdf24_301">OS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_302">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.092em;top:10.2818em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0216em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:11.4018em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0131em;">Mediana de OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:12.4518em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0037em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3042em;top:10.2818em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0049em;">251 (74) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.0642em;top:11.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">14.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7242em;top:12.4518em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0208em;">(11.7, 16.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4783em;top:10.2818em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0031em;">285 (85) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.2383em;top:11.4018em;"><span class="pdf24_14 pdf24_06 pdf24_64">11.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.8958em;top:12.4518em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0199em;">(10.5, 13.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:13.5618em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6258em;top:13.5618em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.77 (0.65, 0.92) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:14.6818em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2258em;top:14.6818em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.00304 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.092em;top:15.7918em;"><span class="pdf24_05 pdf24_06 pdf24_303">PFS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_304">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.092em;top:16.9118em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0216em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:18.0318em;"><span class="pdf24_14 pdf24_06 pdf24_48" style="word-spacing:-0.0189em;">Mediana de PFS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:19.0718em;"><span class="pdf24_14 pdf24_06 pdf24_52" style="word-spacing:-0.0037em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3042em;top:16.9118em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0049em;">238 (70) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2942em;top:18.0318em;"><span class="pdf24_14 pdf24_06 pdf24_64">6.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.1942em;top:19.0718em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0121em;">(5.0, 6.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4783em;top:16.9118em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0031em;">258 (77) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.4683em;top:18.0318em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3658em;top:19.0718em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0112em;">(4.6, 5.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:20.1843em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6258em;top:20.1843em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.72 (0.60, 0.86) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:21.3043em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.00031 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.092em;top:21.3043em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.092em;top:22.4143em;"><span class="pdf24_05 pdf24_06 pdf24_164" style="word-spacing:-0.0123em;">ORR % (CI del 95%) </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_48" style="word-spacing:-0.0195em;">3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.092em;top:23.5343em;"><span class="pdf24_05 pdf24_06 pdf24_16" style="word-spacing:-0.0166em;">Mediana de DoR (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.962em;top:24.6543em;"><span class="pdf24_05 pdf24_06 pdf24_60" style="word-spacing:0.0015em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.9642em;top:22.4143em;"><span class="pdf24_14 pdf24_06 pdf24_167" style="word-spacing:0.0116em;">39 (34, 44) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2942em;top:23.5343em;"><span class="pdf24_14 pdf24_06 pdf24_64">9.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.1342em;top:24.6543em;"><span class="pdf24_14 pdf24_06 pdf24_68" style="word-spacing:-0.0132em;">(7.2, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0258em;top:22.4143em;"><span class="pdf24_14 pdf24_06 pdf24_167" style="word-spacing:0.012em;">24 (20, 29) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.4683em;top:23.5343em;"><span class="pdf24_14 pdf24_06 pdf24_64">5.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3658em;top:24.6543em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0112em;">(4.4, 6.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0845em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.0463em;">1 </span></sup><span class="pdf24_41 pdf24_06 pdf24_90" style="word-spacing:-0.0568em;">Los resultados de la PFS/OS se basan en anlisis planificados que se realizaron 25/45 meses respectivamente despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0445em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:0.0012em;">del inicio del estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.0045em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.0833em;">2 </span></sup><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.029em;">Valores de p bilaterales basados en pruebas de rango logartmico estratificados por PD-L1, histologa y estadio de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9545em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0003em;">enfermedad y comparados con un valor lmite de 0.00735 para PFS y 0.00797 para OS. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9145em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">3 </span></sup><span class="pdf24_41 pdf24_06 pdf24_13" style="word-spacing:-0.0204em;">Respuestas confirmadas con intervalo de confianza de Clopper-Pearson del 95%. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8745em;"><span class="pdf24_41 pdf24_06 pdf24_204" style="word-spacing:0.0035em;">NR = No alcanzado, CI = Intervalo de confianza &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.936em;"><span class="pdf24_05 pdf24_06 pdf24_98" style="word-spacing:-0.0179em;">Figura 3. Curvas de Kaplan-Meier de OS en el estudio POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:53.7785em;"><span class="pdf24_14 pdf24_06 pdf24_24" style="word-spacing:-0.0233em;">Tiempo de la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:56.4387em;"><span class="pdf24_41 pdf24_06 pdf24_38" style="word-spacing:0.0037em;">Nmero de pacientes en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_297">Mes &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.6217em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:11.8917em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:14.1517em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:16.4242em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:18.6742em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9442em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2042em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.4842em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7558em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0258em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2358em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4458em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6458em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.8683em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0783em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:43.2783em;top:57.4284em;"><span class="pdf24_41 pdf24_06 pdf24_45">45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:58.4284em;"><span class="pdf24_41 pdf24_06 pdf24_279" style="word-spacing:-0.0042em;">IMFINZI + tremelimumab-actl + quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">50 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_50" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:9.6717em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">338 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.482em;top:6.942em;"><span class="pdf24_41 pdf24_06 pdf24_19" style="word-spacing:-0.0007em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.6717em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45" style="word-spacing:1.0422em;">337 284 236 204 &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.9117em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">298 &nbsp;</span></div>
					<div class="pdf24_01" style="left:14.1817em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">256 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.4442em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">217 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.7142em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">183 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.7142em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">160 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9842em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">159 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9842em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">132 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2442em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">137 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.2442em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">111 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5242em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">120 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5142em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">91 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7558em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">109 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7558em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">72 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0558em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">95 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.0558em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">62 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2658em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">88 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2658em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4758em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">64 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4758em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6758em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6758em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.8883em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_45">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.8883em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_45">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0983em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:41.0983em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:43.3383em;top:5.982em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:43.3383em;top:7.872em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:10.9618em;"><span class="pdf24_12 pdf24_06 pdf24_240">13.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:10.9618em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.0185em;">Cncer de Pulmn de Clulas Pequeas (CPCP) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.5618em;"><span class="pdf24_55 pdf24_06 pdf24_164" style="word-spacing:-0.0212em;">Cncer de Pulmn de Clulas Pequeas en Etstadio Limitado - ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.1181em;">La eficacia de IMFINZI se evalu en el Estudio ADRIATIC (NCT03703297), un estudio aleatorizado, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.7318em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0077em;">doble ciego, controlado con placebo, multicntrico en 730 pacientes con CPCP-EL confirmado histolgica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.7818em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0397em;">o citolgicamente (Estadio I a III segn el AJCC, 8 edicin) cuya enfermedad no haba progresado despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.8418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.031em;">de la quimiorradioterapia concurrente (QRTc). Los pacientes con enfermedad en Estadio I o II deban ser &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.8943em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.019em;">mdicamente inoperables segn lo determinado por el investigador. Los pacientes elegibles completaron la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.9543em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0097em;">QRTc, que consisti en 4 ciclos de quimioterapia basada en platino y terapia de radiacin de 60-66 Gy una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.0043em;"><span class="pdf24_14 pdf24_06 pdf24_56" style="word-spacing:0.0087em;">vez al da durante 6 semanas o 45 Gy dos veces al da durante 3 semanas dentro de los 42 das previos a la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0543em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1013em;">primera dosis de IMFINZI o placebo. La irradiacin craneal profilctica (PCI, por sus siglas en ingls) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.1143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0337em;">poda administrarse a discrecin del investigador despus del QRTc y deba completarse dentro de los 42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.1643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0076em;">das previos a la primera dosis de IMFINZI o placebo. Los pacientes con enfermedad autoinmune activa o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.2243em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0742em;">previamente documentada dentro de los 5 aos de inicio del estudio; antecedentes de inmunodeficiencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.2743em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.011em;">primaria activa; antecedentes de neumonitis de grado </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:0.0055em;"> </span><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.007em;">2 o tuberculosis activa, hepatitis B o C o infeccin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.3243em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0239em;">por VIH; enfermedad pulmonar intersticial activa no eran elegibles. Tampoco eran elegibles los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.3843em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.121em;">con histologa mixta de CPCP y CPCNP. La aleatorizacin se estratific por estadio (I/II versus III) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4343em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.001em;">recepcin de PCI (s versus no). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5443em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.3497em;">Los pacientes fueron aleatorizados 1:1:1 para recibir IMFINZI como agente nico, IMFINZI en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1113em;">combinacin con otro agente, o placebo. Todos los medicamentos del estudio se administraron por va &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.656em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0002em;">intravenosa. La evaluacin de la eficacia para CPCP-EL se bas en la comparacin entre: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:36.7209em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:6.002em;top:38.9009em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.826em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0017em;">Brazo 1: IMFINZI 1500 mg en combinacin con placebo cada 4 semanas durante 4 ciclos, seguido de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:37.886em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0013em;">IMFINZI 1500 mg cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:39.006em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0305em;">Brazo 2: Placebo en combinacin con un segundo placebo cada 4 semanas durante 4 ciclos, seguido de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:40.056em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0035em;">un solo placebo cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.156em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0244em;">Un total de 530 pacientes fueron aleatorizados entre los Brazos 1 y 2, 264 pacientes al brazo de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.216em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0476em;">y 266 pacientes al brazo de placebo. El tratamiento continu hasta la progresin de la enfermedad, toxicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.266em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1409em;">inaceptable, o por un mximo de 24 meses. Las evaluaciones tumorales se realizaron cada 8 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.326em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0004em;">durante las primeras 72 semanas, luego cada 12 semanas hasta 96 semanas y luego cada 24 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.436em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0435em;">Las principales medidas de resultado de eficacia fueron la Supervivencia Global (OS) y la Supervivencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4885em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0203em;">Libre de Progresin (PFS) evaluadas por el Comit Independiente de Revisin Radiolgica (BICR) segn &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5385em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0001em;">RECIST v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.6585em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0074em;">Las caractersticas demogrficas iniciales y de la enfermedad para los pacientes en los brazos de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7085em;"><span class="pdf24_20 pdf24_06 pdf24_34" style="word-spacing:0.2633em;">y placebo fueron las siguientes: hombres (69%); edad  65 aos (39%); blancos (50%), negros o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7585em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0387em;">afroamericanos (0.8%), asiticos (48%), otra raza (1.3%); hispanos o latinos (4.2%); fumadores actuales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.7985em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1213em;">(22%), exfumadores (68%), nunca fumadores (9%); estado funcional segn OMS/ECOG PS 0 (49%), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.8585em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:-0.0184em;">OMS/ECOG PS 1 (51%); y Estadio I (3.6%), Estadio II (9%), Estadio III (87%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">51 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_51" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_305" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0035em;">Antes de la aleatorizacin, todos los pacientes recibieron quimioterapia basada en platino (66% cisplatino- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.1753em;">etopsido, 34% carboplatino-etopsido) con el 88% de los pacientes recibiendo 4 ciclos; 72% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_20 pdf24_06 pdf24_18" style="word-spacing:0.1252em;">pacientes recibieron radiacin una vez al da (de los cuales el 92% recibi  60 </span><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:0.1154em;">- </span><span class="pdf24_20 pdf24_06 pdf24_50" style="word-spacing:0.1247em;"> 66 Gy QD); 28% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0131em;">recibieron radiacin dos veces al da (de los cuales el 97% recibi 45 Gy dos veces al da) y el 54% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0073em;">pacientes recibieron PCI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:-0.017em;">Los resultados de eficacia se presentan en la Tabla 23 y la Figura 4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_05 pdf24_06 pdf24_53" style="word-spacing:-0.019em;">Tabla 23. Resultados de Eficacia del estudio ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.7242em;top:16.0718em;"><span class="pdf24_05 pdf24_06 pdf24_125">IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.9942em;top:17.1918em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=264) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.7158em;top:16.0718em;"><span class="pdf24_05 pdf24_06 pdf24_57">Placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6858em;top:17.1218em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=266) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:18.3018em;"><span class="pdf24_05 pdf24_06 pdf24_306">OS &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:19.4618em;"><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0166em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.0542em;top:19.4618em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0049em;">115 (44) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6858em;top:19.4618em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">146 (55) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:20.7143em;"><span class="pdf24_14 pdf24_06 pdf24_164" style="word-spacing:-0.0195em;">Mediana de OS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_48" style="word-spacing:-0.0309em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.502em;top:21.9843em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0138em;">HR (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_169" style="word-spacing:-0.022em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:24.6942em;top:20.7143em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0138em;">55.9 (37.3, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.1558em;top:20.7143em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0113em;">33.4 (25.5, 39.9) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.1358em;top:21.9843em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.73 (0.57, 0.93) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9558em;top:23.2243em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0104 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:23.2243em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:24.4143em;"><span class="pdf24_05 pdf24_06 pdf24_307">PFS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_308"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.502em;top:25.5643em;"><span class="pdf24_14 pdf24_06 pdf24_118" style="word-spacing:-0.0211em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:26.8243em;"><span class="pdf24_14 pdf24_06 pdf24_140" style="word-spacing:-0.0142em;">Mediana de PFS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_131" style="word-spacing:-0.0226em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.502em;top:28.1143em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0138em;">HR (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_169" style="word-spacing:-0.022em;"># &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.0542em;top:25.5643em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0049em;">139 (53) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.6858em;top:25.5643em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">169 (64) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.5242em;top:26.8243em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">16.6 (10.2, 28.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6158em;top:26.8243em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0118em;">9.2 (7.4, 12.9) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.1358em;top:28.0743em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.76 (0.61, 0.95) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9558em;top:29.3443em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0161 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:29.3443em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.002em;top:30.6045em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.0151em;"> </span><span class="pdf24_41 pdf24_06 pdf24_151" style="word-spacing:-0.0238em;">Calculado usando la tcnica de Kaplan-Meier. El intervalo de confianza (CI) para la mediana se deriva basado en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.5645em;"><span class="pdf24_41 pdf24_06 pdf24_240" style="word-spacing:-0.0045em;">mtodo de Brookmeyer-Crowley. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5145em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_86" style="word-spacing:-0.0047em;">Basado en el modelo de riesgos proporcionales de Cox estratificado por recepcin de PCI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.4845em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.2026em;"> Comparado con el alfa asignado de 0.0168 para OS y 0.0280 para PFS (funcin de gasto de Lan DeMets &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.4462em;"><span class="pdf24_152 pdf24_06 pdf24_151" style="word-spacing:-0.002em;">aproximando el lmite de OBrien Fleming) para el anlisis intermedio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.4062em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0002em;"> Evaluado por el Comit Independiente de Revisin Radiolgica (BICR) de acuerdo con RECIST v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.3662em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:-0.0114em;"># Basado en el modelo de riesgos proporcionales de Cox estratificado por etapa TNM y recepcin de PCI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.366em;"><span class="pdf24_05 pdf24_06 pdf24_143" style="word-spacing:-0.0194em;">Figure 4. Curvas Kaplan-Meier de OS en el estudio ADRIATIC &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">52 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_52" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_309" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:20.2842em;top:22.3358em;"><span class="pdf24_101 pdf24_06 pdf24_24" style="word-spacing:-0.0001em;">Tiempo de la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.602em;top:23.3458em;"><span class="pdf24_101 pdf24_06 pdf24_53" style="word-spacing:0.0064em;">Nmero de sujetos en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.6043em;"><span class="pdf24_55 pdf24_06 pdf24_32" style="word-spacing:-0.0175em;">CPCP en estado extenso </span><span class="pdf24_242 pdf24_06 pdf24_15" style="word-spacing:-0.0299em;"> </span><span class="pdf24_55 pdf24_06 pdf24_251">CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.7243em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0091em;">La eficacia de IMFINZI en combinacin con etopsido y carboplatino o cisplatino en CPCP-EE no tratado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.7743em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1697em;">previamente se investig en CASPIAN, un estudio aleatorizado, multicntrico, controlado con activo, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.826em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0752em;">abierto (NCT03043872). Los pacientes elegibles tenan un estado de rendimiento de la OMS de 0 o 1 y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.876em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.0547em;">eran adecuados para recibir un rgimen de quimioterapia basada en platino como tratamiento de primera &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.936em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0441em;">lnea para el CPCP. Los pacientes con metstasis cerebrales asintomticas o tratadas fueron elegibles. La &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.986em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1238em;">eleccin del agente de platino fue a discrecin del investigador, teniendo en cuenta el aclaramiento de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.046em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.7513em;">creatinina calculado. Pacientes con antecedentes de radioterapia torcica; antecedentes de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.096em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.043em;">inmunodeficiencia primaria activa; trastornos autoinmunes, incluido el sndrome paraneoplsico; trastornos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.146em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0045em;">autoinmunes o inflamatorios activos o previamente documentados; El uso de inmunosupresores sistmicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.206em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1885em;">dentro de los 14 das previos a la primera dosis del tratamiento, excepto que la dosis fisiolgica de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.256em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0007em;">corticosteroides sistmicos no era elegible. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.316em;"><span class="pdf24_14 pdf24_06 pdf24_08" style="word-spacing:-0.0137em;">La aleatorizacin se estratific mediante la terapia planificada basada en platino en el ciclo 1 (carboplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.366em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:0.0013em;">o cisplatino). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.476em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:-0.019em;">La evaluacin de la eficacia para CPCP-EE se bas en la comparacin entre: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.5885em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0231em;">IMFINZI 1500 mg, y la eleccin del investigador de carboplatino (AUC 5 o 6 mg/ml/min) o cisplatino (75- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.6385em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0201em;">80 mg/m2) el Da 1 y etopsido (80-100 mg/m2) por va intravenosa en los Das 1, 2 y 3 de cada ciclo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.6885em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0521em;">21 das durante 4 ciclos, seguido de IMFINZI 1500 mg cada 4 semanas hasta la progresin de la enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.7485em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0008em;">o toxicidad inaceptable, o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7985em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0095em;">La eleccin del investigador de carboplatino (AUC 5 o 6 mg/ml/min) o cisplatino (75-80 mg/m2) el Da 1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.8585em;"><span class="pdf24_14 pdf24_06 pdf24_84" style="word-spacing:0.0312em;">y etopsido (80-100 mg / m2) por va intravenosa los Das 1, 2 y 3 de cada uno Ciclo de 21 das, hasta 6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.9085em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0016em;">ciclos. Despus de completar la quimioterapia, PCI segn se administre segn el criterio del investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">53 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_53" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAATHElEQVR4nO3aMcqcdRwE4D2K5BSWuUIq7SSpUkv6qEVs0gU1QSWgIFrZ2QqezHfJCTIs8707eR749f9m2JndvVwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPjU/XPce+dcdG+Oe3WCdzh3b/f9ca9P8A7nbnHXLgUU/f7QD4A79ui4bx/6EXCHnh33+KEfATeiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrK3l4+fIg45z7+nhz36gTvcO7e7sVxT0/wDuducdcuBRS9O+4r51x0z497fYJ3OHdv98VxX57gHc7d4gwYKPOzJ+QeXfyFDOBTp0tBmdBBzoABQJeCMqGDnAEDgC4FZUIHOQMGAF0KyoQOcgYMALoUlAkd5AwYAHQpKBM6yBkwAOhSUCZ0kDNgANCloEzoIGfAAKBLQZnQQc6AAUCXgjKhg5wBA4AuBWVCBzkDBgBdCsqEDnIGDAC6FJQJHeQMGAB0KSgTOsgZMADoUlAmdJAzYADQpaDsr+P+dc5F9/dxf57gHc7d2/123B8neIdzt7hrlwKKfGsAOb/AQObZcY8f+hFwI7oUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCsreXDx8izrmPvyfHvTrBO5y7t3tx3NMTvMO5W9y1SwFF7477yjkX3fPjXp/gHc7d27087usTvMO5W5wBA2V+9oTco4u/kEHi2eXDN9ewQJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCMqGDnAEDGQOGJboUlAkd5AwYyBgwLNGloEzoIGfAQMaAYYkuBWVCBzkDBjIGDEt0KSgTOsgZMJAxYFiiS0GZ0EHOgIGMAcMSXQrKhA5yBgxkDBiW6FJQJnSQM2AgY8CwRJeCsmvo3jvnont73K8neIdz93bX7Px0gnc4d4v77QJU+dYAcn6BAUCXgjKhg5wBA4AuBWVCBzkDBgBdCsqEDnIGDAC6FJQJHeQMGAB0KSgTOsgZMADoUlAmdJAzYADQpaBM6CBnwACgS0GZ0EHOgAFAl4IyoYOcAQOALgVlQgc5AwYAXQrKhA5yBgwAuhSUCR3kDBgAdCkoEzrIGTAA6FJQJnSQM2AA0KWgTOggZ8AAoEtB2S/Hfeaci+7z4747wTucc8493P18AaquA+alcy66b457c4J3OOece7i7dimgyM+ekPMXMgB0KSgTOsgZMADoUlAmdJAzYADQpaBM6CBnwACgS0GZ0EHOgAFAl4IyoYOcAQOALgVlQgc5AwYAXQrKhA5yBgwAuhSUCR3kDBgAdCkoEzrIGTAA6FJQJnSQM2AA0KWgTOggZ8AAoEtBmdBBzoABQJeCMqGDnAEDgC4FZUIHOQMGAF0KyoQOcgYMALoUlP133HvnXHQ/HvfDCd7hnHPu4e7apQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADglv4H0KzHMIC5fj0AAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_310" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2025em;">La administracin de IMFINZI como agente nico estaba permitida ms all de la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0206em;">enfermedad si el paciente estaba clnicamente estable y obtena un beneficio clnico segn lo determinado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0076em;">por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.3237em;">La principal medida de resultado de eficacia fue la supervivencia global (OS) de IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.2299em;">quimioterapia versus quimioterapia sola. Las medidas de resultado de eficacia adicionales fueron la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0171em;">supervivencia libre de progresin (PFS) evaluada por el investigador y la tasa de respuesta objetiva (ORR), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0002em;">segn RECIST v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.03em;">Las caractersticas de la poblacin del estudio fueron: mediana de edad de 63 aos (rango: 28 a 82); 40% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_37" style="word-spacing:0.0045em;">de 65 aos o ms; 70% hombres; 84% blanco, 15% asitico y 0.9% negro; 65% OMS/ECOG PS de 1; y el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0235em;">93% eran ex/actuales fumadores. El noventa por ciento de los pacientes tena enfermedad en estado IV y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0074em;">el 10% tena metstasis cerebral al inicio del estudio. Un total del 25% de los pacientes recibi cisplatino y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6718em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0684em;">el 74% de los pacientes recibi carboplatino. En el brazo de quimioterapia sola, el 57% de los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0023em;">recibi 6 ciclos de quimioterapia y el 8% de los pacientes recibi PCI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8544em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0159em;">Los resultados de OS se resumen en la Tabla 24 y la Figura 4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_05 pdf24_06 pdf24_10" style="word-spacing:-0.0145em;">Tabla 24. Resultados de OS para el Estudio CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:26.1043em;"><span class="pdf24_05 pdf24_06 pdf24_208" style="word-spacing:-0.0203em;">Punto final &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5342em;top:26.1043em;"><span class="pdf24_05 pdf24_06 pdf24_21" style="word-spacing:-0.0615em;">IMFINZI con Etopsido y &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.5342em;top:27.1543em;"><span class="pdf24_05 pdf24_06 pdf24_73" style="word-spacing:-0.0212em;">Carboplatino o Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.0642em;top:28.1343em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=268) &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.6358em;top:26.1043em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:-0.0628em;">Etopsido y Carboplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.2758em;top:27.1543em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:0.0023em;">o Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1458em;top:28.1343em;"><span class="pdf24_05 pdf24_06 pdf24_107">(n=269) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:29.2343em;"><span class="pdf24_05 pdf24_06 pdf24_118" style="word-spacing:-0.031em;">Supervivencia Global (OS) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:30.3243em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0181em;">Nmero de muertes (%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_51" style="word-spacing:-0.0287em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:24.0242em;top:30.3243em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0031em;">155 (58) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1058em;top:30.3243em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">181 (67) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:31.4943em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0619em;">Mediana de OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:32.5543em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0038em;">(95% IC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.7742em;top:31.4843em;"><span class="pdf24_14 pdf24_06 pdf24_64">13.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4442em;top:32.4843em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0227em;">(11.5, 14.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.8558em;top:31.4843em;"><span class="pdf24_14 pdf24_06 pdf24_64">10.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7458em;top:32.4843em;"><span class="pdf24_14 pdf24_06 pdf24_208" style="word-spacing:-0.0188em;">(9.3, 11.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:33.5743em;"><span class="pdf24_14 pdf24_06 pdf24_170" style="word-spacing:-0.0063em;">Tasa de Peligro (95% IC)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_75" style="word-spacing:-0.01em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.492em;top:34.676em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.1158em;top:33.5743em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.73 (0.59, 0.91) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.9258em;top:34.676em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0047 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.8246em;"><span class="pdf24_88 pdf24_06 pdf24_15">*</span></div>
					<div class="pdf24_01" style="left:6.612em;top:35.8562em;"><span class="pdf24_41 pdf24_06 pdf24_92" style="word-spacing:0.1538em;">En un anlisis interino previamente especificado, se observaron 336 eventos de SO (79% del total de eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.382em;top:36.8162em;"><span class="pdf24_41 pdf24_06 pdf24_116" style="word-spacing:0.0158em;">planificados), y el lmite para declarar la eficacia (0.0178) se determin mediante una funcin de gasto alfa de Lan- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.382em;top:37.7762em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0011em;">DeMets con el lmite de tipo O'Brien Fleming &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.7262em;"><span class="pdf24_152 pdf24_06 pdf24_85" style="word-spacing:0.0287em;"> El anlisis se realiz utilizando la </span><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.0207em;">prueba de log-rank estratificada, ajustando la terapia de platino planificada en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.382em;top:39.6862em;"><span class="pdf24_41 pdf24_06 pdf24_121" style="word-spacing:0.0015em;">Ciclo 1 (carboplatino o cisplatino) y utilizando las pruebas de rango del enfoque de asociacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.686em;"><span class="pdf24_05 pdf24_06 pdf24_56" style="word-spacing:-0.026em;">Figura 5. Curvas Kaplan-Meier de Supervivencia Global en el Estudio CASPIAN &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.8283em;top:45.009em;"><span class="pdf24_261 pdf24_06 pdf24_151" style="word-spacing:-0.0632em;">IMFINZI + quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.8283em;top:45.689em;"><span class="pdf24_261 pdf24_06 pdf24_311">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.8283em;top:46.359em;"><span class="pdf24_261 pdf24_06 pdf24_190">Censurado &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">54 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_54" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_312" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:21.4942em;top:25.6243em;"><span class="pdf24_14 pdf24_06 pdf24_142" style="word-spacing:-0.0257em;">Tiempo de aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.032em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_38" style="word-spacing:0.0037em;">Nmero de pacientes en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.032em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_210" style="word-spacing:0.0132em;">IMFINZI + quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.032em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_61">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.1542em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:17.7542em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">268 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.7542em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">269 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.6842em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_15">3</span></div>
					<div class="pdf24_01" style="left:20.2742em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">244 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2742em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">242 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.8042em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_15">6</span></div>
					<div class="pdf24_01" style="left:23.3942em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">214 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.3942em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">209 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.9458em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_15">9</span></div>
					<div class="pdf24_01" style="left:26.5342em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">177 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5342em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">153 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8758em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_45">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.6658em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">116 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.8758em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">82 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.0058em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_45">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.0058em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">57 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.0058em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">44 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1258em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_45">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1258em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_45">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.1258em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_45">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2583em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_45">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.4583em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_15">5</span></div>
					<div class="pdf24_01" style="left:39.4583em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_15">1</span></div>
					<div class="pdf24_01" style="left:42.3783em;top:27.0345em;"><span class="pdf24_41 pdf24_06 pdf24_45">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:42.5883em;top:28.0945em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:42.5883em;top:29.0745em;"><span class="pdf24_41 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.1543em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0222em;">La PFS evaluada por el investigador (96% del total de eventos planificados) mostr una HR de 0.78 (IC del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.2043em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0299em;">95%: 0.65, 0.94), con una mediana de PFS de 5.1 meses (IC del 95%: 4.7, 6.2) en el brazo de IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2643em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.148em;">quimioterapia y 5.4 meses (IC 95%: 4.8, 6.2) en el brazo de quimioterapia sola. La ORR confirmada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.316em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0015em;">evaluada por el investigador fue del 68% (IC 95%: 62%, 73%) en el brazo de IMFINZI ms quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.366em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0034em;">y del 58% (IC 95%: 52%, 63%) en el brazo de quimioterapia sola. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.486em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0403em;">En los anlisis exploratorios de subbrazos de OS basados en la quimioterapia de platino planificada recibida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.536em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:0.0127em;">en el ciclo 1, la HR fue de 0.70 (IC 95% 0.55, 0.89) en pacientes que recibieron carboplatino, y la HR fue &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.596em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0033em;">de 0.88 (IC 95% 0.55, 1.41) en pacientes que recibieron cisplatino. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:42.696em;"><span class="pdf24_12 pdf24_06 pdf24_240">13.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:42.696em;"><span class="pdf24_05 pdf24_06 pdf24_170" style="word-spacing:-0.0113em;">Cncer de Vas Biliares (CVB) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.306em;"><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:-0.0328em;">CVB localmente avanzado o metastsico - TOPAZ-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.416em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0559em;">La eficacia de IMFINZI en combinacin con gemcitabina y cisplatino en pacientes con CVB localmente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4685em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0136em;">avanzado o metastsico se investig en TOPAZ-1 (NCT03875235), un estudio multicntrico, aleatorizado, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5185em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0357em;">doble ciego, controlado con placebo en el que participaron 685 pacientes con CVB localmente avanzado, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5785em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0372em;">irresecable o metastsico confirmado histolgicamente que no haban recibido terapia sistmica previa. Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.6285em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1752em;">pacientes con enfermedad recurrente &gt;6 meses despus de la ciruga y/o la finalizacin de la terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.6885em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0058em;">adyuvante fueron elegibles. Los pacientes tenan un estado de rendimiento ECOG de 0 y 1 y al menos una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7385em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.1066em;">lesin objetivo segn RECIST v1.1. No eran elegibles los pacientes con carcinoma ampular; trastornos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.7885em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0885em;">autoinmunes o inflamatorios activos o documentados con anterioridad; infeccin por VIH o infecciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.8485em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0152em;">activas, incluida la tuberculosis o la hepatitis C; uso actual o previo de medicacin inmunosupresora en los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.8982em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0041em;">14 das anteriores a la primera dosis de IMFINZI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">55 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
					<a name="55_0" style="position:absolute;left:4.25em;top:41.8333em;">&nbsp;</a>
				</div>
			</div>
		</div>
		<div id="page_55" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAY0klEQVR4nO3aMatdeRXG4fNJNK0o+AFEyGewsLCxHrQWZpqYStDCiDGMMSHMDHY2NjZ+OfctDqQ7L/vdctcangdW/y8ua/G7+9xuAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADwPfCrY14aY8zJ+fkxPxvwDmPu4+/RbJ5f3ICH/n3Mr40x5uT85pg/DHiHMfd5P+ANxpydf92Ah7577gcAq/3kmN899yPgM+4am3373A+ADSx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBA4EPx7wwxpiT8/KYrwa8w5j7uGtm87y/AQ89LfpXxhhzcl4f82bAO4y5z8cBbzDm7Ly9AQ/51A40/ISMadw1NvMTMghY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIPDhmFfGGHNyXh/zZsA7jLnPxwFvMObsvL0BDz0FzAtjjDk5L4/5csA7jLmPu2Y2z/sb8JBP7UDDT8iYxl1jMz8hg4BFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIfDjmhTHGnJyXx3w14B3G3MddM5vn/Q146GnRvzLGmJPz+pg3A95hzH0+DniDMWfn7Q14yKd2oOEnZEzjrrGZn5BBwKIHGgKGadw1NhMwELDogYaAYRp3jc0EDAQseqAhYJjGXWMzAQMBix5oCBimcdfYTMBAwKIHGgKGadw1NhMwELDogYaAYRp3jc0EDAQseqAhYJjGXWMzAQMBix5oCBimcdfYTMBAwKIHGgKGadw1NhMwELDogYaAYRp3jc0EDAQseqAhYJjGXWMzAQMBix5oCBimcdfYTMBAwKIHGgKGadw1NhMwELDogYaAYRp3jc0EDAQseqAhYJjGXWMzAQOBPz33A4DVfnTMF8/9CPiMu8Zmf3zuB8AG/lMFNHyBYRp3jc18gYGARQ80BAzTuGtsJmAgYNEDDQHDNO4amwkYCFj0QEPAMI27xmYCBgIWPdAQMEzjrrGZgIGARQ80BAzTuGtsJmAgYNEDDQHDNO4amwkYCFj0QEPAMI27xmYCBgIWPdAQMEzjrrGZgIGARQ80BAzTuGtsJmAgYNEDDQHDNO4amwkYCFj0QEPAMI27xmYCBgIWPdAQMEzjrrGZgIGARQ80BAzTuGtsJmAgYNEDDQHDNO4amwkYCFj0QEPAMI27xmYCBgJPi/6TMcacnHfH/GPAO4y5zz8HvMGYs/P1DXjIf6qAhi8wANfxBQYCAgZoCBiA6wgYCAgYoCFgAK4jYCAgYICGgAG4joCBgIABGgIG4DoCBgICBmgIGIDrCBgICBigIWAAriNgICBggIaAAbiOgIGAgAEaAgbgOgIGAgIGaAgYgOsIGAgIGKAhYACuI2AgIGCAhoABuI6AgYCAARoCBuA6AgYCAgZoCBiA6wgYCAgYoCFgAK4jYCAgYICGgAG4joCBwNfHvDTGmJPzy2N+P+AdxhjzfZi/3YCH/n7Mr40x5uT85pg/DHiHMcZ8H+avN+AhPyEDGn5CBnCdb5/7AbCBgAEaAgbgOgIGAgIGaAgYgOsIGAgIGKAhYACuI2AgIGCAhoABuI6AgYCAARoCBuA6AgYCAgZoCBiA6wgYCAgYoCFgAK4jYCAgYICGgAG4joCBgIABGgIG4DoCBgICBmgIGIDrCBgICBigIWAAriNgICBggIaAAbiOgIGAgAEaAgbgOgIGAgIGaAgYgOsIGAgIGKAhYACuI2Ag8M0xn4wx5uS8O+b9gHcYc5+/DHiDMWfnaacCD/gCAzR8gWEad43NfIGBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCH455YYwxJ+flMV8NeIcx93HXzOZ5fwMeelr0r4wx5uS8PubNgHcYc5+PA95gzNl5ewMe8qkdaPgJGdO4a2zmJ2QQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDgm2M+GWPMyXl3zPsB7zDmPt8NeIMxZ+dppwIP+E8V0PAFhmncNTbzBQYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAhY9EBDwDCNu8ZmAgYCFj3QEDBM466xmYCBgEUPNAQM07hrbCZgIGDRAw0BwzTuGpsJGAj8+bkfAKz242N++9yPgM+4a2zm7xcCf3ruBwCr/eiYL577EfAZd43N/vjcD4ANfGoHGn5CxjTuGpv5CRkELHqgIWCYxl1jMwEDAYseaAgYpnHX2EzAQMCiBxoChmncNTYTMBCw6IGGgGEad43NBAwELHqgIWCYxl1jMwEDAYseaAgYpnHX2EzAQMCiBxoChmncNTYTMBCw6IGGgGEad43NBAwELHqgIWCYxl1jMwEDAYseaAgYpnHX2EzAQMCiBxoChmncNTYTMBCw6IGGgGEad43NBAwELHqgIWCYxl1jMwEDAYseaAgYpnHX2EzAQODDMa+MMebkvD7mzYB3GHOfjwPeYMzZeXsDHnoKmBfGGHNyXh7z5YB3GHMfd81snvc34CGf2oGGn5AxjbvGZn5CBgGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBCx6oCFgmMZdYzMBAwGLHmgIGKZx19hMwEDAogcaAoZp3DU2EzAQsOiBhoBhGneNzQQMBL455pMxxpycd8f8Y8A7jLnPdwPeYMzZedqpwAP+UwU0fIFhGneNzXyBgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAhY90BAwTOOusZmAgYBFDzQEDNO4a2wmYCBg0QMNAcM07hqbCRgIWPRAQ8AwjbvGZgIGAv895pUxxpyc18e8GfAOY+7zccAbjDk7/7kBD/30mBfGGHNyfnDMDwe8w5j7/GDAG4w5O09ftQEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA+D/4H557c+jfHr6eAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_313" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0055em;">La aleatorizacin se estratific segn el estado de la enfermedad (recurrente vs. inicialmente irresecable) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.2985em;">la localizacin del tumor primario (colangiocarcinoma intraheptico [ICCA] vs. colangiocarcinoma &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0829em;">extraheptico [ECCA] vs. cncer de vescula biliar [GBC]). Los pacientes fueron aleatorizados 1:1 para &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_122">recibir: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:7.502em;top:11.2667em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01 pdf24_28" style="left:7.502em;top:13.4367em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:11.3718em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.045em;">IMFINZI 1500 mg el Da 1+ gemcitabina 1000 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.0603em;">2 </span></sup><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0397em;">y cisplatino 25 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.0776em;">2 </span></sup><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0418em;">los Das 1 y 8 de cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:12.4218em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0004em;">ciclo de 21 das hasta 8 ciclos, seguidos de IMFINZI 1500 mg cada 4 semanas, o &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:13.5418em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0002em;">Placebo el Da 1+ gemcitabina 1000 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.1465em;">2 </span></sup><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0035em;">y cisplatino 25 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.1465em;">2 </span></sup><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0004em;">los Das 1 y 8 de cada ciclo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:14.5918em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0017em;">21 das hasta 8 ciclos, seguido de placebo cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.7018em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:0.2498em;">El tratamiento con IMFINZI o placebo continu hasta la progresin de la enfermedad o toxicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.7518em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.089em;">inaceptable. Se permiti el tratamiento ms all de la progresin de la enfermedad si el paciente estaba &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.8018em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0018em;">clnicamente estable y obtena un beneficio clnico segn lo determinado por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.9243em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.017em;">La principal medida de resultado de eficacia fue la supervivencia global (OS). Otras medidas de resultado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.9743em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1188em;">de eficacia fueron la supervivencia libre de progresin (PFS), la tasa de respuesta objetiva (ORR) y la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0243em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0437em;">duracin de la respuesta (DoR) evaluadas por el investigador. Las evaluaciones del tumor se realizaron cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.0843em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0437em;">6 semanas durante las primeras 24 semanas despus de la fecha de aleatorizacin, y despus cada 8 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.1343em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0021em;">hasta que se confirmara la progresin objetiva de la enfermedad. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.2443em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:-0.0262em;">Las caractersticas de la poblacin del estudio fueron: 50% varones, mediana de edad de 64 aos (rango 20- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.2943em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1777em;">85), 47% de 65 aos o ms; 56% asiticos, 37% blancos, 2% negros o afroamericanos, 0.1% indios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.3443em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.1283em;">americanos o nativos de Alaska y 4% otros; 51% tenan un ECOG PS de 1; la localizacin del tumor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4043em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0869em;">primario fue ICCA 56%, ECCA 18% y GBC 25%; 20% de los pacientes tenan enfermedad recurrente; &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.4543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0006em;">86% de los pacientes tenan enfermedad metastsica y 14% tenan enfermedad localmente avanzada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5643em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.059em;">En un anlisis interino preespecificado, el estudio demostr una mejora estadsticamente significativa de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.616em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.075em;">OS y PFS en los pacientes aleatorizados a IMFINZI en combinacin con quimioterapia en comparacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.676em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.0655em;">con placebo en combinacin con quimioterapia. En la Tabla 25 se resumen los resultados de eficacia de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.726em;"><span class="pdf24_14 pdf24_06 pdf24_314">TOPAZ-1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:38.836em;"><span class="pdf24_05 pdf24_06 pdf24_37" style="word-spacing:-0.025em;">Tabla 25. Resultados de Eficacia del Estudio TOPAZ-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.502em;top:39.936em;"><span class="pdf24_05 pdf24_06 pdf24_131" style="word-spacing:-0.0186em;">Criterio de valoracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.6942em;top:39.936em;"><span class="pdf24_05 pdf24_06 pdf24_31" style="word-spacing:0.0031em;">IMFINZI con &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5342em;top:40.986em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:-0.0588em;">Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4042em;top:42.046em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.5758em;top:39.936em;"><span class="pdf24_05 pdf24_06 pdf24_204" style="word-spacing:-0.0119em;">Placebo con &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.0758em;top:40.986em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:-0.0579em;">Gemcitabina y &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.9458em;top:42.046em;"><span class="pdf24_05 pdf24_06 pdf24_60">Cisplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6858em;top:43.026em;"><span class="pdf24_05 pdf24_06 pdf24_269" style="word-spacing:0.0166em;">(n = 341) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.2158em;top:43.026em;"><span class="pdf24_05 pdf24_06 pdf24_269" style="word-spacing:0.0179em;">(n = 344) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.502em;top:44.116em;"><span class="pdf24_05 pdf24_06 pdf24_48" style="word-spacing:-0.0332em;">Supervivencia global (OS) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.216em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0216em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:46.316em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0174em;">Mediana de la OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_195" style="word-spacing:-0.0126em;">(CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_236" style="word-spacing:-0.0199em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.7258em;top:45.216em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0031em;">198 (58) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4758em;top:46.316em;"><span class="pdf24_14 pdf24_06 pdf24_64">12.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4442em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_267" style="word-spacing:-0.015em;">(11.1, 14) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4058em;top:45.216em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">226 (66) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.1683em;top:46.316em;"><span class="pdf24_14 pdf24_06 pdf24_64">11.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.8258em;top:47.356em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0199em;">(10.1, 12.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:48.4585em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.0062em;">ndice de riesgo (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_23" style="word-spacing:-0.0098em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.1858em;top:48.4585em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.80 (0.66, 0.97) &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.8158em;top:49.5485em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.021 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:49.5485em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.502em;top:50.6385em;"><span class="pdf24_05 pdf24_06 pdf24_07" style="word-spacing:-0.0356em;">Supervivencia libre de progresin (PFS) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:51.7385em;"><span class="pdf24_14 pdf24_06 pdf24_98" style="word-spacing:-0.0236em;">Nmero de pacientes con evento (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3742em;top:51.7385em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0049em;">276 (81) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4158em;top:52.8285em;"><span class="pdf24_14 pdf24_06 pdf24_64">7.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4058em;top:51.7385em;"><span class="pdf24_14 pdf24_06 pdf24_289" style="word-spacing:0.0058em;">297 (86) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.3983em;top:52.8285em;"><span class="pdf24_14 pdf24_06 pdf24_64">5.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.8985em;"><span class="pdf24_14 pdf24_06 pdf24_98" style="word-spacing:-0.0179em;">Mediana en meses (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_209" style="word-spacing:-0.0283em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.2642em;top:53.8785em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0121em;">(6.7, 7.4) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8942em;top:54.9685em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">0.75 (0.63, 0.89) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.9458em;top:56.0685em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.001 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.2958em;top:53.8785em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0112em;">(5.6, 6.7) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:54.9685em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.0062em;">ndice de riesgo (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_23" style="word-spacing:-0.0098em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.502em;top:56.0685em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0167em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_185" style="word-spacing:-0.0264em;"> &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.002em;top:57.2784em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;">* </span></sup><span class="pdf24_41 pdf24_06 pdf24_86" style="word-spacing:-0.0041em;">Mediana estimada de Kaplan-Meier con CI del 95% derivada mediante el mtodo de Brookmeyer-Crowley. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">56 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_56" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_315" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.042em;"><sup style="top: -0.2917em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:0.1389em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_146" style="word-spacing:0.0037em;">Basado en el modelo de riesgos proporcionales de Cox estratificado por estado de la enfermedad y localizacin del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.002em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:0.0012em;">tumor primario. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.942em;"><sup style="top: -0.29em;"><span class="pdf24_224 pdf24_06 pdf24_15" style="word-spacing:0.1204em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_223" style="word-spacing:-0.0004em;">Valor p bilateral basado en una prueba de rango logartmico estratificada comparada con un lmite alfa de 0.030 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.912em;"><sup style="top: -0.29em;"><span class="pdf24_154 pdf24_06 pdf24_15" style="word-spacing:0.1204em;"> </span></sup><span class="pdf24_41 pdf24_06 pdf24_223" style="word-spacing:-0.0004em;">Valor p bilateral basado en una prueba de rango logartmico estratificada comparada con un lmite alfa de 0.048 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.9218em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0015em;">La ORR evaluada por el investigador fue del 27% (CI del 95%: 22% - 32%) en el brazo de IMFINZI ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.9718em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0032em;">quimioterapia y del 19% (CI del 95%: 15%-23%) en el brazo de quimioterapia sola. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.0818em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0269em;">Figura 6: Curvas de Kaplan-Meier de la OS en el Estudio TOPAZ-1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.1317em;top:30.2691em;"><span class="pdf24_316 pdf24_317 pdf24_89" style="word-spacing:-0.0736em;">IMFINZI + quimioterapia (N=341) &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.1317em;top:30.8791em;"><span class="pdf24_316 pdf24_317 pdf24_13" style="word-spacing:-0.0197em;">Quimioterapia (N=344) &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.4142em;top:33.4128em;"><span class="pdf24_318 pdf24_06 pdf24_37" style="word-spacing:0.0028em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:34.4475em;"><span class="pdf24_101 pdf24_06 pdf24_165" style="word-spacing:0.0048em;">Nmero de pacientes en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.092em;top:35.4975em;"><span class="pdf24_101 pdf24_06 pdf24_155" style="word-spacing:-0.01em;">IMFINZI + &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.3617em;top:35.5075em;"><span class="pdf24_101 pdf24_06 pdf24_254" style="word-spacing:0.0764em;">341 331 324 309 294 278 268 252 238 208 174 151 135 118</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:0.2628em;">&nbsp;</span><span class="pdf24_101 pdf24_06 pdf24_102" style="word-spacing:0.473em;">93 79 74 57 49 39 29 24 15 12 9</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:0.15em;">&nbsp;</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:0.0767em;">8 4 1 0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.092em;top:36.3475em;"><span class="pdf24_101 pdf24_06 pdf24_40">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.092em;top:37.2475em;"><span class="pdf24_101 pdf24_06 pdf24_110">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.3617em;top:37.2475em;"><span class="pdf24_101 pdf24_06 pdf24_254" style="word-spacing:0.0787em;">344 337 329 317 299 283 261 242 220 183 159 143 125</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:0.2495em;">&nbsp;</span><span class="pdf24_101 pdf24_06 pdf24_102" style="word-spacing:0.4937em;">97 78 65 52 40 29 21 15 10</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:3.6567em;">&nbsp;</span><span class="pdf24_101 pdf24_06 pdf24_15" style="word-spacing:0.09em;">4 3 0 0 0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8583em;top:37.2475em;"><span class="pdf24_101 pdf24_06 pdf24_15">8</span></div>
					<div class="pdf24_01" style="left:41.0883em;top:37.2475em;"><span class="pdf24_101 pdf24_06 pdf24_15">4</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:40.456em;"><span class="pdf24_12 pdf24_06 pdf24_240">13.4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:40.456em;"><span class="pdf24_05 pdf24_06 pdf24_165" style="word-spacing:-0.0531em;">Carcinoma hepatocelular (CHC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.066em;"><span class="pdf24_55 pdf24_06 pdf24_19" style="word-spacing:-0.0156em;">CHC no resecable </span><span class="pdf24_242 pdf24_06 pdf24_15" style="word-spacing:-0.0217em;"> </span><span class="pdf24_55 pdf24_06 pdf24_190">HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.176em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0017em;">La eficacia de IMFINZI en combinacin con tremelimumab-actl se evalu en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.226em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0103em;">(NCT03298451), un estudio multicntrico, abierto, aleatorizado (1:1:1) en pacientes con CHC irresecable &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.276em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0003em;">confirmado que no haban recibido tratamiento sistmico previo para CHC. Los pacientes fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3385em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0137em;">aleatorizados a uno de los dos brazos de investigacin (IMFINZI ms trememlimumab-actl o IMFINZI) o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3885em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0009em;">sorafenib. El tratamiento del estudio consisti en 1500 mg de IMFINZI en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4485em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0016em;">tremelimumab-actl como una infusin intravenosa nica nica de 300 mg el mismo da, seguido de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4985em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0009em;">IMFINZI cada 4 semanas; IMFINZI 1500 mg cada 4 semanas; o sorafenib 400 mg por va oral dos veces &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5485em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0004em;">al da, hasta progresin de la enfermedad o toxicidad inaceptable. La evaluacin de la eficacia de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0013em;">IMFINZI se basa en pacientes asignados al azar al brazo de IMFINZI ms tremelimumab-actl frente al &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6585em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0014em;">brazo de sorafenib. La aleatorizacin se estratific por invasin macrovascular (MVI) (s o no), etiologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0003em;">de la enfermedad heptica (virus de la hepatitis B frente a virus de la hepatitis C frente a otros) y estado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7685em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0044em;">funcional ECOG (0 frente a 1). &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">57 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_57" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAalUlEQVR4nO3asaplh3mG4X0lQfdhiQyMjxDp4hRWd4IjkKshjFXZkKkshNRZ4DkDgkFJlSI3kSa3lbWQb2Cv4tv/7+954Ov/YnE271nrdgMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP4+/d+xj2Zmwb0cez/gDuve+Qx+GHCH2b37n2Nf36DYfz36AKDO87HXjz6Ceucz+PzoI+CCL4/906OPgEcSMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6Z8B8NDML7uXY+wF3WPfOZ/DDgDvM7t357D7doJg3MAAAe3gDQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOoJGACAPQQM9QQMAMAeAoZ6AgYAYA8BQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOoJGACAPQQM9QQMAMAeAoZ6H449m5kF99vbLz/Aj77DuvflzXNoO/enY083KHYGzCszs+DeHvtqwB3WvfMZfDvgDrN79+bY5zco5hMyIO38D+LrRx9BvfMZfH70EXCBT8ioJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDvZ+PfTQzC+79sb8OuMO6dz6DLwPuMLt357P76xsU8wYGSHu+eQPD43kDw1bewFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUO/D7Zc/4GZmqf3HsW8G3GHd+8OxdwPuMLt3fzr2dINiZ8C8MjML7u2xrwbcYd377NinA+4wu3dvjn1+g2I+IQPSzv8g+oQM4BqfkFFPwABpAgbgOgFDPQEDpAkYgOsEDPUEDJAmYACuEzDUEzBAmoABuE7AUE/AAGkCBuA6AUM9AQOkCRiA6wQM9QQMkCZgAK4TMNQTMECagAG4TsBQT8AAaQIG4DoBQz0BA6QJGIDrBAz1BAyQJmAArhMw1BMwQJqAAbhOwFBPwABpAgbgOgFDPQEDpAkYgOsEDPUEDJAmYACuEzDU+/nYRzOz4N7/bY++w8xs415u/glEOW9ggLTnmx9fgKu8gaGegAHSBAzAdQKGegIGSBMwANcJGOoJGCBNwABcJ2CoJ2CANAEDcJ2AoZ6AAdIEDMB1AoZ6AgZIEzAA1wkY6gkYIE3AAFwnYKgnYIA0AQNwnYChnoAB0gQMwHUChnoCBkgTMADXCRjqCRggTcAAXCdgqCdggDQBA3CdgKGegAHSBAzAdQKGegIGSBMwANcJGOoJGCBNwABcJ2Co99Oxd2ZmwX1/7M8D7jAz27jzb+jTDYqdAfOJmVlw//C3PfoOM7ON+7djX9ygmE/IAAD28AkZ9QQMAMAeAoZ6AgYAYA8BQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOoJGACAPQQM9QQMAMAeAoZ6AgYAYA8BQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOr957GPZmbBvRx7P+AO6975DH4YcIfZvTuf3acbFPMGBkh7Pvb60UdQ73wGnx99BFzgDQz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCo99Oxd2ZmwX1/7M8D7rDufXvshwF3mN2774493aDYGTCfmJkF9/Wx3wy4w7p3PoO/H3CH2b373bEvblDMJ2RA2vPNJ2Q8nk/I2MonZNQTMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKHeD48+AKhz/vj+46OPoN75DH756CPggn8+9vToI+CRvIEB0ryBYQJvYNjKGxjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6Px37xMwsuK+P/WbAHda9fzn2+wF3mN273x374gbFzoB5Z2YW3PfHvh1wh3XvD8f+fcAdZvfuu2NPNyjmEzIg7fnmEzKAq3xCRj0BA6QJGIDrBAz1BAyQJmAArhMw1BMwQJqAAbhOwFBPwABpAgbgOgFDPQEDpAkYgOsEDPUEDJAmYACuEzDUEzBAmoABuE7AUE/AAGkCBuA6AUM9AQOkCRiA6wQM9QQMkCZgAK4TMNQTMECagAG4TsBQT8AAaQIG4DoBQz0BA6QJGIDrBAz1BAyQJmAArhMw1BMwQJqAAbhOwFDv52MfzcyC+8uxHwfcYWa2cS/Hfn2DYt7AAADs4Q0M9QQMAMAeAoZ6AgYAYA8BQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOoJGACAPQQM9QQMAMAeAoZ6AgYAYA8BQz0BAwCwh4ChnoABANhDwFBPwAAA7CFgqCdgAAD2EDDUEzAAAHsIGOq9HHtlZhbcr459NuAO6975DH464A6ze/fm2Oc3KPbh2LOZWXDvjn0z4A7r3vkMvhtwh9m9++OxpxsU8wkZkHb+AL9+9BHUO5/B50cfARf4hIx6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUOwPmo5lZcC/H3g+4w7p3PoMfBtxhdu/OZ/fpBsW8gQHSnm/ewPB43sCwlTcw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAod7LsVdmZsG9PfbVgDuse+cz+HbAHWb37s2xz29Q7MPtl/9AmZml9u7YNwPusO6dz+C7AXeY3bs/Hnu6QTGfkAFp5w+wT8h4NJ+QsZVPyKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYChnoAB0gQMEwgYthIw1BMwQJqAYQIBw1YChnoCBkgTMEwgYNhKwFBPwABpAoYJBAxbCRjqCRggTcAwgYBhKwFDPQEDpAkYJhAwbCVgqCdggDQBwwQChq0EDPUEDJAmYJhAwLCVgKGegAHSBAwTCBi2EjDUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUO9M2A+mpkF93Ls/YA7rHvnM/hhwB1m9+58dp9uUMwbGACAPbyBoZ6AAQDYQ8BQT8AAAOwhYKgnYAAA9hAw1BMwAAB7CBjqCRgAgD0EDPUEDADAHgKGegIGAGAPAUM9AQMAsIeAoZ6AAQDYQ8BQT8AAAOwhYKgnYAAA9hAw1BMwAAB7CBjqCRgAgD0EDPUEDADAHgKGegIGAGAPAUO9l2OvzMyC+9WxzwbcYd07n8FPB9xhdu/eHPv8BsV+OvbOzCy47499O+AO6975DP4w4A6ze/fdsacbFPMJGZD2fOz1o4+g3vkMPj/6CLjAJ2TUEzBAmoBhAgHDVgKGegIGSBMwTCBg2ErAUE/AAGkChgkEDFsJGOoJGCBNwDCBgGErAUM9AQOkCRgmEDBsJWCoJ2CANAHDBAKGrQQM9QQMkCZgmEDAsJWAoZ6AAdIEDBMIGLYSMNQTMECagGECAcNWAoZ6AgZIEzBMIGDYSsBQT8AAaQKGCQQMWwkY6gkYIE3AMIGAYSsBQz0BA6QJGCYQMGwlYKgnYIA0AcMEAoatBAz1BAyQJmCYQMCwlYCh3v8e+2hmFtxfjv044A7r3o83z6Ht3H8f+9cbAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADU+H81UOFWyB3zkwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_319" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0003em;">El estudio inscribi a pacientes con BCLC en estado C o B (no elegibles para terapia locorregional). El &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.001em;">estudio excluy a pacientes con coinfeccin de hepatitis viral B y hepatitis C; sangrado gastrointestinal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0025em;">(GI) activo o previamente documentado dentro de los 12 meses; ascitis que requiere intervencin no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0159em;">farmacolgica dentro de los 6 meses; encefalopata heptica dentro de los 12 meses anteriores al inicio del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0008em;">tratamiento; trastornos autoinmunes o inflamatorios activos o previamente documentados. La &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0011em;">esofagogastroduodenoscopia no era obligatoria antes de la inscripcin, pero se requera una terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0009em;">endoscpica adecuada, de acuerdo con los estndares institucionales, para los pacientes con antecedentes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0008em;">de hemorragia por vrices esofgicas o aquellos evaluados como de alto riesgo de hemorragia por vrices &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0011em;">esofgicas por el mdico tratante. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0073em;">Se permiti el tratamiento del estudio ms all de la progresin de la enfermedad si el paciente estaba &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0018em;">clnicamente estable y obtena un beneficio clnico segn lo determinado por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0004em;">La principal medida de resultado de eficacia fue la supervivencia global (OS) entre el brazo de IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7843em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0017em;">ms tremelimumab-actl versus el brazo de sorafenib. Los resultados de eficacia adicionales fueron la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0152em;">supervivencia libre de progresin (PFS) evaluada por el investigador, la tasa de respuesta objetiva (ORR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8943em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:-0.0054em;">y la duracin de la respuesta (DoR) segn RECIST v1.1. Las evaluaciones del tumor se realizaron cada 8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0015em;">semanas durante los primeros 12 meses y luego cada 12 semanas a partir de entonces. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0143em;">Los datos demogrficos iniciales de los brazos de IMFINZI ms tremelimumab-actl y sorafenib fueron los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.1143em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0022em;">siguientes: hombres (85 %), edad &lt; 65 aos (50 %), mediana de edad de 65 aos (rango: 18 a 88 aos), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1643em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0005em;">blancos (46 % ), asitico (49 %), negro o afroamericano (2 %), nativo de Hawi u otras islas del Pacfico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0022em;">(0.1 %), raza desconocida (2 %), hispano o latino (5 %), no hispano o latino (94 % ), etnia Desconocida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0014em;">(1%), ECOG PS 0 (62%); Child-Pugh Class score A (99 %), invasin macrovascular (26 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3243em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0022em;">diseminacin extraheptica (53 %), etiologa viral; hepatitis B (31%), hepatitis C (27%) y no infectados &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3843em;"><span class="pdf24_14 pdf24_06 pdf24_54">(42%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.496em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0189em;">Los resultados de eficacia se presentan en la Tabla 26 y la Figura 7. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.596em;"><span class="pdf24_05 pdf24_06 pdf24_58" style="word-spacing:-0.0236em;">Tabla 26. Resultados de eficacia del estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8258em;top:37.686em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0488em;">IMFINZI y &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.1642em;top:38.746em;"><span class="pdf24_05 pdf24_06 pdf24_132">Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2058em;top:39.806em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 393) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:37.706em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0193em;">Criterio de Valoracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6283em;top:37.706em;"><span class="pdf24_05 pdf24_06 pdf24_138">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.7283em;top:38.756em;"><span class="pdf24_05 pdf24_06 pdf24_269" style="word-spacing:0.0151em;">(N = 389) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:40.826em;"><span class="pdf24_05 pdf24_06 pdf24_213" style="word-spacing:-0.0293em;">OS (Supervivencia Global) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:41.926em;"><span class="pdf24_14 pdf24_06 pdf24_209" style="word-spacing:-0.0166em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:43.026em;"><span class="pdf24_14 pdf24_06 pdf24_208" style="word-spacing:-0.0214em;">Mediana OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:44.066em;"><span class="pdf24_14 pdf24_06 pdf24_23" style="word-spacing:-0.0013em;">(IC del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1458em;top:41.926em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0072em;">262 (66.7) &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2458em;top:43.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">16.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.9058em;top:44.066em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0227em;">(14.2, 19.6) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6683em;top:41.926em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0072em;">293 (75.3) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.7783em;top:43.026em;"><span class="pdf24_14 pdf24_06 pdf24_64">13.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4383em;top:44.066em;"><span class="pdf24_14 pdf24_06 pdf24_213" style="word-spacing:-0.0227em;">(12.3, 16.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:45.166em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:-0.0383em;">HR (IC del 95%) </span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_58" style="word-spacing:-0.0607em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.4258em;top:45.166em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.78 (0.66, 0.92) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.492em;top:46.256em;"><span class="pdf24_14 pdf24_06 pdf24_15" style="word-spacing:-0.0166em;">Valor p</span><sup style="top: -0.33em;"><span class="pdf24_135 pdf24_06 pdf24_15" style="word-spacing:0.1207em;">,  &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:33.2458em;top:46.256em;"><span class="pdf24_14 pdf24_06 pdf24_80">0.0035 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:47.346em;"><span class="pdf24_05 pdf24_06 pdf24_303">PFS &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:48.4385em;"><span class="pdf24_14 pdf24_06 pdf24_118" style="word-spacing:-0.0175em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:49.5385em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0222em;">Mediana PFS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:50.5885em;"><span class="pdf24_14 pdf24_06 pdf24_23" style="word-spacing:-0.0013em;">(IC del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1458em;top:48.4385em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0072em;">335 (85.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:49.5385em;"><span class="pdf24_14 pdf24_06 pdf24_64">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.3858em;top:50.5885em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0139em;">(3.7, 5.3) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6683em;top:48.4385em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0072em;">327 (84.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9983em;top:49.5385em;"><span class="pdf24_14 pdf24_06 pdf24_64">4.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.9083em;top:50.5885em;"><span class="pdf24_14 pdf24_06 pdf24_100" style="word-spacing:-0.0139em;">(3.7, 5.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.772em;top:51.6785em;"><span class="pdf24_14 pdf24_06 pdf24_16" style="word-spacing:-0.0122em;">HR (IC del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_246" style="word-spacing:-0.0193em;">* &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.492em;top:52.7685em;"><span class="pdf24_05 pdf24_06 pdf24_297">ORR &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.4258em;top:51.6785em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.018em;">0.90 (0.77, 1.05) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.452em;top:53.8585em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0175em;">ORR % (IC del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.125em;">,  &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.452em;top:54.9585em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0217em;">Respuesta Completa n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.452em;top:56.0585em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.021em;">Respuesta Parcial n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.492em;top:57.1482em;"><span class="pdf24_05 pdf24_06 pdf24_320">DoR &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.9542em;top:53.8585em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">20.1 (16.3, 24.4) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:54.9585em;"><span class="pdf24_14 pdf24_06 pdf24_274" style="word-spacing:0.0051em;">12 (3.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1758em;top:53.8585em;"><span class="pdf24_14 pdf24_06 pdf24_49" style="word-spacing:-0.0061em;">5.1 (3.2, 7.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.3283em;top:54.9585em;"><span class="pdf24_14 pdf24_06 pdf24_15">0</span></div>
					<div class="pdf24_01" style="left:27.3658em;top:56.0585em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">67 (17.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.1183em;top:56.0585em;"><span class="pdf24_14 pdf24_06 pdf24_274" style="word-spacing:0.0051em;">20 (5.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.452em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_126" style="word-spacing:-0.0196em;">Mediana DoR (months) (IC del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.1242em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0138em;">22.3 (13.7, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.7158em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_27" style="word-spacing:-0.0105em;">18.4 (6.5, 26.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">58 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_58" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_321" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.492em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_65" style="word-spacing:-0.0193em;">Criterio de Valoracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8258em;top:5.9818em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0488em;">IMFINZI y &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.1642em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_132">Tremelimumab-actl &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2058em;top:8.1018em;"><span class="pdf24_05 pdf24_06 pdf24_120" style="word-spacing:-0.0065em;">(N = 393) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.6283em;top:5.9918em;"><span class="pdf24_05 pdf24_06 pdf24_138">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.7283em;top:7.0418em;"><span class="pdf24_05 pdf24_06 pdf24_269" style="word-spacing:0.0151em;">(N = 389) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.452em;top:9.1218em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0168em;">% con duracin </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_17" style="word-spacing:-0.0054em;">6 meses &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.452em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0168em;">% con duracin </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0162em;"> </span><span class="pdf24_14 pdf24_06 pdf24_185" style="word-spacing:-0.0043em;">12 meses &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2458em;top:9.1218em;"><span class="pdf24_14 pdf24_06 pdf24_64">82.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.2458em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">65.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.7783em;top:9.1218em;"><span class="pdf24_14 pdf24_06 pdf24_64">78.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.7783em;top:10.2118em;"><span class="pdf24_14 pdf24_06 pdf24_64">63.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.482em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0168em;">* HR (IMFINZI y tremelimumab-actl frente a sorafenib) basado en el modelo estratificado de riesgos proporcionales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.432em;"><span class="pdf24_41 pdf24_06 pdf24_322" style="word-spacing:-0.0014em;">de Cox. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.382em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:-0.003em;"> </span><span class="pdf24_41 pdf24_06 pdf24_33" style="word-spacing:0.0036em;">Basado en una prueba de rango logartmico estratificada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.352em;"><span class="pdf24_152 pdf24_06 pdf24_15" style="word-spacing:0.009em;"> </span><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.0088em;">Sobre la base de una funcin de gasto alfa de Lan-DeMets con lmite de tipo O'Brien Fleming y el nmero real de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.312em;"><span class="pdf24_41 pdf24_06 pdf24_212" style="word-spacing:-0.0016em;">eventos observados, el lmite para declarar la significacin estadstica de IMFINZI y tremelimumab-actl frente a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.272em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:-0.003em;">sorafenib fue de 0.0398 (Lan y DeMets 1983). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.232em;"><span class="pdf24_41 pdf24_06 pdf24_08" style="word-spacing:-0.0004em;"> Respuesta completa confirmada o respuesta parcial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.182em;"><span class="pdf24_41 pdf24_06 pdf24_35" style="word-spacing:-0.0006em;"> Basado en el mtodo de Clopper-Pearson. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.142em;"><span class="pdf24_41 pdf24_06 pdf24_66" style="word-spacing:-0.0049em;">IC=Intervalo de Confianza, HR=Razn de Riesgo, NR=No Alcanzado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1543em;"><span class="pdf24_05 pdf24_06 pdf24_140" style="word-spacing:-0.0181em;">Figura 7. Curvas de Kaplan-Meier de OS en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.4442em;top:37.7388em;"><span class="pdf24_323 pdf24_06 pdf24_210" style="word-spacing:-0.0186em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:42.566em;"><span class="pdf24_12 pdf24_06 pdf24_240">13.5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:42.566em;"><span class="pdf24_05 pdf24_06 pdf24_156" style="word-spacing:-0.0169em;">Cncer de Endometrio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.166em;"><span class="pdf24_55 pdf24_06 pdf24_32" style="word-spacing:-0.027em;">Cncer de Endometrio </span><span class="pdf24_242 pdf24_06 pdf24_15" style="word-spacing:-0.0326em;"> </span><span class="pdf24_55 pdf24_06 pdf24_71" style="word-spacing:-0.0248em;">Estudio DUO-E &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.286em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0753em;">DUO-E fue un estudio de Fase III, multicntrico, aleatorizado, doble ciego y controlado con placebo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3385em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0189em;">primera lnea de quimioterapia basada en platino en combinacin con IMFINZI, seguida de IMFINZI con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3885em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0839em;">o sin olaparib en pacientes con cncer de endometrio avanzado o recurrente. Las pacientes deban tener &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4485em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0223em;">cncer de endometrio en una de las siguientes categoras: enfermedad en Estadio III de nuevo diagnstico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4985em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0339em;">(enfermedad medible segn RECIST 1.1 despus de la ciruga o una biopsia de diagnstico), enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5585em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.2187em;">en Estadio IV de nuevo diagnstico (con o sin enfermedad despus de la ciruga o una biopsia de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6085em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0048em;">diagnstico) o recurrencia de la enfermedad (enfermedad medible o no medible segn RECIST 1.1) donde &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6585em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0275em;">el potencial de curacin mediante ciruga sola o en combinacin es bajo. Para las pacientes con enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.7185em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0065em;">recurrente, se permiti quimioterapia previa solo si se administraba en adyuvancia y haban transcurrido al &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7685em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0345em;">menos 12 meses desde la fecha de la ltima dosis de quimioterapia administrada hasta la fecha subsiguiente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.8282em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0206em;">de recada. El ensayo incluy pacientes con carcinomas epiteliales de endometrio de todas las histologas, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.8782em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0006em;">incluidos los carcinosarcomas. Se excluyeron las pacientes con sarcoma de endometrio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">59 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_59" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:7.0918em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0947em;">La aleatorizacin se estratific segn el estado de reparacin de errores de emparejamiento (MMR) del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0629em;">tejido tumoral (competente frente a deficiente), el estado de la enfermedad (recurrente frente a de nuevo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0985em;">diagnstico) y la regin geogrfica (Asia frente al resto del mundo). Las pacientes fueron aleatorizadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0005em;">1:1:1 a uno de los siguientes brazoss: &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:7.502em;top:12.3167em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:12.4218em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.341em;">Brazo 1 (quimioterapia basada en platino): Quimioterapia basada en platino (paclitaxel y &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:13.4718em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:0.0501em;">carboplatino) cada 3 semanas durante un mximo de 6 ciclos con placebo de durvalumab cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:14.5318em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0084em;">semanas. Una vez finalizado el tratamiento de quimioterapia, las pacientes sin progresin objetiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:15.5818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.004em;">de la enfermedad recibieron placebo de durvalumab cada 4 semanas y comprimidos de placebo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:16.6418em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.046em;">olaparib dos veces al da como tratamiento de mantenimiento hasta la progresin de la enfermedad. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:7.502em;top:18.7067em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:18.8118em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0256em;">Brazo 2 (quimioterapia basada en platino + IMFINZI): Quimioterapia basada en platino (paclitaxel &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:19.8643em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0238em;">y carboplatino) cada 3 semanas durante un mximo de 6 ciclos con 1120 mg de durvalumab cada &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:20.9143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0492em;">3 semanas. Una vez finalizado el tratamiento de quimioterapia, las pacientes sin progresin objetiva &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:21.9743em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0111em;">de la enfermedad recibieron 1500 mg de durvalumab cada 4 semanas con comprimidos de placebo &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:23.0243em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:0.2504em;">de olaparib dos veces al da como tratamiento de mantenimiento hasta la progresin de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:24.0843em;"><span class="pdf24_14 pdf24_06 pdf24_138">enfermedad. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_28" style="left:7.502em;top:26.1492em;"><span class="pdf24_29 pdf24_30 pdf24_15"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:26.2543em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0122em;">Brazo 3 (quimioterapia basada en platino + IMFINZI + olaparib): Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:27.3043em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2028em;">(paclitaxel y carboplatino) cada 3 semanas durante un mximo de 6 ciclos con 1120 mg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:28.3543em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0212em;">durvalumab cada 3 semanas. Una vez finalizado el tratamiento de quimioterapia, las pacientes sin &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:29.4143em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0165em;">progresin objetiva de la enfermedad recibieron 1500 mg de durvalumab cada 4 semanas con 300 &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:30.4643em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.2487em;">mg de olaparib comprimidos dos veces al da como tratamiento de mantenimiento hasta la &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:31.5243em;"><span class="pdf24_14 pdf24_06 pdf24_39" style="word-spacing:-0.0034em;">progresin de la enfermedad. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.626em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0398em;">Las pacientes que suspendieron cualquiera de los medicamentos (IMFINZI/placebo u olaparib/placebo) por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.686em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0407em;">razones distintas a la progresin de la enfermedad, podan continuar el tratamiento con el otro medicamento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.736em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.0005em;">si fuera apropiado segn las consideraciones de toxicidad y el criterio del investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.846em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1859em;">El tratamiento continu hasta la progresin de la enfermedad definida por RECIST v1.1 o toxicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.906em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:-0.0155em;">inaceptable. La evaluacin del estado del tumor se realiz cada 9 semanas durante las primeras 18 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.956em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0048em;">tras la aleatorizacin y posteriormente cada 12 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.066em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0066em;">La variable primaria fue la PFS, determinada mediante la evaluacin del investigador utilizando RECIST &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.116em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:-0.0182em;">1.1. Las variables secundarias de eficacia fueron la OS, la ORR y la DoR. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.226em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1301em;">El estudio demostr una mejora estadsticamente significativa en la PFS en la poblacin ITT, para las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.276em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.2527em;">pacientes tratadas con quimioterapia basada en platino + IMFINZI + olaparib en comparacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.326em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.1428em;">quimioterapia basada en platino [HR=0,55 (CI del 95%: 0,43, 0,69), p=&lt;0,0001], y para las pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.3885em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.1248em;">tratadas con quimioterapia basada en platino + IMFINZI en comparacin con quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4385em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.1095em;">platino [HR=0,71 (CI del 95%: 0,57, 0,89), p=0,003]. En el momento del anlisis de la PFS, los datos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4985em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0em;">interinos de OS tenan una madurez del 28% con acontecimientos en 199 de 718 pacientes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.6085em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0369em;">El estado de reparacin de errores de emparejamiento (MMR) se determin de forma centralizada mediante &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.6585em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0756em;">inmunohistoqumica. De un total de 718 pacientes aleatorizadas en el estudio, 575 (80%) pacientes eran &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.7185em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0021em;">MMR competente (pMMR) y 143 pacientes (20%) MMR deficiente (dMMR). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.8285em;"><span class="pdf24_55 pdf24_06 pdf24_157" style="word-spacing:-0.0261em;">Pacientes con cncer de endometrio MMR deficiente (dMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">60 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_60" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_324" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2533em;">Entre las pacientes dMMR, las caractersticas demogrficas y basales estuvieron generalmente bien &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0349em;">equilibradas entre los brazos de tratamiento. Los datos demogrficos basales en los tres brazos fueron los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0269em;">siguientes: mediana de edad de 62 aos (intervalo: 34 a 85), 41% de 65 aos o ms, 1,5% de 75 aos o ms, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0043em;">62% blancas, 29% asiticas y 2% negras o afroamericanas. Las caractersticas de la enfermedad fueron las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0067em;">siguientes: ECOG PS de 0 (58%) o 1 (42%), 46% de nuevo diagnstico y 54% con enfermedad recurrente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0144em;">Los subtipos histolgicos fueron endometrioide (83%), epitelial mixto (5%), seroso (3%), carcinosarcoma &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0013em;">(3%), indiferenciado (2%) y otro (3%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0777em;">Los resultados en pacientes dMMR se resumen en la Tabla 27 y la Figura 8. La mediana del tiempo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5118em;"><span class="pdf24_14 pdf24_06 pdf24_71" style="word-spacing:0.0985em;">seguimiento de la PFS en pacientes dMMR censuradas fue de 15,5 meses en el brazo de quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:0.1494em;">basada en platino + IMFINZI y de 10,2 meses en el brazo de quimioterapia basada en platino. En el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0375em;">momento del anlisis de la PFS, los datos interinos de OS tenan una madurez del 26% con acontecimientos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6718em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.0247em;">en 25 de 95 pacientes tratadas con quimioterapia basada en platino + IMFINZI y quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_14 pdf24_06 pdf24_229">platino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.592em;top:21.8544em;"><span class="pdf24_05 pdf24_06 pdf24_34" style="word-spacing:-0.0249em;">Tabla 27. Resultados de eficacia del estudio DUO-E (Pacientes con estado de tumor dMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.4742em;top:22.9643em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0672em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.6042em;top:24.0143em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:-0.0002em;">platino + IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.3458em;top:25.0043em;"><span class="pdf24_05 pdf24_06 pdf24_325">N=46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.3458em;top:22.9643em;"><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0584em;">Quimioterapia basada &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.7383em;top:24.0143em;"><span class="pdf24_05 pdf24_06 pdf24_279" style="word-spacing:0.0001em;">en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.6783em;top:25.0043em;"><span class="pdf24_05 pdf24_06 pdf24_325">N=49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:26.2843em;"><span class="pdf24_05 pdf24_06 pdf24_194">PFS</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_190">a,</span><span class="pdf24_70 pdf24_06 pdf24_190">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:27.5943em;"><span class="pdf24_14 pdf24_06 pdf24_149" style="word-spacing:-0.0161em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:28.9043em;"><span class="pdf24_05 pdf24_06 pdf24_164" style="word-spacing:-0.0261em;">Mediana PFS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_48" style="word-spacing:-0.0415em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:27.7158em;top:27.5943em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">15 (32.6) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0383em;top:27.5943em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">25 (51.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0958em;top:28.9043em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0118em;">7.0 (6.7, 14.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.5683em;top:30.2143em;"><span class="pdf24_14 pdf24_06 pdf24_15">-</span></div>
					<div class="pdf24_01" style="left:26.8558em;top:28.9043em;"><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0017em;">NR (NR, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3042em;top:30.2143em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">0.42 (0.22, 0.80) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:30.2143em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:31.5243em;"><span class="pdf24_05 pdf24_06 pdf24_301">OS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_302">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:32.8343em;"><span class="pdf24_14 pdf24_06 pdf24_134" style="word-spacing:-0.0223em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:34.146em;"><span class="pdf24_05 pdf24_06 pdf24_209" style="word-spacing:-0.0178em;">Mediana OS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_220" style="word-spacing:-0.0282em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:35.456em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.9458em;top:32.8343em;"><span class="pdf24_14 pdf24_06 pdf24_127" style="word-spacing:0.0095em;">7 (15.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0383em;top:32.8343em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">18 (36.7) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8558em;top:34.146em;"><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0017em;">NR (NR, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3042em;top:35.456em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">0.34 (0.13, 0.79) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.8058em;top:34.146em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0133em;">23.7 (16.9, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.5683em;top:35.456em;"><span class="pdf24_14 pdf24_06 pdf24_15">-</span></div>
					<div class="pdf24_01" style="left:6.322em;top:36.766em;"><span class="pdf24_05 pdf24_06 pdf24_326">ORR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_327">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:38.076em;"><span class="pdf24_14 pdf24_06 pdf24_196">ORR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.1121em;">d </span></sup><span class="pdf24_14 pdf24_06 pdf24_291" style="word-spacing:0.0138em;">n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:39.386em;"><span class="pdf24_05 pdf24_06 pdf24_277">DoR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_328">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:27.7158em;top:38.076em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">30 (71.4) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.0383em;top:38.076em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">17 (40.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:40.696em;"><span class="pdf24_05 pdf24_06 pdf24_98" style="word-spacing:-0.0166em;">Mediana de DoR (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_208" style="word-spacing:-0.0264em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.8558em;top:40.696em;"><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0017em;">NR (NR, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0358em;top:40.696em;"><span class="pdf24_14 pdf24_06 pdf24_51" style="word-spacing:-0.0063em;">10.5 (4.3, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.9462em;"><span class="pdf24_41 pdf24_06 pdf24_118" style="word-spacing:0.01em;">a Evaluada por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.8962em;"><span class="pdf24_41 pdf24_06 pdf24_86" style="word-spacing:-0.0041em;">b Los resultados se basan en el primer anlisis interino (fecha de corte de datos: 12 de abril de 2023). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.8562em;"><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0025em;">c Calculado usando la tcnica de Kaplan-Meier. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.8262em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0092em;">d Respuesta: Mejor respuesta objetiva como respuesta completa confirmada o respuesta parcial. Basado en el nmero &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.7862em;"><span class="pdf24_41 pdf24_06 pdf24_155" style="word-spacing:0.2488em;">de pacientes en el brazo de tratamiento con enfermedad medible al inicio del ensayo (N=42 en el brazo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.7462em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0016em;">quimioterapia basada en platino + IMFINZI, N=42 en el brazo de quimioterapia basada en platino). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.6987em;"><span class="pdf24_41 pdf24_06 pdf24_35" style="word-spacing:-0.0027em;">CI=Intervalo de Confianza, HR= Razn de Riesgo, NR=No Alcanzada &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">61 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_61" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAABmS0lEQVR4nOzdB5yU1b3/8UnTxJiYRHOj5iaxRhNvkpuoiTe+riX+1auJRrFhIahYCKKgglIFpBeRJtIEpCtIkSIISBPpRXqH0Kt0EEvO/3zP7lmHYVYZnZnz7LOf9+v1e+3u7LMzZ58p5/ye0xIJAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQT+Y4/fvf/zaffPKJ+fjjj4tCP3/66afudwRBEASR61Cdk64O8kLXqQCAPMg0gdmxY4cZN26ceeONN1wMHjyYIAiCIPIWvv5Zs2aNOXLkyFFJTOg6FQCQB5kmMAsXLjQtWrQwr776qhk+fDhBEARB5DXefPNNU61aNTNp0iRz8OBBemAAoLQ53gTGJzHvv/++eeWVV8zy5ctdxUEQBEEQ+YwDBw6Ytm3bmqlTp5oPP/zwqHoqdJ0KAMiDL5PAqPflX//6VyZ/CgBAVqguevnll817771HAgMApZHGDqdOgtRQsdTwEyhJYAAAIZHAAEApp5Vc1q1b5yZDHj582FUASmiWLFli+vXrZ2bNmuW6630SQwIDAAiJBAYASjklKFWrVnXzWnbu3OkqAI0x1vjigQMHmqZNm5rFixcX9dIcTwKj43Rf69evN4cOHTqqd8f//osqp3S3fdHfAQDijwQGAEo5JRhDhgwxgwYNckski762adPGLFiwwHTo0MFMnDjR9cLs2bPHjBo1ynTq1OlzExgdd//995sLLrjArRTTs2dP15uTHHrMZcuWmdGjR5v+/fsX3d63b1/3uEqi1Oujr1q2WbcrkVIvEYkMAJReJDAAUMqpIhg7dqwZOnRoUQKzfft2065dO5dgqGdGCcTevXvNrl27zMiRI03nzp1d70px1Pty/fXXmxNPPNHceuutpn79+qZZs2ZHxdVXX2169eplunXrZpo3b37U76ZMmWL27dtnPvroI5cM9e7d2zzwwAOmS5cuZtu2bSQwAFCKkcAAQCmnXg6fwChx2bRpk5sT07p1a9fjoYRi2rRpbrMwzZeZM2eO61H5vB4YHTd+/HhXweh43e8HH3xwVNx2222uF0ZJkxKj5N+pt0f34XdcVhKjREdD17Zu3ZrruhEAEGEkMABQys2ePdvUrl3blC9f3vWuqJdjxowZLmGoVauW623ZsGFDxpP4lfD4RCSdsmXLus3I1MtyPJWVhpnpcbds2UIPDACUYiQwAFDK7d+/3yUFGzdudD0d6g1R4qGvmzdvdl9VQWQyif94ZJLAyJgxY9z8Gw1PI4EBgNKLBAYASrnk1b2Sv6aGv/2rJjC6D/XmKIG55557TI0aNVxPjw/1BtWpU8d91VwYLTIgSqqUbPmhZb5HCACQP75O0FL79913n7n44ovNH/7wh+OOSy65xA1N1kWzL/sZTgIDAKVcppVGNnpglHzoft5++23Xs6KvyaHbNKSte/fubk6MHtfPh9GKaCtXrnSVFgkMAOSXvwili0orVqxwq0YuXLjwuEPHa1jyV1lRkgQGAEq5TCuNbPXAaI6MKrB0oaWTtfyyVkDzCYz+RlGlShW34IB6Y5TU+PvU9z5Se4+Sj0vXs5RaPhIjACie/1z1n8uZhu9JJ4EBAHwpmVYa2ZoD80WPo6FlSmA0B0c/q8LTfJmHHnrIvPbaa26ZZd2mmDp1qtvHRhtv6sqerxiTK9jk5MY/RvLvPN/ToyCRAYDoIYEBgFIu00ojnwnMU0895faAUY+LYtWqVW5o2c033+zmyWgomTbCvOKKK8zpp5/u4oYbbjCPPPKIqVSpkvv7pUuXFiUkWl2tXr167neKf/7zn+7rrFmzilZL02M0btzYDBs2zO19AwCIFhIYACjlMq00cp3A+J4RJRBPPvmkqVixoks0lLR07NjRJTIDBgwwI0aMcPvLaI+ayy67zG2a+d3vftclJD169DD9+vVzPTLaN8YPC9P+NsOHD3e/86HlmfW/+F4Y3WfVqlVN+/bt3aaZAICj+V5xDffVXBi/yIp6xpPnJ/q5Mvpd8nEaKqwedYaQAQC+lEwrjXwlMKoIlUAoAVF06tTJTerX46rS1OpkqgB1nHpWNPFfq5ZpI05VkDpGofvyVOHq7/zv0h2j79UD89JLL7FpJgCk0Ge0Pns1IV8rSf7+9793oRXGtCKZPqd3797tjtVneIUKFdzKY/q9P1afsevXrz9q+G6mZSCBAYBSLNNKIx8JjJ+7kjwhX70lqRtZKiHxiwEoMdHXr7q8sv62efPmrreHBAYAjuY/o3XxR3MO16xZ42L16tUutPCKvyikz2gtl+x/549VTzerkAEAvrRMK418zIFJR0O9evXq5TbX9EmN71HR0ssaWqbf+dVtvuyVPVW87dq1c8PQlMCkTvIHAHx1X/VCEwkMAJRimVYaIRIY3wOjeTB/+9vfzO233+7ijjvuMDfeeKM577zzzJlnnmmuueYa07JlSzc04cv2xOjvdAVRQyBUMWoIhK4UAgCigQQGAEq5TCuNUD0wSkomTJhg3nrrLbfymELfd+3a1Y27Pvfcc4sm/KuMX3aPgeT9ZFQxalEALRQAAIgGEhgAKOWKqxzSbegYMoHxm1+qsvKh4WNa6njevHlm9uzZ5s033zRPPPGEmT9/flb2cNFj3HnnnWbixIlZ+A8AANlAAgMApVzqBo++ciju9lAJTDpKarQajiowDfOaNGlSUQKTDbpfDVMjgQGA6CCBAYBSThXA66+/7lbdWrJkSVHvhibF9+nTxw3RWrt2bdHKYOrt6NmzZyQSGPE9RSpb7dq1zQUXXOA2v9Tyysk9SZmG7k89PLfccosbljZ9+nS3h4Fu1/wYPdatt95qJk+e7HqGvspj+dA59ptuZqMHCQDiiAQGAEo57VqvfVS0ceTIkSPNjh073MT1Dh06mDlz5pjWrVubqVOnusZ8FBMYUWWmoWSa5H/SSSeZ//3f/zX6v9QbU6VKlS8V/m+vu+46c+WVV5p7773XPP744+62hx56yJxzzjlu40wtIvDYY4996cdJfUzF008/bZYvXx76tAJAJJHAAEApd/fdd7shV5oU361bN5eYKImpWbOmW/lLjXb1xuzZs8f1xGh5Ye1Sr0n1UaJeCy1/fNNNN7khbqtWrXJ7xviNML9MaFlm7XOgc6K9DPSzNspUclG1alVTtmxZM2rUKPe7r/I4ybFu3TpTp04dN1QPAHAsEhgAKOW0k7J6VdQQHzhwoGv0q0LwQ8sqV65s3n33XTdMSqHeGiUxUeqB8TRsTEmANljL5t4tuq+VK1e6/WZ0fnQetBGbeqp0rrI53Es9XQ0aNCCBAYBikMAAQCn3/PPPm+7du5tnn33WjBgxwrRq1cpMmTLFreqlCqJ+/fpm6dKlRRP6ozSJP180dO61115zQ9PUw6Nllf28l2wjgQGAz0cCAwClnHoSNMdFsXPnTjdkSsPF1NMyfvx4N2zM9zKU1gRGw9Nq1aplfvKTn7h5L0rq1BOT7QRG96feI92/Xwo63UT/L7tJJwDEAQkMAJRyqghUAfgeBd/T4pcmTh6KVVoTGJ0DDa+7/fbbzdlnn+16Y9RTkm3+vDdq1Mjcf//9pkKFCseEVj7TKmtaCQ0ASiMSGAAo5TKtNEprAqP5NStWrHDDuzRnSPvP5KIXRL0rmlujhQG0YEBy6LZevXqZwYMHm127dmX9sQGgJCCBAYBSLtNKozQmMH7DTPW6aIidlmzO5TCuz7tfzVN68803SWAAlFokMABQymVaaZTWBEZzU5o0aWIuvvhiU7duXZfIhJiHQgIDoLQjgQGAUi7TSqM0JjAaQrZ//363meXJJ5/svmo4Wb4TGD2eEpiGDRuaLl26uH16+vfv72LZsmVuHhMAxB0JDACUcplWGqU1gdFKZJMnTzZXXXWV2zBTK7blO4FROebMmeMSmCeffNI8/fTT5qmnnjJlypRxm1+WpucEQOlFAgMApVymlUZpTWA0jExzYCpVquQm0msVsBAJjMqwY8cOt5Gmvmrjzpdeesktvbx69eq8lgcAQiCBAYBSLtNKozQmMMn7sFStWtV06NDBJQ4hhpD58JTU6PnQhqQ+gUneM4b9YgDEDQkMAJRymVYapTGB8dT7Ua5cObcXTKtWrVwPSGh6TrQvjBKYVatWHbXZpVZOS97HBwDigAQGAEq5TCuN0pzAaNjYjTfeaE488URTuXJldw5C93Do8TWk7e6773aro7Vp06YolNhs3rw5eBkBIJtIYACglMu00ijNCYx6NSZOnGhatGhhZs6caQ4fPuxuC9nLoedkxowZrkdIvTCNGjVy0bhxY3PfffeZWbNmkcAAiBUSGAAo5TKtNEpzAiMaRvbBBx+YTZs2mY0bN7r9YUInCEqkVCbtDeNDq6RplTIlN6HLBwDZRAIDAKWceg+SI3mieLrbSnsC48/JoEGD3DCttWvXBk8Q0k3Y18/PPvvsl05gWAQAQFSRwABAKbdt2zbXGB8wYICbL6H9ThRLliwx7du3N2+//ba7uq+hUiQwn9H8Eu3HEsWli/U86Tn0CUxqEvpFwSIAAKKMBAYASrkmTZq43d19sqKJ6hqC9MILL5gxY8YY/V6NYFUSasySwBSIegKjBOShhx5yUatWLVO7du2MQhtjasPODRs2hP53AOAoJDAAEE9n2bjCxjdsPGyjkY3vpDtQE721u/vw4cPNa6+9ZrZs2WL279/vGr1KamrUqGHmzp3rrsarUTxv3jzTs2fPUp/A9OnTxyUwK1eujNwwK98DM3jwYLdnjTa6zDQ6duzoNu1csGBB6H8HAI5CAgMA8XSPjXNt/M3GHBuX2yib7sCyZcu6XpXRo0ebHj16uCvuGjKmVa3UiH300UfNlClTXCWhieHqfdGV+fXr1wequqKhb9++LoFZsWJFJBMYJZv79u0ze/bsMXv37s041BPXoEED99oAgCghgQGAeLrLxuk2lti4zMZ3bdyX7kDtH6IellGjRpkhQ4aYqVOnuvkvL774ouuZadmypRk7dqxrDKsXRsPJlOiU9gRm2bJl7lxouF1xc0xCSl6A4cv8rRIgDR9UApPJ/JnQ/zeA+COBAYB4+p6N5jbutnGKjdo2rkp3oPYJ0QR+9baoUT5w4ECXuGiIlDZI1HCi5cuXF03oZg5MAZ0PLamsUG+FeqfUc+X3hinJDXmfwGgvmePtgfHD1kr6/w4g+khgACC+NISslo1KNs4o7iB9+KvhrQb4gQMH3JAjffX7iuzYscM1yv3VfBKYAn6Y1vz5802zZs3cnitXXHGFG4rnFzwoqfz/VrlyZaMeukceeeQLQ8dOmzbN7YtTkv93ANFHAgMA8XSBjbmJgsn71Wx0TRQkNMdIt4RucfvCkMAcTedDPTDbt293ix/8/e9/N8OGDXMVaknvhVD5J0+e7BZ2+KJQD57+d/XaKQEu6f87gGgjgQGAeHrAxkkpt1VId2CmlQYJzLGU6Gn4VIUKFczIkSOLeqxKuiNHjrgelS8K9dj985//dEtLK4EBgFwigQGAePo/G78q/P7bNqrY+Ee6AzOtNEhgjuXnjGgjUK3g5ZecTu6JKO77z7utJPA9c48//jg9MADyggQGAOLp6zZetLHYxic2Xi687RiZVhokMMXT+VHvixIZrdKm0LLUCk3095Pc1bOxdevWot+r0a/bSlqvjZ8ro/9LCYwWffCrsgFArpDAAEA8XZf0vTaz/K2NM9MdmGmlQQLz+TZu3Gi6du3q9ohRPP/88+6r5pNoqJUa/Oql0Waguv3GG280b7zxhts89MsuexyST2CeeOIJN4Ru0aJFJDAAcooEBgDi53Ebk230SIrRNu5Pd3CmlQYJzOfT8DH1tmj1Nq3sptD3Pnnx82W0ypsm/5cvX97079/f7bNTEhv+fvjcxIkTTZkyZcy7775b4pIwACULCQwAxI+GinVKFOz74uN/EwU9McfItNIggckO3/B/7rnn3MR/3wNTUmkoXNmyZV0CAwC5RAIDAPH1AxtnFYYm9F+d7qBMKw0SmOzwS1arF8ZP/C/JCYzm/WjPGBIYALlGAgMA8XSDjeU2JhSGhpTdn+7ATCsNEpjs0jlV8qJhZal78PgoCUhgAOQLCQwAxFNFG79Oue2cdAdmWmmQwGSfNsFs1KiRefDBB4+KwYMHu/k0JWFOCQkMgHwhgQGAeLrARt3EZ3NgtC/M39Md6PfxSK0c/G2p35PAZJ8qYCUAOqd++eW1a9e6if7qmSGBAYDPkMAAQDzdYmNE4rNVyHrauDfdgZpI7lfH8vwEc79vid+UkQQmd/z59ZH8vJDAAMBnSGAAIJ6+aeMSG+clCvZ/+Q8bJ6c7UPMv/BwM31DW9343+dSGNAlMfuicqxdGE/xJYADgMyQwABBPV9hYlvhs4n7jRMGwsmO89dZbpm7duqZixYquMtBO8pp30bZtW1OlShVz1113mREjRrh9TJTEzJ8/nwQmD3SuH3nkEbcBZpQn8vvV1PSa+P3vf+9eN7t27SrqSfK9eSUhCQNQMpDAAEA8/dPGCTZuKvz5ERu10x2o3dMnTZpkBgwYYIYNG2a2bdtmjhw54pb3XbVqlWnQoIGZPXt2US/N3LlzXWNV8zSQO2r433PPPWb8+PGRTmCUnKiXSGX9wQ9+YE4//XTzy1/+0lx44YXmV7/6lQslwYsXLw5dVAAxQQIDAPH0RxvX2njQxvU21icKJvMfQw1PJSXqienSpYsbtuSHlb3zzjtm4MCBbniQkhdtVtizZ0/Trl07emByTEnL888/75LHKPdeqJxqQPTr18+tnNahQwf3elLyq9AmnQ888ICZNWtWpP8PACUHCQwAxJc2rnzZRmcb1xV3kOYtzJkzxzU0+/Tp45IUJSu6qt66dWszb968oiFASmpmzJhhunfvTgKTYzrnzZo1c8lAlHtgRK+NgwcPmh07dpj9+/cfVV7NmXr00UddIpbrMiTvnZM8f8svSOH32gnJly1f5Ug9L/48pFu8AygpSGAAIF78PJcf2jgrKS61cU26P9AQsRYtWpjKlSu7fUd69OjhkhZdUe/bt68bUpZcaTCJPz/UuFQCqTlHJbmRma8ExjfOk5MVvxiFH/4YelU3v7qcXyAjH+XwCYw/F6lfS/JrC6UXCQwAxMfXbLxa+P19NubaGJgoWEZ5pI3y6f5Ic12mTJni5sEoWVm4cKEbMua/qqGTXGmQwOSHGpbaB0aVc/IVdB8lZThWvhKYffv2mY4dOxrN6VKUK1fOPPzww6Zq1aru5/79+5udO3cGb7AvW7bMPPfcc2bQoEFusYxcP5e+d6xz586mfv36rgdVCy1UqlTJTJ061S3akbqEd0l5baH0IoEBgHj6dqJg6eRkaVchU0WgCkAT99WY8leH012dJYHJP3/Oq1ev7ibDK4YMGeIa7FGnsi9atMj87W9/M9dff7258847cxbXXXed+cUvfmG+973vmZNPPtmcdNJJ7vtTTjnFfP/73zdnnXWW+etf/2rKli2b03J8UVx55ZXmjDPOMGeffXZeyqPXyy233GLOOeccc+qpp5r/+q//MmeeeaY7L1o17tZbby16XSmp2rNnT4lKkFE6kcAAQDx9z0bDxGcbWapnply6AzOtNEhg8kvnXL1kEydONMOHD3cT+7VinJYqjjqV/dChQ25vGC3FrXlWuQoNf7ztttvM+eef7xKZn//8524lNDXYzzvvPHP//febXr16uXOYy3J8UbRq1cr8z//8j0teunbtmvPz4s9NmTJl3LmoWbOme+yLLrrIvZaGDh3qyqAhpC1btjQbN24kgUHkkcAAQDw9a6NGomDlMcX/s3FzugMzrTRIYPJPDUr1kGko0OjRo824cePclfKSQK8ZlV1DlXIdW7dudct767Wp0Pf+ZyWB2ssoH+X4vNDiGJs2bTJbtmxxCx7k4zGVRPpzo2GJ/nsNYdPvFC+88IIL3U7ygqgjgQGAeLrKxv+k3Paf6Q7MtNIggQlHQ/vU6NXwMX0PZIPe15oXo0UjtAohEHUkMAAQT2fYGGtjQmFMtHF/ugMzrTRIYMJJXgaXq+TIFhIYlDQkMAAQTzVtPJz4bBnl823cmO7ATCsNEphw/B4iJDDIJhIYlDQkMAAQT7+z8eeU285Nd2CmlQYJTDhKYJYuXeqW4tW8BSAbSGBQ0pDAAEA83WXj/cRnQ8jm26iQ7sBMKw0SmHB0/t966y0zatQoNxkbyAafwPhJ/PncKyd1b6NsbvDp97TxPZep/1fqY3/e6mv+Puj5jAYSGACIp1/YuC7x2RCys238Kd2BmVYaJDBhacnbN998s0Qso4ySITWByWdD3c/pUmjvKUW2Htvva5V838nDL/1wzOQoLonx889Cb4SKAiQwABAvZxV+/WHis+RFcaGNq9P9QaaVBglMWCQwyDafwGgfHb/HUL4SGCUEGram13WPHj3cnkFaaS9b971mzRr3funYsaPbS0nLj/v/Tb/XUMyxY8eamTNnutX90iUwun3gwIFmwoQJbhlsemHCI4EBgPj4mo2Bhd+XTxw9hGySjQfS/VGmlQYJTDhqXGkjxvbt23P+kRV+aFSbNm3chp/aBLRcuXLmqaeeyktUq1bN/OUvf3Ebj55++unmN7/5jXnggQeyct9PP/20ufzyy919//jHPzZnnXXWUf+bfn/fffe5DU8V2uxUt6Xezx133OHOje4n1+dG56NPnz5m27ZtJEqfgwQGAOLpOzZOT7mNfWBKODU0NYm/f//+bsd04Kvyw6z0nr7gggvMT3/6U1O7dm3zyiuvmO7du+c09BjdunUzt956qznttNPMCSec4JKM5557Lmv3f+2115pTTjnFnHjiiebMM880derUOer3devWNeeee6773+vVq+fK4/93fd+1a1dTtWpV87Of/cwlQbVq1crpuXnxxRdNo0aNzMqVK0lgPgcJDADEk5IX9cZ83caZiYI9YL6R7kBfGaRGckXhfyaBCUuNTb+bu8bjA1+Vnzi/e/duN8Rq3rx5ZseOHW7YVD5Cr+UtW7aYOXPmmDFjxmT98Tdt2mRmzZrlhqjps2vnzp1HPbaGy+kxV6xY4b5PLZu+qjwaPjZ//vyj/j4XoRUG27Vr58qD4pHAAEA8VbZxbdLPZRPFDCHTGHBVAlOmTHGVs5/MqspbDZpx48a5CtyPDSeBCYurssgFva7UE6NkJgQ97pEjR3Ly+LpPNXKLm4B/PIsW6NzkYwK/elZfeukl1wOD4pHAAEA8/d3Gjwq//6aNXjaqpjuwQYMGZtKkSaZ3797uKqOuxKqy7ty5sxk6dKhZtGiRuzLoK3kSGADIDRKY40MCAwDxpKTlpUTBBP5NNobbOCndgZqUOnfuXDfEQisQacjF1q1bTfXq1V3odt8Do96aqVOnujHgJDD5p+dAKzQ1adLEDbc5cOBA6CIByCISmONDAgMA8XWWjfNtnGvjlOIOuvvuu12vihrEvXr1chXo5s2bTf369d0QMq1OpOFlaizr9tdee80tSar9IpBfGtqnOTCVKlVyE361mSVDyoD4IIE5PiQwABBPl9lYlyiYvC/NbJyT7kAtWaoJtBouNmTIEPPOO++4hEar9eh2Ldn79ttvuzkxGqOu/RK0XwMJTP75FaOefPJJ9xzkc78OALlHAnN8SGAAIJ4eSxQMGbup8OeHbNRKd6ASllatWpkaNWq4hGXw4MFutR1t/qYkpnXr1mb16tVFk1iZAxOO37NDQ/uUwGjRhXzumg4gt0hgjg8JDADE059tXG7jdhtX2Fhj47p0B2qC/vbt293GaRompmFJ+qrbNRdGjWRVEGook8CElZrAaG4SCQwQHyQwx4cEBgDi6282+tt43UaZ4g5SA9gnJ/qqeRb+Z3+b/5lVyMLT86DNLDWETxU3yQsQHyQwx4cEBgDiKTVhucTGL9MdmGmlQQITnk8qSV6AeCGBOT4kMAAQP9rEckmiYAllHwtt3Jnu4EwrDRIYAMgNEpjjQwIDAPFUPVGwjLKPM2yckO7ATCsNEphwdP7V87J48WIzbtw4N2+JnhggPkhgjg8JDADE09dt3Gajpo16Nuon6IEp8fwcJW0uqqWU33jjDfaCAWKEBOb4kMAAQDxVsdE7UbB8cnkblRIkMCWeX1RB+/VcfPHF5j//8z9Nnz593KpxAEo+EpjjQwIDAPF0baJg4n6ys9IdmGmlQQITjk9gZs+ebf70pz+Zk08+2fTq1cscPHgwdNEAZAEJzPEhgQGAePp7omDyfo/CeNXGfekOzLTSIIEJxw8hU4+LNhr9y1/+YrQRqRIbACUfCczxIYEBgHj6vY3HbVxVGNrE8q/pDsy00iCBCUvPgRKWQ4cOucYOvS9AfJDAHB8SGACIL+37UidRsKzymcUdlGmlQQIDALlBAnN8SGAAIJ4utDHHRsNEwYT+LjbOS3dgppUGCUx0qOLWcLKPPvqIlciAGCCBOT4kMAAQTw/Y+E7KbRXSHejnVRw5csQ1hPW93+ld4SeO6ysJTDToedDQsTp16pg//vGPpmHDhmbDhg3MhQFKOBKY40MCAwDxdL2Niwq/VyLzlI1y6Q5UcrJ3714XSmKUwPiERhWDQj+TwESHngclm1u2bDFt27Y1zz33nFmxYgUJDFDCkcAcHxIYAIgnbWT5go3lNj6y0aHwtmOMHTvWtG7d2lSrVs3MnDnTHD582PW49OjRw7zyyitm+PDhZvv27a5xrJg3b57p2bMnCUxgvmesb9++pn79+iQwQAz4BEbv5927d5s9e/YUXVDSz2qs632vBny+Qp8renxtmqsy7Nu3L/iwVRIYAIivawq/agL/ucUd9Mgjj5gpU6aY1157zSUrO3fudBVk48aNzciRI822bdtcUuN7ZubMmeMSmPXr1wequpCsf//+RQkM82CAkk0JTKtWrUz37t3NzTffbK655hozbNgw07x5c3PllVeaJk2amPnz55t169a5z+Bchx5nzZo17iKXlm3XkNXLL7/c9OvXzyUzoS6akMAAQDzdbeMNG18r/LlaomBp5WOULVvWJSWjRo1ylabmUihRef31103Lli1drFq1yl1x27Fjh+ndu7dp164dPTARoedr8eLF7kotPTBAyaVGuYaFVqhQwVxyySXmhz/8odus9uKLLza/+MUvzHe/+11zzjnnuATi6quvzlsocdHjnnTSSebEE0803/nOd0zdunXdZ4/vDQpxrkhgACB+7k75+ZFEwZLKxx54991FCYx6YVSBqlJSg1i9LzVq1DCTJ08umh+jYWZKdEhgokHPiV+NTJtb6nkhkQFKJr2f9bm7cOFC1+vSoEED10jv06ePefbZZ82QIUPMsmXLzNq1a917Pdc9MHoMPdaAAQNMzZo1TdWqVd3iIZoLqTohVK8vCQwAxJOWTG5m4x826trYkSimB6ZZs2Zm0KBB5sUXXzTjx483HTt2NJoX061bNze/onr16m7eC5P4o0nPiRLO1atXm8cee8zMmDEj2FVRANmh97CGaGneiRro+/fvd8N7/bLp+XqP6zGUVGney65du1yoXLotJBIYAIivnycKVh/T8LFLiztIFZLmTyxZssRVTGoIb9682f2sZEW/U+XpK0wSmGjxk2z1PD344INm2rRpRclmvh4/Ob7M3xzP3/ljMn0soCTy7+vU5eyTf85XApP6mFF475HAAEA8acWxW22ULwz1xtyQ7kB94PsJ+r6yUkWln1Ov9JHARJOeFy27ev/997sEJp8NDL1W9Drxewj5Jbe/6G/8/kN+haVM/8a/NgGUPiQwABBPD9loY+M1G/VsvG7j/HQHZlppkMBET8gERknEoUOH3Jj9pUuXuqEmX/T4PhFR75+GJ2qsvZKYL/obJS3qJdQqTBqXn9pwAVA6kMAAQDzdW/j1Zhs/ThQMIbsz3YGZVhokMNHie82WL19uypcvXzSETKGlTuvVq+dWDPKhpbKVBOjvVPFrcq6WYU4+ZujQoe4Y0X1rAnHq/eg1oAUflFSMGTPGrVT0u9/9zlSsWNFN8tUxWq1OKxX5+9FiEC1atHC/V9xyyy3mggsuMPfcc49LflTmBQsWmDZt2hz1WJqnpf9PSY4aLZdeeqn585//bB5//HG3iacWL/DlBRB/JDAAEE+/tjHDxn/YGGZjvY0y6Q7MtNIggYkW3zOhyb3ar2Hv3r1FY9a1spwqeS3MoNAGeRMnTixaclkVv5KPzp07Fx2jmDBhgutJEfWUjBgx4qj7UWhvCm1wqscZN26cS15OO+008/TTT7vH0THao0YrKokeb/bs2W4PIX8fSmBOPfVU91VLQeu+NPdKS3X78uqrNlRVj4v+T5VDS7pedNFFLgnS4z3xxBNuZSYApQMJDADE3zdtnFHcLzOtNEhgosX3tiTPC/FJjRZfULKipEahXoqDBw8eNSlYP/vf+9DGpX5Oir4qmUm9H93ml9bW75TQKJFRj4s/1i/+IHrtaKiZfudXV1LCpZXu5s6d637nh6PpvvX3Otbflxopfi8i/Y0aLkqOtKzsU089ZRYtWhTyaQCQRyQwAFDKZVppkMCUDLmeB5O6ipiSnuOZjJ/89zpWCYtfQMLf/kWPqb9RMqPv1fOkniDmwwClBwkMAJRymVYaJDAAgJBIYAAgnjRsrLaN/2fjdBt/Le7ATCsNEhhERbq9ZHzPThT2qgCQGyQwABBPFWy0tnFX4c9P2Lgp3YGZVhokMIgKzZnZtGmTm0OjJZk1V0aT/lu3bu02ZGWfGCCeSGAAIJ7uK/zqk5YmNmqkOzDTSoMEBlGhnhYtzXzHHXeYMmXKmL/+9a/m5z//uTnjjDPc0s9aRABA/JDAAEA8nZko2MCys40eNtbZ+Fm6AzOtNEhgEBV6PSpJGT9+vBk0aJDbP+ZPf/qTueyyy9xtX7Q5JoCSiQQGAOLr2zautXGDjf+08Y10B2VaaZDAIEr0mlSiotXItDSzXpcKLbGs1cqYCwPEDwkMAMSHEpS6iYKel+RoamN44jjnwHzRMrYkMIii5L1wFIMHD3aNGyU2AOKFBAYA4qWRjZsTBYlMfRtXFUYVG5en+wNtKqjhNwMGDDBbtmxxjUC/EeLWrVuLJkj7lZ1IYBBVfjUyvVb79evnNtbURpjHuzcNgJKBBAYA4uWbhV/vSLn9nEQxk/jr1atnevfubZo2bWpGjhzpkhUlL9qhvXnz5qZOnTpm1apVLqkhgUFJoNepT2CUoLOsMhAvJDAAEE8X2mhj4zYbj9pYbOP6dAeWK1fOTJ8+3QwZMsQlMhs3bnQVgnplevbs6ZKY5cuXuwRGjcERI0aYTp06kcAgknwPTN++fU21atXc63flypWuZ9EnMj70mlak3p68rwyA6CGBAYD4Ot9GSxtdEp+zkeXdd99t5s2bZ0aNGmW6du1q1q5d65amrVu3rqlZs6a59957zYQJE8zhw4fdcJzRo0ebLl26mPXr1wequoDi+cRECcx///d/mx//+MfutazEvEGDBubaa681V155pYurr77aVK1a1axYscIlMUrQ1QOpRQFIYIDoIoEBgFJOCcqUKVPMwIEDXa+L5rwoiVGjTrc3atTILFiwwDXqFLNnz3Y9MyQwiCI1bNTbotfwfffdZ/7whz+YN954wy23rJ7EmTNnmhkzZriYNm2aWbRokfudEhgtvTx8+HCzY8cOEhggwkhgAKCUU+9Ky5YtTfXq1c2sWbNMr169XBKjHpfNmzeb119/3axbt65oqA1zYBB1vhdm06ZNZvXq1S5B8bcpuUkOP7dLr23NAVMiryWYSWCA6CKBAYD4O9vGn4r7pZaZ3b59u0tW/F4afv8MNe727dvnKghWIUNJk8lcFh1HAgOUDCQwABBPlRIFSydfZONfNlolipnE769KJ39NbrwpcUme6EwCgzjS61sLVKjHkQQGiDYSGACIpzKFX4fYeLDw+zvTHegrg+OtNEhgEEc+gfE9MCy9DEQXCQwAxNOvbfS08ZqN7yUK9oApm+7ATCsNEhjEjZ8Do/2ONNFfQylJYIDoIoEBgPhS4vKDwvhGcQdlWmmQwCCutIGrVtrTJq5agW/o0KEuhg0b5kKveQ2nFC25PHHixKJjfKhBpeXGSX6A3CGBAYB40tyXzTYq2Pi2jWY2fpLuwEwrDRIYxJnfsPWFF14wlSpVKorHHnvsqMaSXv/NmjU76hhFnz59GIIG5BgJDADEkybw/9jGTYU/P5AoGEZ2jEwrDRIYxJkSD/XC7Ny502zZssVs3brVhVbpU8+Mfi9a8ELH+N/70Cp+ftU+ALlBAgMA8XRNomD5ZCUwZ9mYZ+P2dAdmWmmQwCDuMu05UbLiQz04PuiBAXKDBAYA4usRG2/ZmG6janEHZVppkMAAR/OJixpSGn6mTWBJYIDcIYEBgHi618Y9x3NgppUGCQxwNL+K2erVq03r1q3NsmXLjkpe/IaaoROa5HL4Mn/RcbkuR74esyTj3ByLBAYA4um3Nv6e9PMJNi5Ld2CmlQYJDHAsvTe0BHO9evXMwoULj/qdemO0wlnoXhk9tubuqCz6qkiXxPjkxm9gm6tyKPz58I9ZXJlKM39eks9XaUcCAwDx9LiNXTbWFsbGRMGKZMfItNIggQGOlZzALFq06KjfaVll7TGjCf4hG+daHW3NmjWup2jt2rVm//79aZMq/bxv3z5X5h07dhQtHZ0tSqDWrVtnNmzY4BZMED2GFkVYuXKle2wa6p85dOiQe760qITOHUhgACCufpQomLyf7NfpDky+0po8Adlf8VP435PAAMfS+0LvEQ0du//++02nTp1cw99fOX/++efNb3/7W1OmTBnTsGFDN8xM7yGtbObfbzNmzDCdO3d2v1O8+OKLpmPHju595hvzS5cuNd27dy86RtG7d2+3+pkvx/Tp04+6H4UaegsWLDDly5c3F154obngggtceapWrWpatWpVdJySB/8+b9u2rbnkkkvM9ddfb+rXr190zJw5c1yDWmXetWuX6dev31GPpZg0aZJLjkT//6BBg9z/439frVo1d9+XXXaZGTdunCu/7ufWW291ZbvnnntM06ZNzeTJk4vuRw331PvR9yNHjnTl8J9fb731lmnXrp37vZbC1tf+/fub7du3F50j7fGjc5Jc5m7durmEyi/GMH/+fNO1a9dj7kdJoJfufvQ3xd2PL7NCCYl/XpVQ9uzZ86j70THqyVPjXM/FpZdeaq688kozbdo0emIMCQwAxNXXbVSzMd7GoEQxw8dEDQM/vCU1adHVUT/cxF+pJYEBjuaHP6mnRclD3759XUPXv4eUKJx66qmuEfrMM8+4xrlvMPv329SpU0379u3d73yoEaseE99YVc+OkqPkY5TQ6Mq8qAxqVKsBn3yMTzxuuOEGc8IJJ5hvfetb5uSTTzb/+Mc/TKNGjYqOUw+ST2AaNGhgzjjjDHPRRReZp556yv1e+94o0dJy0n4ZaX0WJD+W4p133jkq8VDDP/n3FStWND/72c/MaaedZgYPHmw2btzo7ueKK64wp5xyimuo16xZ04wfP/6o+9EeO40bNz7qvoYMGeLOtT+P2ky0RYsWRb9v0qSJSw6SkzyVT+dEv/PHdejQwSUV/n5mzpzpbvP3ocfV/ehc++dD96PnKLk8eg7Vu+SHDc6aNcu89NJLRb/X/SjUu+XvZ8WKFe51k3w/esy5c+e6ZFF7EP3oRz9yoYSNZbpJYAAgrjRc7G0bl9i40EZNG/+V7kDtJq4Glxo9/oqfrmjqqp9CFamuLPux6bqiSAIDfCZ5zsjevXtdKHHxty1ZssQlHupR8HvFaLUy3xDVMUoKdLsPvQf1VffjG7r6XklS8nF6LD/ES8el3o+/L90+YcIE88orr5guXbq4nhu9r5WE+OOShyetX7/eNbzffvttl2DoPvz9+M8ClUePn/p4anT7Bra+6hj//yiUBOjx1aOi7/39qLGv3go1SnWelLyk3o/K6+9LXzXczF+AUejn5P9boXOtMvtzdODAgaPOsQ89H763Wf+n/i75fvT4/n5E5fO/S76f5Oc++X4UKr9Cj+WfV61al1oefa/zqMdT4tqmTRszcOBA15Ok/5cEhgQGAOJICcw1Kbc9lO7Ahx9+2A1L0JXMESNGuKEvqlA1vEVXiHXVVUmL74WZN2+eS2DUwAHwxfS+UaNZDc+QQ3/UsFaDWmXxw8CKowayGujJCZQU930mfKKlz5nkhrg+Y3Jxnkr6cCudFz0X/nyV9P8nG0hgACA+vmmjXmE0sDE06ecOiWKWVb777rvdsLDRo0e7q7NKTPyEWg3FqFu3rhtaokpUQyN69OjhemvogQEAhEACAwDx8rKN+22UTxPfSvcHmjCrHhYlMBrSoaEbSlZ05VXfawKyfu836tMYeI27J4EBAIRAAgMA8XLS5/zuV+lu1ApDmkBavXp1M3z4cDfOWhNYx4wZ4ybYVqlSxU0AZhUyAEAUkMAAQHx8zcaMwu8fSHy2B4xid6KYfWDUy6LJvZqsqwm16mHRCjmqGDQvRgmLxqWzChkAIApIYAAgnv4jUbD6mKfk5qJ0B6oi0ORQP0FUlYGGkOmrEpfU3bJJYAAAIZHAAEDpcWG6GzOtNEhgAAAhkcAAQHxoFbL3E0cPHfOxIVHMELJMKw0SGABASCQwABAvfynm9q/b+EO6X2RaaZDAAABCIoEBgFIu00qDBAYAEBIJDACUcplWGiQwAICQSGAAIP5+ZOPc4n6ZaaVBAgMACIkEBgDi6R82HrVxlo31NrrbuCrdgZlWGiQwAICQSGAAIJ7KFH7tZaNK4fe3pzsw00qDBAYAEBIJDADEk1Yce9XGOzZOs9HAxiPpDsy00iCBAQCERAIDAPF2ko0TP++ATCsNEhgAQEgkMAAQT+fYWJco6HU5NVHQA3NKugMzrTRIYAAAIZHAAEA8PZkoWHnspsKfH7BRLd2BmVYaJDAAgJBIYAAgnm6w8eNEQQKjZZSn2CiX7sBt27aZ119/3QwYMMBs3brVfPrpp65CUMXQvn17M3XqVLN//353OwkMACA0EhgAiKev2XjKxgQbc200tvH1dAc2btzYjB492nTu3NlMmjTJ7N271yUss2fPNnPnzjVNmjQxCxYsIIEBAEQCCQwAxNPvUn4+P1Ewof8Y5cqVM7NmzTJDhw51PTFbtmwxH3/8sTl48KDZuXOnadSokZk/fz4JDAAgEkhgACB+brPRxUb5pGiSKJgHc4x77rnH9bSMHDnS9OjRw6xfv94lMIqePXuafv36uaTmyJEjZvv27aZPnz6mXbt2JDAAgCBIYAAgfrTvi4aO1UsKTeD/UbqD1QMzZ84cM2LECDNkyBA3jGzz5s0uoRk0aJBZvXq1OXTokPnoo4/M4cOHXYXRvXt3l+gAAJBvJDAAEE8/THPbr9MdqORFCUmrVq3MkiVLXBIzbdo007RpU1O5cmVTvXp1M336dJfEaBgZQ8gAACGRwABAPGkOzPs2ZiYKemO22qiQ7kB9+O/atcvs2LHD9bDs3r3bTeLXzxo6pt4Y/fzJJ58wBwYAEBwJDADEk4aM/SnpZ61K9vt0B6pXxc958aFkJTl0G5P4AQBRQAIDAPF0no0HbZxVGGfbuCLdgb4ySI50lYX/SgIDAAiJBAYA4ulhGysSBcPHFNMSBQnNMTKtNEhgAAAhkcAAQDydbOPMlNt+mu7ATCsNEhgAQEgkMAAQTz+xMcXGIzbOSBTMifl2ugMzrTRIYAAAIZHAAEA8PW3jShu3Fv6s4WOPpzsw00qDBAYAEBIJDADE0y02TrJxk40TbAy38Wi6AzOtNEhgAAAhkcAAQDx900ZdG9NtrLLRK1GQyBwj00qDBAYAEBIJDACUHj9Od2OmlQYJDAAgJBIYAIgPbVbZrfB7DR3rkRRv2Cif7o8yrTRIYAAAIZHAAEC8/Kbw669t/NPGVYVxtY0b0/1BppUGCQwAICQSGACIrx8Ufv2PRDHzX+STTz4xn376qYvk7xWqJFIrDRIYAEBIJDAAEE9X2VidKBhWpgn99RLHbmzpHDlyxHz88cfmo48+cqHvfaQmMSQwAIDQSGAAIJ4esPGNpJ/L2qiV7sDRo0ebatWqmfvuu89MnDjRHDx40PXEzJs3zzRq1MgsW7bsqEqDBAYAEBIJDADE0x9t/MPGWTaut7E8UcwcmIceeshMmjTJDBgwwAwdOtRs3769KIGpXLmy++orDPXKzJo1y/To0YMEBgAQBAkMAMTX/9kYmChYgeyO4g4qW7as61VRT0znzp3NunXrXKKinpiGDRuaBQsWuEpBw8l2795t+vXrZ9q3b08CAwAIggQGAOLrjERBD4yinI3fpTtICYx6Wd566y3Tv39/s3nz5qI5MU2aNHHJjSoLJTC6bcaMGaZ79+4kMACAIEhgACCebrYxw8YiGxNszLNxZboD69atazp06GCefvppM2zYMJecKKGZPHmyuffee02bNm3M1q1biyb0MwcGABASCQwAxNO9hV81dExLKP+PjSvSHag5L6oElLBs2bLFLFq0yH1dvHixGTVqlJvYv2vXrqIllklgAAAhkcAAQDxp40rNfznbRl8bY208mu5AJSWqABRKUjRMTF+1vPLhw4dd+N4XemAAAKGRwABAfP00UbAPzM9t3JYo2A/mGJlWGiQwAICQSGAAIJ60B8yziYL5L28mCubEpJVppUECAwAIiQQGAOKpoo2JNq6ycb6NfxZ+f4xMKw0SGABASCQwABBPmsR/fcptdxV+/X7yjZlWGiQwAICQSGAAIJ60ZPJgG/UKo1uiYDK/vq+ffGCmlQYJDAAgJBIYAIinS200sVE+TTyTfGCmlQYJDAAgJBIYAIivE4u5/eTkHzKtNEhgAAAhkcAAQCmXaaVBAgMACIkEBgDiS5P1T7Nxqo1vFXdQppUGCQwAICQSGACIp9/Y2GSjgo0TbDSzcUa6AzOtNEhgAAAhkcAAQDw9kSjoebmp8OcHbNRId2CmlQYJDAAgJBIYAIinv9g4L1GQwOjrAhu3pjsw00qDBAYAEBIJDADE10M2RtiYbOOfxR106NAh8+6775rJkyebnTt3mk8++cTF6tWrzZgxY8zMmTPNvn37XIWh2+fPn08CAwAIhgQGAOLjazbOKib+z8bP0/1R/fr1zfjx402vXr3MO++8Y3bv3m0OHDhg2rRp425v0aKF63X56KOPXAIzd+5c07NnTxIYAEAQJDAAEB/fsLEyUdDjMtvGThsTCmOJjbvS/VG5cuXMrFmzzJtvvmn69+9vNm/ebLZt2+YSmEWLFpm2bdu6RGb//v1m7dq1pnv37qZdu3YkMACAIEhgACBezi/8Wt7G95JuP8tGmXR/cO+995p58+aZUaNGuV6YjRs3mq1bt7okZenSpS5hUQKjYWRHjhwxM2bMcLeRwAAAQiCBAYB40uT9Xyb9XM1G9XQHPvTQQ64HZtCgQWbIkCFm6tSpZvny5aZ58+Zu6FizZs3MtGnTXPLCJH4AQGgkMAAQT1+30drGchtbbbxn4wfpDpwwYYJp2bKleeaZZ8ycOXPMgAED3DwXDSmrVauW+52Gjmn+CwkMACA0EhgAiLeTbPzk8w7Q3BbNedGwMa1ItmfPHnPw4EE3ZGzLli1mx44d5vDhw+bTTz+NVAKjxQY0X0dD3giCIEKEVm78+OOPg34WlkYkMABQyml1MVXA6mFJ/uq/96EKI0oJjBYYGDdunBk9ejRBEESQmD17trvgg/wigQGAUk4VQXKlkBypFYZ6YTTh3y+j7HtlUkO3KwEq7vfZCPUUqddIvUSZhq6cbtq06Uv9bS5DPUoql76GLktJKJdC5Ypy2aJYLv+cRq1s/nUWuhzFPZfpns8PPvjAfdbl6nPueCIfn7dfpWypF8GydZ9KYDRnUyMHdBsJDADEw6mJz/aB+a2Nv6Q7KJMrXn4jS82L0RwZTe6fPn162tCVseJ+Fzo+r9yhQ2WLWvlUnqg+n1Eum8oVtecyNbSqoCJ0OfxzGboMJbGMUfzMyGX5/P3VqFHDaA6n9i3zCRIJDACUbH+zsSzx2T4wk2zcn+7ATBMYXYXs16+f6dy5s+nWrVva6Nq1q6lTp47bS6a4Y0KFyvbcc8+5/W1ClyU1mjRp4pLDTp06uXKGLo8/X4q6detG8vnUVdh69eq5Zb9DlyU19DrTOYvKc+mjQ4cOplGjRu5r6LKkRuPGjU2rVq0+9/MlRLzyyiuRfQ907NjRPP/886Z9+/bBy5Ia/j2Qi/vWZ/jixYvdEDJ6YAAgHh6x8euU285Jd+DxJjDeJzaJ0cT/vXv3Fhu7du1y48NXrFjhhnp93rH5Dk3+f+uttyJZNl0J1xwjDU1ROUOXR6EhMno+x4wZY1atWhW8PKnPpYb0aC7UmjVrgpcnOfTa0jnTkuQqZ5ReaxpCOXHiRLN27VpXriiUTedIr7XJkyebBQsWuMnxocuU/FyqbPrcWLlyZSTOV3IkvweiVjZfD+TqPaA5nKnDnXNfvQIAckV7wNS1cVVh3G7jlnQHZprAHA+Nx9ZcGa1gllq5hKYrdRoGF8WyqUGpxqUmBSdfUQxJz6UaCUqs1IiLEiXTOlcLFy50jaMo0Wsrqu8BDblZsmSJa1RG5XX2SeE8CSV8apBHaWUvPX/+M03JfNToPaBFTfT+jNprTZ8b27dvP2qIV67lrZYFAGTdzTaG2qhXGG1t3J3uwFxUIGoUaenlKDVCPFWiGnIQxbIpUVBEpVEpftJs6jCNqIhy2aL6OtNzqo1p/aTvqPDlymdj93j5zzSVLWpUpqiWzb8H8vlay2M9CwDIsm/YOM3GpTbOK7zt5HQH5qVGAQAgD/JVyQIAsu/7NmbamJEomMT/uo3vpTswdGUDAEC25LGeBQBkySs2TrFRIVGwdLJ3ko170v1BLioQP549eUPM0ENCUssUlSFHfnW31M1DQ58vL7lsUTh3yefL73+hn/2GrKGf1+QypUaUypb6nKZOhi5uH49sSn3tJ4d/TkOes+T/PfWzw+/9Ekryaz65jP62EGVL3pPGny9fHv99Pp7TPNSzAIAsu8TGnTb+buPbSbf/xkbldH+QiwpEq5RpKeDmzZu7FWg0rj10g9yvnqYloLUcqlYU2rdvX9AyiZ8grIpdk9G1jPLgwYPdBOsoUGNj7ty5pmnTpmbIkCFudaiQCZZvVGrissqlCcKzZs0yDRs2dMu1aoPV0A1LrVS1bt06V0atLDd8+HAzYsQIs379+qDzFHTuli1b5sqhsmnlKi1z279/f7Nt27ZjEhgdP2zYMDd5Xcfn4rzqta+J+61bt3avMS2Lq88L3aYFEEImMHqu3n77bVOzZk0zatQo955U2fR60yIImncSip6vLl26uNe9Vm3TwiQq49ChQ82UKVOCLGrh5wnpc0J7tLz66qtuQQa99rXMs/ZwSd2zJRfyUM8CAHLkRzYG2+iRKNgDZmGiYE7MMXJRgSg56NOnj3nttddcY1zLAkfhqr0aYWoYKVTxa+WeKFDZVq9e7RokavBqNaGoTMjVc6c9OVQu7VOjxlIUnks1vp999ln3HCph0BKy2htCSxeHTEyVUOk86bWvZO+FF15w504NSk1oDplcqTGp/Zm0Ca3eA9oHRhsCKnmYPXt20dVxvRaVuCgJ0wUIvS51jnNRdj2eEio9pj4rBg4c6FaueuKJJ1xDPOT7QMmVVgVU0qf9afTaf/fdd02VKlXcvjB6fkPRZ4SWNdfzpPenyqjXmJKFAQMGmK1bt+a9TL73Ra8ZhV5rSqq0r48SQe1To9ddrt8DeaxnAQA5oIn8f7RxnY0TCuMYuahAVGGp0aZGiTZZU+MnClRxquLv3r272/hww4YNoYtU1APTq1cvtyGjKn0lgNrjIArUK6QG7tKlS13Sp6vxoYdCiXrTdFVXjV01vJUc6DkdO3asS1RD0XOpRrgalkpm1KOmjSy1Y7iW4A2ZwKhseu2rMamGea1atdw5VOj51XnUFXT1nOr1OGfOHNdIV8+IznOuEhj1auix9ZjqIVWipcecOXNm0ARGj62yafPeBg0auOSgR48ebgNFPcd6fkPR+VLZVCb1dCgJVO+GztvUqVPd70LQa0TvPyWjel3pXKlHRs+pTwJzLZ+VLAAgO+4r/PoHG+WTolKiYC+YY+SiAtEVaDV0VWnpqpuuxkXFoUOHXHJVv35912gLzScwuoqqRq96FNQI0RCVKFBjREOM9JyWKVPGXbGPwhwdNXxVJjWsRa83vdb0nIbuIdKQMYUauBoGpV4sPacaQqOGZ0hKEMaPH+96V1q0aOF6VypXrmzee++9okRCDc+qVauakSNHumFTOs8aopSL59zPlVAPkN6Tem+qHOq50m2he2CUFPTu3dudM72+KlasaG655RZz2223Fb32QtBrXJ+rjRo1ckPalHiqjD179gw+jNLvmVO7dm33nKoXRheOlMDk45zlp6oFAGTL12w8Ufj9tTa6JT7bB6aBjbvS/VEuKhANH9OVwXfeecddVQ1dofrx/GoYqSLVFVVV/FEaQqbk5fXXX3e9VmrsRqVsvtdKQ1TUQ5SrK/GZlMdPVlaDSPNgdK7US6SeK/WqhUwS/HOpBEZXxdX7qF4MNeYmTpwYtGw6d3379nW9VOpZU++orogrQdFVezWC/TBL9X4oidDznssERu9LJevqedSwOw0F1EUGn8D4YW0hXnM6H0rwdM70utcFGSWjep/6+R2h6LGVZKp3T0PJlGjqPaAkWeUOkcT796Ze7yqP5lepLtBQRT+PTq83hpABAIqjZCZ12eS87QOjq7u6WqnhM7oSp6uYoa+Kq2JVpaqhHxoKpQQrCru3+x4YXanX8BRdFVfipyFSUaDzpnP18ssvu94XzS8JncCoUauy6DWm4VCauKxhTzp3mt+hhCsUNXD1GtOVcA3B0pAtNdzUENb7IuT7QI1e9aapR0FJinpY1OhVI1NDyvQ61FA8JV96Lep1qIRayYSSxFwlMDpPGnaq51DPpZIrnT/N5VC5QiUxmkeinlE9fzoHShR0jpRwKaEJ+R7Va0nDs5RcDho0yCWYSkL1ORJqNT4/iV/Pod6LL730kkuA9XrTOVRPjIZRsgoZAKA459h4N1GQyJyZKFiB7MR0B+aiAlGDQxWVKlNdTU1dojXffAKjHhglLVrBR42PKMzlEN+joLJp2FHohC+ZGkMql55PPZehh4/53jSdIyUqmiuk8umqr15v+jnksCP/GlPZVEadNz2nfgWrkOdOrzGdH5VFDU0loyqbyquy+eFc+r3Op36vIWejR4/O2fwdPZd6Xen+9Zgqn35WGfzCB6GWBdZj63nU60rhd7vX7YqQ71E9lyqbf/7Uc+Y/a0Mt2e0n8eu502esyqdzpp9VTr2eWEYZAPB5NOflN0k/32HjsXQH5rIi8XtJ5Krhk26vjc+L4vbniEJEuWxRjtT9c6IQ6fY0iWKkK59f0lsNdDU+1eugxqe+z+f/krpfTehzVVyEvtAQei5aOsmf+8mf/7mqC1LlpYYFAOTEDYmCXhj5vo3hNh5Nd2DOa5Mc0XAYDYPRpG2CILIbGjKm0FAp/72GToUuV9RC85xCrfiF9PJVyQIAsk9DxxramGNjo41ONr6V7sDQlc2XpTHfmrTtV3wiCCI7oXlE6SJ0uaIYfnNGREce61kAQJbdaOPm4zkwdGUDAEC25LhuBQDk0JU2bkq57aJ0B4aubAAAyJbcV68AgFx52MYuG2sLY4ONCukODF3ZAACQLXmsZwEAWfZTG79L+lnzX/6U7sDQlQ0AANmSlxoWAJAzl9noaKNJ4ugllY8SurIBACBb8lbDAgCy7g82JiQKlk4uZ6Opjd+mOzB0ZQMAQLbksZ4FAGRZeRvfTLnt4XQHhq5sAADIltxXrwCAXPmLjWsLvz/fRksbt6U7MHRlAwBAtuSrkgUA5EY1GwsTBSuQ1S7uoNCVDQAA2ZK3GhYAkBOn27jDxv/ZOKG4g0JXNgAAZEvealgAQNb90cYHNl638bKNgYmChOYYoSsbAACyJY/1LAAgy2rYKJv08zds3JXuwNCVDQAA2ZKXGhYAkBNnJD5LWL5m41Ibf7fxbRs3JB8YurIBACBb8lvVAgCyScsob7WxNk30TT4wdGUDAEC25L22BQBkzXds/KKY3/0y+YfQlQ0AANmS++oVAJBLdWxstDHPRpXiDgpd2QAAkC15q2EBAFl3q416Ns5OFMx7uS6RMvfFC13ZAACQLXmsZwEAWXZHys8n2ngs3YFftbL497//nY06BwCAL011kSL31SsAIFf+y0bzRMFSypVsTLdxcboDv2qF8emnn5qZM2eaUaNGEQRBEESQWLx4sdm3bx8JDACUcH9IFCQx2sjyT8Ud9FUTmI8//tjs37/f7N2711Ue+p4gCIIg8hWqew4cOGA+/PBDEhgAKME0af/R4znwqyQwPokhCIIgiJCh0QCKHNetAIAc+rON2jauKoxrEgUbWR7jqyYwAABERd5qWQBA1t1jY6qNHoUx2Mb96Q4MXdkAAJAt+atmAQDZ9A0bZ9j4ScrtqT87oSsbAACyJec1LAAg6861sd6GPsS7Hs8fhK5sAADIlpzWsACAnGiVKBg+dpaNzjZ+8UV/ELqyAQAgW3JcxwIAcuCZpO9/beNXKT8fI3RlAwBAtuS0hgUA5ER/GxMKY46Ndwu/f89GhXR/ELqyAQAgW/JW2wIAsubJxGdLJyfHX22USfcHoSsbAACyJR8VLQAgu07O9HehKxsAALIlR3UrACBKQlc2AABkS+g6FQCQB6ErGwAAsiV0nQoAyIPQlQ0AANkSuk4FAORB6MoGAIBsCV2nAgDyIHRlAwBAtoSuUwEAeRC6sgEAIFtC16kAgDwIXdkAAJAtoetUAEAehK5sAADIltB1KgAgD0JXNgAAZEvoOhUAkAehKxsAALIldJ0KAMiD0JUNAADZErpOBQDkQejKBgCAbAldpwIA8iB0ZQMAQLaErlMBAHmQ68rk3//+t4t0t0dRVMrly5H6NbTkckSlTMWJevmiqLj3ayhRe/17USpPlN+TIV5PoetUAEAe5LIi+fTTT81HH31kPv74Y/PJJ5+4n/XVh37ON18GlUll8+XwFW1y+fJd8erxfPmSz1uo8qSWzZ83RepzGaJsqWXwZUv+OQrnLrWcoV77XvJzmXxuks9hVM5X8mdHSMnvTV+uqCQLKlfy51ro13sy/1nmP8/yUb7QdSoAIA9yVouYzxpK27ZtMwcOHDAHDx40q1evNitXrnQ/+8Qhn/SYhw8fduVYtGiR2bVrl/nXv/5lli5dapYsWWI2bdrkfh+igaLH27Fjh1m+fLkr3/79+13Fv27dOrN27Vpz6NChvJYnmc6HyrF48WKzfft2V64PP/zQ7N27130N8Vz6Btvu3bvNihUr3HO4b98+VzY9j3qdqXyhG5s6X3q9q7wbNmwoev2HKpMeV+fkyJEj7nzpe1H59Drbs2dP0PPlPydWrVrlzpNPmEOfL72udH70OaGv+pyIAp0bvc71utI50+dG6ITP02tKn7H6TNNnm84ZCQwA4CvLRQXir1YqZsyYYR5//HEzZ84c061bN9O6dWszcOBAs2XLliBXClUmNSjffPNN06JFC/PKK6+4crVt29Y8++yzpkuXLq7xG6ps8+bNM6NHjzZPP/20mThxohkyZIjp0KGDGT9+vGukhKLG0bBhw0yvXr1My5YtXSLTpk0b91zu3LkzWG+aYs2aNWbEiBHu+dNXnavu3bu786iyhboircd85513TOXKlc3cuXPN9OnTzauvvmpefvllV7YPPvggWKNcyXDv3r1Np06dzMaNG915fO+990yZMmXc6y5kA7hPnz5mwIABpnbt2ubdd991ZQ3dIPcJTM2aNU2dOnXM4MGD3WsrCvQa8u+BevXqmbFjx7okJgqUIHft2tV9zuqzXxcacv1chq5TAQB5kIsKxF8Znzp1qunbt6+pVKmSGTlypGnYsKFrnCxYsMBVbKEavbryrCuoauQq/NXBF154wTU4VfmHSmDUWNPV57p165rJkye7RlyPHj3M/Pnz3dXoUHTOlNiNGjXKJXk6fyrXoEGDgjfk1LDU60nJlRLTGjVquO+VMChJCDkccP369eaZZ55xCbwShjFjxrhk8MUXX3RX8kOVTedswoQJpmPHjq7xqzKpfA8//LCZOXNm0IShefPm7rlTkqfXly52hOyBET9ES8+lLnioJ833XEWBnk99bnXu3NldaFCvZBTotaXERQl8o0aN3OcYCQwA4CvLRQWiil7DUJ577jlX2T/yyCPuSq8q/6FDh5oGDRq4nhlVuvmmylMND/UgKGFRo00NJA0/at++vfuaPC8mn3yjV70w9evXN1OmTDEVK1Z0V3ubNGniGpahGk0qmxpt6g1SD4Ia5nouhw8f7oaIhKZhijpnSpTvvfdel8A0bdrUNdJDDNfyz6USPyXuasApIa1Vq5YrZ4UKFdxtoRIYPe7ChQvdlXENO1Iio4sNer0pCdQwrlD0PlRPx1NPPeVea3rdRWHOkD6v+vXr53oeVUYNPY0SvQeULMyePTvIZ2s6SkSVkC5btsw0btzYfbaRwAAAvrJcVSJqaKthpN4EXRFXoqAK7P333zft2rVzvTOaO5FvPoFRT8esWbPckAs15NTY1RXfKMxNUBk0dEwNSg2/U+Lir96HGkamsun50vA7Db3TOVNDV6HbQi7IsHXrVpcU+6GJavxOmzbN9a4pyVKCFSJJ8JOWlXz6HjT1dKicSp51dToEXzbNAfMJjOY3qTxKsDSETIlXKHo9qVdUvQl6T+r5C53A+AVJdGFGPZH6vNBFkCjQe0CveyXGer2r1zH0kDtPFzqU7Km3kQQGAJA1uaxIVLGqIaSKSw1KDTnS0Cj9rAotRG+CyqSyqBH+4IMPugacrtr7BknohpJ6DjTGXlefNSdBPVgaRqbeKzU4Q5VPQ8aUeGpujq5AqyGuOSd33XWXefvtt4P1cuj5VDJw8803u94DnT9dhVYSU758eTcfRslqqARGw3luuOEGU716dXdl/KWXXjJVq1Y1kyZNCjoJXM+XnsdbbrnFzctR0qAEVcmWEnud11A070XvRz2PSq6UOIRukOu5VC+CyqXnT+8FJTJRoOdK5+rOO+90Fzw0TFdDYqNAPXkaOvbEE0+4MipRJoEBAHxluaxIfANTVwfVYNK4bFVgumKuxluIRonKpEpVjQ/1DqlMumKp4RcqU+ilijWfROdIw2b8OdNQFU20DtFj5akRqTLoKr1fTUjlUqPOzzPJN7/09ebNm11CpedTrzWdQ50/JV1+la1QyZXvTfCre6lcOo8hkqrksumc6D2gSdX+/ajbdP70/gj5PtB50nvAJ1WhlwX2z6WeM/Uo6D2gXqGQSV4yfY76Vff0HtDzGZUhZCqbPlv1+vfPJwkMAOAry2lNUih5M7PQk3E9PyzEly0qG/ilK1dUzplf9Su5XFEoW3JZovacpp6nKJwvryS8B6IkSq/5VCWhbPkqV+g6FQCQB3mpUQAAyIPQdSoAIA9CVzYAAGRL6DoVAJAHoSsbAACyJXSdCgDIg9CVDQAA2RK6TgUA5EHoygYAgGwJXacCAPIgdGUDAEC2hK5TAQB5ELqyAQAgW0LXqQCAPAhd2QAAkC2h61QAQB6ErmwAAMiW0HUqACAPclmRpO6Q/vHHH5tPPvmkKELsGK1yJJfBh8qm34WUbtd2X67QO2z78qQ7d4rQ5y61bCpvyLKlPr4/f1GR/L6MwvOXLLlMyecvlOTnMvTnVzrJr7Ooli35czbX5QtdpwIA8iBntYgpaIhs2rTJtGzZ0sydO9f07t3bPP300+bVV181W7duDVLR+qTgo48+Mn379jVz5swxe/fuNe+884558803zY4dO/JanmQ6F++9955p0KCBadiwoVmxYoV54403TK1atUybNm3Mhg0bgjVM9Ljr1q0zXbp0MatWrTIjRoxw5Xr88cdN8+bN3e9Clm3p0qVm4MCB7hwNGzbM1KxZ0zRu3NisWbPGPd/5Lpse7/Dhw6ZPnz7mmWeeMd27dzdbtmyJRMNSZVi/fr2pW7eueeyxx0zHjh3d+zQKZRP/HmjUqJFZuXJlkOcvmU9g9Bpv3bq1efLJJ83o0aPN/v37g5Upmcq2fft20759e/Pcc8+ZhQsXunMWBUeOHHGf99WqVTP9+/c327ZtI4EBAHx1OatFrEOHDpkXX3zR3H777Wbw4MGmXbt2ZurUqa6SnTZtmksi8s0nMOPHjzfly5c3I0eOdI23tm3buvLp+1BUqe/atcts3rzZNGvWzMycOdPUqFHDjB071jXGFyxYELQhp0ZblSpVzPvvv2/27NnjGuRvvfWWeeWVV8y//vWvYGXT86lkVEmfGrxqzG3cuNE0adLEvPvuu+51GCKBUWNNz+OUKVNM06ZNgz9/yWVTctyhQwf3GlPSroZmFMomH3zwgXsP6PnUBQZ9TkQhgdm9e7dLkJctW+YuKCxfvjxYmZLp9a+LQ2PGjHHvUSUKOn9RoPeAzpXeA7rQsXjx4pw/l6HrVABAHmS78vCVvRqNAwYMcJWqrkArgVFPjBpxurI6YcIEd4U635TAqDLVlXH1IEycONFdSdVtvXr1cg3fUHTufO+QehCU7LVq1cpdvVSo4RTSgQMHzPPPP2/mz5/vnmM9f0r6lIyGSBI83wOjBrka5jp/ej5VVl2NDtEA1uMdPHjQlUFJn5Ip9VxFJUlQb4JeY1WrVjWTJ082+/bti0zZ9B5QQvXss8+694Cev9BD3PR6Vzk+/PBD8/bbb7tehZAXO5Lp3ChRnj17tutZU0+M3gdRoM97fYbp/amLMLr4kWuh61QAQB7kogJRhaqrleppefjhh83ll1/uKtiuXbuabt26mYoVK7or4yGu+qohol4XNdyuuuoq17hUw1KVv67iRyGB0VA2JXy6iqor9yqvGpv6qkZxyPKpIe4TGD2Hej41TCv0uHs1yDt16uR6YFQWDQtUw2ncuHEuQQ2RwOj5e+GFF9zzpgR00qRJ7jUfmsqmhriujut136JFC7No0aLgSYKncug9MHToUFfG0AmMf18qdL504WP69OlBepDT0bnR+1LDdPWaUwITld4hXUAggQEAZF2uKhE/LlsJge9NUCNTjTkNDdFQAh2Tb6rs1aBVw8g3LjVsSz0xmt+hMoai8zF8+HDXoFTvlSp9jbdXY0nDLzTsLUSvlaekVPMm1OOi3hjNUwiViCbTY6sBrudTDaYlS5a457FOnTquBzBUAqOr4f+/nTtWkauO4jg+r5AX0DxAfId0PoK1JI1gIz5FEIQUImKxXTRYLFospDGFFpFIAkZsUqTJKwh2es/oxS1k0pxz7j3j5wM/ErHIn9nZ3fnOnZm4AhNfv4j5uCq0hwe96+0Vi/t/RHJc3dvLFZjLy8vj98DDhw+PVxK2vLoX1qvKcZY7d+4cb6/4eRGRvAdxtrh6HLdb/PngwYPjewz3YH0JWXwPdL0MduvfqQA0qPxFsj5zGfESzwzGs5fx5u94sBRXErZ81j7+3Xg2MN67EaEVD3TjdeTxoDP+3xbnin8zXvMfD0DiJSpPnz49vv8lno2ORQxu9Uz0+gEDFxcXxw88iGd440Fc3HZbi/tRXN2Ir1+Ecfw9nr2/uro63u+2eglZxGa8VDI+VCBedhQP5vZylSOuVEW8RCjH90G8hGwvZ4ufF/FAPBY/M7Y+2/pzLN7/Eldp4z1fcf/a8gM/rovbJr4P4/1o8f6X+N6MK2x7EE9uPH/+/Pi9GD/PIvqqP1Vu69+pADQo+y3y57/PXEasxC+yeCY8foHF37f+2OL1AWb8ol/PFlcY1qsJWwVMnCneIB9niTPFlY7477jdtvxkofU9Heu54pxxti2uov2X9XaKZ+vjfPH3+HO9r23xaXdx28S54msXf259peq6uN/HueLrGbfZ1m+Uvy7uZ/H1W7+e68+KLZ/siK/l9dts6+/H69azRejFbRbfm3uJ0TjH+jNtvZ9Vn23r36kAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPT6bdmFmVnxPlv2xQ7OYXZqny67v4Nz2PntctnHByBFBMxtM7PiPV727g7OYXZq8SDzvR2cw85vXy776ACk+H3rAwD/C6+X3dj6EPAGT5bd2voQnKVPln2w9SHgXAgYoIOAYQIBQxUBA4kEDNBBwDCBgKGKgIFEAgboIGCYQMBQRcBAIgEDdBAwTCBgqCJgIJGAAToIGCYQMFQRMJBIwAAdBAwTCBiqCBhIJGCADgKGCQQMVQQMJBIwQAcBwwQChioCBhIJGKCDgGECAUMVAQOJBAzQQcAwgYChioCBRAIG6CBgmEDAUEXAQCIBA3QQMEwgYKgiYCCRgAE6CBgmEDBUETCQSMAAHQQMEwgYqggYSCRggA4ChgkEDFUEDCQSMEAHAcMEAoYqAgYSCRigg4BhAgFDFQEDiQQM0EHAMIGAoYqAgUQCBuggYJhAwFBFwEAiAQN0EDBMIGCoImAgkYABOggYJhAwVBEwkEjAAB0EDBMIGKoIGEgkYIAOAoYJBAxVBAwkEjBABwHDBAKGKgIGEgkYoIOAYQIBQxUBA4kEDNBBwDCBgKGKgIFEAgboIGCYQMBQRcBAIgEDdBAwTCBgqCJgIJGAAToIGCYQMFQRMJBIwAAdBAwTCBiqCBhIJGCADgKGCQQMVQQMJBIwQAcBwwQChioCBhIJGKCDgGECAUMVAQOJBAzQQcAwgYChioCBRAIG6CBgmEDAUEXAQCIBA3QQMEwgYKgiYCCRgAE6CBgmEDBUETCQSMAAHQQMEwgYqggYSCRggA4ChgkEDFUEDCQSMEAHAcMEAoYqAgYSCRigg4BhAgFDFQEDiQQM0EHAMIGAoYqAgUQCBuggYJhAwFBFwEAiAQN0EDBMIGCoImAgkYABOggYJhAwVBEwkEjAAB0EDBMIGKoIGEgkYIAOAoYJBAxVBAwkEjBABwHDBAKGKgIGEgkYoIOAYQIBQxUBA4kEDNBBwDCBgKGKgIFEAgboIGCYQMBQRcBAIgEDdBAwTCBgqCJgIJGAAToIGCYQMFQRMJBIwAAdBAwTCBiqCBhIJGCADgKGCQQMVQQMJBIwQAcBwwQChioCBhIJGKCDgGECAUMVAQOJBAzQQcAwgYChioCBRAIG6CBgmEDAUEXAQCIBA3QQMEwgYKgiYCCRgAE6CBgmEDBUETCQSMAAHQQMEwgYqggYSCRggA4ChgkEDFUEDCQSMEAHAcMEAoYqAgYSCRigg4BhAgFDFQEDiV4uu2lmVrxny97ZwTnMTu3Rsts7OIed3+4tu3sAUvy07LGZWfG+XXa1g3OYndpXy77ZwTns/Pb1svcPQAovIQMAqOUlZJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJBIwAAA1BIwkEjAAADUEjCQSMAAANQSMJDo5bKbZmbFe3sHZzB70+J++tYOzmHnt3vL7h6AFBEwr8zMivfLshc7OIfZqf34z7Y+h53fvjsIGEjjJWRAh9fLbmx9CHiDJ8tubX0IzpKXkEEiAQN0EDBMIGCoImAgkYABOggYJhAwVBEwkEjAAB0EDBMIGKoIGEgkYIAOAoYJBAxVBAwkEjBABwHDBAKGKgIGEgkYoIOAYQIBQxUBA4kEDNBBwDCBgKGKgIFEAgboIGCYQMBQRcBAIgEDdBAwTCBgqCJgIJGAAToIGCYQMFQRMJBIwAAdBAwTCBiqCBhIJGCADgKGCQQMVQQMJBIwQAcBwwQChioCBhIJGKCDgGECAUMVAQOJBAzQQcAwgYChioCBRAIG6CBgmEDAUEXAQCIBA3QQMEwgYKgiYCCRgAE6CBgmEDBUETCQ6NWym2ZmxXu27J0dnMPs1B4tu72Dc9j57f6yDw9Aij8Of0eMmVnlfl72YgfnMDu175f9sINz2Pnt12WfHwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYE/+AgHc2l48KSfHAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_329" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_05 pdf24_06 pdf24_94" style="word-spacing:-0.023em;">Figura 8. Curva de Kaplan-Meier de la PFS en DUO-E (Pacientes con estado de tumor dMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:28.4758em;top:7.4346em;"><span class="pdf24_323 pdf24_06 pdf24_96" style="word-spacing:-0.0412em;">Quimioterapia basada en platino + IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.6958em;top:8.2046em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.0268em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3542em;top:19.3646em;"><span class="pdf24_323 pdf24_06 pdf24_138" style="word-spacing:-0.0131em;">Mediana PFS &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.5358em;top:19.3646em;"><span class="pdf24_323 pdf24_06 pdf24_52" style="word-spacing:-0.0135em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.9642em;top:20.3271em;"><span class="pdf24_323 pdf24_06 pdf24_215" style="word-spacing:-0.0213em;">Quimioterapia + IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.1842em;top:21.1171em;"><span class="pdf24_323 pdf24_06 pdf24_219">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6858em;top:20.3271em;"><span class="pdf24_323 pdf24_06 pdf24_330">NR &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:21.1171em;"><span class="pdf24_323 pdf24_06 pdf24_331">7.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0158em;top:20.3271em;"><span class="pdf24_323 pdf24_06 pdf24_64">(NR-NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.9358em;top:21.1171em;"><span class="pdf24_323 pdf24_06 pdf24_221">(6.7-14.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.3842em;top:21.9071em;"><span class="pdf24_323 pdf24_06 pdf24_246" style="word-spacing:-0.0123em;">Hazard Ratio &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5742em;top:22.6671em;"><span class="pdf24_323 pdf24_06 pdf24_326">0.42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.5358em;top:21.9071em;"><span class="pdf24_323 pdf24_06 pdf24_52" style="word-spacing:-0.0135em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:30.7058em;top:22.6671em;"><span class="pdf24_323 pdf24_06 pdf24_137" style="word-spacing:-0.0206em;">(0.22, 0.80) &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.8617em;top:22.6671em;"><span class="pdf24_323 pdf24_06 pdf24_71" style="word-spacing:-0.0219em;">Quimioterapia + IMFINZI vs.</span><span class="pdf24_323 pdf24_06 pdf24_15" style="word-spacing:0.2939em;">&nbsp;</span><span class="pdf24_323 pdf24_06 pdf24_219">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.8742em;top:25.9371em;"><span class="pdf24_323 pdf24_06 pdf24_210" style="word-spacing:-0.0186em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.702em;top:27.9871em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.0213em;">Nmero de pacientes en riesgo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.4817em;top:28.7671em;"><span class="pdf24_323 pdf24_06 pdf24_210" style="word-spacing:-0.017em;">Quimioterapia basada en platino + IMFINZI &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.4817em;top:30.3671em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.028em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5143em;"><span class="pdf24_55 pdf24_06 pdf24_164" style="word-spacing:-0.0263em;">Pacientes con cncer de endometrio MMR competente (pMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.636em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.2533em;">Entre las pacientes pMMR, las caractersticas demogrficas y basales estuvieron generalmente bien &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.686em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0349em;">equilibradas entre los brazos de tratamiento. Los datos demogrficos basales en los tres brazos fueron los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.736em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0269em;">siguientes: mediana de edad de 64 aos (intervalo: 22 a 86), 48% de 65 aos o ms, 8,1% de 75 aos o ms, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.796em;"><span class="pdf24_14 pdf24_06 pdf24_94" style="word-spacing:0.0043em;">56% blancas, 30% asiticas y 6% negras o afroamericanas. Las caractersticas de la enfermedad fueron las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.846em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0067em;">siguientes: ECOG PS de 0 (69%) o 1 (31%), 47% de nuevo diagnstico y 53% con enfermedad recurrente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.896em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0315em;">Los subtipos histolgicos fueron endometrioide (54%), seroso (26%), carcinosarcoma (8%), epitelial mixto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.956em;"><span class="pdf24_14 pdf24_06 pdf24_36" style="word-spacing:-0.0033em;">(4%), de clulas claras (3%), indiferenciado (2%), mucinoso (&lt;1%) y otro (3%). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.066em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:0.0098em;">Los resultados en las pacientes pMMR se resumen en la Tabla 25 y la Figura 8. La mediana del tiempo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.116em;"><span class="pdf24_14 pdf24_06 pdf24_33" style="word-spacing:0.1008em;">seguimiento en pacientes pMMR censuradas fue de 15,2 meses en el brazo de quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.166em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:0.1245em;">platino + IMFINZI + olaparib, y de 12,8 meses en el brazo de quimioterapia basada en platino. En el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.226em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0366em;">momento del anlisis de la PFS, los datos interinos de OS tenan una madurez del 29% con acontecimientos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.2785em;"><span class="pdf24_14 pdf24_06 pdf24_32" style="word-spacing:-0.0494em;">en 110 de 383 pacientes tratadas con quimioterapia basada en platino + IMFINZI + olaparib y quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3385em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:0.0035em;">basada en platino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4385em;"><span class="pdf24_05 pdf24_06 pdf24_07" style="word-spacing:-0.0217em;">Tabla 28. Resultados de eficacia del ensayo DUO-E (Pacientes con estado del tumor pMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1742em;top:52.5585em;"><span class="pdf24_05 pdf24_06 pdf24_35" style="word-spacing:-0.0672em;">Quimioterapia basada en</span><span class="pdf24_05 pdf24_06 pdf24_15" style="word-spacing:0.6313em;">&nbsp;</span><span class="pdf24_05 pdf24_06 pdf24_36" style="word-spacing:-0.0584em;">Quimioterapia basada &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.9342em;top:53.6085em;"><span class="pdf24_05 pdf24_06 pdf24_38" style="word-spacing:0.0007em;">platino + IMFINZI + &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4458em;top:54.6685em;"><span class="pdf24_05 pdf24_06 pdf24_144">olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1458em;top:53.6085em;"><span class="pdf24_05 pdf24_06 pdf24_279" style="word-spacing:0.0001em;">en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.7958em;top:55.6485em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=191 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.8383em;top:55.6485em;"><span class="pdf24_05 pdf24_06 pdf24_190">N=192 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:56.9382em;"><span class="pdf24_05 pdf24_06 pdf24_194">PFS</span><sup style="top: -0.3297em;"><span class="pdf24_207 pdf24_06 pdf24_190">a,</span><span class="pdf24_70 pdf24_06 pdf24_190">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_118" style="word-spacing:-0.0175em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1558em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0072em;">108 (56.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1858em;top:58.2382em;"><span class="pdf24_14 pdf24_06 pdf24_169" style="word-spacing:-0.0045em;">148 (77.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">62 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_62" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_332" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:8.282em;top:6.1118em;"><span class="pdf24_05 pdf24_06 pdf24_164" style="word-spacing:-0.0237em;">Mediana PFS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_213" style="word-spacing:-0.0375em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.0042em;top:6.1118em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">15.0 (12.4, 18.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:7.4218em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">0.57 (0.44, 0.73) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.5058em;top:6.1118em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0118em;">9.7 (9.2, 10.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9683em;top:7.4218em;"><span class="pdf24_14 pdf24_06 pdf24_15">-</span></div>
					<div class="pdf24_01" style="left:8.282em;top:7.4218em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:8.7318em;"><span class="pdf24_05 pdf24_06 pdf24_301">OS</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_302">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:10.0418em;"><span class="pdf24_14 pdf24_06 pdf24_118" style="word-spacing:-0.0175em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:11.3518em;"><span class="pdf24_05 pdf24_06 pdf24_37" style="word-spacing:-0.0243em;">Mediana OS (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_10" style="word-spacing:-0.0385em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:12.6619em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:-0.0061em;">HR (CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4058em;top:10.0418em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">46 (24.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4483em;top:10.0418em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">64 (33.3) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5542em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_09" style="word-spacing:-0.0008em;">NR (NR, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:12.6619em;"><span class="pdf24_14 pdf24_06 pdf24_196" style="word-spacing:-0.0171em;">0.69 (0.47, 1.00) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.2058em;top:11.3518em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0133em;">25.9 (25.1, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9683em;top:12.6619em;"><span class="pdf24_14 pdf24_06 pdf24_15">-</span></div>
					<div class="pdf24_01" style="left:6.322em;top:13.9718em;"><span class="pdf24_05 pdf24_06 pdf24_326">ORR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_327">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.282em;top:15.2818em;"><span class="pdf24_14 pdf24_06 pdf24_196">ORR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_15" style="word-spacing:0.0086em;">d </span></sup><span class="pdf24_14 pdf24_06 pdf24_333" style="word-spacing:0.0144em;">n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.322em;top:16.5918em;"><span class="pdf24_05 pdf24_06 pdf24_277">DoR</span><sup style="top: -0.33em;"><span class="pdf24_70 pdf24_06 pdf24_328">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:27.4058em;top:15.2818em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">90 (61.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.4483em;top:15.2818em;"><span class="pdf24_14 pdf24_06 pdf24_229" style="word-spacing:0.0061em;">92 (59.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.282em;top:17.9018em;"><span class="pdf24_05 pdf24_06 pdf24_164" style="word-spacing:-0.0269em;">Mediana DoR (meses) (CI del 95%)</span><sup style="top: -0.33em;"><span class="pdf24_207 pdf24_06 pdf24_48" style="word-spacing:-0.0426em;">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:26.1742em;top:17.9018em;"><span class="pdf24_14 pdf24_06 pdf24_78" style="word-spacing:-0.0138em;">18.7 (10.5, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.5058em;top:17.9018em;"><span class="pdf24_14 pdf24_06 pdf24_10" style="word-spacing:-0.0118em;">7.6 (7.1, 10.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.232em;"><span class="pdf24_41 pdf24_06 pdf24_118" style="word-spacing:0.01em;">a Evaluada por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1745em;"><span class="pdf24_41 pdf24_06 pdf24_86" style="word-spacing:-0.0041em;">b Los resultados se basan en el primer anlisis interino (fecha de corte de datos: 12 de abril de 2023). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1345em;"><span class="pdf24_41 pdf24_06 pdf24_15" style="word-spacing:-0.0045em;">c Calculado usando la tcnica de Kaplan-Meier. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.1045em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:-0.0092em;">d Respuesta: Mejor respuesta objetiva como respuesta completa confirmada o respuesta parcial. Basado en el nmero &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0645em;"><span class="pdf24_41 pdf24_06 pdf24_153" style="word-spacing:0.2176em;">de pacientes en el brazo de tratamiento con enfermedad medible al inicio del ensayo (N=147 en el brazo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.0245em;"><span class="pdf24_41 pdf24_06 pdf24_82" style="word-spacing:-0.0008em;">quimioterapia basada en platino + IMFINZI + olaparib, N=156 en el brazo de quimioterapia basada en platino). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9845em;"><span class="pdf24_41 pdf24_06 pdf24_35" style="word-spacing:-0.0027em;">CI=Intervalo de Confianza, HR= Razn de Riesgo, NR=No Alcanzada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.9843em;"><span class="pdf24_05 pdf24_06 pdf24_83" style="word-spacing:-0.023em;">Figura 9. Curva de Kaplan-Meier de la SLP en DUO-E (Pacientes con estado de tumor pMMR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4742em;top:28.9671em;"><span class="pdf24_323 pdf24_06 pdf24_32" style="word-spacing:-0.0269em;">Quimioterapia basada en platino</span><span class="pdf24_323 pdf24_06 pdf24_15" style="word-spacing:0.2088em;">&nbsp;</span><span class="pdf24_323 pdf24_06 pdf24_57" style="word-spacing:-0.0034em;">+ IMFINZI + olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.6958em;top:29.7471em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.0268em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2758em;top:31.6671em;"><span class="pdf24_323 pdf24_06 pdf24_138" style="word-spacing:-0.0156em;">Mediana PFS &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.4458em;top:32.4471em;"><span class="pdf24_323 pdf24_06 pdf24_326">15.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2783em;top:31.6671em;"><span class="pdf24_323 pdf24_06 pdf24_52" style="word-spacing:-0.0135em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.5083em;top:32.4471em;"><span class="pdf24_323 pdf24_06 pdf24_334">(12.4-18.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6783em;top:33.2271em;"><span class="pdf24_323 pdf24_06 pdf24_221">(9.2-10.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.3642em;top:32.4471em;"><span class="pdf24_323 pdf24_06 pdf24_210" style="word-spacing:-0.0222em;">Quimioterapia + IMFINZI + olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:33.2271em;"><span class="pdf24_323 pdf24_06 pdf24_219">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6058em;top:33.2271em;"><span class="pdf24_323 pdf24_06 pdf24_331">9.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2458em;top:34.0188em;"><span class="pdf24_323 pdf24_06 pdf24_246" style="word-spacing:-0.0148em;">Hazard Ratio &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.4358em;top:34.8488em;"><span class="pdf24_323 pdf24_06 pdf24_326">0.57 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2783em;top:34.0188em;"><span class="pdf24_323 pdf24_06 pdf24_52" style="word-spacing:-0.0135em;">(CI del 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.4583em;top:34.8488em;"><span class="pdf24_323 pdf24_06 pdf24_137" style="word-spacing:-0.0206em;">(0.44, 0.73) &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.4542em;top:34.8488em;"><span class="pdf24_323 pdf24_06 pdf24_195" style="word-spacing:-0.0239em;">Quimioterapia + IMFINZI + olaparib vs. &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:35.5488em;"><span class="pdf24_323 pdf24_06 pdf24_219">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.1942em;top:47.417em;"><span class="pdf24_335 pdf24_06 pdf24_49" style="word-spacing:-0.0183em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.6417em;top:48.8613em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.0211em;">Nmero de pacientes en riesgo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.4217em;top:49.7413em;"><span class="pdf24_323 pdf24_06 pdf24_71" style="word-spacing:-0.0223em;">Quimioterapia basada en platino</span><span class="pdf24_323 pdf24_06 pdf24_15" style="word-spacing:0.2092em;">&nbsp;</span><span class="pdf24_323 pdf24_06 pdf24_57" style="word-spacing:-0.0046em;">+ IMFINZI + olaparib &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.4217em;top:51.3413em;"><span class="pdf24_323 pdf24_06 pdf24_74" style="word-spacing:-0.0268em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5985em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0154em;">En las pacientes pMMR, los HR de la PFS fueron 0,44 (CI del 95%: 0.31, 0.61) en pacientes con expresin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6485em;"><span class="pdf24_14 pdf24_06 pdf24_83" style="word-spacing:0.0105em;">positiva de PD-L1 (236/383; 62%) y 0,87 (CI del 95%: 0.59, 1.28) en pacientes con expresin negativa de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7085em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:0.2005em;">PD-L1 (140/383; 37%), para el brazo de quimioterapia basada en platino + IMFINZI + olaparib en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.7582em;"><span class="pdf24_14 pdf24_06 pdf24_07" style="word-spacing:0.0243em;">comparacin con el brazo de quimioterapia basada en platino. La expresin positiva de PD-L1 se defini &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">63 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_63" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0239em;">como la positividad del rea tumoral (TAP) </span><span class="pdf24_20 pdf24_06 pdf24_15" style="word-spacing:-0.0271em;"> </span><span class="pdf24_14 pdf24_06 pdf24_102">1%. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:8.1208em;"><span class="pdf24_12 pdf24_06 pdf24_13" style="word-spacing:0.4665em;">14. </span><span class="pdf24_05 pdf24_06 pdf24_61" style="word-spacing:-0.0259em;">DATOS FARMACUTICOS &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:10.1918em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:10.1918em;"><span class="pdf24_05 pdf24_06 pdf24_169" style="word-spacing:-0.0052em;">Lista de excipientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.7518em;"><span class="pdf24_14 pdf24_06 pdf24_72">L-Histidina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.8018em;"><span class="pdf24_14 pdf24_06 pdf24_66" style="word-spacing:-0.0706em;">L-Histidina clorhidrato monohidrato &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.8518em;"><span class="pdf24_20 pdf24_06 pdf24_19">,</span><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:0.0062em;">-Trehalosa dihidrato &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.9018em;"><span class="pdf24_14 pdf24_06 pdf24_58" style="word-spacing:-0.0458em;">Polisorbato 80 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.9518em;"><span class="pdf24_14 pdf24_06 pdf24_181" style="word-spacing:-0.0187em;">Agua para inyeccin &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:18.0118em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:18.0118em;"><span class="pdf24_05 pdf24_06 pdf24_127">Incompatibilidades &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.5718em;"><span class="pdf24_14 pdf24_06 pdf24_119" style="word-spacing:0.0046em;">No aplica. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:21.6243em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:21.6243em;"><span class="pdf24_05 pdf24_06 pdf24_74" style="word-spacing:-0.0176em;">Tiempo de vida til &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.1743em;"><span class="pdf24_14 pdf24_06 pdf24_157" style="word-spacing:-0.0176em;">No sobrepasar la fecha de caducidad indicada en el envase. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:25.2343em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.4. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:25.2343em;"><span class="pdf24_05 pdf24_06 pdf24_118" style="word-spacing:-0.0262em;">Precauciones especiales de conservacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.7843em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0154em;">Almacenar IMFINZI (durvalumab) bajo refrigeracin entre 2 C y 8 C. Proteger de la luz conservndolo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.8343em;"><span class="pdf24_14 pdf24_06 pdf24_50" style="word-spacing:0.0028em;">en su envase original hasta el momento de su uso. No congelar ni agitar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9043em;"><span class="pdf24_14 pdf24_06 pdf24_31" style="word-spacing:-0.0118em;">Para las condiciones de almacenamiento despus de la preparacin de la Perfusin, consultar </span><span class="pdf24_55 pdf24_06 pdf24_37" style="word-spacing:-0.0131em;">Dosis y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9543em;"><span class="pdf24_55 pdf24_06 pdf24_35">Administracin</span><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.0031em;">, Almacenamiento de la solucin de Perfusin. &nbsp;</span></div>
					<div class="pdf24_01 pdf24_11" style="left:6.002em;top:32.0043em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.9517em;top:32.0043em;"><span class="pdf24_05 pdf24_06 pdf24_98" style="word-spacing:-0.0206em;">Naturaleza y contenido del envase &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5543em;"><span class="pdf24_336 pdf24_06 pdf24_22" style="word-spacing:-0.0118em;">Vial de vidrio tipo I de 2.4 ml de concentrado para solucin para perfusin, con un tapn de elastmero y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.616em;"><span class="pdf24_336 pdf24_06 pdf24_31" style="word-spacing:0.0018em;">un precinto de aluminio gris de apertura fcil (flip-off), que contiene 120 mg de durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.666em;"><span class="pdf24_336 pdf24_06 pdf24_96" style="word-spacing:-0.0165em;">Contenido del envase: 1 vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.786em;"><span class="pdf24_336 pdf24_06 pdf24_19" style="word-spacing:-0.0113em;">Vial de vidrio Tipo 1 de 10 ml de concentrado para solucin para perfusin, con un tapn de elastmero y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.836em;"><span class="pdf24_336 pdf24_06 pdf24_21" style="word-spacing:-0.0035em;">un precinto de aluminio blanco de apertura fcil (flip-off), que contiene 500 mg de durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.876em;"><span class="pdf24_336 pdf24_06 pdf24_74" style="word-spacing:-0.0159em;">Contenido del envase: 1 vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">64 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_64" class="pdf24_ pdf24_02">
			<div class="pdf24_46">
				<img src="data:image/png;base64,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" alt="" class="pdf24_337" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_03 pdf24_04">
					<div class="pdf24_01 pdf24_11" style="left:5.742em;top:5.7002em;"><span class="pdf24_12 pdf24_06 pdf24_240">14.6. &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.7017em;top:5.7002em;"><span class="pdf24_05 pdf24_06 pdf24_96" style="word-spacing:-0.0271em;">Precauciones especiales para la eliminacin y otras manipulaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:7.2618em;"><span class="pdf24_14 pdf24_06 pdf24_73" style="word-spacing:-0.0211em;">Ninguna en especial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:10.4119em;"><span class="pdf24_55 pdf24_06 pdf24_149" style="word-spacing:-0.0211em;">IPP Clave: 1-2025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:11.4718em;"><span class="pdf24_55 pdf24_06 pdf24_98" style="word-spacing:-0.0175em;">Fecha de preparacin de esta versin: 11 de marzo de 2025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:12.5318em;"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0446em;">Versin en espaol: VV-RIM-07914859 v1.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:13.5818em;"><span class="pdf24_14 pdf24_06 pdf24_35" style="word-spacing:-0.002em;">Versin en ingls: VV-RIM-07914861 v1.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:15.6818em;"><span class="pdf24_14 pdf24_06 pdf24_18" style="word-spacing:-0.0178em;">Documento de referencia: USPI 12/2024 (VV-RIM-01435135 v24.0), SmPC EMA Jul-2024 (VV-RIM- &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.742em;top:16.7418em;"><span class="pdf24_14 pdf24_06 pdf24_21" style="word-spacing:-0.0092em;">01435067 v35.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:24.5543em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.008em;">MATPROM: PE-2626 Prep: 12-2025. &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:26.6543em;"><span class="pdf24_14 pdf24_06 pdf24_34" style="word-spacing:0.0042em;">AstraZeneca Per SA, Calle Las Orqudeas 675, Interior 802, San Isidro, Lima-Per, tel.: 6101515. RUC: &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:27.7143em;"><span class="pdf24_14 pdf24_06 pdf24_35">20513645547. &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:29.8243em;"><span class="pdf24_14 pdf24_06 pdf24_38" style="word-spacing:-0.0004em;">IMFINZI 50 mg/mL (Per). Registro sanitario: BE-01202. Material exclusivo para el profesional de la salud. &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:30.8743em;"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0007em;">Informacin aplicable a Per. Mayor informacin Departamento Mdico AstraZeneca Per. En caso de evento &nbsp;</span></div>
					<div class="pdf24_01" style="left:4.5em;top:31.9343em;"><a href="https://aereporting.astrazeneca.com" target="_blank"><span class="pdf24_14 pdf24_06 pdf24_22" style="word-spacing:-0.0017em;">adverso ingrese a https://aereporting.astrazeneca.com y seleccione en pas Per, o escriba al correo electrnico &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:4.5em;top:32.9843em;"><a href="https://bit.ly/35p2CRf" target="_blank"><span class="pdf24_14 pdf24_06 pdf24_19" style="word-spacing:-0.0001em;">PatientSafety.Peru@astrazeneca.com. Link de Data Privacy para reporte de eventos adversos: https://bit.ly/35p2CRf. &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:22.8242em;top:62.3404em;"><span class="pdf24_41 pdf24_06 pdf24_42" style="word-spacing:0.0034em;">Pgina </span><span class="pdf24_43 pdf24_06 pdf24_173" style="word-spacing:-0.0151em;">65 </span><span class="pdf24_41 pdf24_06 pdf24_44" style="word-spacing:-0.0141em;">de </span><span class="pdf24_43 pdf24_06 pdf24_45">65 &nbsp;</span></div>
				</div>
			</div>
		</div>
	</body>
</html>
`;